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Abstract
This thesis describes stereoselective synthetic approaches to the bicyclic and 
tricyclic guanidine cores of batzelladines A and C.
Chapter 1 introduces the batzelladine alkaloids, discussing important biological 
properties, literature syntheses and previous synthetic studies within the Elliott 
group.
Chapter 2 describes our key synthetic step, a modified version of the Kishi 
three-component coupling in detail. In addition to studies to determine the 
stereochemistry of this reaction, experimental evidence has been gathered to 
ascertain the reaction mechanism.
Chapter 3 discusses a diastereoselective synthetic route to the western half of 
batzelladine A. The three-component coupling proceeds with total 
diastereocontrol, enabling the bicyclic pyrrolo[1,2-c]pyrimidine core of the 
left-hand side of the natural product to be constructed in an efficient manner. 
The stereoselectivity of this central synthetic step also offers further evidence 
towards the proposed reaction mechanism.
Chapter 4 describes a first-generation synthetic approach towards batzelladine 
C, utilising a novel stereoselective reaction of a chiral A/-acyliminium ion and 
allenylsilane as a key step.
In Chapter 5, the second-generation synthetic route to Batzelladine C is 
discussed. With no requirement for protecting groups, a tricyclic guanidine core 
corresponding to batzelladine C is synthesised diastereoselectively. It is 
anticipated that only a few more steps will be required to achieve the total 
synthesis of the natural product.
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Chapter 1
Introduction to the Batzelladine Alkaloids
1
1.1 The Batzelladine Alkaloids -  an Introduction
In the mid-1990’s, a team from SmithKline Beecham were investigating a range 
of natural product extracts for their potential therapeutic use. Of these extracts, 
several members of a family of guanidines from the Caribbean marine sponge 
Batzella sp. were found to possess a range of interesting and useful biological 
activity, in particular anti-HIV activity.1 Of the 21 compounds isolated, five were 
found to be novel alkaloids with key structural similarities. These natural 
products were christened the batzelladines, and were designated by letters A-E. 
Figure 1 illustrates their structures. Batzelladine C (3) is the only member of this 
initial quintet that has since not been synthesised.
Batzelladine A (1) Batzelladine B (2)
Batzelladine C (3) Batzelladine D (4)
2>P
O u r ©
Batzelladine E (5)
Figure 1
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Two years later, a further four batzelladines were discovered.2 Their structures 
are shown in Figure 2.
o
A
Batzelladine F (6)
O
A
OH
Batzelladine G (7)
OH
Batzelladine H (8)
2X
OH
Batzelladine I (9)
Figure 2
The tenth member of the batzelladine family, batzelladine J, was isolated from 
an extract of the Caribbean marine sponge Monanchora unguifera in 2005 
(Figure 3).3
HoN
3XH
N
Me'
Me
Batzelladine J (10)
Figure 3
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Finally, in 2007, batzelladines K -  N and dehydrobatzelladine C were extracted 
from the same marine sponge, Monanchora unguifera (Figure 4).4
H J  \  xvH
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Batzelladine K (11)
Me O
Me1
Me'
Batzelladine M (13)
Me'v> N N X 9H19 
H
Batzelladine L (12)
R =
NBocx
BocHN N' 
H
Me O
Me1
rC7HMe'
Batzelladine N (14)
Figure 4
N 'CyH7n 15
Dehydrobatzelladine C (15)
As previously mentioned, this family of natural products possess potentially 
significant biological activity; in particular, several members are known to inhibit 
the binding of the HIV envelope gp120 to CD4 cells. The nature of these 
interactions and their implications are discussed in the following section.
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1.2 Biological Aspects of the Batzelladine Alkaloids
As one of the most prevalent diseases in the developing world, AIDS is now 
recognised as pandemic, with an estimated 0.6% of the World's population 
infected by the Human Immunodeficiency Virus (HIV).
The structure of HIV is represented in Figure 5, with the outer layer consisting of 
two types of glycoprotein: gp120, which is implicated in binding to the target 
cells, and gp41, which helps the HIV "dock" itself to the cell.5 Inside the virus are 
the RNA and various enzymes, which will enter and takeover the infected cell.
Lipid
Membrane
Figure 56
As the name suggests, HIV primarily infects the immune system of humans, 
targeting vital cells such as macrophages and helper T-cells (specifically CD4 
cells). HIV infection leads to low levels of CD4 cells by three main mechanisms:
• Direct killing of cells 
• Increased rate of apoptosis (a programmed form of cell death)
• Killing of infected cells by lymphocytes that recognise infected cells
When CD4+ cell numbers drop below a certain critical level, cell-mediated 
immunity is lost, meaning the body becomes highly susceptible to infections.7
gpi2<K
Docking
Glycoprotein
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Reverse /  
Transcriptase
5
HIV enters the host cell by docking to a surface glycoprotein, known as the CD4 
receptor on the cell's surface. This interaction occurs through the gp120 protein 
on the surface of the virus. Upon binding, the gp120 protein undergoes a 
structural change, allowing the virus to bind to further receptors. HIV will then 
become attached to the cell membrane, allowing the HIV RNA and enzymes 
such as reverse transcriptase and ribonuclease to enter the cell.8,9 Figure 6 
illustrates this principle.
4
HIV
CD4-Receptor
Cell membrane
Y Y Y
ReverseTranscriptase
Synthesizes RNA y
into DNA A. A V  Virus RNA
A M A A A
T  Double-
Iniegrase stranded
Integrates viral DNA
DNA into I he — -
cell genome /  ^  _ ..
/  \  SLu,
^  Integration ^  
▼
Transcription 
\  /
/
ViraJ RNA leaves 
the nucleus ▼
Cytoplasm
Translation
Pn?i«ase 
Cuts up 
the protein
▼
Virus protein RNA
Reconstruction 4
N
New virus
O- - 6'
Figure 610
6
A number of drugs are widely available which block this initial entry of the virus, 
known as fusion inhibitors. Two such examples are Maraviroc11 and 
Enfuviritide.12 The latter binds to the gp41 region of the virus and prevents the 
development of an entry pore for the cell.
The Overman group conducted a biological study of the inhibition of HIV fusion 
by a range of batzelladine analogues, including variation of the number and 
nature (bicyclic/tricyclic) of the guanidine rings, absolute configuration of the 
guanidine units, and number and position of substituents. Figure 7 shows four 
examples (compounds 8a-d) from the study and their IC50 values (in pM).13
IC50 (pM)
17.0 ±3.3
7.7 ± 1.5
1.8 ± 0.4
0.8 ± 0.2
The most effective inhibitor, compound 8d, exhibits very close structural 
similarities to batzelladine F.
Me o  o
X X 8a
HO
CqHMe'
Me' NH
Me1
Me'
Me1
0 1 0  8b
8c
8d
Figure 7
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The tricyclic core of the batzelladine family was discovered to be vital in the 
binding of the alkaloid to the glycoprotein, with interactions of the carboxylate 
terminus of an aspartic acid residue to the guanidine implicated (Figure 8).
O
o
©
Asp 368
H H
OH
Tricyclic Batzelladine analogue 
(similar in structure to Batzelladine 
F)
Figure 8
In a later biological study, five members of the batzelladine family, batzelladines 
K, L, M, N and dehydrobatzelladine C (see Figure 4) along with the structurally 
similar alkaloids Ptilomycalin A (16) and Crambescidine 300 (17) (Figure 9), 
were evaluated for their activity against cancer-cell lines, protozoa, HIV-1 and 
AIDS opportunistic infectious pathogens.4
NH
n h 2
'2
Ptilomycalin A (16): R = H 
Crambescidin 800 (17): R = OH
Figure 9
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The evaluated batzelladines were found to be more active against M. 
intracellulare and M. Tuberculosis than Ptilomycalin and Crambescidine, and 
also more active against the malaria parasite P. falciparum.
1.3 Partial and Total Syntheses of the Batzelladines
Since their discovery, there has been considerable synthetic attention towards 
the Batzelladine alkaloids. The leading syntheses published thus far will be 
summarised in the next few pages.
Although the synthesis of a tricyclic unit corresponding to the western half of 
Batzelladine F had been reported independently by Snider14 and Murphy15 
previously, the Snider group published the very first total synthesis of a 
Batzelladine alkaloid.16,17 The key step in their approach to batzelladine E 
involved a condensation of bis-enone 18 with O-methylisourea, constructing the 
pyrimidine core 19 (Scheme 1). The racemic natural product was synthesised in 
nine steps, with a 3% overall yield.
BocHN
CcH5n 11
DMSO, /-Pr2NEt, 
55 °C
NH
O CT R U
MeO NH2
18 67%
BocHN
19
Scheme 1
The Overman group synthesised Batzelladine F enantioselectively, leading to 
structural and stereochemical revision of the natural product.18 The key step was 
a tethered Biginelli condensation of fragments 20 and 21 to establish the eastern 
core (22) of the natural product (Scheme 2). This elegant synthesis was 
achieved in 24 steps, and 1.4% overall yield.
9
BR
Me1
20
OH
HO
©
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x
h2n nh2 
21
C7H1;
Morpholine, AcOH, 
Na2S04, CF3C 02H, 
59%
©
HO
Me'
Me' NH22
Scheme 2
In addition to Batzelladine F, the Overman group used this Biginelli chemistry in 
the enantioselective syntheses of both Batzelladine D19 and dehydrobatzelladine
C.20'21
The first of two Batzelladine A total syntheses to date has been reported by the 
Nagasawa group.22 Their asymmetric, thirty-step sequence (0.03% overall yield) 
utilised a 1,3-dipolar cycloaddition of enantiopure nitrone 23 as a key step in the 
synthesis of the western half of the natural product (Scheme 3).
10
TIPSO y C 02Et
Toluene, 90°C
,,/(CH2)9OPMB
24
Steps
OH
NBoc
NBoc
25
Scheme 3
The Nagasawa group had also previously reported the enantioselective 
synthesis of batzelladine D (the eastern half of batzelladine A is identical to 
Batzelladine D),23 in addition to the synthesis and confirmation of the 
stereochemistry of the left-hand side of batzelladine f .24,25,26
One of the more elegant syntheses to date has been published by Gin et a l27 
Batzelladine D was prepared enantioselectively in 14 steps, with a 5% overall 
yield. Their key step involves an [4+2] annulation of pyrrole 26 (prepared by 
Cp2ZrHCI-mediated reduction of the corresponding lactam) and 
vinyl-carbodiimide 27, establishing the bicyclic guanidine core of the natural 
product with the vital pyrrolidine stereogenic centres in place (Scheme 4).
TIPSO c ° 2 Et
'(CH2)8OPMB
23
11
Cp2ZrHCI
OTBDPS
OTBDPS
26
Bn02C
Me
PMB
27
(CICH2)2, 98%
OTBDPS
Me' NPMB
28
Scheme 4
Earlier studies by the Gin group had resulted in the synthesis and 
stereochemical determination of the western core of batzelladine A,28 
culminating in a total synthesis of the natural product.29
In 2007, Evans and co-workers reported the enantioselective total synthesis of 
batzelladine D (Scheme 5).30,31 The key step involves a stereoselective radical 
cyclisation of compound 29 with tributyltin hydride and triethyl borane in the 
presence of air.
3 U  Y V
Me' N ^ S )i
R
29
R = (1S)-(+)-Camphorsulphonyl
Bu3SnH, Et3B, 
benzene, 0 2
d.r. > 19:1
'W f 'o
9' '19
Me''"
R
30
Scheme 5
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1.4 The Elliott Group’s Approaches Towards the Batzelladines
The group first began to explore approaches to these natural products when 
investigating their own diastereoselective annulations of alkenyloxazolines 
(Scheme 6).32
Et
+ R'NCO
Et
O
Ox
N NR'
'R
O
Ox
N NR'
V - R
C r ' N H R '
31 32 33
Scheme 6
Oxazoline 31 first undergoes a stepwise, diastereoselective formal-hetero- 
Diels-Alder reaction to yield pyrimidine 32 (exhibiting trans relative 
stereochemistry between the substituents across the oxazolo[3,2-c]pyrimidine 
ring), with a calculated structure of the helical transitional state shown.33 The 
other diastereoisomer is not formed, due to unfavourable interactions between 
the isocyanate oxygen and substituent on the oxazoline ring. Further acylation of 
the alkene moiety affords then affords compound 33.
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The structure of compound 33 bears obvious similarities with that of the western 
half of batzelladine A (1) (Figure 10), in particular sharing a fused pyrimidine 
core and a carbonyl group attached to the alkene.
NH
NH
V, N
"X,,
h2n x . n h
T
NH
Figure 10
With alteration of precursor 31 into an alkenylpyrroline 34, one can envisage a 
diastereoselective entry to bicyclic urea 35, with excellent control over structure 
and stereochemistry (Scheme 7). This could provide a very efficient way to 
construct the left-hand side of batzelladine A.
NH
+ RNCO
34
NR"
NHR
35
NH
Scheme 7
Unfortunately, this route proved not to be viable.34 However, the 
three-component coupling used in Kishi’s synthesis of (-)-decarbamoylsaxitoxin 
provides a structurally similar heterocycle.35 This transformation is a trimolecular 
cyclisation of an alkylidenepyrrolidine (37), silicon tetraisothiocyanate, and an 
aldehyde.36 With a chiral aldehyde (38) providing the chiral information for this
14
three component coupling in this instance, thiourea 39a is formed with 
significant diastereoselectivity (9:1) (Scheme 8).
sS ^ ^ C 0 2Me
37
Si(NCS)4
39a:39b = 9:1 OMe
39a
NH
+
OMe
39b
Cyclisation
A . ..Si(NCS)3
GN HS - \ ^ \ ^ c 0 2Me
RCHO
C02Me
40 41
Scheme 835
It was suggested that the reaction involves proceeds by way of intermediates 40 
and 41 (Scheme 8), arising from initial acylation of the alkylidenepyrrolidine by 
the isothiocyanate (this mechanism will be discussed in more depth in Chapter 
Two).
Based on this mechanism, it appeared reasonable that introduction of a directing 
group at the 5-position of the pyrrolidine ring would provide stereocontrol due to 
steric interactions between this substituent and the sulphur atom in the same 
way as previously described (see Scheme 6 and Figure 11).
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C02Me
42
Figure 11
The first synthetic foray within the group was undertaken by Matthew Long 
towards the western half of batzelladine A, using a modified version of the Kishi 
annulation as a key synthetic step . 2 9
This approach constructed the pyrrolidine with a bulky silyloxy group at the 
5-position of the alkylidenepyrrolidine, with steric bulk from the ring-substituent 
influencing the stereoselectivity of the three component coupling.
Alkylidenepyrrolidine 46 was therefore synthesised in 6  steps from glutamic acid 
(43) (Scheme 9).
H02C (') SOCI2, EtOH Et02C
(ii) LawessorTs reagent,
c o 2h ---------------
66%
NH2  toluene, reflux
S
43 44
O
24% (v) TBSCI, imidazole
,, (vi) NaOEt, EtOH, reflux
(iii) 45, NaHC03, reflux
(iv) NaBH4, EtOH
Br
OTBS
NH
• 'k ^C 0 2Et
46
Scheme 9
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For the three-component coupling, compound 46 was treated with freshly 
prepared silicon tetraisothiocyanate and a simple aliphatic aldehyde, 
acetaldehyde. With benzene as the solvent of choice, the optimum reaction 
conditions were three hours at room temperature. Encouragingly, the silyloxy 
directing group conferred some level of stereoselectivity, with a 2.3:1 ratio of 
diastereoisomers 47a and 47b formed (Scheme 10).
Si(NCS)4, MeCHO, 
benzene, rt, 3 h
47a:47b = 2.3:1
47b (27%)46
Scheme 10
The stereoisomers were readily separated by column chromatography, and nOe 
NMR studies carried out in order to determine the stereochemistry of the 
three-component coupling. While the major diastereoisomer showed no 
diagnostic enhancements, a 1% nOe was discovered between the protons on 
the 8 and 9-positions in the minor isomer (47b) (Figure 12).
y\ * 1 % nOe
>H S 
TBSO" l|1
N ^N H
C 02Et
Minor isomer
47b
Figure 12
Based on this initial spectroscopic evidence, the relative stereochemistry of the 
protons across the pyrrolo[1,2-c]pyrimidine ring (positions 3 & 7) in the major 
diastereoisomer was assigned as trans (Figure 13).
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Trans
TBSO NH
Me
OEt
Major diastereoisomer
Figure 13
47a
Following determination of the stereochemistry of the three-component coupling, 
the major diastereoisomer was then converted into the required guanidine (48), 
with concomitant removal of the silyl protecting group (Scheme 11).
TBSO
NH
Me
C02Et
Mel, NH3; 
then NH3, NH4 OAc, 
sealed tube, 80 °C, 48 h
73%
NHo HCOHO
NH
Me
47a 48
Scheme 11
The next synthetic efforts within the group by Stuart Wordingham3 7  concentrated 
on the previously unsynthesised Batzelladine C. The three-component coupling 
again formed a key part of the synthetic approach, with an allyl group as the 
stereochemical directing group. Racemic alkylidenepyrrolidine 50 was 
synthesised in four steps from succinimide (Scheme 12). This route will be 
discussed in more depth in Chapter Four.
N
H
49
4 steps
43% overall yield EtO20
50
Scheme 12
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Experimental studies at the time found that using commercially available 
trimethylsilylisothiocyanate in place of Si(NCS) 4  led to improvements in the 
reliability of the three-component coupling. It was also discovered that 
quenching the reaction with a weakly basic aqueous solution removed the 
silicon-oxide by-products, thus resolving previous problems encountered with 
chromatography.
The key step was then performed with the appropriate aldehyde for the natural 
product (Scheme 13).
Et02C
50
TMS-NCS, CgHnCHO, 
CH2 CI2i rt, 3 h
74%
51a:51b = 2.3:1
Et02C
51a
51b
Scheme 13
As with Matthew Long’s studies, the ratio of diastereoisomers 51a and 51b was 
determined by relative integration of two distinct signals (proton Ha on the 
pyrrolidine ring; Figure 14) in the 1H NMR spectrum. A 2.3:1 ratio of 
diastereoisomers had again been formed.
In the 1H NMR spectra of compounds 47a and 51a, hydrogen Ha is upfield of the 
corresponding hydrogen in the minor isomer. Based on this observation, it was 
suggested that the trans-stereochemistry was again observed in the major 
diastereoisomer (Figure 14).
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Trans
TBSO NH
Me
OEt
Et02C
Trans
47a
Major isomer
Matthew Long 
approach (Batzelladine A)
51a
Major isomer
Stuart Wordingham 
approach (Batzelladine C)
Figure 14
The clean mixture of stereoisomers (51 a & b) was first converted into the 
required guanidine, and then subjected to an intramolecular iodoamination to 
construct the tricyclic guanidine core (Scheme 14). A single diastereoisomer 
(52) was isolated in a 46% yield.
(i) Mel, NH3; 
then NH3, NH4 OAc, 
sealed tube, 80 °C, 48 hEtOoC
51 a & b
(ii) l2, K2 C03, MeCN 
46% (step ii)
Et02C
N N
52
Scheme 14
However, difficulties were then encountered with replacing the terminal iodide 
with the correct length alkyl chain for the natural product (Scheme 15).
52
or C4 H9 C^C-Li CsH,
C6 H1 3 Li, CuBr.SMe2  a 0 2 c ^  ' N _
-X ► l H _ 7  1J>= CH2 OCC 4 H9
Scheme 15
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1.5 Conclusions
Although there are many efficient and stereoselective synthetic routes towards 
the batzelladine alkaloids, there is not yet one method which would allow entry 
into all of the cores of this family.
It is anticipated that with a greater understanding and control of our key step, we 
will be able to develop highly efficient and stereoselective routes to a number of 
the batzelladine family.
Chapter Two will discuss mechanistic and stereochemical aspects of the 
three-component coupling in detail, and how this may be applied to future 
syntheses.
21
Chapter 2
Mechanistic and Stereochemical Aspects of 
the Three-Component Coupling
22
2.1 Introduction
Thus far, the central step to the group's synthetic approaches has been our 
modification of a trimolecular cyclisation first reported by Kishi. 3 5  The three 
components employed are an alkylidenepyrrolidine (53), an aliphatic aldehyde 
and trimethylsilyl isothiocyanate. With a stereochemical directing group placed 
at the 5-position of the alkylidenepyrrolidine, diastereoselectivities ranging from 
2 - 2.4:1 are observed (Scheme 16).34,37
R' R'
C02Et
53
Scheme 16
Et02C NH
R'CHO, TMS-NCS,
54:55 = 2 - 2.4:1
54
NH
+
55
Because of the relatively low diastereoselectivity of this variation of the 
three-component coupling, a more detailed understanding of the reaction was 
required.
The reaction mechanism will inevitably involve initial coupling of two 
components to form an intermediate, followed by reaction with the third 
component.
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2.2 Mechanistic Studies
2.2.1 The First Proposed Mechanism: Alkylidenepyrrolidine &
Isothiocyanate
A mechanism for this reaction was first postulated by the group of Kishi, when 
investigating the stereoselectivity of their three-component coupling.
The mechanism involves initial reaction of the alkylidenepyrrolidine (53) and the 
silylisothiocyanate (56) (Scheme 17). For the required bicyclic thiourea to be 
formed by this pathway, acylation of the pyrrolidine at the A/-atom has to initially 
occur to afford a thiourea intermediate (57). Thiourea 57 then reacts with the 
aldehyde, eliminates TMS-oxide and cyclises to yield pyrimidine 59.
-co ’Et / a n te ,  Et° 2 c
V ii
R
Et° 2 Cy ^ N H
R
59
TMS-<
°)
H ^ R
GN-SiMe3 Et02C-u n h TMSB ° 2C
M . A A _
R ' R
57
Et02C
"Y  R
NH 
R
Et02C t © H E,O20
-  o A s --TMSO
R
58
R
•n jV >HN'^OTMS
Scheme 17
24
The Elliott group have previously studied the asymmetric hetero-Diels-Alder 
reactions of dihydroalkenyloxazoles with isocyanates. 3 2  High 
diastereoselectivities are observed because of steric interactions between the 
isocyanate oxygen and substituent on the 5-position of the oxazoline ring in 
intermediate 60 (Scheme 18).
Regarding the Kishi three-component coupling, one can envisage the 
stereoinduction arising from interactions of the isothiocyanate sulphur and the 
substituent on the aforementioned position in a similar manner. The iminium ion 
(58) could be formed as a mixture of geometrical isomers 58a and 58b (Scheme 
18). Each of these isomers would be expected to cyclise with a high level of 
stereocontrol.
Therefore, according to this postulated mechanism, the overall stereocontrol 
observed during the reaction is reflected by the stereoselectivity of the iminium 
ion formation.
It would appear reasonable to surmise that the Z-isomer (58b) would be less 
favoured then the E-isomer, due to steric interactions between the R group of 
the iminium ion and the alkene moiety of the alkylidenepyrrolidine.
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Scheme 18
In order to provide support for the existence of this particular pathway, it was 
decided that experimental evidence was needed. For the three-component 
coupling to occur via this mechanism, the heterocumulene first has to acylate on 
the nitrogen atom of the pyrrolidine, affording silyl thiourea 61, at an appreciable 
rate at room temperature.
An equimolar amount of an achiral alkylidenepyrrolidine (62)38 and trimethylsilyl 
isothiocyanate (56) (Scheme 19) were mixed at room temperature, and 1H and 
13C NMR spectra of the crude product recorded.
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C02Et Et02C
N=C=S S
NH + Me3Si N N
/ H
6162 56
Scheme 19
The 1H NMR spectrum was then compared to that of the alkylidenepyrrolidine 
starting material.
Encouragingly, no starting material remained, and the protons on the pyrrolidine 
ring had shifted downfield. The alkene CH and NH peaks were no longer 
evident, and unexpectedly no peak at ~ 0  ppm (corresponding to MesSi) was 
observed. These results appear ambiguous, as it is unclear whether the 
isothiocyanate has acylated on nitrogen, or done something else entirely.
No further information could be ascertained from the 13C NMR data, and mass 
spectrometry failed to find the expected molecular ion. A strong peak was seen 
at m/z 264, although a consistent structure could not be deduced from this.
Due to the ambiguous nature of these initial experimental studies, a mechanism 
involving initial A/-acylation of the alkylidenepyrrolidine could not yet be ruled out. 
It was beginning to become apparent that understanding of the regioselectivity 
of electrophilic addition to alkylidenepyrrolidines would be vital to proving or 
disproving the existence of this mechanism.
An alkylidenepyrrolidine is a heterocyclic enamine, with nucleophilic substitution 
taking place either at the alkene p-carbon, or at the nitrogen atom to afford two 
possible regioisomers (63 & 64) (Scheme 20) . 3 9
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A/-substitution 63
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Scheme 20
One such example of the reaction of an alkylidenepyrrolidine with an 
isothiocyanate has been published by the Elliott group . 3 4  During initial studies 
towards the western half of Batzelladine A, the three-component coupling was 
attempted with benzoyl isothiocyanate (Scheme 21). Instead of the predicted 
bicyclic thiourea (65), the C-acylated regioisomer (6 6 ) was formed, with none of 
the /V-acylated isomer observed.
C02Et
+ MeCHO + ph N=C=S
'CH2OTBS
46
Benzene, rt, 3 h
Ph
Me O
+
'c h 2o tbs c h 2o tb s
Scheme 21
65
Not formed
6 6  (36%)
The sole previous literature example of acylation of alkylidenepyrrolidines with 
heterocumulenes (namely isocyanates) was reported by the group of Tronche.40 
Scheme 22 illustrates the reaction of alkylidenepyrrolidine 62 with aryl and alkyl 
isocyanates, affording regioisomers 67 and 6 8 .
O
C 02Et Et02C
R-N=C=0
42 - 47%
N NHR
NHR
+
NH
6867
A/-acylation C-acylation
Scheme 22
Regardless of the nature of the R group used, an approximate ratio of 7:3 in 
favour of /V-acylation was reported, with isolated yields between 42 and 47%. 
The first six A/-acylated regioisomers from the aforementioned paper are 
illustrated in Figure 15. The key alkene CH and NH peaks from the 1H NMR 
data are annotated. These chemical shifts all appear reasonable.41
g r 0 C
EtQ2C ^ .H  ' E tO sC ^H  ' Et02C ^ .H  EtQ2C ^ H
N N N N
T ° T 0
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The reported chemical shifts for the same protons in the remaining three 
A/-acylated isomers are significantly higher, leading us to question the structural 
assignments (Figure 16) 40
75 76 77
Figure 16
After closer interpretation of the results, it was suggested that the chemical shifts 
published for compounds 75-77 were in fact more consistent with structure 78; 
i.e. the C-acylated isomer, with both signals corresponding to the two NH 
protons (Figure 17). The 13C NMR data, which would have allowed 
unambiguous proof of these structures, was not presented in the paper.
Figure 17
We therefore decided to repeat Tranche's experiments, to determine whether 
the correct regioisomers were reported, and to see if the regioselectivity of these 
reactions favoured A/-acylation. In addition to repeating the isocyanates from the 
paper, we also wanted to extend the study to encompass other 
heterocumulenes, particularly isothiocyanates.
30
2.2.2 Acylation Studies 4 2
Firstly, alkylidenepyrrolidine 62 was treated to the conditions described in the 
paper4 0  at reflux temperature in benzene. A 5.2:1 ratio of isomers 79 and 74 
was observed in favour of the C-acylated product. The isomers were then 
readily separated by column chromatography, with isolated yields approximately 
reflecting the crude ratio. Upon alteration of the reaction solvent to chloroform 
and tetrahydrofuran, the regioselectivity still favoured C-acylation, giving a ratio 
of 3.4:1 and 7:1 respectively (Scheme 23).
The reaction was then repeated at room temperature in chloroform. Under these 
conditions, the C-acylated isomer (A) still predominated, affording a 2.1:1 ratio 
of regioisomers. The table in Scheme 23 shows the (crude) ratio of isomers 79 
and 74 for each reaction, with isolated yields in brackets.
PhNCO
NH
reflux, 2  h
62
NHPh
NH
79
+
74
O
A.
Scheme 23
Benzene 5.2 (not purified)
CHCI3  3.4(71%)
THF 7 (not purified)
1  (not purified) 
1 (17%)
1  (not purified)
CHCI3
(rt, 18 h) 2.1 (53%) 1 (20%)
The 1H NMR and melting point data obtained for A/-acylated isomer 74 were 
entirely in line with Tranche's data. Therefore, although the compound has been 
correctly assigned in this instance (Figure 18), the ratio of regioisomers clearly 
disagrees with the reported results.
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Tranche: 6.4 ppm, s
This work: 6.34 ppm, apparent t, J 1.6 Hz
/
Et02C . M  ^  O
-NA N 'Ph Tranche: 7.0 ppm, m This work: 6.95 ppm, broad s
Figure 18
74
Our attention then turned to benzyl isocyanate. At reflux, a 1:1 mixture of 
isomers 80 and 72 was observed. However, upon lowering the reaction 
temperature to room temperature, a ratio of 2:1 favouring A/-acylation was 
formed, therefore the regioselectivity is in line with Tronche’s results (Scheme 
24). The experimental data obtained for the compound 72 also agrees with the 
data reported by Tronche.40
o
BnNCO
NH
62
Scheme 24
Et02C NHBn
NH
80
Et02C
+
72
NHBn
CHCI3, reflux, 2 h 1 (39%) 1 (50%)
CHCI3 , rt, 18 h 1 (13%) 2  (25%)
At this point, we were tempted to speculate that alkyl isocyanates react 
predominately on nitrogen, and aryl isocyanates on carbon.
The next logical step, therefore, was to repeat the reaction of another alkyl 
isocyanate from the paper.
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In our hands, both butyl and cyclohexyl isocyanate were highly unreactive at 
room temperature in pyridine (the conditions reported by Tronche), and gave 
negligible quantities of products.
Butyl isocyanate required highly forcing conditions (sealed tube, 100 °C, 65 h) in 
order for the reaction to go to completion. Even then, the regioselectivity still 
favoured C-acylation, with a 2.3:1 ratio of isomers 81 and 70 observed (Scheme 
25). Cyclohexyl isocyanate proved to be far too bulky to react under any 
conditions, although a 45% yield of the A/-acylated isomer for this reaction was 
reported in the original paper.
C02Et EtOzCv ^ \ Kl^ n-Bu Et02C
/7-Bu NCO
Pyridine, 100 °C, 65 h 
62 81
2.3 (63%)
Scheme 25
1 (19%)
Reaction of alkylidenepyrrolidine 62 with p-tolyl isocyanate at reflux also 
contradicted the reported regioselectivity, producing a 2.3:1 ratio favouring the 
C-acylation (Scheme 26). The melting-point data obtained for compound 82 was 
very similar to that reported by Tronche for compound 77 (Figure 16). Although 
the NH chemical shifts from compound 82 are significantly higher than those 
reported by Tronche for compound 77, our data for compound 77 are entirely in 
line with expectations. We can surmise that in this instance that Tronche has 
obtained the C-acylated isomer as the major product.
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Scheme 26
These initial acylation results are highly perplexing. Whilst benzyl isocyanate 
corroborates Tronche’s findings, predominantly acylating on nitrogen, the other 
three isocyanates preferentially acylate on carbon.
Both of the alkyl isocyanates appear far less reactive than reported, requiring 
elevated temperatures and extended reaction times.
In an attempt to alter the regioselectivity of the reaction in favour of A/-acylation, 
we used two more reactive isocyanates; tosyl and trichloroacetyl isocyanate. 
Both reacted exclusively on carbon, the former requiring just two hours at room 
temperature to go to completion in virtually quantitative yield (Scheme 27).
O
,C02Et Et° 2 CY ^ N H R  B ° 2C'
R—N=C=0 I
NH ------------------------ ► (  NH +
CHCI3  \— /
6 2  R = Tosyl (rt, 2 h) 1  (94%) (83) 0 (0%)
= CI3 C-C=0 (rt, 18 h) 1 (51%) (84) 0 (0%)
Scheme 27
Following on from the acylation studies with isocyanates, we decided to 
investigate the regioselectivity with isothiocyanates.
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The first to be studied was phenyl isothiocyanate. The C-acylated isomer was 
formed exclusively. The isothiocyanate was also far less reactive than the 
corresponding isocyanate, with only a 58% yield achieved after an overnight 
reflux in chloroform.
Benzyl isothiocyanate produced only the C-acylated isomer, and was also 
relatively unreactive compared to the isocyanates.
Butyl isothiocyanate required high temperature in order to force a reaction, and 
still none of the A/-acylated isomer was observed (Scheme 28).
Et02CEtOoC NHR
NH NH
62
R = Ph (CHCI3, reflux, 18 h) 1 (58%) (86) 0 (0%)
= Bn (CHCI3 , reflux, 18 h) 1 (51 %) (86) 0 (0%)
= n-Bu (pyridine, 100 °C, 48 h, 1 (89%) (87) 0 (0%)
sealed tube)
Scheme 29
These further reactions (summarised in Tables 1 & 2) corroborated what was 
now becoming the established trend for acylation of alkylidenepyrrolidines with 
heterocumulenes; regardless of temperature, solvent or reaction time, acylation 
will always occur preferentially on the alkene p-carbon. The only anomaly 
appears to be benzyl isocyanate, whereby reaction at room temperature 
produces a 2:1 ratio favouring A/-acylation.
It was then hypothesised that by deprotonating the alkylidenepyrrolidine prior to 
addition of heterocumulene, we could make the nitrogen more nucleophilic, 
therefore more susceptible to acylation at that site.
Pyrrolidine 62 was therefore stirred with 1 equivalent of sodium hydride, followed 
by addition of 1 equiv. of heterocumulene (PhNCO, BnNCO or PhNCS). The 
results were highly surprising. Along with an increased proportion of C-isomer, a 
novel pyrrolo[1,2-c]pyrimidine was synthesised (Scheme 30).
35
X
C02Et Et02 C. Et02C
2  NaH, THF; then 2  Y  NHR
R-N=C=X, rt, 18 h
RN NH
+
x = o,s \_/
PhNCO 79; (31%) 7 4 ; (0%) 88; (13%)
BnNCO 8 0 ; (35%) 72; (0%) 8 9 ; (9%)
BnNCS 8 6 ; (38%) Not formed 9 0 ; (25%)
Scheme 30
The mechanism of formation of the pyrrolo[1,2-c]pyrimidine is believed to occur 
via initial acylation on carbon, followed by further acylation on nitrogen. The 
subsequent anion intermediate then cyclises onto the ester moiety, forming the 
pyrimidine ring (Scheme 31).
.co2Et
N © ^ c  
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X o  
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Scheme 31
The acylation studies are summarised in Tables 1 and 2.
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Heterocumulene Conditions Ratio C:N 
Acylation
Products (% isolated yields)
PhNCO Benzene, reflux, 2 h 5.2:1 Not purified
CHCb, reflux, 2 h 3.4:1 79 (71%); 74(17%)
THF, reflux, 2 h 7:1 Not purified
CHCI3 , 25 °C, 18 h 2 .1 : 1 79 (53%); 74 (20%)
NaH, THF, 18 h 1 : 0 79 (31%); 74 (0%); 8 8  (13%)
BnNCO CHCI3 , 25 °C, 18 h 1 : 2 80 (13%); 72 (25%)
CHCI3 , reflux, 20 h 1 : 1 80 (39%); 72 (50%)
NaH, THF, 18 h 1 : 0 80 (39%); 72 (0%); 89 (9%)
n-BuNCO Pyridine, 100 °C, 65 h, sealed tube 2.3:1 81 (65%); 70 (19%)
4-MeC6 H4NCO CHCI3 , reflux, 2 h 2.3:1 82 (56%); 77 (23%)
Table 1
0 0  iiEt02C. J i  A  Et02C ^ X  1LJ„ Et02C.
NHPh P h N ^ T j ^ N P h  T  NHBn NHBn
< K , \  » ^A , ^  & K
74 88 80 72
o o o o r ^ V Me ^ y Me
B n N ' Y n Bh ^ C ^ N H n - B u ^ S  N i w g 0 ^ ^  EK* S
H C H 0  \  /NH ( _ / N^ °  u j nh C _ /N^ °
89 81 70 82 77
NHPh
NH
79
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Heterocumulene Conditions Ratio C:N 
Acvlation
Products (% isolated 
vields)
TsNCO CHCI3 , 25 °C, 2  h 1 0 83 (94%)
CI3 CCONCO CHCI3 , 25 °C, 18 h 1 0 84 (51%)
PhNCS CHCI3 , reflux, 18 h 1 0 85 (58%)
BnNCS CHCI3 , reflux, 18 h 1 0 8 6  (6 6 %)
NaH, THF, 18 h 1 0 8 6  (38%); 90 (25%)
n-BuNCS Pyridine, 100 °C, 46 h, sealed tube 1 0 87 (89%)
Table 2
NHTs
NH
83
O O
&
84
'CCI3 NHPh
NH
85
NHBuNHBn BnN NBn
NHNH
86 90 87
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The proposed mechanism of the Kishi three-component coupling requires a 
reaction pathway whereby initial acylation of the alkylidenepyrrolidine with 
trimethylsilyl isothiocyanate takes place on nitrogen. It now seems highly unlikely 
that this could be taking place, given the regioselectivity trends for acylation of 
these alkylidenepyrrolidines. The three-component coupling reaction is also 
considerably faster than the vast majority of these acylation reactions, particularly 
with isothiocyanates.
Although no evidence could be ascertained from the reaction of trimethylsilyl 
isothiocyanate and alkylidenepyrrolidine 62, the general acylation trends appear 
to point away from the existence of this reaction pathway.
2.2.3 The Second Postulated Mechanism: Alkylidenepyrrolidine & Aldehyde
The second possible mechanism involves the initial reaction of 
alkylidenepyrrolidine (53) and aldehyde (91) to produce an aza-diene 
intermediate (92). Based on the group’s studies of annulation reactions of 
alkenyloxazoline with heterocumulenes, the heterocumulene would be expected 
to react with the aza-diene in a stepwise, formal hetero-Diels-Alder pathway via 
intermediate 93, affording pyrimidine 94 (Scheme 32).32 Cyclisation onto the 
sulphur of the thiourea would be disfavoured, owing to the steric bulk of the 
sulphur atom.
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It is known from previous studies32 that intermediate 60 will cyclise 
stereospecifically to give the corresponding trans-isomer (95) (Scheme 33). To 
compare this to the three-component coupling, one can envisage the 
corresponding trans-isomer 54 resulting from double-bond isomer 93a, with the 
c/s-isomer 55 resulting from double-bond isomer 93b.
Therefore, formation of an approximate 2:1 mixture of double-bond isomers 93a 
and 93b could explain the overall stereochemical outcome of the reaction.
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Again, in order to prove, or indeed disprove the mechanism, experimental 
evidence would be required.
Equimolar amounts of alkylidenepyrrolidine 62 and aldehyde 91 were therefore 
mixed together (Scheme 34). On a laboratory scale, and in an NMR tube, no 
reaction was observed.
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Scheme 34
These results suggest that the aldehyde alone is probably not electrophilic 
enough to react with the pyrrolidine, particularly within the short time-frame of the 
three-component coupling ( 1 - 3  h). Trimethylsilyl isothiocyanate is also a 
relatively poor electrophile, making the formal hetero-Diels-Alder step also 
unlikely.
However, there is the possibility of the aldehyde being activated by the third 
component (TMS-NCS), making it a relatively powerful electrophile. This 
hypothesis led us to consider a third possible mechanism, which will be 
discussed in the following section.
2.2.4 The Third Postulated Mechanism: Aldehyde & Isothiocyanate
Thus far, the proposed reaction pathways for our key step have involved initial 
coupling of two of the components, followed by reaction with the third. As 
previously discussed, the aldehyde appears to be unreactive towards 
nucleophilic attack by the alkylidenepyrrolidine. However, if the aldehyde is 
activated beforehand by the isothiocyanate component, an electrophilic iminium 
ion species may be formed.
Scheme 35 illustrates this principle, whereby nucleophilic attack of the 
isothiocyanate nitrogen onto the aldehyde initially takes place to form compound 
97, an ‘extended heterocumulene’. This species then reacts with a nucleophile at 
the position shown.
Scheme 35
97
Nishiyama and co-workers reported the zinc chloride-catalysed reaction of 
trimethylsilyl isothiocyanate and a range of aliphatic aldehydes (Scheme 36).43 
Two reaction pathways were proposed, with pathway b resulting from formation 
of an a-siloxy isothiocyanate intermediate (99) which arose through electrophilic 
addition of the aldehyde to the nitrogen of compound 56.
o
x
Pathway a
TMS-NCS
Pathway b
TMS-NCS
99
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S Sii iic cII II
N N
R ^ O ^ R
TMS. O
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With intermediate 99 in mind, a full mechanistic pathway for the three-component 
coupling was proposed (Scheme 37). Beginning with reaction of TMS-NCS and 
aldehyde, intermediate 97 could either exist as an ‘extended heterocumulene’ 
97a, or as AMhiocarbamoyl imine 97a. As both 97a and 97b will lead to the same 
eventual product, only one pathway has been described to simplify matters. 
Electrophilic addition of the iminium ion to alkylidenepyrrolidine 53 takes place on 
the alkene carbon, creating a new stereogenic centre. The alkene double bond of 
compound 101 then isomerises, allowing cyclisation onto the isothiocyanate 
moiety to occur, affording pyrimidine 54/55.
TMS 56
N=C=S -TMS-O Sx
N OTMS
+
O
91 97a 97b
R
53 n
C
i i
R ’ N
R R
101
R
54/55
Scheme 37
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The experimental procedure for the three-component coupling consists of mixing 
the aldehyde and isothiocyanate, stirring the reaction for half an hour, and then 
adding the alkylidenepyrrolidine. We have attempted to mix all three components 
simultaneously, and although we have observed some signs of the product, 
although the reaction is not as clean as with the former method.
In the same manner as the first two mechanisms, equimolar quantities of the two 
components were mixed together together (Scheme 38).
snc
O N® QO-SiMe3
Me3Siv ]f CHCI3 /CDCI3 y u
N=C=S + R^ H ...............................r ^ h
56 91 97
Scheme 38
The first set of reactions were carried out in an NMR tube on a 1 mmol scale. 
One equivalent of the aldehyde and isothiocyanate were dissolved in 1 ml_ of 
deuterated chloroform, and 1H NMR spectra recorded at intervals often minutes. 
If the iminium ion intermediate were to be formed, even at low levels, it could 
appear as a slight shift in the frequency of the aldehyde proton (ca. 10 ppm). This 
is exactly what occurred during one such experiment, although this result could 
not be repeated. This anomalous result appears quite dubious, and may have 
been attributed to a small amount of water in the NMR tube. Upon changing the 
conditions to a laboratory scale (1 mmol scale), we failed to see any sign of a 
reaction. This was the case regardless of temperature or time.
Despite the lack of an observable reaction, we were not prepared to dismiss this 
mechanism. The first two proposed mechanisms appear highly unlikely; with the 
first pathway (A/-acylation), results have shown that an alkylidenepyrrolidine will 
almost always preferentially acylate at the alkene carbon, ruling this mechanism 
out. The second pathway (aza-Diels-Alder reaction) also appears disfavoured, 
given the relatively low reactivity of both the isothiocyanate, and the short 
timeframe (1 -  3 h) required for the three-component coupling.
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2.2.5 Tentative Support for the ‘Extended Heterocumulene’ Mechanism
As previously discussed, the three-component coupling is a convenient and 
reliable method to construct the required bicyclic thiourea core(s) of the 
Batzelladine alkaloids (102) (Scheme 39).
Et02C ^ X
R
NH 
S
C02Et
102 62 56
Scheme 39
The thiourea can then be converted into the required guanidine (103).28 If, 
however, the guanidine can be installed directly from the alkylidenepyrrolidine, 
then the synthetic advantages would be significant. If the same retrosynthetic 
analysis is applied to guanidine 103 (Scheme 40), one can envisage replacing 
the isothiocyanate with a directly analogous heterocumulene. An apposite 
reagent might be a carbodiimide equivalent (104).
r\
Et02C ^ X
Xa
R
NH 
NH
C02Et
103 62 104
Scheme 40
The standard conditions of the three-component coupling were repeated within 
the group, replacing trimethylsilyl isothiocyanate with a nitrogen equivalent, 
bis-trimethylsilylcarbodiimide (105) (Scheme 41 ).44 Unfortunately, no reaction 
was observed.
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105 T  L
 * ---------   / ' M ' SHexanal, CH2 CI2, \  /’ NH
rt, 3 h N— 1
62 R = SiMe3  1 0 6
Scheme 41
Compound 104 can exist either as its carbodiimide (104) or cyanamide tautomer 
(107) (Scheme 42). Therefore, the next logical step was to repeat the 
three-component coupling, replacing bis-trimethylsilylcarbodiimide with 
cyanamide.
NH t N
m Tautomerism m 
C , Cn i
NH NH2
104 107
Scheme 42
C02Et
62
I
C5 HH
Et° 2CY ^ N H
Hexanal, CH2 CI2, \  /
rt, 3 h N '
NH2CN
107
106
The initial results were promising, producing very clean 1H NMR spectra. There 
was no discernible trace of alkylidenepyrrolidine, and the coupling patterns 
indicated the presence of diastereotopic hydrogen atoms on the pyrrolidine ring, 
implying the formation of a stereogenic centre during the reaction.
However, this compound was found to be clearly different from guanidine 106 (as 
the acetate salt) prepared by an independent route (see Experimental, Section 
6.2).
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The 13C NMR spectrum corroborated this, with a clear signal corresponding to 
the C=N peak still present.
However, the synthetic material proved unexpectedly unstable to column 
chromatography or a mild aqueous wash.
Compound 108 was then proposed according to the combined spectroscopic 
evidence (Scheme 43).
Scheme 43
It is known that intramolecular hydrogen bonding exists between the NH and the 
ester carbonyl; intermediate 108 almost certainly has further hydrogen bonding 
between the cyanamide unit and the ether oxygen of the ester. This extra 
bonding would lead to a more stable structure, resulting in cyclisation becoming 
less favoured (Scheme 44).
,CN
HN
NH2 CN, Hexanal 
CH2 CI2, rt, 3 h
87% crude yield
62 108
0  Cyclisation
; disfavoured
108 106
Scheme 44
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A mechanism analogous to that proposed for the three-component coupling can 
be envisaged (Scheme 45).
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h2 n -c = n
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R ^ H
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NH
N
NH
C 02Et
NH
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Sii
C
i i
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Scheme 45
Compound 108 is analogous to intermediate 101 proposed for the 
three-component coupling. The isolation of this compound therefore provides 
support for the proposed mechanism.
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2.3 Stereochemical Aspects of the Three-Component Coupling
Particularly with a view to future synthetic approaches, understanding the
stereochemistry of this key step is of utmost importance. As previously
discussed, the reaction of alkylidenepyrrolidine 53 with a stereochemical
directing group at the 5-position, leads to a readily separable mixture of
diastereomers (Scheme 46).
C02Et
53
R = allyl, CH2OTBS
NH
R'CHO, TMS-NCS,
54
NH
+
55
2-24:1
Scheme 46
As Scheme 46 illustrates, an approximate 2:1 mixture of diastereoisomers is 
obtained, with the major diastereoisomer bearing a frans-relationship of 
substituents across the pyrrolo[1,2-c]pyrimidine rings. This stereochemical 
assignment is based on initial nOe evidence.34
Upon interpretation of the 1H NMR spectra of these three-component couplings, 
it was found that the diastereomeric ratio could be determined from the relative 
integrations of the proton on the 5-position of the pyrrolidine rings (54 & 55).
The 1H NMR spectrum of isomers 110 and 111 (Scheme 47, Figure 19) was the 
first three-component coupling to be analysed in this manner.
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-C02Et Et02C
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CH2 CI2, rt, 3 h 
NH ________
'CH2OTBS
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81% 
110:111 =2.38:1
H 'CH2OTBS
Trans
Et02C
H CH2OTBS
Scheme 47
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H-5
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H-5
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Figure 19
Figure 19 shows the region of the 1H NMR spectrum from 4.3 - 5.2 ppm, with an 
approximate 2.38:1 ratio of diastereoisomers measured. The proton on the 
5-position of the major (trans) isomer is upfield that in of the minor isomer.
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The same analysis was then applied to the three-component coupling with an 
allyl directing group on the 5-position of the alkylidenepyrrolidine (see Chapter 
Five) (Scheme 48, Figure 20).
CsHu C5H11
,C02Me Me02 C>
TMS-NCS, Hexanal,
'NH CH2 CI2, rt, 2 h
✓
112
Scheme 48
78% 
113:114= 1.8:1
Me02C
H
113
Trans
H
114
Cis
H-5
H-5
114 113
T T T T T T T T T T T T T TT T T T T T
—  100
—  50
—0
5.10 5.00 4.90
ppm (11)
Figure 20
4.70 4.60
The equivalent region of the 1H NMR of diastereoisomers 113 and 114 is shown 
in Figure 20. As with the aforementioned three-component coupling, the 5-H in
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the major isomer is upfield of the minor, with an approximate d.r. of 1.8:1 
calculated.
The diastereoselectivity is slightly lower than Stuart Wordingham’s 
three-component coupling (see Page 19; also with allyl). However, these 
differences may be attributed to experimental error.
Although the assigned trans stereochemistry for the major diastereoisomer is 
based on initial nOe studies,34 it was not definitive. However, we were able to 
obtain crystals of X-ray quality from the major diastereoisomer (113) from this 
three-component coupling (see Chapter Five), corroborating the nOe evidence. 
Therefore, we can confidently say that the major isomer shows a trans 
relationship between the protons across the pyrrolo[1,2-c]pyrimidine rings.
However, when the stereochemical directing group was altered to an ethyl ester 
(Scheme 49), an unexpected result was observed.
Upon analysis of the 1H NMR spectra of diastereoisomers 116 and 117, the 
protons on the 5-position of the alkylidenepyrrolidine were found in the opposite 
positions; i.e. the major diastereoisomer (116) was downfield of the minor (117) 
(Figure 21). The diastereoselectivity of this three-component coupling was also 
far lower (1.25:1) than the previous two approaches.
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116
C/'s
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One possible explanation for this result is that C02Et might be producing the 
opposite stereochemical outcome; i.e. the major isomer has a c/s-relationship 
between the protons across the pyrrolo[1,2-c]pyrimidine rings.
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With an ester moiety present, the diastereoisomers can be reduced to the 
primary alcohols, and hence, the TBS-ethers. If the c/'s-isomer is the major 
product, then its corresponding silyl ether should produce very similar 1H NMR 
data as the minor product (111) from the aforementioned three-component 
coupling (Scheme 47).
Diastereoisomers 118 and 119, from a similar three-component coupling (with 
acetaldehyde rather than hexanal), were treated initially with sodium borohydride 
to afford the primary alcohol, with surprisingly only the major diastereoisomer 
being reduced. This chemoselectivity may be due to the conformations of 
isomers 118 and 119, with the latter being relatively inaccessible to nucleophilic 
attack by a hydride molecule.
Having separated compound 120 from the unreacted starting material, the 
alcohol moiety was then converted to the silyl ether (47a)34 (Scheme 50).
The 1H NMR data (particularly the proton at the 5-position of the pyrrolidine ring 
in Scheme 50) of compound 47a did indeed correspond that of the minor 
diastereoisomer from the three-component coupling with CH2OTBS.34 Therefore, 
the major diastereoisomer 118 definitely has a c/'s-relationship between the 
substituents across the pyrrolo[1,2-c]pyrimidine rings.
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To summarise the results from the stereochemistry studies: with CH2OTBS and 
allyl as the directing group, the trans-isomer is the major diastereoisomer. 
However, with C 02Et, the major isomer is cis (Scheme 51).
Trans Cis
R' R'
COoEt
NH
R'CHO, TMS-NCS,
54
NH
+
55
R = CH2 OTBS; R' = C5Hu 2.38 (110) 1 (111)
R = allyl; R' = CgH^ (C02 Me) 1.81 (113) 1 (114)
R = C0 2 Et; R' = CsHu 1 (117) 1.25(116)
R = C0 2 Et; R' = Me 1 (H*> 1.2(118)
Scheme 51
Although electronically different from allyl or alkyl, there are no obvious reasons 
why an ethyl ester directing group should induce the opposite stereochemical 
outcome for the reaction.
One possible postulation is that intramolecular hydrogen bonding between the 
ester directing group and NH of the alkylidenepyrrolidine may have an additional 
influence on the stereochemistry.
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2.4 Conclusions
Through experimental evidence, we now strongly believe that the mechanism of 
our key step proceeds by initial activation of the isothiocyanate by the aldehyde 
to produce a reactive species, which then reacts with the alkylidenepyrrolidine. 
However, it would be highly useful to be able to further validate, and ultimately 
prove the existence of the ‘extended heterocumulene’ mechanism through 
synthetic methodology.
Chapter Three will discuss an asymmetric synthetic route to the western half of 
batzelladine A, with the three-component coupling employed as the key synthetic 
step. The stereochemical directing group of the alkylidenepyrrolidine component 
will be located adjacent to the double bond, close to the proposed reaction 
centre.
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Chapter 3
A Highly Diastereoselective Approach to the 
Western Half of Batzelladine A
59
3.1 Introduction
The group’s previous synthetic studies towards the western half of Batzelladine A 
(Scheme 51) utilised this three-component coupling as a central step.34 With a 
stereochemical directing group at the 5-position of alkylidenepyrrolidine 46, a 
diastereomeric ratio of 2.3:1 of47a:47b was obtained.
TBSOTBSO
NHMeCHO, Si(NCS) 4NH
Me
47a:47b = 2.3:1
TBSO
C02Et
Scheme 51
46 47a (54%) 47b (27%)
This synthetic approach (along with other three-component couplings; see 
Chapter Two) used a stereochemical directing group remote from what we now 
believe is the site of reaction. If a directing group can be placed at a closer 
position to the reaction centre, then the stereoselectivity of the reaction should be 
influenced to a far greater degree.
Scheme 52 illustrates this hypothesis, whereby a bulky directing group (X) is 
situated at the 3-position of alkylidenepyrrolidine (d), reacting with the ‘extended 
heterocumulene’ (97) at the alkene carbon.
X^NH
C02Et
121
Sn
-
97
/  NH
y \ , c o 2E\
X R N.
s
X
/ " 'N  NH
£ v »x C02Et 
122
Scheme 52
If a high diastereoselectivity arises from this three-component coupling, then this 
would offer further supporting evidence for the postulated reaction mechanism.
60
3.2 Retrosvnthetic approach to Batzelladine A
Scheme 53 shows the planned approach to the western half of Batzelladine A. 
The natural product (123) should be formed via a transesterification of compound 
124 and the appropriate guanidine alcohol. It is anticipated that thiourea 125 can 
be protected as the S-methyl isothiourea, and converted to the thioacyl derivative 
(126). An oxygen-containing directing group alpha to the double-bond would be 
an ideal choice, as a Barton deoxygenation can be used to remove this group in 
the presence of an S-methyl isothiourea,45 forming guanidine 124 as a single 
enantiomer.
The three-component coupling of enantiopure alkylidenepyrrolidine 127, 
aldehyde and isothiocyanate will be the key step in the synthesis, establishing 
the bicyclic core with the appropriate length alkyl-chain for the left-hand side. 
Compound 127 will in turn be synthesised from hydroxy lactam 128.
Barton de-oxygenation
R"-V U C°2R
s
R'
123 NH 124 126
OTBDPS
S
H_
Three-component /  N NH 
, coupling X
128 127 125
Scheme 53
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3.3 Synthetic Strategies Towards the Natural Product
As we were aiming towards an asymmetric total synthesis, the 
commercially-available (S)-enantiomer of amino acid 129 was chosen as the 
building block (Scheme 54).
Scheme 54
(TMS)2 NH, TMS-CI (cat.) 
/^ N H 2  Xylene, reflux,
V - co2h
then HCI(aq)
91%
129 128
Ring-closing via the trimethylsilyl ester afforded the lactam, protected as the 
trimethylsilyl-ether.46 Straightforward silyl-deprotection with aqueous HCI then 
yielded lactam 128 in very high purity. The next synthetic step was protection of 
the hydroxy group as the fe/t-butyldimethylsilyl ether. Under standard protecting 
conditions,47 a 1:1 mixture of desired lactam 130 and undesired imino-ether 131 
was produced (Scheme 55).
TBS-CI, NEt3, 
DMAP, CH2 CI2
92% (both isomers) TBSO 
128 130 131
OTBS
Scheme 55
However, by alteration of the reaction solvent and base, the regioselectivity was 
enhanced in favour of the desired isomer (130) (Scheme 56).
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TBS-CI, imidazole, 
DMAP, THF
O O
HO 70% TBSO
128 130
Scheme 56
Pleasingly, the first two steps could be carried out on a 5 - 15 g scale, with no 
requirement for chromatography.
3.4 Approaches Towards Alkvlidenepvrrolidine Formation (I)
The Elliott group have devised a novel method for alkylidenepyrrolidine 
formation, involving the use of ester-enolate chemistry.38 The general protocol 
begins with Boc-protected lactam (132), which is treated with the appropriate 
enolate, opening-up the five-membered ring to afford 133. With an excess of 
trifluoroacetic acid, ring-closing is promoted, followed by dehydration and 
Boc-deprotection to afford pyrrolidine 134 (Scheme 57).
Scheme 57
However, it is expected that the te/T-butyldimethylsilyl protecting group may not 
survive the acid-mediated ring-closing step.
It is known that carbamate 133 will spontaneously ring-close and dehydrate if left 
on the bench for a substantial length of time. If Boc-protected
>2 equiv. TFA 
(neat)
NBoc NHBoc
THF, -78 °C
132 133 134
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alkylidenepyrroiidine 135 can be isolated, milder methods of Boc-removal could 
be investigated (Scheme 58).
ro 2c c o 2r
Boc-removal?
NBoc NH
135 134
Scheme 58
Lactam 130 was treated with di-te/f-butyl dicarbonate in order to prepare the 
terf-butyl carbamate precursor for alkylidenepyrroiidine formation (Scheme 59).
Scheme 59
Compound 136 was then reacted with the enolate derived from ethyl acetate, 
affording the ring-opened carbamate (137).
To test the efficacy of the ring-closing reaction, compound 137 was treated with 1 
equivalent of TFA (neat; the standard conditions38 employ 2 equivalents of acid), 
and stirred at room temperature for 3 h (Scheme 60).
B0 C2 O, NEt3 , DMAP, 
CHoCL NBoc
130 136
64
/ ^ N R  / — NHBoc
( l  00 LDA, EtOAC, THF, (  ^ CQ2Et
TBSO . 7 8  °C -> rt, 20 h TBS0 0
, , ,  87% crude yield136 y 137
2 equiv. TFA, 
rt, 3 h
/  NH
y V c o 2B
TBSO
NHBoc
TBSO
137
NBoc
+
TBSO
138
(0%) (17% of original SM) (27%)
Scheme 60
Upon purification of the crude reaction mixture, several products were isolated: 
Boc-protected alkylidenepyrroiidine 138, some unreacted starting material and 
indeterminable impurities. However, none of the desired alkylidenepyrroiidine 
was isolated.
With Boc-protected alkylidenepyrroiidine (138) isolated, efforts were then made 
to de-protect the Boc group. Several acids, including TFA and p-TsOH were 
employed, but unfortunately, less than 10% of the required product was 
synthesised on any occasion.
The ring-closing step was then re-attempted with the aforementioned acids, with 
still none of the desired alkylidenepyrroiidine formed.
As a result of these studies, we elected to employ an alternative method to 
synthesise our key alkylidenepyrroiidine, particularly one which avoided the use 
of an acid source.
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3.5 Approaches Towards Alkylidenepyrroiidine Formation (II)
Of the main methods for synthesising alkylidenepyrrolidines,39 the Eschenmoser 
sulphide contraction48,49 was chosen as the most suitable reaction for our 
synthesis, most notably for the lack of acid required (Scheme 61). The reaction 
mechanism of the sulphide contraction is believed to involve initial alkylation of 
thiolactam 139 with an a-bromocarbonyl compound. Subsequent deprotonation 
with a weak base affords thiirane intermediate 140, with sulphur extrusion then 
occurring to give alkylidenepyrroiidine 141.
Scheme 61
Thiolactam 142 was first prepared, by reacting lactam 130 with Lawesson’s 
reagent (Scheme 62).50
(i) BrCH2 C02 R'
140
Lawesson's reagent,
130 142
Scheme 62
66
Alkylation of compound 142 then afforded imino thioether 143 in highly pure 
form, which could be isolated51 and stored in the freezer for several weeks 
(Scheme 63).
Although the sulphide contraction step of the reaction required long, forcing 
conditions to go to completion,48 a straightforward flash silica gel column was 
required to purify alkylidenepyrroiidine 144, with the silyl protecting group 
pleasingly remaining intact.
BrCH2 0O 2 Et, PPh3, f-BuOK, / ^ 1LJ-s* /  NHCH2 CI2  /  i| Xylene, reflux, 60 h
C02Et
TBSO 94% TBSO I 87% TBSO
C02Et
142 143 144
Scheme 63
On a small scale (100 - 600 mg of thioether 143; 0.32 -  1.9 mmol), the sulphide 
contraction proceeded in high yield. However, upon scaling up the reaction, the 
yields dropped quite drastically (Table 3).
Quantity of 143 Moles of 143 Yield of compound 144
(143 —► 144)
108 mg 0.34 mmol 79%
576 mg 1.82 mmol 87%
1.03 g 3.25 mmol 19%
5.24 g 16.53 mmol 8%
Table 3
Despite the scale-up difficulties, we were still able to synthesise a substantial 
amount of the alkylidenepyrroiidine to use in the three-component coupling.
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3.6 A Highly Diastereoselective Three-Component Coupling
With a quantity of the alkylidenepyrroiidine 144 prepared, the group's standard 
three-component coupling conditions (see Chapters 1 & 2) were employed 
(Scheme 64), with hexanal as a 'test' aldehyde. Surprisingly, instead of the 
expected thiourea 145 formed as a mixture of diastereoisomers, a very small 
amount of de-silylated thiourea 146 was isolated as a single diastereoisomer. 
Aside from compound 146, no other determinable products could be recovered. 
The 1H NMR spectrum of the crude reaction mixture had also confirmed that the 
starting materials had been consumed.
s s
CsHnCHO, TMS-NCS, 
CH2 CI2, rt, 3 h
TBSO
144 145 (0%) 146 (3%)
Scheme 64
The key diagnostic region (1 - 5 ppm) of the 1H NMR spectrum of thiourea 146 is 
shown in Figure 22. All peaks clearly show the existence of only one 
diastereoisomer. This is also corroborated by the 13C NMR spectrum.
—2500
•2000
NH
—  1500
HO
-1 0 0 0
—500
—0
T T TT
7.0 6.0 5.0 4.0 3.0 2.0 1.0
ppm (t1)
Figure 22 -  1H NMR spectrum of Compound 146 (400 MHz; CDCI3 )
There were various explanations postulated for this perplexing result. One such 
explanation was that thiourea 146 may have arisen from a small proportion of 
de-silylated alkylidenepyrroiidine in the starting material.
Alkylidenepyrroiidine 144 was therefore treated with tetra-butylammonium 
fluoride52 to remove the silyl protecting group.
Under identical three-component coupling conditions, de-silylated thiourea 145 
was again formed as a single diastereoisomer (Scheme 65).
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H 0  C02Et 
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VV-'
Scheme 65
According to our proposed mechanism, the bulky silicon protecting group is 
expected to block one face of the alkylidenepyrroiidine towards electrophilic 
attack. However, the TBS group appears to hinder the reaction altogether.
Because a single diastereoisomer is formed in the three-component coupling, the 
iminium ion 97 may be approaching in one orientation only. If the hydroxy group 
reacts with the iminium ion first, then this could perhaps explain the high 
observed levels of diastereocontrol (Scheme 66).
It would be interesting to see whether the same high levels of diastereoselectivity 
are observed with a relatively bulky methyl ester as the directing group.
h
97
Scheme 66
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We have so far been unable to determine the configuration of the new 
stereogenic centre, as no diagnostic nOe signals are observed.
With a completely diastereoselective synthetic route to the western half of 
Batzelladine A developed, it was now left to repeat the three-component coupling 
with the correct alkyl linkage for the natural product. The ester moiety was also 
altered from ethyl to methyl, for comparison with literature syntheses.22'28,29
The Eschenmoser sulphide contraction of thiolactam 142 was therefore 
performed with methyl bromoacetate, with the sulphur extrusion step proceeding 
as before (Scheme 67). De-silylation with TBAF then afforded 
alkylidenepyrroiidine 150.
NH
BrCH2 C0 2 Me, 
CH2 CI2, 90%
TBSO
142
Scale: 0.87 mmol
PPh3, KOlBu, Xylene,
TBSO
reflux, 77% / ^ * \ H
V ^ / C 0 2Me 
TBSO
148
C02Me
149
TBAF, THF, 
85%
/  NH
V ^ ^ C 0 2Me
HO
150
Scheme 67
Note: imino-thioether 148 was isolated and fully-characterised (see
Experimental).
The requisite aldehyde for the three-component coupling was synthesised in two 
steps. Beginning with undec-10-en-1-ol, TBDPS-protection and oxidative
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cleavage under Lemieux-Johnson conditions53 yielded aldehyde 15254 (Scheme 
68).
7 OH
(i) TBDPS-CI, NEt3l DMAP
CH2 CI2
(ii) K2 0s04) Nal04, Dioxane q
OTBDPS
H
152
83%
151
Scheme 68
Because of excess osmium impurities, which were difficult to completely remove 
by column chromatography, we were slightly concerned that the aldehyde might 
be unstable. Therefore, the three-component coupling was carried out 
immediately. Although producing a slightly lower yield than with hexanal, bicyclic 
thiourea 153 was still obtained as a single diastereoisomer (Scheme 69).
s
H
% OTBDPS
150 153
Scheme 69
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3.7 Further Elaboration of the Natural Product Core
As discussed in Section 3.2, further functional group manipulation of the bicyclic 
thiourea would be required to synthesis the western half of the natural product. 
Scheme 70 shows the amended retrosynthetic pathway.
NH
.A ./ — N'^^NH Transesterification
X  R ^c r f n  nh
123 H
NH'
=  AW
OTBDPS
NH SMe
^ N ^ N H  Barton de-oxygenation/— N^^N
c o 2r  y % ° co2R
s
124
s
XX^N NH
V V *
c o 2r
125
HO
126
SMe
V V *
c o 2rHO
154
Scheme 70
The thioacyl group on the 3-position of the pyrrolidine, which is not present in the 
natural product, will be removed by Barton deoxygenation. There is literature 
precedent for the selective removal of an oxygen-containing group in the 
presence of an S-methyl isothiourea (Scheme 71 ).45
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NTBSO
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T
s 155
NH,
MeS—^ ]| I
NH:
N N
Bu3 SnH, AIBN, TBSO 
toluene, reflux, 2  h
MeS—^ ]| IN
60%
156
Scheme 71
Once the oxygen directing has been removed, the S-methyl isothiourea moiety 
can then be converted into the guanidine.28
The manipulation of the bicyclic core began with protection of the thiourea unit. 
Thiourea 153 was alkylated with a large excess (up to 20 equivalents) of 
iodomethane, with forcing conditions required for the reaction to go to completion 
(Scheme 72). Following an unusual work-up (washing with dry triethylamine!),37 
isothiourea 157 was obtained following flash column chromatography.
SMe
Mel, CH2 CI2, reflux; then dry 
NEt3, rtNH
r8 OTBDPS
HO
153
91%
% OTBDPS
HO
157
Scheme 72
Several methods of forming thioacyl derivatives were then investigated (Scheme 
73).
Unfortunately, S-methyl isothiourea 157 failed to react with either 
carbonylthioimidazole55 or carbon disulphide/methyl iodide,56 even following 
initial deprotonation (although the starting material was recovered in each case).
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% OTBDPS
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% OTBDPS
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SMe
157
NaH, CS2,
Mel, THF, 0 °C -> rt
>8 OTBDPSMeS,
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Scheme 73
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3.8 Conclusions & Future Work
To summarise, we have developed a highly diastereoselective, efficient synthetic 
route to the core of the western portion of batzelladine A. The three-component 
coupling, with a hydroxy directing group adjacent to the double-bond of the 
alkylidenepyrroiidine, proceeds with total diastereocontrol.
With further elaboration, including conversion to the guanidine and removal of the 
oxygen-containing directing group, the total synthesis of the left-hand side of the 
natural product will be achieved.
It is also anticipated that once the western half of the natural product is 
synthesised, it may be coupled to a tricyclic guanidine, either to complete the 
total synthesis of batzelladine A, or to construct a batzelladine A analogue, with 
the batzelladine C core as the eastern half (1a) (Figure 24).
Batzelladine A analgoue (1a)
Figure 24
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Chapter 4
Batzelladine C: A First-Generation Approach
77
4.1 Introduction
Having already developed a highly diastereoselective synthetic route to the 
western half of Batzelladine A, we then investigated approaches to other 
members of the Batzelladine family.
Our attention turned to the previously unsynthesised Batzelladine C, which we 
envisaged our own alkylidenepyrroiidine methodology and three-component 
coupling would be key steps in the synthesis. An approach to the tricyclic core of 
this natural product has previously been developed in the group by Stuart 
Wordingham.37 The synthetic pathway is outlined in Scheme 74.
Allylmagnesium bromide,
a 2° :
/ V then NaCNBH3, HCI 
 -N
H
49
61%
Boc20 ,  NEt3, 
DMAP, CH2CI2
83%
160 161
Hexanal, TMS-NCS 
s CH2CI2, rt, 3 h
(i) EtOAc, LDA, 
THF 
(ii) TFA
72% (2 steps)
Mel, MeOH, reflux; 
then NH3, NH4OAc, 8 6% 
sealed tube, 80 °C
l2, K2C 03, 
MeCN
46%
Scheme 74
Beginning with an allylation reaction under reductive conditions,57 allyl lactam 
157 was formed from succinimide. Subsequent Boc-protection, and then reaction 
under the group’s conditions afforded alkylidenepyrroiidine 162.37 Compound 162 
was then treated with hexanal and trimethylsilyl isothiocyanate to form thioureas 
51a and 51b. Subsequent reaction with ammonia and ammonium acetate 
converted the thiourea moiety to a guanidine, followed by base-mediated 
iodocylisation to form the tricyclic guanidine (52). Spectroscopic data obtained 
from this guanidine was in close agreement with the corresponding data from the 
natural product paper,1 therefore the stereochemistry of the protons at positions 
8, 10 and 12 was tentatively assigned as shown in Scheme 74.
However, there were several disadvantages with this synthetic route, namely the 
approach being inherently racemic (there is no stereocontrol in the allylation 
step), and problems were also encountered in replacing the alkyl iodide from 
compound 52 with the appropriate alkyl chain for the natural product.
4.2 A First-Generation Synthetic Approach to Batzelladine C
4.2.1 Organometallic Chemistry
Because we were aiming for an asymmetric route to the natural product, we 
would ideally be looking to start with enantiopure building blocks. Scheme 75 
shows the proposed retrosynthesis.
79
R—= ©
Scheme 75
Alkylidenepyrroiidine 164 will be used to construct the bicyclic thiourea core of 
Batzelladine C via a three-component coupling. It is anticipated that an 
intramolecular iodoamination will be in turn be employed to synthesise the 
tricyclic guanidine core, with the correct carbon side-chain already in place. 
Compound 166,58 disconnected at the 3-4 C-C bond, can be synthesised from an 
appropriate organometallic species (167) (Scheme 75).
An apposite literature reaction to synthesise an enantiopure lactam of structure 
167 was reported by the Hiemstra group.59 lodo-lactam 168 is first treated with 
zinc metal to form the organozinc species, and then reacted with CuCN.2LiCI 
and iodo-acetylide 169, affording the progargylic lactam (166) (Scheme 76).
CuCN.2LiCI
168 169 166
R = O5H-1-), CH2SiMe3
Scheme 76
Compound 168 was prepared in three steps from (S)-glutamic acid. Lactonisation 
to synthesise ethyl(S)-pyroglutamate (170), reduction of the ester moiety to the 
alcohol and halogenation with l2/PPh360 yielded the desired alkyl iodide (Scheme 
77).
(i) SOCI2) EtOH, 
refluxC° 2H fii) NaBHEtOH / “ \  oH PPh3, l2. Imidazole, / \  |(N) NaBH4  EtOH, CH2 CI2, reflux, 3 h
H2 N rt - - -h o 2c H    H
73% (2 stePs) ™  75%43 170 168
Scheme 77
lodo-acetylide 171 was synthesised by reaction of 1-octyne, /7-butyl lithium and 
iodine (Scheme 78).61
n-BuLi, l2) THF, 
rt, 10 mins
C 5 H - 1  -| —  C 5 P 1 1  —  I
79% 171
Scheme 78
The zinc-iodide species was then formed according to literature procedure.62 For 
the zinc-copper coupling, lactam 172 was kept in solution in DMF, and added to 
the reaction vessel via cannulation (Scheme 79).
I Zn, DMF
N 
H
168
Znl
N
H
172
CuCN.2LiCI
C5 H1 1  =  
167
---------X----- O
C«H5 n 11
THF, 0 °C->30 °C 
->rt
N 
H
173
Scheme 79
Although the 1H and 13C NMR spectra of the crude reaction mixture showed that 
the starting materials had been consumed, the expected lactam was not formed.
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4.2.2 M-Acyliminium Ion Chemistry
Scheme 80 shows an amended retrosynthetic pathway from 
alkylidenepyrroiidine 164. Disconnection at the propargylic lactam stage 
(compound 174) this time occurs at the 2-3 C-C bond, rather than the 3-4 bond 
from the previous route. With a chiral directing group attached to the nitrogen to 
direct the stereochemistry, hydroxy lactam 175 will react with an appropriate 
propargyl anion equivalent. It is anticipated that the most suitable reagent for this 
step will be an allenylsilane (176).63,64
N
Me02C H 
164
r = c6h 13
o N
H
165
#
*  4i °
R*
174
©
Ni
R*
-R
h2 c = c= ^
175
= h2 c=c=^
SiMe,
176
Scheme 80
There is one literature example of addition of an allenylsilane to an A/-acyl 
iminium ion (Scheme 81 ).65 Mixing lactam 177 and titanium(IV) chloride creates 
the A/-acyliminium ion (178),66 which is then treated with allenylsilane 179 to 
afford an approximate 2:1 mixture of propargyl lactam 180 and pyrrolidinone 181.
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N
H
177
OEt
TiCI4, CH2CI2
Scheme 81
0°C -»rt
180
59%
N
H
178
SiMe3
H2 C = C =(
179 Me
Me
TMSMe
181
28%
The initial reaction pathway for compound 181 is initially identical to 180, 
producing vinyl cation intemediate 178a (stabilised by hyperconjugation with the 
C-Si bond). A 1,2-cationic shift of the trimethylsilyl group produces isomeric vinyl 
cation 178b, which is in turn trapped by the lactam nitrogen to form heterocycle 
181 (Scheme 82).
cP
 /SiM03O H2 C -C = \
H Me
178 179
1 ,2 -cationic
178a 178b
cP
180 181
Scheme 82
Although there is no precedent for the chiral addition of an allenylsilane to 
lactams in this manner, the Polniaszek group reported the related reaction of
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allyltrimethylsilane and a series of chiral hydroxy lactams (Scheme 83; explained 
in more detail in Chapter Five).67
o OH
175
R* = CH(Me)Ar
SnCI4  
182:183 > 5:1 182
Ni
R*
183
Scheme 83
It was then hypothesised that due to the structural similarity of an allenylsilane 
and allyltrimethylsilane, if we attach a chiral directing group to the central 
nitrogen atom, the addition of an allenylsilane to the corresponding 
/V-acyliminium ion should proceed with some level of stereocontrol.
Our synthesis therefore began with condensation of commercially available 
succinic anhydride (184), available inexpensively and in multigram quantities. For 
introduction of the stereochemicaf directing group, (S)-phenylethylamine was 
reacted with succinimide to form the chiral imide, followed by a chemoselective 
reduction to afford hydroxy lactam 186 (Scheme 84).
(S)-phenylethylamine, 
toluene;
then CDI, THF, reflux ^  ^  Super-hydride, THF O m  OHN u r ^
Me" ^ Ph 87% (2 steps) Me' Ph
184 185 186
Scheme 84
Both reactions were very clean and high-yielding, with little or no purification 
required.
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The allenylsilane (188) was then prepared in accordance with a literature 
procedure (Scheme 85).68
(i) MsCI, NEt3, O °C
(ii) CuBr, LiBr, C6H13MgBr,
/— = — SiMe3 THF, -78 °C =  SiMe3
HO
187 188
78% CeHl3
Scheme 85
Chiral hydroxy lactam 186 was then treated with tin(IV) chloride and allenylsilane 
188 to yield diastereoisomers 189a and 189b, with a diastereomeric ratio of 2.5:1 
measured from integration traces of the 1H NMR spectrum (Scheme 86). By 
analogy with the work by Polniaszek et. a/.,67 the required (S)-stereochemistry for 
the natural product should be present at the newly-formed stereogenic centre of 
the major diastereoisomer (189a).
O N' 0H +
Me''^ Ph
=#==<
SiMe^
CrH6 n 13
186
SnCI4, CH2CI2, 
-78 °C
188
189a:189b = 2.5:1
N(S)
C«H6 n 13
o N't*)"
Me"''^ Ph
C«H6 n 13
o N
Me'''^ Ph
189a
45%
189b 190
40%
Scheme 86
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The mechanism is believed to involve initial nucleophilic addition of the 
allenylsilane, followed by elimination of chlorotrimethylsilane to afford the desired 
product (Scheme 87).
Scheme 87
Although synthetically a very useful and novel reaction, it is not without its 
disadvantages. The allene itself is expensive and non-trivial to synthesise, and 
three equivalents are required for the reaction. The low yield is not surprising, 
with 40% of undesired pyrrolidinone 190 isolated. This is probably due to 
tautomerism of the iminium ion competing with nucleophilic substitution of the 
allene.
However, despite these limitations, a substantial quantity of compound 189a was 
synthesised.
c?
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4.3. Synthesis of the Bicvclic Guanidine Core of Batzelladine C
With the propargylic lactam in hand (unfortunately, the isomers were inseparable 
by column chromatography), the next synthetic step was removal of the chiral 
directing group. While the phenylethyl group was removed, the alkyne moiety 
was surprisingly left untouched by the reductive conditions.69 Further reduction of 
the alkyne moiety to the Z-alkene with nickel-boride70 then afforded alkenyl 
lactam 192 (Scheme 88). Both steps proceeded in very high yield, with no 
requirement for purification.
Me"' Ph
I3  /C 6H13
Scheme 88
Na, NH3 -EtOH-THF,
-78 °C
-------------------------   0  N
r a  ^
'
H
100%
189a 191
97% Nickel-boride, NH2 (CH2 )2 NH2 , EtOH
O NH C6H13
192
Lactam 192 was first protected as the tert-butyl carbamate derivative, and then 
reacted under the group’s novel conditions for alkylidenepyrroiidine formation38 
(Scheme 89).
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N 
H
192
CrH6r ,13
Boc20, NEt3l 
DMAP, CH2 CI2
94%
N 
Boc
193
C6H1:
LDA, Methyl acetate, 
THF, -78 °C, 93%
MeO
BocHN
6n 13
I
194
Scheme 89
Conversion to alkylidenepyrrolidine 195 was then achieved by treating 
ring-opened carbamate 194 with an excess of trifluoroacetic acid (Scheme 90).
MeO
BocHN
194
-C6HTFA (>4 equiv), CH2 CI2, rt
81%
195
Scheme 90
Upon analysis of the NMR data, it was found that alkylidenepyrrolidine 195 had 
isomerised to afford a mixture of E/Z geometrical isomers. By measurement of 
the alkene CH peaks from the 13C NMR of alkylidenepyrrolidine 195, the E/Z ratio 
was estimated to be at least 3:1.
Analysis of the coupling constants from the 1H NMR spectrum of the alkene OH 
peaks confirmed that the E-alkene was present. The alkene coupling constant for 
compound 194 was 10.8 Hz, while the corresponding coupling constant for 
compound 195 was 15.2 Hz (a trans alkene would be expected to have coupling 
constants in the range of 12 -18 Hz) (Figure 24).
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o
MeO
Hb
Ha: 5.46 (1H, apparent dt, J 10.9 & 7.3)
0 H Hb: 5.27 (1H, m, apparent dt, J 10.9 & 7.5)
BocHN
194
Me02C
Ha: 5.49 (1H, apparent dt, J 15.2 & 6.7) 
Hb: 5.28 (1H, apparent dt, J 15.2 & 7.1)
195
Figure 24
Nevertheless, we saw no reason why the outcome of the subsequent 
iodocyclisation reaction would depend on the double-bond geometry, and 
continued with the synthesis.
The three-component coupling was then employed to construct the bicyclic 
pyrimidine core of Batzelladine C, with the correct length side-chain (pentyl) for 
the natural product (Scheme 91).
CeHi3 TMS-NCS, CgHnCHO 
CH2CI2, rt, 3 h
H
196a (58%)
82%
+
195 196a:196b = 2:1 iv
196b (24%)
Scheme 91
89
The 1H NMR spectrum of the three-component coupling reaction was analysed in 
the same manner as before (see Chapter Two) (Figure 25)
15.0
— 10.0
- 5 .0
0.0
5.00 4.90 4.80 4.70 4.60 4.50 4.40 4.30
ppm (t1)
Figure 25
Figure 25 shows an expansion of the 1H NMR spectrum for diastereoisomers 
196a and 196b. The two key signals, at 4.82 and 4.49ppm respectively, show an 
approximate ratio of 2:1. The chemical shift of the 5-H in the major 
diastereoisomer (196a) is upfield of that of the minor isomer, implying that the 
relative stereochemistry of the protons across the pyrrolo[1,2-c]pyrimidine rings 
once again is trans.
Following column chromatography, the two diastereoisomers were isolated in 
approximately the same ratio.
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With the major isomer isolated, the required guanidine was then formed. The 
thiourea was first heated under reflux with iodomethane, and then treated with 
ammonia and ammonium acetate, before being heated in a sealed tube.34 
Following purification on a silica gel column with a small amount of formic acid in 
the eluent, guanidine 197 was isolated as the formate salt (Scheme 92).
Scheme 92
The guanidine (predominately as the E-isomer) was reacted then under 
iodocyclisation conditions previously used within the group (see Chapter One, 
Page 20).37
Disappointingly, guanidine 197 failed to cyclise (Scheme 93).
Scheme 93
While there is no literature precedent for this type of intramolecular iodoamination 
with a trans-alkene, we see no discernible reasons why cyclisation should be 
disfavoured.
We have attempted to suppress the proportion of E-isomer at the 
alkylidenepyrrolidine formation stage; however, reducing the equivalents or using
Mel, MeOH; then 
NH3, NH4 OAc, sealed tube, 
80 °C, 48 h
196a 197
I2, K2CO3, 
MeCN, rt, 3 h
197 198
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alternative acids failed to hinder isomerism, and also led to greatly reduced 
yields.
While the iodocyclisation was being developed within the group,37 the Gin group 
published their synthesis of batzelladine D, employing a similar intramolecular 
iodoamination of a cis-alkene (Scheme 94).27
AcO
BocN
C8HNHBoc NHPMBMe'
199
i2, k2 c o 3, dme,
70%
o
ABocN
NHBoc
PMB
200
Scheme 94
It is unclear whether the cis-alkene is a requirement for iodocyclisation in this 
instance, as reaction of the trans-alkene isn’t reported.
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4.4 Conclusions
To summarise, we have developed an efficient, diastereoselective route to the 
bicyclic core of batzelladine C, with a novel addition of an allenylsilane to a chiral 
/V-acyliminium ion, and a modified version of the Kishi three-component coupling 
used as key synthetic steps.
However, this approach suffers from a number of shortcomings. The allenylsilane 
(188) is expensive to prepare, and is used in excess. More importantly, the 
E-double bond in the pyrrolidine side-chain fails to undergo the required 
iodocyclisation, whereas literature precedent27 suggests that the corresponding 
Z-isomer will permit formation of the tricyclic guanidine core.
Chapter Five will discuss a second-generation synthetic route towards 
batzelladine C, where problems encountered with the present route were tackled 
and solved.
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Chapter Five
A Diastereoselective Synthesis of 
Batzelladine C Ethyl Ester
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5.1 Introduction
In light of the problems encountered with the previous route to batzelladine C, in 
particular the failure of the intramolecular iodoamination with an E-alkene and 
number of equivalents required for the allenylsilane reaction, a
second-generation synthesis was devised. The retrosynthetic approach is 
illustrated in Scheme 95.
Eschenmoser 
sulphide contraction
0 = = »  s
R* R*
175 204
Scheme 95
Following the first-generation approach (see Chapter Four), it is now known that 
a Z-alkene is mandatory for the intramolecular iodocyclisation. Our common 
synthetic intermediate, the alkylidenepyrrolidine (201), will be synthesised via an 
Eschenmoser sulphide contraction,49 negating any problems associated with 
double-bond isomerism. Thiolactam 202 can be disconnected further to allyl 
lactam 204, with a chiral directing group employed to influence the 
stereochemistry.
As with the first-generation synthesis (see Chapter Four), succinic anhydride was 
used as the building block.
5.2 A Second-Generation Synthetic Approach to Batzelladine C
The first synthetic steps proceeded as before, with condensation of commercially 
available succinic anhydride with (S)-phenylethylamine, followed by a 
chemoselective reduction of the imide carbonyl to produce compound 186 
(Scheme 96).
Scheme 96
As previously mentioned, the Polniaszek group have described the 
diastereoselective addition of 7c-nucleophiles to chiral A/-acyliminium ions 
(Scheme 97).67 Chlorination of the aromatic moiety was found to drastically 
affect the stereochemical outcome of the reaction. Various experimental and 
theoretical studies ascertained that the stereoselectivity of the coupling was 
influenced by subtle electronic interactions of the nucleophile with the aromatic 
system, rather than solely by steric factors.
(i) (S)-phenylethylamine, toluene; 
then CDI, THF, reflux
(ii) Super-hydride, THF
184
87% Me'' Ph 
186
96
Me Ar
SnCL
186
Me'
205a
+ 0^> ..
Me'" Ar 
205b
Ar Yield
Ratio of 
diastereoisomers 
205a:205b
Ph 90% 82:18
2-CIC6 H4 90% 71:29
2,6-CIC6 H3 91% 9:91
CI5 C6 CI5 91% 3:97
Scheme 97
With the prospect of a much improved diastereomeric ratio and yield, as well as 
replacing expensive allenylsilane 188 with commercially available 
allyltrimethylsilane, we were soon in a position to synthesise multigram quantities 
of material. With phenyl as the stereochemical directing group, major isomer 
206a possesses the correct stereochemistry for the natural product core 
(Scheme 98, Compounds 3 and 206a).
In our hands, both boron trifluoride and tin(IV) chloride resulted in very similar 
stereoselectivities and yields, but boron trifluoride was preferred for its low 
toxicity. Although the diastereoisomers were inseparable by column 
chromatography, the peaks for the major diastereoisomer from the 1H NMR of 
the crude reaction mixture was in line with the literature data for compound 
206a,67'71 confirming that the major isomer had the required (S)-stereochemistry 
at position 5 (Scheme 98).
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o N
Me"'^Ph
186
OH
BF3.OEt2, allyl-TMS, 
CH2CI2, -78 °C,
95%
206a:206b = 5.5:1 206a
O N
AMe Ph 
206b
H
HN
Batzelladine C (3)
Scheme 98
To introduce the required alkyl chain for the natural product, the terminal alkene 
was first oxidatively cleaved with 0 s0 4-Nal04,53 affording aldehyde 207. A Wittig 
reaction then proceeded smoothly to give alkenyl lactam 208 (Scheme 99), with 
no chromatography problems encountered regarding removal of excess 
phosphonium salts. The Wittig reaction could be used on scales up to 5g of 
aldehyde.
K20 s0 4.2H20, Nal04 
2,6-lutidine, Dioxane-H20
90%
O N
Me'''^Ph
O
206a 207
C7H15PPh3l, n-BuLi, 
THF
O
56%
N
Me"'^Ph
208
ZIE >15:1 
\
^ 6  hi 13
Scheme 99
98
Pleasingly, analysis of the 13C NMR spectrum of compound 208 showed a very 
high proportion of Z-isomer, with less than 5% of the unwanted E-isomer 
observed (see comparison with Chapter Four). This was also corroborated by the 
1H NMR data from the alkene CH proton signals at a later step in the sequence 
(see Compound 211a), with a coupling constant of 10.8 Hz measured.
With multigram quantities of alkenyl lactam in hand, the chiral directing group 
was removed, giving deprotected compound 192 in quantitative yield and very 
high purity.
Thiolactam 209, the starting material for the Eschenmoser sulphide contraction72 
was then prepared from by reaction with Lawesson’s reagent (Scheme 100).
Na, NH3 -EtOH-THF
100%
208 192
Lawesson's reagent, 
THF, 90%
209
Scheme 100
An Eschenmoser sulphide contraction of 209 then afforded alkylidenepyrrolidine 
210, with the required Z-double-bond geometry still in place (Scheme 101). 
Unfortunately, scaling up the reaction resulted in a significant reduction in yield. 
The purity of the potassium te/t-butoxide may be a factor in these inconsistent 
yields. We were still able to synthesise sufficient quantities (>2 grams) of 
alkylidenepyrrolidine with which to continue the synthesis.
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sBrCH2C02Et, CH2CI2; 
then PPh3, KO'Bu, 
Xylene, reflux
62% (500 mg scale)
Et02C H
209 210
Scheme 101
The alkylidenepyrrolidine was then treated to the standard three-component 
coupling conditions, yielding diastereoisomers 211a and 211b in a 2.1:1 ratio 
(Scheme 102). The chemical shifts of 5-H in the major and minor isomers are in 
line with those previously observed with CH2OTBS and allyl directing groups, so 
that we once again assign the relative trans stereochemistry for the major 
isomer.
Scheme 102
However, all of these stereochemical assignments stem from observation of a 
very weak nOe in the initial synthetic studies.34 We therefore sought conclusive 
evidence.
211b (28%)
100
5.3 Determination of the Three-Component Coupling Stereochemistry
We felt that the combination of an allyl directing group and a methyl ester 
provided the best chance of producing a crystalline compound to prove the 
stereochemistry. Beginning with allyl lactam 206a, alkylidenepyrrolidine 112 was 
formed in 4 steps (Scheme 103) using the Elliott group’s methodology.38
Scheme 103
The three-component coupling was then carried out, with a diastereomeric ratio 
of 1.8:1 observed (Scheme 104).
Scheme 104
Compounds 113 and 114 were readily separated by column chromatography, 
with both isomers pleasingly in solid form.
Various methods were then employed to attempt recrystallisation of the major 
isomer, including mixed and single solvent methods. As with the acylation studies 
(see Chapter Two), the trusty ethanol-water combination produced high quality 
crystals of the major diastereoisomer. The crystal structure gave us the result we
, k Ph
(i) Na, NH3 -EtOH-THF 
(ii) Boc20, NEt3, DMAP, CH2 CI2  
(iii) CH3 C0 2 Me, LDA, THF 
(iv) TFA
206a 6 6 % overall yield 112
Me02C H
\\ c 5 h„cho, tms-ncs, MeQ c
/  CH2 CI2, rt, 1 h 2
90% 
113:114 = 1.8:1
CsHn'
112 113 114
1 0 1
were expecting; the relationship between protons Ha & Hb (compound 113) 
(Figure 26) was indeed trans.
M6O2C
113
Figure 26
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5.4 Construction of the Tricyclic Core of the Natural Product
Having carried out the three-component coupling with the alkenyl directing group 
(see Section 5.2), the major diastereoisomer (211a) was isolated. The next 
synthetic goal was to convert the thiourea moiety into a guanidine (Scheme 105).
Scheme 105
Following straightforward column chromatography, guanidine 212 was isolated 
as the formate salt, still predominately as the Z geometrical isomer (Z:E >18:1). 
The guanidine was then treated under iodocyclisation (see Chapter Four, Page 
88) conditions. Very encouragingly, the intramolecular iodoamination proceeded 
efficiently, affording tricyclic guanidine 213 in excellent yield (Scheme 106). A 
simple flash silica gel column provided very clean material, with the 1H NMR 
spectrum clearly showing the presence of a single diastereoisomer (see Figure 
34). There is literature precedent for this type of intramolecular iodoamination 
proceeding with complete diastereocontrol.27
Mel, MeOH; 
then NH3, NH4 OAc, sealed 
tube, 80 °C, 60 h
H H
2 1 1 a 212
l2, K2 C03, MeCN
Crude yield -  93%
212 213
Scheme 106
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Because of the potentially unstable nature of tricyclic iodo-guanidine 213, the 
iodine was immediately removed by palladium in the presence of a hydrogen 
atmosphere.73 A swift filtration through Celite®, followed by a flash silica gel 
column afforded the de-iodinated guanidine 213a in high purity and good yield 
(Scheme 107).
* ° 2c y L NXh
H2, Pd/C, NEt3, 
EtOAc, rt Et02C^
J  \cvH
c5h,1""^n^n'^YC6H' 15 11 H j
86% CsHu"'
I N N ^C7H15 H
213 213a
Scheme 107
We know that the relative stereochemistry between H-8 and H-12 in compound 
213a is anti. This is by analogy with the crystal structure data from compound 
113 (see Section 5.3) (Figure 27).
H
C7h15
213a
Figure 27
Et02C
CsHi 1 - N N H H
To determine the relative stereochemistry of protons H-8 and H-10, NOESY 
spectroscopy was employed. Figure 28 shows the g-NOESY spectrum of 
compound 213a.
104
ppm (12)
Figure 28 - g-NOESY NMR Spectrum of Compound 213a (500 MHz; 
MeOH-d4)
Figure 28 highlights the key area of the 1H NMR from 1 . 5 - 5  ppm, with the 
relevant peaks labelled. The key diagnostic cross-peaks (H8, H9a/p & H10) are 
marked in red, with all other cross-peaks assigned on the spectrum.
H8 shows a cross-peak to H9p, but not to H9a. H9p in turn shows a cross-peak 
to H10, therefore protons H8, H9p and H10 are on the same face of the tricyclic 
system.
The stereochemistry of compound 213a is therefore assigned as follows (Figure 
29).
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Figure 29
The relative H-8 and H-10 stereochemistry is therefore the same as that of 
batzelladine C, so that compound 213a is one of the two possible 
diastereoisomers of batzelladine C ethyl ester. However, the stereochemistry of 
H-12 in batzelladine C could not be determined spectroscopically (Figure 30).
The structures of synthetic tricyclic guanidine 213a, batzelladine C and 
batzelladine D are shown in Figure 30. For comparison purposes, the carbon 
atoms of each guanidine are numbered.
C5H-m'12
13-17
H15 Me''i2 
18-24  13-17
9
H
19 
18-24
15 
18-24
C 5 H 1 1  
13 -17
213a Batzelladine C (3) Batzelladine D (4)
Figure 30
With the tricyclic guanidine cores of batzelladines A, D, F -  I and K - M, there is a 
common trend in the relative stereochemistry of H-8 and H-12 (Figure 31). When 
there is an ester group at the 4-position (compound 214), H-8 and H-12 are anti 
to each other. When there is no group on the 4-position (compound 215), the two 
protons are syn to each other.
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Figure 31
Therefore, according to this precedent, H-12 will most likely be anti to H-8 in 
batzelladine C (Figure 32).
Batzelladine C (3)
Figure 32
The 1H NMR spectra of batzelladine C and compound 213a (Figures 33 & 34 
respectively) show considerable similarities, although some differences were 
observed.
13-17 18-24
Batzelladine C (3)
6a 74/-
W 7 „
A  K
oCM"r*moCDcr»
CMCMCM
3.03.5
Figure 3 3 - 1H NMR Spectrum of Batzelladine C (3)1 74 (400 MHz; MeOH-d4)
- 1 0 0
13-17 18-24
213a
6 a - 5 0
-0
4.00 3.50 3.00 2.50
ppm (t1)
Figure 34 -  1H NMR Spectrum of Compound 213a (500 MHz; MeOH-c/4)
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The coupling constants for protons 6a and 60 in compound 213a (H6a: 
18.8/11.2/8.3 Hz, H6p: 18.8/9.3 Hz) differ considerably from those of batzelladine 
C (3) (H6a: 14/8/6 Hz; H6p: 14/6 Hz). However, upon examination of the 1H NMR 
spectrum of the natural product, it appeared that these coupling constants might 
be in error. Since the spectrum of the natural product provided in the original 
report did not contain a peak-pick, we were unable to calculate the coupling 
constants precisely. However, a crude measurement from the spectrum gives 
coupling constants in line with our own data, so that we are not concerned about 
this discrepancy.
The other key difference is in the chemical shift of H8, which is approximately 0.2 
ppm downfield in compound 213a compared to the natural product.
The 13C NMR data of the key carbon peaks in both batzelladine C and compound 
213a are shown in Table 4, with the differences between the two values as a 
point of comparison.
6c
(batzelladine C, 
formate salt)
6C
(compound
213a)
A5C
2 65.0 60.8 -4.2
3 166.3 164.4 -1.9
4 101.2 103.4 +2.2
5 150.4 148.9 -1.9
6 31.5 31.7 +0.2
7 30.3 31.2 +0.9
8 58.6 57.2 -1.4
9 32.9 33.8 +0.9
10 53.5 51.2 -2.3
11 149.9 148.1 -1.8
12 52.2 50.7 -1.5
13 38.2 36.9 -1.3
18 35.8 34.5 -1.3
Table 4
109
Although there are differences between the chemical shifts of compound 213a 
and batzelladine C, the A5C are generally similar (typically -1.5 to -2.5 ppm, with 
the exception of the few anomalies highlighted in blue).
However, the natural product has been isolated as the formate salt (clearly 
indicated by a broad singlet at ca. 8 ppm in the 1H NMR spectrum), whereas 
213a is isolated as the free guanidine. Therefore, any chemical shift differences 
from the 1H and 13C NMR spectra may be because of this fact.
The optical rotation of 213a has the same sign as the natural product data ([a]o: - 
150° (c = 0.2, CH2CI2), [a]D: -30° (c 0.2, MeOH); lit.1: batzelladine C: [a]D: -3.7° (c 
2.4, MeOH), batzelladine C methyl ester. [a]o: -4.2° (c 0.93, MeOH).
Others30 have noted significant discrepancies in the specific optical rotations of 
natural and synthetic batzelladine D, which have subsequently been attributed to 
purity.
Figure 35 compares compound 213a to the two possible diastereoisomers of 
batzelladine C, compounds 216 and 217.
Because our data is very similar, but not quite identical to that of the natural 
product, we cannot be 100% certain that 213a corresponds to the natural product 
stereochemistry (Figure 35). We still feel that according to the general 
stereochemical trends for the tricyclic cores of the batzelladines (see Figure 31), 
diastereoisomer 216 has the most likely stereochemistry for batzelladine C.
213a Batzelladine C - diastereoisomer 1 (216)
Batzelladine C - 
diastereosiomer 2 (217)
Figure 35
1 1 0
5.5 Further Manipulation of the Tricyclic Guanidine Core
In order to achieve our original goals, that being the synthesis of Batzelladine C, 
a few functional group modifications were required. Firstly, the ethyl ester has to 
be exchanged with the required alkyl guanidine side-chain (Scheme 108).
Scheme 108
Because of its nucleophilic nature, the guanidine unit was first protected. The 
tert-butyl carbamate was found to be the most apposite choice, as it should be 
robust enough to survive the ensuing steps, and labile enough to be deprotected 
in the final step. Free guanidine 213a was therefore treated to the standard 
Boc-protection conditions to afford compound 218 (Scheme 109). The structure 
of 219 was confirmed by comparison with the chemical shift of H-12 from the 
starting material. The regioselectivity of this step is surprising, since the two 
nucleophilic guanidine nitrogen atoms are in extremely similar environments.
H
Exchange 
ester side-chains
213a Batzelladine C (3)
1 1 1
Et02C. 
C5H , f ^ N ^ N ^ C 7H,5
Et02C
’C7H
213a
Boc20 , NEt3) DMAP, 
CH2CI2, rt
218 (82%)
Et02C
CsHu''' N N X 7H
219 (0% )
15
Scheme 109
Boc-protected guanidine 218 was then hydrolysed with a concentrated sodium 
hydroxide solution in methanol (Scheme 110).75
h o 2C
Et02C
NaOH, MeOH, 
sealed tube, 100 °C, 
18 h
CgH^" N N C7H15
C5H •(-('' N N X 7H
(-34%)
15
h o 2c
CsHu'" N N ^ C 7H15 H
221
(-66%)
Scheme 110
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However, instead of desired compound 220, an inseparable mixture of 
Boc-protected acid (220; -34% - estimated from the 1H NMR spectrum) and 
deprotected acid 221 (-66%) was obtained. This result is not too surprising, as 
te/f-butyl carbamate groups are often labile under relatively high temperature, 
basic conditions.
We then decided to alter the order of steps. A modified retrosynthesis to the 
natural product is covered in Scheme 111.
H2N N
N
A  ^c5h u "  n n ^ c 7h15H
H 
.N
NBoc
BocH N y  
OEt
C6H
2 1 1 a
CsHu'" N NHM
223
R = C02H
CrH6 n 13
CgHn'' N S CrH6 n 13
Scheme 111
H
BocHN^.N.
T
NBoc
'OH
Thiourea 211a can be readily protected as the S-methyl isothiourea, allowing 
ester hydrolysis76 to be carried out to produce carboxylic acid 222. Acid-alcohol 
coupling77,78 then installs the alkyl guanidine side-chain, followed by functional 
group interconversion to the guanidine (223).28 It is then expected that formation
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of the tricyclic core will be accomplished by the previously employed 
iodocyclisation conditions.
This approach began with protection of compounds 211a/b with iodomethane, 
yielding S-methyl isothiourea 224. It was discovered that this step is 
chemoselective, with only the major diastereoisomer becoming alkylated 
(Scheme 112). This negated the need to separate the stereoisomers prior to 
S-methylation.
Scheme 112
Having isolated the S-methylisothiourea, it was then hydrolysed76 to afford acid 
225 (Scheme 113), with purification taking place on a swift flash silica gel 
column.
Me
224
80 % (based on 
amount of 2 1 1 a)Mel; CH2 CI2, reflux, 
13h
2 1 1 b
(recovered 
minor isomer)
NaOH, MeOH, 
sealed tube, 100 °C, 
18 h
75%Me Me
224 225
Scheme 113
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With carboxylic acid 225 in hand, a coupling with the requisite alkyl guanidine 
was attempted. Mesylate 226 (prepared in 3 steps from thiourea),79 caesium 
carbonate and the carboxylic acid were reacted together (Scheme 114).
ho2c
CgHn'' n  s
C«H6n 13 BocN^^NHBoc
CS2 CO3 , DMF, 
40 °C 
 X *
N
BocHN ^  N 
H
HN
Me
C6 H1;
227
226
Scheme 114
Unfortunately, 1H NMR, 13C NMR and mass spectrometry confirmed that only 
starting material was present, with no sign of the coupled product (227).
Guanidine ester formation was also attempted with the reaction of carboxylic acid 
225, alcohol guanidine 228 and a coupling reagent; BOP-CI (Scheme 115).
ho2c
C5HAf  N S crh6r ,13
,BocN
X  ^  ^
BocHN N^ 2  OH 
H
228
Scheme 115
BocN^^NHBoc
BOP-CI, NEt3, 
CH2 CI2) rt
 x------
HN
c6h
Me
227
However, this reaction was also unsuccessful.
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5.6 Conclusions & Future Work
In summary, we have developed a diastereoselective, efficient synthetic route to 
the tricyclic guanidine core of batzelladine C, with no requirement for protecting 
groups. The spectroscopic data recorded for compound 213a does have a few 
discrepancies with the natural product data,1 therefore the stereochemistry of 
batzelladine C either corresponds to that of compound 213a, or its epimer, 
compound 213b.
Recently, 213b has been prepared within the group.80 Beginning at the bicyclic 
thiourea stage, minor diastereoisomer 229b was first converted to the guanidine, 
and then iodocyclised with iodine monochloride to again form the tricyclic 
guanidine core. Compound 213b (with protons H-8 and H-12 syn to each other) 
was isolated in highly pure form following a reductive de-iodination (Scheme 
116).
213a229a (Major)
+
sH
11
229b (Minor)
(i) Mel, MeOH; 
then NH3, NH4OAc,
sealed tube
(ii) ICI, MeCN
(iii) H2, Pd/C, 
NEt3, EtOAc
r
Me02C.
J ±2 A  X V\H
C5H-11* h K n vc7h15
213b
Scheme 116
The 1H NMR spectrum of compound 213b is virtually identical to that of the 
natural product, in particular the relative position of proton H-8 (which was ca. 0.2
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ppm downfield in the 1H NMR spectrum of compound 213a; see Figures 33 & 
34). The coupling patterns, particularly protons 6(3 and 6a, are also extremely 
similar.
We therefore have conclusive evidence of the stereochemistry of batzelladine C.
With compound 213b in hand, only three steps (including transesterification and 
reduction of the subsequent alkyl azide) will be required to complete the first 
synthesis of batzelladine C.
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Chapter 6
Experimental Section
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6.1. General Experimental Points
Melting points were determined on a Gallenkamp melting point apparatus and 
are uncorrected. Mass spectra were recorded on a Fisons VG Platform II 
spectrometer, a Micromass Q-TOF Micro spectrometer. A Waters 2795 Alliance 
HT Separation Module, a Micromass ZMD and a Waters Photodiode Array 
Detector along with a Phenomenex Gemini 5 micron C18 110A 50 x 2mm 
Column were used for LC-MS. NMR spectra were recorded on a Bruker DPX 400 
spectrometer or Bruker Avance 400 spectrometer operating at 400 MHz for 1H 
and at 100 MHz for 13C at 25 °C, or on a Bruker Avance 500 spectrometer 
operating at 500 MHz for 1H and 125 MHz for 13C at 25 °C. All chemical shifts are 
reported in ppm downfield from TMS. Coupling constants (J) are reported in Hz. 
Multiplicity in 1H NMR is reported as singlet (s), doublet (d), double doublet (dd), 
double double doublet (ddd), double double double doublet (dddd), double 
double triplet (ddt) double triplet (dt), double quartet (dq), triplet (t), triple triplet 
(tt), quartet (q) and multiplet (m). Multiplicity in the 13C NMR was obtained using 
the DEPT pulse sequence. Column chromatography was obtained using Matrex 
silica 60 35-70 micron, and Silicycle Silicaflash Prepacked Silica Cartridges.
Compound 230 was kindly prepared by Stuart Wordingham.
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6.2. Experimental Data for Chapter 2
A/-Phenyl-2-pyrrolidin-(2E)-ylidene-malonamic acid ethyl ester (79) and 
(1-Phenylcarbamoyl-pyrrolidin-(2£)-ylidene)-acetic acid ethyl ester (74)
. . . EtOoC—NHPh ^  NHPh
*
62 79 74
(2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester was prepared according to ref. 
38.
Phenyl isocyanate (89 pL, 0.8 mmol) was added to a solution of (2Z)-Pyrrolidin-2- 
ylidene-acetic acid ethyl ester38 (106 mg, 0.7 mmol) in dry CHCb (6 mL), and the 
reaction stirred at rt for 18 h under N2. The solvent was then removed in vacuo, 
and the resulting orange oil (79:74=2.1:1) purified by column chromatography 
(eluting with EtOAc-Hexane, 4.5:7) to afford title compounds 79 (Rf 0.8; yellow 
solid) and 74 (Rf 0.37; colourless solid).
N-Phenyl-2-pyrrolidin-(2E)-ylidene-malonamic acid ethyl ester (79; 99 mg, 53%); 
Mp: 7 6 -7 8  °C.
6h (400 MHz; CDCI3): 11.44 (1H, broad s, CH2Nhi), 11.29 (1H, broad s, PhNH), 
7.50 (2H, d, J 7.6, aromatic CH), 7.21 (2H, apparent t, J 7.9, aromatic CH), 6.95 
(1H, t, J 7.4, aromatic CH), 4.14 (2H, q, J 7.1, C02CH2CH3), 3.52 (2H, t, J 7.7, 
CH2NH), 3.11 (2H, t, J 7.9, CH2C=C), 1.91 (2H, m, CH2CH2NH) and 1.25 (3H, t, J
7.1, C02CH2CH3).
5C (100 MHz; CDCI3): 174.9 (C=C-C02Et), 169.9 (C=0), 168.9 (C=0), 139.2 
(aromatic C), 128.7 (aromatic CH), 123.0 (aromatic CH), 120.6 (aromatic CH),
1 2 0
87.0 (C=C-C02Et), 59.9 (C02CH2CH3), 47.7 (CH2NH), 36.5 (CH2C=C), 21.3 
(CH2CH2NH) and 14.6 (C02CH2CH3).
IR (solution in CH2CI2): 3236, 1650 and 1614 cm'1.
MS-ES: m/z (%): 297 (MNa+, 7); 275 (MH+, 2); 182 (100).
HRMS-ES: m/z [MH]+: found: 275.1373; C i5Hi9N20 3 requires 275.1396.
(1-Phenylcarbamoyl-pyrrolidin-(2E)-ylidene)-acetic acid ethyl ester (74; 38 mg, 
20%):
Mp: 127-  129 °C (lit.40m.p. 128 °C).
5h (400 MHz; CDCI3): 7.31 (2H, d, J 7.7, aromatic CH), 7.22 (2H, apparent t, J 
7.9, aromatic CH), 7.01 (1H, t, J 7A, aromatic CH), 6.95 (1H, broad s, NHPh), 
6.34 (1H, apparent t, J 1.6, CH=C), 4.03 (2H, q, J 7.1, C 02CH2CH3), 3.64 (2H, t, 
J 7.1, CH2NCO), 3.12 (2H, apparent dt, J 1.6 & 7.8, CH2C=C), 1.87 (2H, 
apparent quintet, J 7.4, CH2CH2NCO) and 1.16 (3H, t, J 7.1, C 02CH2CH3).
5c (100 MHz; CDCI3): 168.9 (ester C=0), 158.2 (C=CH-C02Et), 152.1 (urea 
C=0), 137.5 (aromatic C), 129.0 (aromatic CH), 124.3 (aromatic CH), 120.7 
(aromatic CH), 95.6 (C=CH-C02Et), 59.4 (C02CH2), 49.4 (CH2NCO), 31.9 
(CH2C=C), 21.1 (CH2CH2NCO) and 14.5 (CH3CH2OCO).
IR (solution in CH2CI2): 3377, 1689, 1660 and 1594 cm'1.
MS-ES: m/z (%): 275 (MH+, 55); 156 (100).
HRMS-ES: m/z [MH]+: found: 275.1397; C i5Hi9N20 3 requires 275.1396.
1 2 1
A/-Benzyl-2-pyrrolidin-(2E)-ylidene-malonamic acid ethyl ester (80) and 
(1-Benzylcarbamoyl-pyrrolidin-(2E)-ylidene)-acetic acid ethyl ester
(72)
NHBn
NHNH
8062
+
72
Benzyl isocyanate (80 pL, 0.7 mmol) was added to a solution of (2Z)-Pyrrolidin-2- 
ylidene acetic acid ethyl ester (103 mg, 0.7 mmol) in dry CHCI3  ( 6  mL), and the 
reaction stirred at rt for 18 h under N2 . The solvent was then removed in vacuo 
and the resulting orange oil (80:72=1:2) purified by column chromatography 
(eluting with EtOAc-Hexane, 3:7) yielding, in order of elution, title compounds D 
(Rf = 0.41; yellow solid) and E (Rf = 0.18; off-white solid).
N-Benzyl-2-pyrrolidin-(2E)-ylidene-malonamic acid ethyl ester (D; 25 mg, 13%): 
Mp: 9 5 - 9 8  °C.
5h (400 MHz; CDCI3): 11.40 (1H, s, CH2 NH), 9.51 (1H, m, PhCH2 NH), 7.27 7.18 
(5H, m, aromatic CH), 4.43 (2H, d, J 5.7, PhCH2 NH), 4.09 (2H, q, J 7.1, 
C0 2 CH2 CH3), 3.50 (2H, t, J 7.4, CH2 NH), 3.09 (2H, t, J 7.9, CH2 C=C), 1.92 (2 H, 
apparent quintet, J 7.7, CH2 CH2 NH) and 1.22 (3H, t, J 7.1, C 0 2 CH2 CH3).
5c (100 MHz; CDCI3): 174.4 (C=C-C02 Et), 170.5 (C=0), 169.7 (C=0), 139.6 
(aromatic C), 128.5 (aromatic CH), 127.3 (aromatic CH), 126.8 (aromatic CH), 
8 6 . 6  (C=C-C02 Et), 59.5 (C0 2 CH2 CH3), 47.5 (PhCH2 NH), 43.0 (CH2 NH), 36.2 
(CH2 C=C), 21.4 (CH2 CH2 NH) and 14.6 (C0 2 CH2 CH3).
IR (solution in CH2 CI2): 3408, 1639 and 1594 cm'1.
MS-ES: m/z (%): 289 (MH+, 10); 182 (100).
HRMS-ES: m/z [MH]+: found: 289.1548; Ci6H2 2 N2 0 3  requires 289.1552.
1 2 2
(1-Benzylcarbamoyl-pyrrolidin-(2E)-ylidene)-acetic acid ethyl ester (E; 48 mg, 
25%):
Mp: 88 -  92 °C (lit.40 mp 86 °C).
5h (400 MHz; CDCI3): 7.28 -  7.14 (5H, m, aromatic CH), 6.41 (1H, apparent t, J
1.7, CH=C), 5.32 (1H, broad s, NHCH2Ph), 4.38 (2H, d, J 5.6, NHCH2Ph), 4.02 
(2H, q, J 7.1, C02CH2CH3), 3.54 (2H, t, J 7.1, CH2NCO), 3.11 (2H, apparent dt, J 
1.7 & 7.8, CH2-C=C), 1.87 (2H, apparent quintet, J 7.5, CH2CH2NCO) and 1.16 
(3H, t, J7.1, C02CH2CH3).
6c (100 MHz; CDCI3): 169.1 (ester C=0), 158.3 (C=C-C02Et), 154.5 (urea C=0), 
158.5 (aromatic C), 128.7 (aromatic CH), 127.7 (aromatic CH), 127.5 (aromatic 
CH), 95.0 (C=C-C02Et), 59.2 (C02CH2CH3), 49.1 (NHCH2Ph), 44.5 (CH2NCO),
31.8 (CH2C=C), 21.1 (CH2CH2NCO) and 14.5 (C02CH2CH3).
IR (nujol): 3357, 1669 and 1604 cm'1.
MS-ES: m/z (%): 329 (M+Na+H20, 65); 156 (100).
HRMS-ES: m/z [M H f: found: 289.1548; C16H22N20 3 requires 289.1552.
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A/-Butyl-2-pyrrolidin-(2E)-ylidene-malonamic acid ethyl ester (81) and 
[1-n-Butyl carbamoyl-pyrrolidin-(2E)-ylidene]-acetic acid ethyl ester
(70)
NH
62
Et02C NHn-Bu
NH
81
+
70
NHn-Bu
A .
(2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (147 mg, 0.9 mmol) was 
dissolved in pyridine (0.5 mL), and butyl isocyanate (128 pL, 1.1 mmol) added. 
The solution was stirred at 100 °C in a sealed tube for 65 h, after which time the 
solvent was removed under reduced pressure. The resultant dark brown oil 
(81:70=2.3:1) was purified by column chromatography (eluting with 
EtOAc-Hexane, 4:7), yielding title compounds 81 (Rf = 0.33; yellow oil) and 70 (Rf 
= 0.11; pale yellow oil) in order of elution.
N-Butyl-2-pyrrolidin-(2E)-ylidene-malonamic acid ethyl ester (81; 156 mg, 65%): 
6h (400 MHz; CDCI3): 11.45 (1H, broad s, CH2NH), 9.10 (1H, broad s, 
CH2NHCO), 4.10 (2H, q, J 7.1, C02CH2), 3.51 (2H, t, J 7.4, CH2NH), 3.21 (2H, 
apparent q, J 6.5, CH2NHCO), 3.08 (2H, t, J 7.9, CH2C=C), 1.93 (2H, apparent 
quintet, J 7.7, CH2CH2NH), 1.46 (2H, apparent quintet, J 7.3, CH3CH2CH2), 1.31 
(2H, sextet, J 7.4, CH3CH2CH2), 1.23 (3H, t, J 7.1, C02CH2CH3) and 0.85 (3H, t, 
J 7.3, CH3CH2CH2).
6 c (100 MHz; CDCI3): 174.1 (C=C-C02Et), 170.3 (C=0), 169.6 (C=0), 86.5 
(C=C-C02Et), 59.3 (C02CH2), 47.3 (CH2NH), 38.6 (CH2NHCO), 36.0 (CH2C=C),
31.8 (CH3CH2CH2), 21.3 (CH2CH2NH), 20.3 (CH3CH2CH2), 14.4 (C02CH2CH3) 
and 13.8 (CH3CH2CH2).
IR (solution in CH2CI2): 3314, 1654 and 1598 cm"1.
MS-APCl: m/z (%): 255 (MH+, 24); 182 (100).
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HRMS-ES: m/z [MH]+: found: 255.1704; C13H23N2O3 requires 255.1709.
[1-n-Butyl carbamoyl-pyrrolidin-(2E)-ylidene]-acetic acid ethyl ester (70; 45 mg, 
19%):
5h (400 MHz; CDCI3 ): 6.28 (1H, broad s, alkene CH), 4.97 (1H, broad s, NH-Bu), 
4.04 (2H, q, J 7.1, C0 2CH2), 3.56 (2H, t, J 7.1, CH2NCO), 3.21 (2H, apparent q, J 
6 .6 , CH2NHCO), 3.13 (2H, t, J 7.7, CH2C=C), 1.89 (2H, apparent quintet, J 7.4, 
CH2CH2NCO), 1.47 (2H, quintet, J 7.4, CH3CH2CH2), 1.29 (2H, sextet, J 7.4, 
CH3CH2CH2), 1.18 (3H, t, J 7.1, CO2CH2CH3) and 0.87 (3H, t, J 7.3, 
CH3CH2CH2).
6 c (100 MHz; CDCI3): 169.0 (ester C=0), 158.4 (C=C-C02 Et), 154.4 (urea C=0),
94.3 (C=C-C02 Et), 59.2 (C0 2 CH2), 49.2 (CH2 NCO), 40.4 (CH2 NHCO), 32.0 
(CH2 C=C), 31.9 (CH3 CH2 CH2 ), 21.1 (CH2 CH2 NH), 20.9 (CH3 CH2 CH2), 14.5 
(CO2 CH2 CH3 ) and 13.8 (CH3 CH2 CH2).
IR (solution in CH2 CI2 ): 3348, 1646 and 1565 cm"1.
MS-APCI: m/z (%): 273 (M+H3 0 \  42); 255 (MH+, 19); 156 (100).
HRMS-ES: m/z [MH]+: found: 255.1704; C1 3 H2 3 N2 O3  requires 255.1709.
2-Pyrrolidin-(2£)-ylidene-M-p-tolyl-malonamic acid ethyl ester (82) and 
(1-p-tolyl carbamoyl-pyrrolidin-(2E)-ylidene)-acetic acid ethyl ester (77)
62 82 77
p-Tolyl isocyanate (130 pL, 1 mmol) was added to a solution of (2Z)-Pyrrolidin-2- 
ylidene-acetic acid ethyl ester (161 mg, 1 mmol) in dry CHCI3 ( 6  mL), and the 
reaction stirred under reflux for 2 h under N2. The solvent was removed in vacuo
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to produce a yellow oil, which solidified on standing. The resulting yellow solid 
(82:77=2.3:1) was purified by column chromatography (eluting with 
EtOAc-Hexane, 4.5:7) giving, in order of elution, title compounds 82 (Rf = 0.76; 
pale yellow solid) and 77 (Rf = 0.29; colourless solid).
2-Pyrrolidin-(2E)-ylidene-N-p-tolyl-malonamic acid ethyl ester (82; 168 mg, 56%): 
Mp: 150-153 °C.
6h (400 MHz; CDCI3): 11.40 (1H, broad s, CH2NH), 11.25 (1H, broad s, ArNH),
7.37 (2H, apparent d, J 7.4, aromatic CH), 7.01 (2H, apparent d, J 7.4, aromatic 
CH), 4.12 (2H, q, J 7.1, C 02CH2), 3.49 (2H, t, J 7.4, CH2NH), 3.08 (2H, t, J 7.9, 
CH2C=C), 2.20 (3H, s, CH3Ar), 1.88 (2H, apparent quintet, J 7.7, CH2CH2NH) 
and 1.23 (3H, t, of 7.1, C02CH2CH3).
6c (100 MHz; CDCI3): 174.8 (C=C-C02Et), 169.9 (C=0), 168.8 (C=0), 136.5 
(aromatic C), 132.5 (aromatic C), 129.3 (aromatic CH), 120.4 (aromatic CH), 87.0 
(C=C-C02Et), 59.8 (C02CH2), 47.6 (CH2NH), 36.5 (CH2C=C), 21.3 (CH2CH2NH), 
20.9 (CH3Ar) and 14.6 (C02CH2CH3).
IR (solution in CH2CI2): 3216, 1649 and 1619 cm'1.
MS-ES: m/z (%): 311 (MNa+, 30); 289 (MH+, 30); 182 (100).
HRMS-ES: m/z [MH]+: found 289.1537; Ci6H22N20 3 requires 289.1552.
(1-p-tolyl carbamoyl-pyrrolidin-(2E)-ylidene)-acetic acid ethyl ester (77; 69 mg, 
23%):
Mp: 132 -  135 °C (lit.40 m.p. 155 °C).
5h (400 MHz; CDCI3): 7.25 (2H, d, J 8.3, aromatic CH), 7.04 (2H, d, J 8.3, 
aromatic CH), 6.77 (1H, s, NHAr), 6.31 (1H, apparent t, J 1.7, CH=C), 4.04 (2H, 
q, J 7.1, C02CH2), 3.66 (2H, t, J 7.1, CH2NCO), 3.15 (2H, apparent dt, J 1.7 &
7.8, CH2C=C), 2.24 (3H, s, CH3Ar), 1.90 (2H, apparent quintet, J 7.4, 
CH2CH2NCO) and 1.17 (3H, t, J7.1, C02CH2CH3).
6C (100 MHz; CDCI3): 168.8 (ester C=0), 158.1 (C=CH-C02Et), 152.1 (urea 
C=0), 134.8 (aromatic C), 134.0 (aromatic C), 129.5 (aromatic CH), 120.7
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(aromatic CH), 95.4 (C=CH-C02Et), 59.3 (C02CH2), 49.4 (CH2NCO), 32.0 
(CH2C=C), 21.1 (CH2CH2NCO), 20.8 (CH3Ar) and 14.5 (C02CH2CH3).
IR (solution in CH2CI2): 3448, 1694 and 1609 cm'1.
MS-ES: m/z (%): 311 (MNa+, 22); 289 (MH+, 8); 156 (100).
HRMS-ES: m/z [MNa]+: found: 311.1356; Ci6H20N2O3Na requires 311.1372.
3-Oxo-2-pyrrolidin-(2E)-ylidene-3-(toluene-4-sulfonylamino)-propionic acid
ethyl ester (83)
o
NHTs
NH NH
62 83
(2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (102 mg, 0.7 mmol) was 
dissolved in dry CHCI3 (6 mL), and p-tosyl isocyanate (100 pL, 0.7 mmol) added. 
The reaction mixture was then stirred at reflux for 2 h under N2. The solvent was 
removed in vacuo to yield the title compound (220 mg, 94%) as a white 
crystalline solid.
Mp: 154-158 °C.
5h (400 MHz; CDCI3): 12.20 (1H, s, CH2NH), 11.30 (1H, s, S02NHCO), 7.83 (2H, 
d, J 8.3, aromatic CH), 7.18 (2H, d, J 8.3, aromatic CH), 4.09 (2H, q, J 7.1, 
C02CH2CH3), 3.46 (2H, t, J 7.5, CH2NH), 3.05 (2H, t, J 7.9, CH2C=C), 2.29 (3H, 
s, CH3Ar), 1.89 (2H, apparent quintet, J 7.7, CH2CH2NH) and 1.20 (3H, t, J 7.1, 
C02CH2CH3).
6c (100 MHz; CDCI3): 175.9 (C=C-C02Et), 169.5 (C=0), 167.7 (C=0), 143.9 
(aromatic C), 137.4 (aromatic C), 129.3 (aromatic CH), 128.1 (aromatic CH), 86.5 
(C=C-C02Et), 60.5 (C02CH2CH3), 48.1 (CH2NH), 36.6 (CH2C=C), 21.6 (CH3Ar),
20.8 (CH2CH2NH) and 14.4 (C02CH2CH3).
IR (nujol): 3447, 1644 and 1594 cm'1.
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MS-ES: m/z (%): 353 (MH+, 34); 182 (100).
HRMS-ES: m/z[MH]+: found: 353.1166; C1 6 H2 1 N2 O5 S requires 353.1171.
3-Oxo-2-pyrrolidin-(2£)-ylidene-3-(2,2,2-trichloro-acetylamino)-propionic
acid ethyl ester (84)
Trichloroacetyl isocyanate (48 |jL, 0.4 mmol) was added to a stirred solution of 
(2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (63 mg, 0.4 mmol) in dry CHCI3 (3 
ml_) under N2, and the resultant mixture stirred for 18 h at rt. The solvent was 
then removed in vacuo. The resulting yellow oil was purified by column 
chromatography (eluting with EtOAc-Hexane, 4:7), early fractions (Rf = 0.25) 
yielding the title compound (72 mg, 51%) as an off-white solid.
Mp: 110-112  °C.
6 h (400 MHz; CDCI3): 13.38 (1H, broad s, CI3 CCO-NH-CO), 11.31 (1H, broad s, 
CH2 NH), 4.20 (2H, q, J 7.1, C0 2 CH2), 3.66 (2H, t, J 7.5, CH2 NH), 3.20 (2H, t, J
7.9, CH2 C=C), 2.04 (2H, apparent quintet, J 7.8, C/-/2 CH2 NH) and 1.28 (3H, t, J
7.1, CO2 CH2 CH3 ).
6 c (100 MHz; CDCI3): 176.6 (CI3 CCONH), 174.9 (C=C-C02 Et), 169.8 (ester 
C=0), 167.8 (NH-CO-C=C), 93.2 (CI3 C), 87.8 (C=C-C02 Et), 60.8 (C0 2 CH2), 48.4 
(CH2 NH), 36.9 (CH2 C=C), 20.9 (CH2 CH2 NH) and 14.4 (C0 2 CH2 CH3).
IR (solution in CH2 CI2): 3197,1750, 1664 and 1614 cm'1.
MS-ES: m/z (%): 343 (MH+, 18) (+ consistent isotope peaks); 182 (100). 
HRMS-ES: m/z [MH]+: found: 343.0015; CnHi4 N2 0 4 3 5 Cl3  requires 343.0019.
O O
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Phenylthiocarbamoyl-(2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (85)
s
NHPh
NHNH
8562
Phenyl isothiocyanate (46 pL, 0.4 mmol) was added to a solution of (2Z)- 
Pyrrolidin-2-ylidene-acetic acid ethyl ester (60 mg, 0.4 mmol) in dry CHCI3  ( 6  
mL), and the reaction stirred under N2  for 20 h at reflux. The solvent was 
removed in vacuo and the resulting brown solid recrystallised from aqueous 
ethanol to yield the title compound (65 mg, 58%) as colourless needles.
Mp: 118-120  °C.
5h (400 MHz; CDCI3): 13.28 (1H, broad s, CH2 NH), 12.47 (1H, broad s, PhNH),
7.38 (2H, d, J 7.6, aromatic CH), 7.31 (2H, apparent t, J 7.9, aromatic CH), 7.16 
(1H, t, J 7.4, aromatic CH), 4.18 (2H, q, J 7.2, C0 2 CH2), 3.64 (2H, t, J 7.4, 
CH2 NH), 3.15 (2H, t, J 7.8, CH2 C=C), 1.98 (2H, apparent quintet, J 7.6, 
CH2 CH2 NH) and 1.28 (3H, t, J 7.2, C0 2 CH2 CH3).
5C (100 MHz; CDCI3): 190.2 (thioamide C=S), 174.1 (C=C-C02 Et), 170.2 (ester 
C=0), 139.7 (aromatic C), 128.6 (aromatic CH), 126.3 (aromatic CH), 126.2 
(aromatic CH), 95.0 (C=C-C02 Et), 60.4 (C0 2 CH2), 48.0 (CH2 NH), 37.8 
(CH2 C=C), 21.9 (CH2 CH2 NH) and 14.4 (C0 2 CH2 CH3).
IR (solution in CH2 CI2): 3176, 1649 and 1248 cm 1.
MS-ES: m/z (%):291 (MH+, 29); 198 (100).
HRMS-ES: m/z [MH]+: found: 291.1172; C i5 Hi9 N2 0 2S requires 291.1167.
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Benzylthiocarbamoyl-(2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (86)
NHBn
NHNH
8662
(2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (155 mg, 1 mmol) was dissolved 
in dry CHCI3 ( 6  mL), and benzyl isothiocyanate (160 |jL, 1.2 mmol) added. The 
reaction was then stirred at reflux under N2  for 23 h. The mixture was allowed to 
cool and the solvent removed in vacuo. The resulting dark orange oil was then 
purified by column chromatography (eluting with EtOAc-Hexane, 1:4), 
mid-fractions (R f = 0.41) affording the title compound (204 mg, 6 6 %) as buff waxy 
solid.
Mp: 83 -  87 °C.
5h (400 MHz; CDCI3): 13.05 (1H, broad s, CH2 NH), 12.22 (1 H, broad s, 
PhCH2 NH), 7.18 -  7.11 (5H, m, aromatic CH), 4.79 (2H, apparent d, J 4.9, 
PhCH2 NH), 4.08 (2H, q, J 7.2, C0 2 CH2), 3.59 (2H, t, J 7.3, CH2 NH), 3.09 (2H, t, J 
7.8, CH2 C=C), 1.93 (2H, apparent quintet, J 7.6, CH2 CH2 NH) and 1.20 (3H, t, J
7.2, C0 2 CH2 CH3).
5C (100 MHz; CDCI3): 190.0 (thioamide C=S), 173.4 (C=C-C02 Et), 169.9 (ester 
C=0), 137.7 (aromatic C), 128.7 (aromatic CH), 127.9 (aromatic CH), 127.3 
(aromatic CH), 94.3 (C=C-C02 Et), 60.1 (C02 CH2), 49.1 (PhCH2 NH), 47.8 
(CH2 NH), 37.5 (CH2 C=C), 21.9 (CH2 CH2 NH) and 14.4 (C0 2 CH2 CH3).
IR (solution in CH2 CI2): 3197, 1639 and 1268 cm’1.
MS-ES: m/z (%): 305 (MH+, 100); 259 (24); 198 (78).
HRMS-ES: m/z [MH]+: found: 305.1300; C,6 H2 iN 2 0 2S requires 305.1324.
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/i-Butylthiocarbamoyl-(2Z)-pyrrolidin-2-ylidene acetic acid ethyl ester (87)
COoEt
NHNH
8762
(2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (160 mg, 1.0 mmol) was 
dissolved in pyridine (0.5 mL), and /7 -butyl isothiocyanate (149 pL, 1.2 mmol) 
added. The reaction was stirred at 100 °C in a sealed tube for 46 h, after which 
time the solvent was removed under reduced pressure. The resulting dark 
orange solid was recrystallised from aqueous ethanol to give the title compound 
(240 mg, 89%) as an orange solid.
Mp: 5 3 -5 6  °C.
5h (400 MHz; CDCI3): 13.05 (1H, broad s, pyrrolidine CH2 NH), 10.92 ( 1 H, broad 
s, CH2 NH-C=S), 4.13 (2H, q, J 7.2, C0 2 CH2), 3.59 (2H, apparent q, J 7.3, 
CH2 NH-C=S), 3.58 (2H, t, J 7.3, CH2 NH), 3.08 (2H, t, J 7.8, CH2 C=C), 1.94 (2H, 
apparent quintet, J 7.6, CH2 CH2 NH), 1.58 (2H, apparent quintet, J 7.3, 
CH3 CH2 CH2), 1.36 (2H, sextet, J 7.4, CH3 CH2 CH2), 1.24 (3H, t, J 7.2, 
C0 2 CH2 CH3) and 0.88 (3H, t, J 7.3, CH3 CH2 -alkyl).
5c ( 1 0 0  MHz; CDCI3): 189.5 (C=S), 173.1 (C=C-C02 Et), 169.9 (ester C= O), 94.0 
(C=C-C02 Et), 60.0 (C0 2 CH2), 47.6 (CH2 NH), 44.7 (CH2 NH-C=S), 37.4 
(CH2 C=C), 30.3 (CH3 CH2 CH2), 21.8 (CH2 CH2 NH), 20.4 (CH3 CH2 CH2), 14.3 
(C0 2 CH2 CH3) and 13.8 (CH3 CH2 -alkyl).
IR (solution in CH2 CI2): 3176, 1633 and 1257 cm'1.
MS-APCI: m/z (%): 271 (MH\ 74).
HRMS-ES: m/z [MH]+: found: 271.1476; Ci3 H2 3 N2 0 2S requires 271.1480.
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1,3-Dioxo-2-phenyl-1,2,3,5,6,7-hexahydro-pyrroloII ,2-c]pyrimidine-4-
carboxylic acid phenylamide (88)
A solution of (2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (207 mg, 1.3 mmol) 
in dry THF (5 mL) at 0 °C under N2was added dropwise to a stirred suspension 
of sodium hydride (60% dispersion in oil, 35 mg, 1.5 mmol) in THF (15 mL). The 
mixture was stirred for 2 h at rt, phenyl isocyanate (159 mg, 1.3 mmol) added 
and the mixture stirred for 18 h at rt. The reaction mixture was then quenched 
with sat. aqueous NH4CI solution (30 mL), the organic layer extracted and the 
aqueous layer washed with CH2CI2 (3 x 30 mL). The combined organic washings 
were washed with brine ( 2  x 50 mL), dried over MgS04  and the solvent removed 
in vacuo. The resulting residue was recrystallised from ethanol to give the title 
compound (60 mg, 13%) as a pale yellow solid.
Mp: 253-255  °C.
5h (400 MHz; CDCI3): 11.12 (1H, broad s, PhNHCO), 7.60 -  7.35 (5H, m, 
aromatic CH), 7.30 -  7.15 (4H, m, aromatic CH), 7.00 (1H, t, J 7.3, aromatic CH),
4.00 (2H, t, J 7.5, CH2 NCO), 3.77 (2H, t, J 7.9, CH2C=C) and 2.17 (2H, apparent 
quintet, J 7.7, CH2 CH2 NCO).
5C (100 MHz; CDCI3): 164.9 (C=0), 163.5 (C=0), 160.6 (C=0), 147.8 
(C=C-C(0)NHPh), 137.2 (aromatic C), 133.4 (aromatic C), 128.7 (aromatic CH),
128.3 (aromatic CH), 127.9 (aromatic CH), 127.1 (aromatic CH), 123.0 (aromatic 
CH), 119.3 (aromatic CH), 100.3 (C=C-C(0)NHPh), 48.2 (CH2 NCO), 33.4 
(CH2 C=C) and 19.4 (CH2 CH2 NCO).
IR (solution in CH2 CI2): 3239, 1705,1682,1591 and 1437 cm'1.
MS-ES: m/z (%): 370 (MNa*, 92); 348 (Ml-T, 100).
HRMS-ES: m/z [MH]+: found: 348.1343; C2 0 H1 8 N3 O3  requires 348.1348.
O O
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1,3-Dioxo-2-benzyl-1,2,3,5,6,7-hexahydro-pyrrolo[1,2-c]pyrimidine-4-
carboxylic acid benzylamide (89)
A solution of (2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (159 mg, 1.0 mmol) 
in dry THF (5 mL) at 0 °C under N2  was added dropwise to a stirred suspension 
of sodium hydride (60%  dispersion in oil, 45 mg, 1.1 mmol) in THF (15 mL). The 
mixture was then stirred for 2 h at rt. Benzyl isocyanate (0 .13  mL, 1.0 mmol) was 
added, and the mixture stirred for 18 h at rt. The reaction mixture was quenched 
with sat. aqueous NH4CI solution (30 mL), the organic layer was separated and 
the aqueous layer washed with CH2 CI2  (3 x 30 mL). The combined organic layers 
were washed with brine ( 2  x 50 mL), dried over MgS04  and the solvent removed 
in vacuo. The resulting orange solid was purified by column chromatography 
(eluting with EtOAc-Hexane, 3:7), early fractions (Rf 0 .41) affording the title 
compound (103 mg, 35 %) as a yellow solid.
Mp: 117-120  °C.
5h (400 MHz; CDCI3): 11.10 ( 1 H, broad s, CH2 NHCO), 7.31 (4H, apparent t, J
7.6, aromatic CH), 7.26 -  7.12 (6 H, m, aromatic CH), 5.04 (4H, s, 2 x PhCH2 N), 
3.64 (2H, t, J 7.6, CH2 NCO), 3.39 (2H, t, J 8.0, CH2 C=C) and 2.06 (2H, apparent 
quintet, J 7.8, CH2 CH2 NCO).
6 c ( 1 0 0  MHz; CDCI3): 165.2 (C=0), 162.4 (C=0), 160.9 (C=0), 151.6 
(C=C-C(0)NHBn), 137.6 (aromatic C), 137.6 (aromatic C), 128.5 (aromatic CH), 
128.4 (aromatic CH), 128.2 (aromatic CH), 127.4 (aromatic CH), 127.3 (aromatic 
CH), 88.5 (C=C-C(0)NHBn), 48.2 (CH2 NCO), 44.19 (PhCH2 N), 44.16 (PhCH2 N),
35.3 (CH2 C=C) and 20.8 (CH2 CH2 NCO).
IR (solution in CH2 CI2): 3248, 1705, 1646, 1623, 1545 and 1442 cm'1.
O O
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MS-ES: m/z (%): 376 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 376.1657; C2 2 H2 2 N3 O3  requires 376.1661.
2-Benzyl-3-oxo-1 -thioxo-1,2,3,5,6,7-hexahydro-pyrrolo[1,2-c]pyrimidine- 
4-carbothioic acid benzylamide (90)
A solution of (2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (62  mg, 0.4 mmol) in 
dry THF (2 mL) under N2  was cooled to 0 °C, and added dropwise to a 
suspension of sodium hydride (60%  dispersion in oil, 18 mg, 0.44  mmol) in THF 
(5 mL). The resultant orange suspension was stirred for 2 h at rt, benzyl 
isothiocyanate (53 pL, 1.0 mmol) added and the mixture stirred for 18 h. The 
reaction mixture was then quenched with sat. aqueous NH4CI solution (30 mL), 
the organic layer separated and the aqueous layer extracted with CH2 CI2  (3 x 30 
mL). The combined organic layers were washed with brine (2 x 50 mL), dried 
over MgS04, and the solvent removed in vacuo. The resulting dark orange solid 
was purified by column chromatography (eluting with EtOAc-Hexane, 3:7), early 
fractions (Rf = 0 .45) yielding the title compound (42 mg, 25% ) as a pale solid.
Mp: 1 3 0 - 1 3 2  °C.
6 h (400 MHz; CDCI3): 14.0 ( 1 H, broad s, NH-C=S), 7.45 -  7.05 ( 1 0 H, m, 
aromatic CH), 6.45 (2H, s, one of PhCH2 N), 5.73 (2H, s, one of PhCH2 N), 3.74 
(2H, t, J 7.4, CH2 N-C=S), 3.55 (2H, t, J 7.9, CH2C=C) and 2.17 (2H, apparent 
quintet, J 7.7, CH2 CH2 N-C=S).
6 c (100 MHz; CDCI3): 191.0 (C=S), 183.4 (C=S), 176.6 (C=0), 157.8 
(BnNH-C(S)-C=C), 135.6 (aromatic C), 135.5 (aromatic CH), 127.3 (aromatic 
CH), 127.2 (aromatic CH), 126.5 (aromatic CH), 126.1 (aromatic CH), 125.6
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(aromatic CH), 125.6 (aromatic CH), 102.8 (BnNH-C(S)-C=C), 56.0 (CH2 NH),
50.5 (CH2 NH), 47.9 (CH2 N-C=S), 37.1 (CH2 C=C) and 20.1 (CH2 CH2 N-C=S).
IR (solution in CH2 CI2): 3337, 1664 and 1288 cm'1.
MS-ES: m/z (%): 408 (MH+, 100); 182 (58).
HRMS-ES: m/z [MH]+: found: 408.1208; C2 2 H2 2 N3 OS2  requires 408.1204.
4-(Ethoxycarbonyl)-3-pentyl-2,3,5,6,7-pentahydropyrrolo[1,2-c]pyrimidine-1-
iminium acetate (106)
To a solution of ethyl 3,5,6,7-tetrahydro-1-(methylthio)-3-pentylpyrrolo[1,2- 
f]pyrimidine-4-carboxylate (230)38 (100 mg, 0.32 mmol) in dry MeOH (4 mL) was 
added ammonium acetate, and gaseous ammonia bubbled through the solution 
for 10 min. The solution was then heated at 80 °C for 48 h in a sealed tube. The 
reaction was allowed to cool and the volatiles removed in vacuo to afford the title 
compound (90 mg, 84% crude yield) as a yellow gum.
230 106
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1H NMR Spectrum of Compound 106 (400 MHz; CDCI3)
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Selected peaks: 7.74 (2H, broad s, (NH2)+), 4.33 (1H, apparent dd, J 6 . 8  & 4.4, 
CH-pentyl), 3.78 -  3.74 (1H, m, one of CH2 -N-C=N), 3.68 -  3.59 (1H, m, one of 
CH2 -N-C=N), 3.24 (1H, ddd, J 18.3, 8.3 & 2.3, one of CH2 C=C), 2.86 (1H, 
apparent dt, J 18.3 & 9.3, one of CH2 C=C).
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(2Z)-Ethyl 3-(cyanoamino)-2-(pyrrolidin-2-ylidene)octanoate (108)
Cyanamide (16 mg, 0.4 mmol) was added to a solution of hexanal (48 pL, 0.4 
mmol) in dry CH2 CI2  (4 mL) under N2, and the resulting suspension stirred at rt 
for 30 mins. A solution of (2Z)-Pyrrolidin-2-ylidene-acetic acid ethyl ester (60 mg, 
0.4 mmol) in CH2 CI2  ( 2  mL) was added, and the resulting mixture stirred at rt for 
3 h. The solvent was then removed in vacuo (temperature of the water bath < 30 
°C) to afford the title compound as a pale yellow gum (94 mg, 87% crude yield). 
5h (500 MHz; CDCI3): 8.26 (1 H, broad s, NH), 4.37 (1H, broad s, NH-CN), 4.18 -
4.0 (2H, m, CO2 CH2 ), 3.75 (1H, apparent q, J 7.4, CH-NHCN), 3.50 (2H, 
apparent t, J 7.0, CH2 NH), 2.78 (1H, ddd, J 16.1, 9.1 & 7.0, one of CH2 C=C), 
2.58 (1H, ddd, J 16.1, 9.2 & 6.9, one of CH2 C=C), 2.03 -  1.89 (2H, m, pyrrolidine 
CH2 CH2 NH), 1.85 -  1.64 (2H, m, CH2 CH-NHCN), 1.26 -  1.14 (9H, m, 3 x alkyl 
CH2 protons & C0 2 CH2 CH3) and 0.81 (3H, t, J 6.9, CH3 CH2 -alkyl).
5c (125 MHz; CDCI3): 169.0 (ester C=0), 166.0 (C=C-C02 Et), 117.3 (NH-C=N),
88.3 (C=C-C02 Et), 59.0 (C0 2 CH2), 47.3 (CH-NHCN), 35.2 (CH2 NH), 31.55 
(CH2 C=C), 31.5 (CH2 CH-NHCN), 26.6 (pyrrolidine CH2 CH2 NH), 22.5 (CH2), 22.4 
(CH2), 21.6 (CH3 CH2 -alkyl), 14.6 (C0 2 CH2 CH3) and 13.9 (CH3 CH2 -alkyl).
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(3R,7S)-Ethyl 1,2,3,5,6,7-hexahydro-7-((fe/t butyl dimethyl silyl)oxy methyl)- 
3-pentyl-1-thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (110) and (3S,7S)- 
Ethyl 1,2,3,5,6,7-hexahydro-7-((terf butyl dimethyl silyl)oxy methyl)-3- 
pentyl-1 -thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (111)
C5 H1 1
G nA s
'c h 2o tb s  
111
COoEt Et02C
CHoOTBSc h 2o tb s
A mixture of hexanal (22 pL, 0.18 mmol) and trimethylsilyl isothiocyanate (25 pL, 
0.18 mmol) in dry CH2 CI2  (3 mL) was stirred at rt under N2  for 30 mins. A solution 
of (2Z)-Ethyl-2-[(S)-5-(tertbutyldimethylsilyl)oxymethyl)pyrrolidin-2-
ylidene)acetate2 9  (46) (54 mg, 0.18 mmol) in CH2 CI2  ( 2  mL) was added, and the 
resulting pale solution stirred at rt for 3 h. The reaction was then quenched with 
the addition of 0.1 M aqueous NaOH solution (30 mL), the layers separated and 
the aqueous layer washed with CH2 CI2  (3 x 25 mL). The combined organic 
washings were dried over Na2 S0 4  and the solvent removed in vacuo. The 
resultant orange oil was purified by flash column chromatography (CH2 CI2  
EtOAc) to afford the title compounds (64 mg, 81%) as a viscous orange oil 
(110:111=2.38:1).
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1H NMR spectrum (400 MHz; CDCI3) of compounds 110 and 111.
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Selected peaks: 4.97 -  4.90 (111; 1H, m, CHN-C=S), 4.61 -  4.55 (110; 1 H, m, 
CHN-C=S) and 4.28 -  4.19 (110 & 111; 1H, m, CH-pentyl).
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(Z)-Methyl 2-((5S)-5-allylpyrrolidin-2-ylidene)acetate (112)
o
o
NBoc
O NHBoc
C02Me
NH
112
Ring-opening step:
Diisopropylamine (0.35 mL, 2.49 mmol) was added dropwise to /7 -butyl lithium 
(2.5 M solution in hexanes; 1.0 mL, 2.49 mmol) at 0 °C under N2 , and the 
resulting gel stirred for 10 min. Dry THF (10 mL) was added, and the yellow 
solution stirred for a further 20 min. The reaction was then cooled to -78 °C, and 
dry methyl acetate (0.20 mL, 2.49 mmol) added dropwise. After 30 min, a 
solution of (S)-tert-butyl 2-allyl-5-oxopyrrolidine-1-carboxylate (640 mg, 2.49 
mmol) in THF (3 mL) was added dropwise, and the resultant orange solution 
allowed to warm to rt over 20 h. The reaction mixture was quenched with sat. 
NH 4CI solution (30 mL), the layers separated and the aqueous layer washed with 
CH2 CI2  (3 x 20 mL). The combined organic layers were washed with brine (30 
mL), dried over MgS0 4  and the solvent removed in vacuo. tert-Butyl (S)-8- 
(methoxycarbonyl)-7-oxooct-1-en-4-y/carbamate was obtained in sufficient purity, 
and used immediately in the ring-closing step.
Ring-closing step:
Trifluoroacetic acid (0 .32 mL, 4.14 mmol) was added to tert-butyl (S)-8- 
(methoxycarbonyl)-7-oxooct-1-en-4-ylcarbamate (589 mg, 1.97 mmol), and the 
resulting dark orange residue stirred for 3 h at rt. The reaction was then 
neutralized to pH 7 with NaHCC> 3  solution, and the residue washed with CH2 CI2  
(3 x 30 mL). The comined organic washings were then dried over Na2 S0 4, and 
the solvent removed in vacuo. The resulting oil was purified by column 
chromatography (eluting with EtOAc-Hexane, 1:4), early fractions (Rf 0.42) 
affording the title compound (307 mg, 6 8 %) as a viscous orange oil.
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1H NMR spectrum (400 MHz; CDCI3) of compound 112
2000CO CO
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Selected peaks: 7.88 (1H, broad s, NH), 5.75 -  5.59 (1H, m, CH=CH2), 5.08 -  
4.99 (2H, m, CH=CH2), 4.39 (1H, broad s, C=CH-C02 Me), 3.76 (1H, apparent 
quintet, J 6.7, CH-NH), 3.51 (3H, s, C0 2 CH3) and 2.58 -  2.42 (2H, m, one of 
pyrrolidine CH2C=C & one of CH2 CH=CH2).
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(3R,7S)-Methyl 7-allyM ,2,3,5,6-hexahydro-3-pentyl-1 -thioxopyrrolo[1,2- 
c]pyrimidine-4-carboxylate (113) and (3S,7S)-Methyl 7-allyl-1,2,3,5,6- 
hexahydro-3-pentyl-1-thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (114)
CsHu CgHn
NH
NH
Me02C NH
+
112 113 114
Trimethylsilyl isothiocyanate (0.22 mL, 1.58 mmol) was added to a solution of 
hexanal (0.19 mL, 1.58 mmol) in dry CH2 CI2  (15 mL) under N2 , and the resulting 
yellow solution stirred for 30 min at rt. A solution of (2Z)-methyl 2-((allylpyrrolidin-
2-ylidene)acetate (1 1 2 ) (287 mg, 1.58 mmol) in CH2 CI2  (3 mL) was then added, 
and the mixture stirred for a further 2 h at rt. The reaction was then quenched 
with -0.1 M aqueous NaOH solution (40 mL), the layers separated and the 
aqueous layer extracted with CH2 CI2  (3 x 35 mL). The combined organic 
washings were then dried over Na2 S04, and the solvent removed in vacuo to 
afford the title compounds (399 mg, 78%) as a yellow gum (113:114=1.81:1).
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1H NMR spectrum (400 MHz; CDCI3) of compounds 113 and 114.
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Selected peaks: 6.74 (114; broad s, NH), 6.61 (113; 1H, broad s, NH), 5.01 -
4.95 (114; 1H, m, CH-allyl), 4 .64 -4 .59  (113; 1H, m, CH-allyl), 4 .30 -4 .26  (113 
& 114; 1H, m, CH-pentyl) and 3.74 (114; 3H, s, C0 2 CH3) and 3.74 (113; 3H, s, 
CO2CH3).
Diastereoisomers 113 and 114 were then purified by column chromatography 
(eluting with EtOAc-Hexane, 1:6), mid-fractions (Rf 0.45) affording the major 
diastereoisomer (113) (276 mg, 54%) as a yellow solid. Subsequent 
recrystallisation from aqueous ethanol produced crystals suitable for X-ray 
analysis.
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(3R, 7S)-Methyl 7-allyl-1,2,3,5,6-hexahydro-3-pentyl-1-thioxopyrrolo[1,2- 
c]pyrimidine-4-carboxylate (113):
Mp: 120-124 °C.
5h (400 MHz; CDCI3): 6.94 (1H, broad s, NH), 5.73 -  5.67 (1H, m, CH=CH2), 
5.09 -  5.03 (2H, m, CH=CH2), 4.56 -  4.52 (1H, CH-allyl), 4.23 -  4.21 (1H, m, 
CH-pentyl), 3.65 (3H, s, C0 2 CH3), 3.32 -  3.26 (1H, m, one of pyrrolidine 
CH2 C=C), 3.04 (1H, apparent dd, J 13.3 & 4.5, one of pyrrolidine CH2 C=C), 2.90 
-  2.80 (1H, m, one of CH2 CH=CH2), 2.15 (1H, apparent dt, J 13.5 & 9.0, one of 
CH2 CH=CH2), 1.94 -  1.83 (2H, m, pyrrolidine CH2 CH-N), 1.61 -  1.44 (2H, m, 
CH2 CH-NH), 1.48 -  1.12 (6 H, m, 3 x alkyl CH2  protons) and 0.81 (3H, t, J 6 .8 , 
CH3 CH2 -alkyl).
6 c (125 MHz; CDCI3): 175.2 (thiourea C=S), 166.1 (ester C=0), 149.8 
(Me02 C-C=C), 134.1 (CH=CH2), 118.1 (CH=CH2), 99.8 (Me0 2 C-C=C), 62.5 
(CH-allyl), 52.1 (C0 2 CH3), 51.3 (CH-pentyl), 37.7 (CH2 CH=CH2), 35.4
(pyrrolidine CH2 C=C), 31.4 (CH2), 30.4 (CH2), 25.7 (pyrrolidine CH2 CH-allyl),
23.5 (CH2), 22.5 (CH3 CH2 -alkyl) and 14.0 (CH3 CH2 -alkyl).
[a]D: +20° (c=0.5, CH2 CI2).
IR (CH2 CI2): 3265, 3212, 2834, 1690, 1647, 1527, 1354 and 1 2 2 1  cm'1.
MS-ES: m/z (%) = 323 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 323.1792; C i7 H2 7 N2 0 2S requires 323.1793.
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(3S,7S)-Diethyl 1,2,3,5,6,7-hexahydro-3-pentyl-1 -thioxopyrrolo[1,2- 
flpyrimidine-4,7-dicarboxylate (116) and (3R,7S)-diethyl 1,2,3,5,6,7- 
hexahydro-3-pentyl-1-thioxopyrrolo[1,2-c]pyrimidine-4,7-dicarboxylate
(117)37
CsHu C5H11
B 0 2C ^ NH Et02C y k NH
 / ^ n ^ s  + < y y ^ s
C02Et ''C02Et
116 117
C02Et
C02Et
A mixture of hexanal (0.11 mL, 0.9 mmol) and trimethylsilyl isothiocyanate (0.12 
mL, 0.9 mmol) in dry CH2 CI2  (5 mL) was stirred at rt under N2  for 30 min. A 
solution of (S,Z)-Ethyl 5-((ethoxycarbonyl)methylene)pyrrolidine-2-carboxylate 
(115) ( 2 0 0  mg, 0.9 mmol) in CH2 CI2  ( 2  mL) was added, and the resulting pale 
yellow solution stirred at rt for 3 h. The reaction was then quenched with the 
addition of ~0.1 M aqueous NaOH solution (30 mL), the layers separated and the 
aqueous layer washed with CH2 CI2  (3 x 25 mL). The combined organic washings 
were dried over Na2 S0 4  and the solvent removed in vacuo. The resultant orange 
oil was purified by flash column chromatography (CH2 CI2  —► EtOAc) to afford the 
title compounds (263 mg, 81%) as a viscous orange gum (116:117=1.25:1).
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(3S,7S)-diethyl 1,2,3,5,6,7-hexahydro-3-methyl-1 -thioxopyrrolo[1,2- 
c]pyrimidine-4,7-dicarboxylate (118) and (3ft,7S)-diethyl 1,2,3,5,6 ,7- 
hexahydro-3-methyl-1-thioxopyrrolo[1,2-c]pyrimidine-4,7-dicarboxylate
(119)37
Me Me
EtOoC.
2  T  NH
C02Et
C02Et 'C02Et
118 119
NH
+
<302Et
A mixture of acetaldehyde (0.15 mL, 2.62 mmol) and trimethylsilyl isothiocyanate 
(0.37 mL, 2.62 mmol) in dry CH2 CI2  (5 mL) was stirred at rt under N2  for 30 min. 
A solution of (S,Z)-Ethyl 5-(ethoxycarbonyl)methylene)pyrrolidine-2-carboxylate 
(115) (297 mg, 1.31 mmol) in CH2 CI2  was then added, and the resulting yellow 
solution stirred for rt for 2h. The reaction was then quenched with the addition of 
-0.1 M aqueous NaOH solution (40 mL), the layers separated and the aqueous 
layer washed with CH2 CI2  (3 x 30 mL). The combined organic washings were 
dried over Na2 S0 4  and the solvent removed in vacuo. The resultant orange oil 
was purified by flash column chromatography (CH2 CI2-> EtOAc) to afford the title 
compounds (310 mg, 76%) as a viscous orange gum (118:119 = 1.2:1).
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(3S,7S)-Ethyl 1,2,3,5,6,7-hexahydro-7-(hydroxymethyl)-3-methyl-1 - 
thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (120)
Me
Et02C ^ p NH
C ”A s
'CH2OH
118/119 120
(2S)-diethyl 1,2,3,5,6,7-hexahydro-3-methyl-1-thioxopyrrolo[ 1,2-c]pyrimidine-4,7- 
dicarboxylate (118/119) (160 mg, 0.51 mmol) was dissolved in absolute EtOH ( 8  
mL), and sodium borohydride (492 mg, 10.3 mmol) added portion-wise. The 
resulting suspension was stirred at reflux for 21/S h under N2 . The mixture was 
then quenched by dropwise addition of sat. aqueous NH 4 CI solution (20 mL), the 
reaction diluted with EtOAc (30 mL) and the layers separated. The aqueous layer 
was washed with further portions of EtOAc (3x15  ml). The organic layers were 
combined, washed with brine (40 mL), dried over Na2 S0 4  and the solvent 
removed in vacuo. The resultant oil was purified by column chromatography 
(eluting with EtOAc-Hexane, 1:2), mid-fractions (Rf CH 2CI2 : 0.29) affording the 
title compound (46 mg, 60 % -  based on theoretical amount of sm (118)) as a 
clear gum.
5h (400 MHz; CDCI3): 7.06 (1H, broad s, NH), 5.03 -  4.98 (1H, m, CH-CH2 OH), 
4.34 (1H, apparent dq, J 2.5 & 6 .2 , CH-Me), 4.15 (2 H, q, J 7.2, CO2CH2), 3.92 
(1H, dd, J 11.2 & 4.3, one of CH2 OH), 3.71 (1H, dd, J 11.2 & 5.5, one of CH2 OH), 
3.24 (1H, ddd, J 18.9, 10.0 & 3.2, one of CH2 C=C), 3.06 -  2.97 (1H, m, one of 
CH2 C=C), 2.57 (1H, broad s, CH2 OH), 2.07 (1H, apparent dq, 12.9 & 9.5, 
pyrrolidine CH2 CH-NCS), 1.89 (1H, apparent ddt, J 12.9, 9.5 & 2.9, pyrrolidine 
CH2 CH-NCS) and 1 .24-1 .17 (6 H, m, CH3-CH & C0 2 CH2 CH3).
5c (500 MHz; CDCI3): 176.2 (thiourea C=S), 165.3 (ester C=0), 150.1 
(C0 2 Et-C=C), 102.2 (C0 2 Et-C=C), 65.0 (C0 2 CH2), 64.0 (CH2 OH), 60.4 
(CH-NCS), 47.8 (CH-Me), 30.7 (pyrrolidine CH2 C=C), 23.9 (CH3 -CH), 23.1 
(pyrrolidine CH2 CH-NCS) and 14.4 (CH3 CH2 0 C0 ).
Me
EtOoC NH
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IR (solution in CH2 CI2): 3085 -  3647 (broad OH stretch), 1693, 1647, 1515, 
1377 and 1262 cm'1.
MS-APCI: m/z (%): 271 (MH+, 100).
HRMS-APCI: m/z [MH]*: found: 271.1105; C1 2 H,8 N2 0 3S requires 271.1116.
(3S,7S)-Ethyl 1,2,3,5,6,7-hexahydro-7-((teft butyl dimethyl silyl)oxy methyl)-
3-methyl-1 -thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (47a) 3 4
Me Me
NHNH
'CH2OH
120 47a
Triethylamine (15 pL, 0.11 mmol), tert-butyl dimethyl silyl chloride (11 mg, 0.08 
mmol) and DMAP (0.5 mg, catalytic) were added to a solution of (3S,7S)-Ethyl 
1,2,3,5,6,7-hexahydro- 7-(hydroxymethyl)-3-methyl- 1-thioxopyrrolo[ 1,2- 
f]pyrimidine-4-carboxylate (19 mg, 0.07 mmol) in CH2 CI2  ( 2  mL). The resulting 
suspension was stirred at rt under N2  for 17 h. The reaction was then quenched 
with sat. aqueous NaHCC> 3  solution (15 mL) and diluted with CH2 CI2  (20 mL). 
The layers were separated, and the aqueous layer washed with further portions 
of CH2 CI2  ( 3x10  mL). The combined organic extracts were dried over Na2 S0 4  to 
afford the crude title compound as a pale yellow solid.
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1H NMR spectrum (400 MHz; CDCI3) of crude compound 47a.
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Selected peaks:
My data:
4.96 -  4.90 (1H, m, CH-CH2 OTBS), 4.39 -  4.29 (1H, m, CH-Me), 4.04 (1H, dd, J
10.4 & 3.7, one of CH2 OTBS) and 3.66 (1H, dd, J 10.4 & 2.2, one of CH2 OTBS). 
Lit. data:34
4.93 (1H, m, CH-CH2 OTBS), 4.35 (1H, m, CH-Me), 4.06 (1H, dd, J 10.4 & 3.6, 
one of CH2 OTBS) and 3.67 (1H, dd, J 10.4 & 2.3, one of CH2 OTBS).
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6.3. Experimental Data for Chapter 3
(S)-3-hydroxy-pyrrolidin-2-one4 6  (128)
nh2
c o 2h
/""NH
o
HO HO
128
1,1,1,3,3,3-hexamethyl disilazane (12.48 mL, 58.8 mmol) was added to a 
suspension of (S)-4-amino-2-hydroxy butyric acid (1 g, 8.39 mmol) in dry xylene 
(200 mL), and a few drops of chlorotrimethylsilane added. The mixture was 
stirred at reflux for 16 h under N2, and the xylene removed under reduced 
pressure. The residue was re-dissolved in THF/H20  (9:1), a few drops of 12M 
HCI added and the solution stirred for 10 min at rt. The solvent was then 
removed in vacuo. The resulting pale yellow oil was purified by column 
chromatography (eluting with CHCI3 -MeOH, 7:1), late fractions yielding the title 
compound as a white solid (775 mg, 91%).
(S)-3-((te/T-Butyldimethylsilyl)oxy)-pyrrolidin-2-one 8 1  (130)
(S)-3-hydroxypyrrolidin-2-one (128) (429 mg, 4.25 mmol) was dissolved in dry 
THF (40 mL), and te/t-butyldimethylsilyl chloride (703 mg, 4.67 mmol), imidazole 
(578 mg, 8.5 mmol) and a catalytic amount of DMAP added. The resulting 
mixture was stirred under N2  at rt for 18 h. The mixture was then washed with 
sat. aqueous NaHC03  solution (40 mL), the organic layer separated and the 
aqueous layer washed with CH2 CI2  (3 x 50 mL). The combined organic washings
HO TBSO
128 130
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were washed with brine ( 2  x 50 mL), dried over MgSCU and the solvent removed 
in vacuo, yielding the title compound as a pale yellow solid (639 mg, 70%).
5h (400 MHz; CDCI3): 7.87 ( 1 H, broad s, NH), 4.13 ( 1 H, apparent t, J 7.8, 
CH-OTBS), 3.23 (1H, ddd, J 10.0, 9.4 & 2.8, one of CH2 NH), 3.10 (1H, apparent 
dt, J 10.0 & 7.6, one of CH2 NH), 2.21 (1H, dddd, J 12.6, 7.8, 7.3 & 2.8, one of 
CH2 CH2 NH), 1.85 (1H, apparent dq, J 12.6 & 8.2, one of CH2 CH2 NH), 0.78 (9H, 
s, ((CH3 )3 C), 0.01 (3H, s, one of CH3 Si) and 0.00 (3H, s, one of CH3 Si).
5c (125 MHz; CDCI3): 177.3 (lactam C=0), 70.5 (CH-OTBS), 38.5 (CH2 NH), 31.4 
(CH2 CH-OTBS), 25.7 ((CH3 )3 C), 18.2 ((CH3 )3 C), -4.6 (One of CH3 Si) and -5.2 
(One of CH3 Si).
(S)-tert-Butyl 3-((fe/T-butylsilyldimethyl)oxy)-2-oxopyrrolidine-1-
carboxylate8 1  (136)
</^NBoc  
TBSO
130 136
Triethylamine (1.66 mL, 12.0 mmol) and a few crystals of DMAP were added to a 
solution of (S)-3-((tert-butyldimethylsilyl)oxy)-pyrrolidin-2-one (130) (1.7131 g, 8.0 
mmol) in dry CH2 CI2  (25 mL) under N2. A solution of di-te/7-butyl dicarbonate 
(1.9107 g, 8.76 mmol) in CH2 CI2  (10 mL) was then added, and the resulting 
orange mixture stirred at rt for 18 h. The reaction was then quenched with sat. 
aqueous NaHC03  solution (35 mL), the layers separated and the aqueous layer 
washed with CH2 CI2  (3 x 25 mL). The combined organic extracts were dried over 
MgSCU and the solvent removed in vacuo to afford the title compound (2.310 g, 
92%) as an orange oil.
5h (400 MHz; CDCI3): 4.20 (1H, apparent dd, J 9.6 & 8.0, CH-OTBS), 3.65 (1H, 
apparent ddd, J 13.6, 10.9 & 8.9, one of CH2 N-Boc), 3.35 (1H, apparent ddd, J
13.6, 10.0 & 6.7, one of CH2 N-Boc), 2.22 -  2.15 (1H, m, one of CH2 CH-OTBS),
TBSO
NH
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1.78 (1H, apparent dq, J 12.5 & 9.4, one of CH2 CH-OTBS), 1.39 (9H, s, 
((CH3 )3 C-OCO), 0.77 (9H, s, ((CH3 )3 C-Si), 0.04 (3H, s, one of CH3 Si) and 0.00 
(3H, s, one of CH3 Si).
fe/7-Butyl-(S)-5-(ethoxycarbonyl)-3-((fe/7-butyldimethylsilyl)oxy)-4- 
oxopentylcarbamate (137)
NHBocNBoc COoEt
O
TBSO TBSO
136 137
n-BuLi (2.5M solution in hexanes; 0.94 mL, 2.36 mmol) was added dropwise to a 
solution of diisopropylamine (0.33 mL, 2.36 mmol) in dry THF ( 8  mL) at 0 °C 
under N2, and the resulting pale yellow mixture stirred for 30 mins. The reaction 
was then cooled to -78 °C, and a solution of dry ethyl acetate (0.23 mL, 2.36 
mmol) in THF (2 mL) added dropwise. The reaction was stirred for a further 30 
min, and a solution of (S)-tert-butyl 3-((tert-butylsilyldimethyl)oxy)-2- 
oxopyrrolidine-1-carboxylate (136) (744 mg, 2.36 mmol) in THF (2 mL) added 
dropwise. The resultant pale orange solution was allowed to warm slowly to rt 
(gradual darkening in colour) over 17 h. The reaction was then quenched with 
sat. aqueous NH4CI solution (20 mL), and the layers separated. The aqueous 
layer was washed with CH2 CI2  (3 x 30 mL), and the organic washings were 
combined, washed with brine (40 mL) and dried over Na2 S04. The solvent was 
removed in vacuo to afford the title compound as a viscous orange oil (828 mg, 
87% crude yield).
5h (400 MHz; CDCI3): 4.97 ( 1 H, m, NH), 4.13 -  4.11 (1H, m, CH-OTBS), 4.07 
(2H, q, J 7.2, C0 2 CH2 CH3), 3.51 (1H, d, J 16.2, one of C(0)-CH 2 -C0 2 Et), 3.45 
(1H, d, J 16.2, one of C(0)-CH 2 -C0 2 Et), 3.16 -  3.04 (2H, m, CH2 NH-Boc), 1.92 -  
1.80 (2H, m, CH2 CH-OTBS), 1.32 (9H, m, ((CH3 )C)-OCO), 1.16 (3H, t, J 7.1,
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C0 2 CH2 CH3), 0.83 (9H, s, ((CH3 )3 C)-Si), 0.00 (3H, s, one of CH3 -Si) and -0.01 
(3H, s, one of CH3 -Si).
(S)-3-((fer#-Butyldimethylsilyl)oxy)-pyrrolidine-2-thione (142)
/""'NH
O H s
TBSO TBSO
130 142
Lawesson’s reagent (382 mg, 0.94 mmol) was added to a solution of (S)-3-((tert- 
butyldimethylsilyl)oxy)-pyrrolidin-2-one (130) (339 mg, 1.57 mmol) in dry toluene 
(20 mL), and the reaction stirred at reflux under N2  for 11/4 h. The solvent was 
removed in vacuo, and the resulting dark orange oil purified by column 
chromatography (eluting with CH2 CI2 -EtOAc, 9:1), mid-fractions (Rf 0.62) yielding 
the title compound (270 mg, 74%) as a pale yellow crystalline solid.
Mp: 6 5 - 6 8  °C.
6 h (400 MHz; CDCI3): 9.44 (1H, broad s, NH), 4.34 (1H, apparent t, J 7.2, 
CH-OTBS), 3.44 -  3.40 (1H, m, one of CH2 NH), 3.30 (1H, apparent dt, J 11.2 &
7.4, one of CH2 NH), 2 .28-2.22 (1H, m, one of CH2 CH2 NH), 1.85 (1H, apparent 
dq, J 12.6 & 8.1, one of CH2 CH2 NH), 0.74 (9H, s, ((CH3 )3 C), 0.02 (3H, s, one of 
CH3 Si) and 0.00 (3H, s, one of CHsSi).
6 C (125 MHz; CDCI3): 205.5 (thiolactam C=S), 79.6 (CH-OTBS), 45.6 (CH2 NH), 
32.8 (CH2 CH-OTBS), 25.8 ((CH3 )3 C), 18.3 ((CH3 )3 C), -4.2 (One of CH3 Si) and 
-4.9 (One of CH3 Si).
IR (solution in CH2 CI2): 3236, 2951, 1523, 1452 and 1264 cm'1.
[a]D: -60.0° (c = 1, CH2 CI2).
MS-ES: m/z (%): 232.2 (MH+, 84 %); 216.1 (MH+-  CH3, 100).
HRMS-ES: m/z[MH]+: found 232.1181; C i0 H22NOSSi requires 232.1191.
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Ethyl 2-[(S)-4,5-dihydro-3-((ferf-butyldimethylsilyl)oxy-3H-pyrrol-2-
ylthio]acetate (143)
TBSO
C02Et
143
Ethyl bromoacetate (0.23 mL, 2.06 mmol) was added to a solution of (S)-3-((tert- 
butyldimethylsilyl)oxy)-pyrrolidine-2-thione (142) (461 mg, 2.0 mmol) in dry 
CH2 CI2  (30 mL), and the reaction stirred for 3 h at rt under N2. The mixture was 
then washed with sat. aqueous NaHC0 3  solution (40 mL), the layers separated 
and the aqueous layer washed with CH2 CI2  (3 x 50 mL). The combined organic 
washings were dried over Na2 S0 4, and the solvent removed in vacuo to yield an 
orange oil (595 mg, 94%), which was used immediately in the Eschenmoser 
sulphide contraction.
154
1H NMR (400 MHz; CDCI3) spectrum of compound 143.
—4000
-3000
-2000
-1 00 0
- 0
T T T
ppm (t1)
6 h (400 MHz; CDCI3): 4.75 (1H, apparent t, J7.6, CH-OTBS), 4.04 (2H, q, J 7.1, 
CO2 CH2 ), 3.96 (1H, d, J 16.2, one of CH2 S), 3.84 (1H, apparent dd, J 14.4 & 8 .6 , 
one of CH2 N), 3.76 (1H, d, J 16.2, one of CH2 S), 3.58 (1H, apparent dt, J 14.4 &
7.4, one of CH2 N), 2.29 -  2.22 (1H, m, one of CH2 CH-OTBS), 1.74 (1H, apparent 
dq, J 12.4 & 8.2, one of CH2 CH-OTBS), 1.12 (3H, t, J 7.1, C0 2 CH2 CH3), 0.76 
(9H, s, ((CH3 )3 C), 0.00 (3H, s, one of CH3 Si) and -0.04 (3H, s, one of CH3 Si).
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(Z)-Ethyl 2-[(S)-3-((fe/t-butyldimethylsilyl)oxy)]pyrrolidin-2-
ylidene]acetate (144)
TBSO I TBSO
C02Et
143 144
Ethyl 2-[(S)-4,5-dihydro-3-((tert-butyldimethylsilyl)oxy-3H-pyrrol-2-ylthio]acetate 
(143) (576 mg, 1.82 mmol) was dissolved in dry xylene (20 mL), and potassium 
terf-butoxide (31 mg, 0.27 mmol) added. The resultant mixture was stirred at rt 
for 15 min under N2, and triphenylphosphine (1.9 g, 7.27 mmol) added. The 
reaction was then stirred at reflux for 48 h under N2. The mixture was washed 
with sat. aqueous NaHCC> 3  solution (25 mL), and the organic layer separated. 
The aqueous layer was washed with CH2 CI2  (3 x 30 mL), the organic layers 
combined, washed with brine, dried over MgS0 4  and the solvent removed in 
vacuo. The resulting solid was purified by flash column chromatography (CH2 CI2  
-> EtOAc), affording the title compound (450 mg, 87%) as a pale yellow solid.
Mp: 60 -  64°.
6 h (400 MHz; CDCI3): 7.57 (1H, broad s, NH), 4.56 (1H, apparent t, J 7.6, 
CH-OTBS), 4.50 (1H, broad s, CH=C), 3.98 (2H, q, J 7.1, CH2 OCO), 3.46 -  3.40 
(1H, m, one of CH2 NH), 3.29 -  3.23 (1H, m, one of CH2 NH), 2.13 -  2.06 (1H, m, 
one of CH2 CH-OTBS), 1.76 (1H, apparent dq, J 12.3 & 8.3, CH2 CH-OTBS), 1.13 
(3H, t, J 7.1, CH3 CH2 OCO), 0.80 (9H, s, ((CH3 )3 C), 0.02 (3H, s, one of CH3 Si) 
and 0.00 (3H, s, one of CH3 Si).
5c (125 MHz; CDCI3): 171.0 (CH=C), 165.6 (ester C=0), 77.0 (CH=C), 74.2 
(CH-OTBS), 58.7 (C0 2 CH2), 43.9 (CH2 NH), 33.0 (CH2 CH-OTBS), 25.8 
((CH3 )3 C), 18.1 ((CH3 )3 C), 14.7 (C0 2 CH2 CH3), -4.7 (CH3 -Si) and -4.7 (CH3 -Si). 
[a]D: -8 ° (c=1, CH2 CI2).
IR (solution in CH2 CI2): 3362, 2935, 2842, 1665, 1613, 1464, 1365 and 1239 
cm*1.
MS-ES: m/z (%): 286 (MH+, 100).
HRMS-MS: m/z [MH]+: found: 286.1838; Ci4 H2 8 N03Si requires 286.1838.
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(5S)-Ethyl 1,2,3,5,6,7-hexahydro-5-hydroxy-3-pentyl-1 -thioxopyrrolo[1,2-
c]pyrimidine-4-carboxylate (146)
s
Hexanal (35 |jL, 0.3 mmol) was added to a mixture of trimethylsilyl isothiocyanate 
(26 |jL, 0.3 mmol) in dry CH2 CI2  (3 mL), and the resulting pale yellow solution 
stirred for 30 min at rt under N2. (Z)-Ethyl 2-((S)-3-hydroxypyrrolidin-2- 
ylidene)acetate (147) (49 mg, 0.3 mmol) in CH2 CI2  (2 mL) was added, and the 
reaction stirred for 3 h. The reaction was then quenched with ~0.1 M aqueous 
NaOH solution (20 mL) and the layers separated. The aqueous layer was 
washed with CH2 CI2  (3 x 25 mL), the combined organic layers dried with Na2 S0 4  
and the solvent removed in vacuo. The resulting orange gum was purified by 
column chromatography (eluting with EtOAc-Hexane, 1:3), early fractions (Rf 
0.42) affording the title compound (40 mg, 41%) as a yellow gum (single 
diastereoisomer).
5h (400 MHz; CDCI3): 7.05 (1H, broad s, NH), 5.27 (1H, apparent d, J 1.4, OH), 
5.11 (1H, apparent t, J 8.0, CH-OH), 4.26 (1H, apparent dt, J 7.8 & 3.9, 
CH-pentyl), 4.20 (2H, q, J 7.1, C0 2 CH2), 4.06 (1H, ddd, J 11.8, 9.0 & 3.4, one of 
CH2 N-CS), 3.89 (1H, ddd, J 11.8 , 9.3 & 7.7, one of CH2 N-CS), 2.42 -  2.34 (1H, 
m, one of CH2 CH-OH), 2.05 -  1.95 (1H, m, one of CH2 CH-OH), 1.58 -  1.31 (4H, 
m, 2 x alkyl CH2  protons), 1.26 -  1.18 (7H, m, CH3 CH2OCO & 2 x alkyl CH2  
protons) and 0.82 (3H, t, J 6.7, CH3 CH2 -alkyl).
5c ( 1 0 0  MHz; CDCU): 176.3 (thiourea C=S), 166.8 (ester C=0), 154.0 
(C=C-C02 Et), 100.9 (C=C-C02 Et), 72.2 (CH-OH), 61.3 (C0 2 CH2), 51.8 
(CH-pentyl), 49.7 (pyrrolidine CH2 N), 37.0 (pyrrolidine CH2 CH-OH), 31.3 
(CH2 CH-NH), 29.2 (CH2 CH2 CH-NH), 23.7 (CH3 CH2 CH2), 22.5 (CH3 CH2 CH2),
14.2 (C0 2 CH2 CH3) and 14.0 (CH3 CH2 -alkyl).
[<x]D: -26° (c= 1, CH2 CI2).
H
147 146
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IR (solution in CH2 CI2): 3425, 2941, 1671, 1632, 1444, 1408, 1323 and 1251 
cm'1.
MS-AP: m/z (%): 313 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 313.1577; C1 5 H2 5 N2 O3 S requires 313.1586.
(Z)-Ethyl 2-((S)-3-hydroxypyrrolidin-2-ylidene)acetate (147)
/""NH /""  NH
V - ^ / C 0 2Et  V - k ^ c o 2Et
TBSO HO
144 147
(Z)-Ethyl 2-[(S)-3-((tert-butyldimethylsilyl)oxy)]pyrrolidin-2-yiidene]acetate (144) 
(233 mg, 0.30 mmol) was dissolved in THF (20 mL), and TBAF (1 M solution in 
THF; 1.72 mL) added. The reaction mixture stirred at rt for 40 min, after which 
time the excess solvent was removed in vacuo. The resulting orange gum was 
purified by column chromatography (eluting with EtOAc-Hexane, 1:1), early 
fractions (Rf 0.40) affording the title compound as a pale yellow crystalline solid 
(117 mg, 84%).
Mp: 4 0 -4 4  °C.
6 h (400 MHz, CDCI3 ): 7.53 (1H, broad s, NH), 4.65 (1H, broad s, CH=C), 4.60 
(1H, apparent t, J 6.7, CH-OH), 4.04 (2H, q, J 7.2, CH2 OCO), 3.57 -  3.51 (1H, m, 
one of CH2 NH), (1H, apparent dt, J 9.9 & 7.0, one of CH2 NH), 2.89 (1H, broad s, 
OH), 2.25 -  2.17 (1H, m, one of CH2 CHOH), 1.85 (1H, apparent dq, J 14.1 & 6.5, 
one of CH2 CH-OH) and 1.19 (3H, t, J 7.2, CH3 CH2 OCO).
5C (125 MHz, CDCI3 ): 171.1 (CH=C), 165.6 (ester C=0), 77.0 (CH=C), 73.7 
(CH-OH), 58.8 (CO2 CH2 ), 44.5 (CH2NH), 32.0 (CH2CH-OH) and 14.6 
(CO2CH2 CH3).
[a]D: -2 2 ° (c=1 , CH2 CI2).
IR (solution in CH2 CI2): 3581, 3385, 3154, 2981, 2865, 1648, 1602, 1492, 1331 
and 1239 cm'1.
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MS-ES: m/z (%): 172 (M H\ 100).
HRMS-ES: m/z [MH]+: found: 172.0966; C8 Hi3 N0 3  requires 172.0974.
Methyl 2-[(S)-4,5-dihydro-3-((ferf-butyldimethylsilyl)oxy)-3H-pyrrol-2-
ylthio]acetate (148)
Methyl bromoacetate (98 pL, 1.04 mmol) was added to a solution of (S)-3-[(tert- 
butyldimethylsilyl)oxy]-pyrrolidine-2-thione (142) (200 mg, 0.87 mmol) in dry 
CH2 CI2  (10 mL), and the reaction stirred for 3 h at rt under N2. The mixture was 
then washed with sat. aqueous NaHC03  solution (40 mL), the organic layer 
separated and the aqueous layer washed with CH2 CI2  (3 x 2 0  mL). The 
combined organic washings were dried over Na2 S0 4, and the solvent removed in 
vacuo to yield the title compound as an orange oil (236 mg, 90%).
6 h (400 MHz; CDCI3): 4.71 (1H, apparent t, J 7.6, CH-OTBS), 3.90 (1H, d, J 
16.0, one of CH2 S), 3.88 -  3.82 (1H, m, one of CH2 N), 3.68 (1H, d, J 16.0, one of 
CH2 S), 3.62 (3H, s, C 0 2 CH3), 3.55 (1H, apparent dt, J 14.7 & 7.2, one of CH2 N), 
2.24 (1H, dddd, J 12.7, 7.6, 7.4 & 2.5, one of CH2 CH-OTBS), 1.74 (1H, apparent 
dq, J 12.7 & 8.1, one of CH2 CH-OTBS), 0.80 (9H, s, ((CH3 )3 C), 0.04 (3H, s, CH3- 
Si) and 0.00 (3H, s, CH3 -Si).
5C (125 MHz; CDCI3): 175.9 (imine C=N), 169.4 (ester C=0), 79.6 (CH-OTBS),
57.5 (CH2 S), 52.7 (C0 2 CH3), 34.6 (CH2 N=C), 32.8 (CH2 CH-OTBS), 25.7 
«CH3 )3 C), 18.1 ((CH3 )3 C), -4.7 (CH3 Si) and -5.0 (CH3 Si).
IR (neat): 2953, 2858, 1744, 1598, 1471, 1436, 1362, 1300 and 1255 cm 1. 
MS-AP: m/z (%): 304 (M H M  00).
HRMS-AP: m/z [MH]+: found: 304.1389; C13H26N03SiS requires 304.1403.
TBSO
C02Me
142 148
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(Z)-Methyl 2-[(S)-3-((fert-butyldimethylsilyl)oxy)pyrrolidin-2-
ylidene]acetate (149)
TBSO
148 149
Methyl 2-[(S)-4,5-dihydro-3-((tert-butyldimethylsilyl)oxy)-3H-pyrrol-2-
ylthio]acetate (148) (220 mg, 0.73 mmol) was dissolved in dry xylene (15 mL), 
potassium terf-butoxide ( 1 2  mg, 0 . 1 1  mmol) added and the resulting suspension 
stirred at rt for 15 min under N2. Triphenylphosphine (761 mg, 2.90 mmol) was 
then added, and the mixture stirred at reflux for 48 h. The mixture was quenched 
with sat. aqueous NaHCC> 3  solution ( 2 0  mL) and the organic layer was 
separated. The aqueous layer was washed with CH2 CI2  (3 x 20 mL), the organic 
layers combined, washed with brine, dried over MgS04  and the solvent removed 
in vacuo. The resulting solid was purified by flash column chromatography 
(CH2 CI2  —> EtOAc), affording the title compound (152 mg, 77%) as an orange 
crystalline solid.
Mp: 60 -  64 °C.
5h (400 MHz; CDCI3 ): 7.54 (1H, broad s, NH), 4.55 (1H, apparent t, J 7.6, 
CH-OTBS), 4.51 (1H, broad s, CH=C), 3.51 (3H, s, C0 2 CH3), 3.43 (1H, m, one of 
CH2 NH), 3.26 (1H, m, one of CH2 NH), 2.09 (1H, m, one of CH2 CH2 NH), 1.75 
(1H, m, one of CH2 CH2 NH), 0.70 (9H, s, ((CH3 )3 C), 0.00 (3H, s, one of CH3 Si) 
and -0.02 (3H, s, one of CH3 Si).
5c (125 MHz; CDCI3): 171.2 (CH=C), 166.7 (ester C=0), 76.6 (CH=C), 74.1 
(CH-OTBS), 50.1 (C0 2 CH3), 44.0 (CH2 NH), 32.8 (CH2 CH-OTBS), 25.8
((CH3 )3 C), 18.1 ((CH3 )3 C), -4.7 (One of CH3 Si) and -4.8 (One of CH3 Si).
IR (solution in CH2 CI2): 3362, 1665, 1464 and 1365 cm’1.
[a]D: -6 ° (c = 1 , CH2 CI2 ).
MS-ES: m/z (%): 272 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 272.1671; C i3 H2 6 N03Si requires 272.1676.
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(Z)-Methyl 2-((S)-3-hydroxypyrrolidin-2-ylidene)acetate (150)
<:5 ^ C 0 2Me
/  NH
' ^ C 0 2Me
TBSO HO
149 150
TBAF (1 M solution in THF; 1.18 mL) was added to a solution of (Z)-Methyl 2- 
[(S)-3-((tert-butyldimethylsilyl)oxy)pyrrolidin-2-ylidene]acetate (149) (152 mg, 
0.56 mmol) in THF ( 8  mL), and the reaction stirred at rt for 40 min. The excess 
solvent was removed in vacuo, and the resulting orange gum purified by column 
chromatography (eluting with EtOAc-Hexane, 1:1), early fractions (Rf 0.32) 
affording the title compound as a pale yellow solid (75 mg, 85%).
Mp: 3 7 -3 9  °C.
5h (400 MHz; CDCI3): 7.53 ( 1 H, broad s, NH), 4.65 (1H, broad s, CH=C), 4.61 
(1H, apparent t, J 6.7, CH-OH), 3.58 (3H, s, C0 2 CH3), 3.54 (1H, one of CH2 NH), 
3.37 (1H, apparent dt, J 10.0 & 6.9, one of CH2 NH), 2.73 (1H, broad s, OH), 2.21 
(1H, m, one of CH2 CH2 NH) and 1. 8 6  (1H, m, one of CH2 CH2 NH).
6 c (125 MHz; CDCI3): 170.4 (CH=C), 165.54 (ester C=0), 75.7 (CH-OH), 72.9 
(CH=C), 49.4 (C0 2 CH3), 43.5 (CH2 NH) and 31.1 (CH2 CH2 NH).
[a]D: -22° (c = 1, CH2 CI2).
MS-ES: m/z (%): 158 (MH+, 100).
HRMS-ES: m /z[MH]+: found: 158.0810; C7 H1 2 N0 3  requires 158.0812.
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(5S)-Methyl 1,2,3,5,6,7-hexahydro-5-hydroxy-3-(9-fe/T- 
butyldiphenylsilyloxynonyl)-1-thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate
(153)
Trimethylsilyl isothiocyanate (62 pL, 0.45 mmol) was added to a solution of 
10-((tert-butyldiphenylsilyl)oxy decanal (152) (183 mg, 0.45 mmol) in dry CH2 CI2  
(3 mL) under N2, and the resulting brown solution stirred for 30 min at rt. A 
solution of (Z)-Methyl 2-((S)-3-hydroxypyrrolidin-2-ylidene)acetate (150) (70 mg, 
0.45 mmol) in CH2 CI2  (2 mL) was then added, and the reaction stirred for 3 h. 
The reaction was quenched with ~0.1 M aqueous NaOH solution (20 mL) and the 
layers separated. The aqueous layer was washed with CH2 CI2  (3 x 25 mL), the 
combined organic layers dried with Na2 SC> 4  and the solvent removed in vacuo. 
The resulting orange gum was purified by column chromatography (eluting with 
EtOAc-Hexane, 1:2.5) mid-fractions (Rf 0.55) affording the title compound (79 
mg, 29%) as a yellow gum (single diastereoisomer).
5h (500 MHz; CDCI3): 7.70 -  7.55 (4H, m, aromatic CH), 7.41 -  7.28 (6 H, m, 
aromatic CH), 6.99 (1H, broad s, NH), 5.20 (1H, broad s, OH), 5.10 (1H, 
apparent t, J 8.0, CH-OH), 4.24 (1H, apparent dt, J 7.8 & 3.8, CH-NH), 4.06 (1H, 
ddd, J 11.6 , 8 . 8  & 3.3, one of CH2 N-CS), 3.89 (1H, ddd, J 11.6 , 9.0 & 8.0, one of 
CH2 N-CS), 3.65 (3H, s, C 0 2 CH3), 3.58 (2H, t, J 6.5, CH2 OTBDPS), 2.40 -  2.33 
(1H, m, one of CH2 CH-OH), 2.0 -  1.95 (1H, m, one of CH2 CH-OH), 1.54 -  1.40 
(6 H, m, 3 x alkyl CH2  protons) and 1.36 -  1.10 (19H, m, 5 x alkyl CH2  protons & 
«CH3 )3 C).
5c (125 MHz; CDCI3): 175.3 (thiourea C=S), 166.2 (ester C=0), 153.2 
(C=C-C02 Me), 139.8 (aromatic C), 134.6 (aromatic CH), 128.5 (aromatic CH),
126.6 (aromatic CH), 99.6 (C=C-C02 Me), 71.2 (CH-OH), 63.0 (CH2 OTBDPS), 
51.15 (C0 2 CH3), 50.9 (CH-NH), 48.7 (CH2 N-C=S), 36.1 (pyrrolidine CH2 CH-OH),
S
HO
f8 OTBDPS
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31.6 (CH2 CH-NH), 28.8 (CH2), 28.6 (CH2), 28.4 (CH2), 28.2 (CH2), 28.1 (CH2),
25.9 ((CH3 )3 C), 24.8 (CH2), 23.0 (CH2) and 18.2 ((CH3 )3 C).
IR (solution in CH2 CI2): 3401, 3205, 2883, 1675, 1629, 1531, 1462, 1416, 1324 
and 1255 cm'1.
[a]D: -16° (c= 1 ,C H 2 CI2).
MS-ES: m/z (%): 609 (MH+, 25), 279 (100).
HRMS-ES: m/z [MH]+: found: 609.3196; C s ^ g N ^ S iS  requires 609.3182.
(5S)-Methyl 3-(9-ferf-butyldiphenylsilyloxynonyl)-3,5,6,7-tetrahydro-5- 
hydroxy-1 -(methlthio)pyrrolo[1,2-c]pyrimidine-4-carboxylate (157)
S SMe
' 8  OTBDPS
HO COoMe
157
NH
fe OTBDPS
HO
(5S)-Methyl 1,2,3,5,6,7-hexahydro-5-hydroxy-3-(9-tert-
butyldiphenylsilyloxynonyl)-1 -thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (153) 
(21 mg, 0.035 mmol) was dissolved in dry CH2 CI2  (10 ml_), methyl iodide (43 pL, 
0.69 mmol) added and the resultant orange solution stirred at reflux under N2  for 
16 h. The reaction was allowed to cool to rt, dry triethylamine (96 pL, 0.69 mmol) 
added and the reaction stirred for 30 min. The volatiles were then removed in 
vacuo, and the subsequent solid was washed with hexane (30 mL) and removed 
via gravity filtration. The filtrate was concentrated in vacuo to produce an orange 
oil, which was purified by flash column chromatography (eluting with 
EtOAc-Hexane, 1:1.5; Rf 0.95), affording the title compound as an orange gum 
(19.6 mg, 91%).
5h (500 MHz; CDCI3): 7.70 -  7.55 (4H, m, aromatic CH), 7.41 -  7.28 (6 H, m, 
aromatic CH), 5.73 (1H, broad s, OH), 5.10 (1H, apparent t, J 8.4, CH-OH), 4.66 
-  4.54 (1H, m, CH-N=C), 3.81 -  3.72 (1H, m, one of pyrrolidine CH2 N-C=N), 3.66
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(3H, s, CO2 CH3 ), 3.58 (2H, t, J 6.2, CH2 OTBDPS), 3.40 -  3.30 (1H, m, one of 
pyrrolidine C/-/2 N-C=N), 2.46 -  2.21 (4H, m, one of pyrrolidine CH2 CH-OH & 
S-CH3), 2.03 -  1.87 (1H, m, one of pyrrolidine CH2 CH-OH), 1.55 -  1.42 (6 H, m, 3 
x alkyl CH2 protons) and 1.32 -  1.04 (19H, m, 5 x alkyl CH2 protons & {{CHz)zC). 
6 C (125 MHz; CDCI3): 168.1 (ester C=0), 155.1 (C=C-C02 Me), 145.5 
(MeS-C=N), 139.1 (aromatic C), 134.6 (aromatic CH), 128.5 (aromatic CH),
126.5 (aromatic CH), 95.9 (C=C-C02 Me), 70.4 (CH-OH), 63.0 (CH2 OTBDPS),
54.9 (CH-N=C), 50.6 (C0 2 CH3), 45.3 (pyrrolidine CH2 N-C=N), 36.3 (pyrrolidine 
CH2 CH-OH), 31.6 (CH2 CH-N=C), 28.9 (CH2), 28.72 (CH2), 28.6 (CH2), 28.4 
(CH2), 25.9 ((CH3 )3 C), 24.8 (CH2), 23.6 (CH2), 21.7 (CH2), 19.0 ((CH3 )3 C) and
13.1 (S-CH3).
IR (solution in CH2 CI2): 2850, 1673, 1628, 1544, 1466 and 1420 cm'1.
[a]D: -8 ° (c = 0.5, CH2 CI2).
MS-AP: m/z (%): 623 (MH+, 100).
HRMS-AP: m/z [MH]+: found: 623.3315; C3 5 H5 iN 2 0 4 SiS requires 623.3339.
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6.4. Experimental Data for Chapter 4
(5S)-5-(lodomethyl)pyrrolidin-2-one8 2  (168)
168
Iodine (1.347 g, 5.31 mmol) was added to a solution of triphenylphosphine 
(1.390g, 5.31 mmol) in dry CH2 CI2  ( 1 0  mL), and the reaction stirred at rt for 15 
min under N2. Imidazole (0.410 g, 6.03 mmol) and a solution of (S)-5- 
(hydroxymethyl)pyrrolidin-2-one (0.275 g, 2.41 mmol) in CH2 CI2  (5 mL) were 
added, and the reaction stirred at reflux for 3 h. The reaction was then quenched 
with sat. aqueous sodium thiosulphate solution (20 mL) and the layers separated. 
The aqueous phase was washed with EtOAc (3 x 40 mL), and the organic layers 
were combined and dried with MgS04. The solvent was removed in vacuo to give 
a yellow oil, which was purified by column chromatography (eluting with EtOAc -  
1% triethylamine-EtOAc), late fractions (Rf 0.21) affording the title compound 
(373 mg, 69%) as a colourless oil which crystallised on standing.
5h (500 MHz; CDCI3): 3.77 ( 1 H, apparent quintet, J 5.9, CH-NH), 3.18 (2 H, d, J
6.1, C/-/2 I), 2.43 -  2.36 (1H, m, one of CH2 C=0), 2.32 -  2.23 (2H, m, one of 
CH2 C=0 & one of CH2 CH-NH) and 1.80 -  1.73 (1H, m, one of CH2 CH-NH).
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5-Hydroxy-2-((S)-1 -phenylethyl)pyrrolidin-2-one83 (186)
°^ N ^ ° -------------- O ^ f ^ O H
Me'' ^Ph Me'' ^Ph
185 186
LiEt3BH (1.0 M sol. in THF; 68.2 mL, 68.2 mmol) was added dropwise to a 
solution of 1 -((S)-1 -phenylethyl)pyrrolidine-2,5-dione (185) (8.94 g, 48 mmol) in 
dry THF (80 mL) at -78 °C under N2 , and the resultant mixture stirred for 40 min. 
The excess THF was then removed in vacuo, and the residue cooled to 0 °C. 
The reaction was quenched by the dropwise addition of sat. aqueous NaHC03  
solution (70 mL). CH2 CI2  (50 mL) was added, the layers separated, and the 
aqueous layer washed with further portions of CH2 CI2  (3 x 40 mL). The combined 
organic layers were treated with a few drops of hydrogen peroxide solution 
(30%), washed with brine (50 mL) and dried over Na2 S04. The volatiles were 
then removed in vacuo to yield the title compound (d.r. ~6:1; 8.486 g, 94%) as a 
pale yellow solid.
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1H NMR spectrum of compound 186 (400 MHz; CDCI3).
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6 h (400 MHz; CDCI3): 7.39 -  7.19 (5H, m, aromatic CH), 5.28 (1H, q, J 7.3, 
CH-Me major diastereoisomer), 5.23 (1H, q, J 7.2, CH-Me minor), 4.86 (1H, 
apparent dd, J 6.3 & 1.2, CH-OH), 2.57 (1H, apparent dt, J 17.2 & 8.7, one of 
CH2 C=0), 2.19 (1H, ddd, J 17.2, 9.8 & 2.8, one of CH2 C=0), 2.07 -  1.97 (1H, m, 
one of CH2 CH-OH), 1.82 -  1.73 (1H, m, one of CH2 CH-OH) and 1.60 (3H, d, J 
7.2, CH3 -CH).
[a]0: -96° (c = 1, EtOH). L it83 data ((R)-hydroxy lactam): +112.46° (c = 1, EtOH).
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Trimethyl(nona-1,2-dien-3-yl)silane (188)
7 MSMsO , ■ I p_« __/
^ —TMS 2  V h'■'6'■13
188
Lithium bromide (601 mg, 6.92 mmol) was added to a suspension of copper(l) 
bromide (993 mg, 6.92 mmol) in dry THF (20 mL) under N2 , and the mixture 
stirred until a green colour was obtained. The reaction was cooled to -78 °C, and 
hexylmagnesiumbromide (2.0 M sol. in Et2 0 ; 3.46 mL, 6.92 mmol) added 
dropwise. The resulting dark yellow solution was stirred for 2 h, and a solution of 
3-(trimethylsilyl)prop-2-ynyl methanesulphonate (1.299 g, 6.30 mmol) in THF (3 
mL) added dropwise. The subsequent brown mixture was allowed to warm to rt 
overnight. The reaction was then quenched with sat. aqueous NH4CI solution (25 
mL), the layers separated and the aqueous layer extracted with Et2 0  (3 x 20 mL). 
The combined organic washings were dried over Na2 S04, and the solvent 
removed in vacuo. The resulting oil was purified by flash column chromatography 
(eluting with Hexane; Rf 0.98), producing the title compound as a colourless oil 
(803 mg, 65%).
5h (400 MHz; CDCI3): 4.22 (2H, t, J 3.3, H2C=C=C-TMS), 1.84 (2H, apparent tt, 
J 6.7 & 3.3, H2 C=C=C-CH2 CH2), 1.36 (2 H, qnt, J 7.3, H2 C=C=C-CH2 CH2), 1.24 -  
1.18 (6 H, m, 3 x alkyl CH2 protons), 0.79 (3H, t, J 6 .8 , C/-/3 CH2 -alkyl) and 0.00 
(9H, s, ((CH3 )3 Si).
5C (125 MHz; CDCI3): 219.0 (H2 C=C=C), 96.3 (H2 C=C=C), 70.3 (H2 C=C=C),
33.4 (CH2 CH2 -C=C=CH2), 32.3 (CH2), 31.4 (CH2), 30.8 (CH2), 24.4 
(CH3 CH2 -alkyl), 15.8 (CH3 CH2 -alkyl) and 0.00 ((CH3 )3 Si).
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(5S)-5-(Non-2-ynl)-1 -((S)-1 -phenylethyl)pyrrolidin-2-one (189a), (5/?)-5-(non- 
2-ynl)-1-((S)-1-phenylethyl)pyrrolidin-2-one (189b) and 1-((S)-1-phenylethyl)-
1H-pyrrol-2(5H)-one (190)
Me'' Ph
189a
Me''”^Ph
189b
CrH6n 13
Me'' ^Ph 
190
5-hydroxy-2-((S)-1-phenylethyl)pyrrolidin-2-one (186) (824 mg, 4.02 mmol) was 
dissolved in dry CH2 CI2  (45 mL) at -78 °C under N2. Tin(IV) chloride (1.11 mL, 
6.02 mmol) and a solution of trimethyl(nona-1,2-dien-3-yl)silane (2.366g, 12.05 
mmol) in CH2 CI2  (4 mL) were then added. The resulting yellow suspension was 
allowed to warm slowly to rt, and stirred at that temperature for 18 h. The 
reaction mixture was then quenched with dropwise addition of sat. aqueous 
NaHCC> 3  solution (40 mL), the organic layer separated and the aqueous layer 
washed with CH2 CI2  (3 x 35 mL). The combined organic layers were dried over 
MgS04, and the solvent removed in vacuo. The subsequent dark orange oil 
(189a:189b=2.5:1) was purified by column chromatography (eluting with 
EtOAc-Hexane, 1:4), affording, in order of elution, title compounds 189a/189b 
and 190.
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(5S)-5-(Non-2-ynl)-1-((S)-1-phenylethyl)pyrrolidin-2-one (189a) and (5R)-5- 
(non-2-ynl)-1-((S)-1-phenylethyl)pyrrolidin-2-one (189b) (pale yellow oil): (563 
mg, 45%; Rf 0.26):
6 h (400 MHz; CDCI3): 7.39 -  7.24 (5H, m, aromatic CH), 5.44 (189b; 0.44 H, q, J
7.1, CH-Me), 5.36 (189a; 1H, q, J7.7, CH-Me), 3 .74-3.69 (189b; 1H, m, CH-N), 
3.29 -  3.24 (189a; 0.44 H, m, CH-N minor), 2.62 -  2.45 (1H, m, one of CH2 C=0), 
2 .40-2.23 (1H, m, one of CH2 C=0), 2 .12-1.95 (2H, m, CH2C=C), 1.89-1.81 
(1H, m, one of CH2 C=C), 1.62 (1H, apparent dd, J 13.3 & 5.9, one of CH2 C=C), 
1.56 (3H, d, J 7.2, CH3 -CH), 1.43 -  1.38 (1H, m, one of CH2 CH2 C=0), 1.37 -  
1.31 (1H, m, one of CH2 CH2 C=0), 1.28 -  1.12 (8 H, m, 4 x alkyl CH2  protons) and 
0.81 (3H, t, J6.9, CH3 CH2 -alkyl).
6 c (125 MHz; CDCI3): 175.4 (lactam C=0), 141.5 (aromatic C), 128.7 (aromatic 
CH), 127.6 (aromatic CH), 127.4 (aromatic CH), 77.4 (CsC), 75.6 (CeC), 55.8 
(pyrrolidine CH-N), 49.3 (CH-Ph), 31.3 (CH2 C=0), 31.0 (CH2 CeC), 30.8 
(CH2 C=C), 28.8 (CH2), 28.6 (CH2), 25.1 (pyrrolidine CH2 CH-N), 24.6 (CH2), 22.6 
(CH3 CH2 -alkyl), 18.7 (CH3 -CH) and 14.1 (CH3 CH2 -alkyl).
IR (neat): 2930, 1687, 1496, 1413 and 1278 cm'1.
[a]D: -12° (c= 1, CH2 CI2).
MS-ES: m/z (%): 312 (MH+, 92); 623 (2M+H+, 100).
HRMS-ES: m/z [MH]+: found: 312.2317; C2 1 H30NO requires 312.2327.
1-((S)-1-phenylethyl)-1H-pyrrol-2(5H)-one (190; dark orange oil): (391 mg, 
52%):
5h(400 MHz ; CDCI3): 7.36 -  7.24 (5H, m, aromatic CH), 6.94 (1H, apparent d, J 
5.9, CO-CH=CH), 6.07 (1H, apparent d, J 5.9, CO-CH=CH), 5.47 (1H, q, J 7.1, 
CH-Me), 3.87 (1H, apparent d, J 20.4, one of CH2 N), 3.54 (1H, apparent d, J 
20.4, one of CH2 N) and 1.61 (3H, d, J 7.2, CH-Me).
5c (100 MHz; CDCI3): 171.0 (C=0), 142.8 (CO-CH=CH), 141.0 (aromatic C),
128.7 (aromatic CH), 128.0 (CO-CH=CH), 127.5 (aromatic CH), 127.0 (aromatic 
CH), 48.9 (CH2 N), 48.6 (CH-Me) and 17.8 (CH3 -CH).
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(5S)-5-(Non-2-ynl)pyrrolidin-2-one (191)
A H 13.c6h
189a
N
H
191
Note: only the major diastereoisomer is reported.
(5S)-5-(non-2-ynl)-1-((S)-1-phenylethyl)pyrrolidin-2-one (189a) (1.13g, 3.63
mmol) was dissolved in liquid ammonia-THF-absolute EtOH (4:1:1; 90 mL), and 
the resulting yellow solution cooled to -78 °C. Sodium chunks (836 mg, 36.3 
mmol) were then added portion-wise, until the blue colour had persisted for 
longer than 3 min. The reaction was then allowed to warm to rt for 30 min (until 
the mixture had turned colourless), and solid NH4CI (763 mg, 14.5 mmol) added. 
The ammonia was allowed to evaporate, water (20 mL) and EtOAc (30 mL) 
added, and the layers separated. The aqueous layer was then washed with 
EtOAc (3 x 30 mL), the combined organic layers dried over Na2 S0 4  and the 
excess solvent removed in vacuo. The title compound was afforded (751 mg, 
1 0 0 %) as a pale yellow oil.
5h (CDCI3; 400 MHz): 6.70 (1H, broad s, NH), 3.69 (1H, apparent quintet, J 6.2, 
CH-NH), 2.32 -  2.19 (4H, m, CH2 C=0 & CH2C=C), 2.08 -  2.03 (2H, m, 
C/-/2 C=C), 1.81 -  1.72 (1H, m, one of pyrrolidine CH2 CH-NH), 1.55 -  1.52 (1H, 
m, one of pyrrolidine CH2 CHNH), 1.40 (2H, quintet, J 7.3, C=C-CH2 CH2 CH2), 
1.30-1.15 (6 H, m, 3 x alkyl CH2) and 0.82 (3H, t, J 6.9, CH3 CH2 -alkyl).
5c (CDCIs; 125 MHz): 176.9 (lactam C=0), 82.0 (CsC), 74.4 (CsC), 52.6 
(CH-NH), 30.3 (CH2 C=0), 29.3 (CH2 CsC), 27.9 (CH2 CeC), 27.6 (CH2), 25.7 
(CH2), 25.3 (pyrrolidine CH2 CH-NH), 21.6 (CH2), 17.8 (CH3 CH2 -alkyl) and 13.0 
(CH3 CH2 -alkyl).
IR (neat): 3240, 2956, 2928, 1699,1462,1424,1379, 1346 and 1302 cm'1.
[a]D: -4° (c = 0.5, CH2 CI2).
MS-ES: m/z (%): 208 (MH+, 6 8 ); 249 (M+MeCN, 100).
HRMS-EI: m/z [M]+: found; 207.1625; C i3 H2 iNO requires 207.1623.
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(5S)-5-((Z)-Non-2-enyl)pyrrolidin-2-one (192)
O ^ N
H
191 192
Sodium borohydride (51 mg, 1.35 mmol) was added to a solution of Ni(OAc) 2  
(291 mg, 1.2 mmol) in abs. EtOH (20 mL), and the resulting solution stirred for 15 
min at rt under N2. NH2 (CH2 )2 NH2  (60 pL, 0 . 8  mmol) was added, the mixture 
stirred for 5 min and a solution of (5S)-5-(non-2-ynl)pyrrolidin-2-one (191) (185 
mg, 0.8 mmol) in abs. EtOH (3 mL) added. The atmosphere in the flask was then 
evacuated and purged with H2. The reaction was then stirred under a hydrogen 
atmosphere for 16 h. The resulting purple suspension was quenched with sat. 
aqueous NaHC03  solution (15 mL) and EtOAc (20 mL). The organic layer was 
separated, and the aqueous layer washed with EtOAc (3 x 20 mL). The 
combined organic washings were then dried over Na2 S0 4  and the excess solvent 
removed in vacuo. The title compound was afforded (181 mg, 97%) as a yellow 
oil.
6 h (400 MHz; CDCI3): 5.55 (1H, broad s, NAT), 5.58 -  5.37 (1H, m, one of 
C/-/=CH), 5.19 -  5.13 (1H, m, one of CH=CH), 3.51 (1H, apparent quintet, J 6.7, 
CH-NH), 2.24 -  2.10 (4H, m, CH2 C=0 & CH2 C=C), 1.90 -  1.83 (3H, m, CH2 C=C 
& one of pyrrolidine CH2 CHNH), 1.64 -  1.57 (1H, m, one of pyrrolidine 
CH2 CHNH), 1.22 -  1.07 (8 H, m, 4 x CH2 protons) and 0.73 (3H, t, J 6.9, CH3 CH2- 
alkyl).
5c (125 MHz; CDCI3): 178.5 (lactam C=0), 133.5 (CH=CH), 123.7 (CH=CH), 
54.5 (CH-NH), 34.2 (CH2 C=0), 31.7 (CH2 C=C), 30.363 (CH2 C=C), 29.5 (CH2),
28.9 (CH2), 27.4 (CH2), 26.5 (pyrrolidine CH2 CH2 C=0), 22.6 (CH3 CH2 -alkyl) and
14.1 (CH3 CH2 -alkyl).
IR (neat): 3221, 2854, 1687, 1624 and 1456 cm 1.
[a]D: -14°(c = 1, CH2 CI2).
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MS-ES: m/z (%) = 210 (M H\ 100).
HRMS-ES: m/z [MH]+: found: 210.1849; C i3 H24NO requires 210.1858.
(5S)-ferf-Butyl 2-((Z)-non-2-enyl)-5-oxopyrrolidine-1 -carboxylate (193)
Triethylamine (0.12 mL, 0.87 mmol) and DMAP (catalytic, 5 mg) were added to a 
solution of (5S)-5-((Z)-non-2-enyl)pyrrolidin-2-one (192) (120 mg, 0.58 mmol) in 
dry CH2 CI2  (15 mL) under N2. A solution of di-terf-butyl dicarbonate (138 mg, 
0.63 mmol) in CH2 CI2  ( 6  mL) was added dropwise, and the resulting dark orange 
solution stirred for 17 h. The reaction was then quenched with sat. aqueous 
NaHCC> 3  solution (35 mL), the layers separated and the aqueous layer washed 
with CH2 CI2  (3 x 25 mL). The combined organic extracts were dried over MgS04  
and the solvent removed in vacuo. The resulting orange solid was purified by 
flash column chromatography (EtOAc; Rf 0.95), affording the title compound (167 
mg, 94%) as an orange oil.
5h (400 MHz; CDCI3): 5.46 -  5.41 (1 H, m, one of CH=CH), 5.29 -  5.24 (1 H, m, 
one of CH=CH), 4.13 -  4.05 (1H, m, CH-NBoc), 2.53 -  2.44 (1H, m, one of 
CH2 C=0), 2.38 -  2.24 (2H, m, one of CH2 C=0 & one of CH2 C=C), 2.19 (1H, 
apparent dt, J 14.0 & 7.9, one of C/-/2 C=C), 2.06 -  1.96 (1H, m, one of pyrrolidine 
CH2 CH-NBoc), 1.93 (2H, apparent q, J 7.1, CH2 C=C), 1.78 -  1.72 (1H, m, one of 
pyrrolidine CH2 CH-NBoc), 1.46 (9H, s, ((CH3 )3 C), 1.28 -  1.07 (8 H, m, 4 x alkyl 
CH2  protons) and 0.81 (3H, t, J6.9, CH3 CH2 -alkyl).
6 c (100 MHz; CDCI3): 173.4 (lactam C=0), 148.9 (carbamate C=0), 134.3 
(CH=CH), 123.1 (CH=CH), 81.6 ((CH3 )3 C), 56.8 (CH-NBoc), 35.9 (CH2 C=0),
31.7 (CH2 C=C), 30.7 (CH2 C=C), 28.4 (CH2), 27.9 (CH2), 27.1 ((CH3 )3 C), 26.5
192 193
173
(CH2 ), 21.7 (pyrrolidine CH2 CHN-B0 C), 20.6 (CH3 CH2 -alkyl) and 13.1
(CH3 CH2 -alkyl).
[a]D: -6 ° (c= 1, CH2 CI2 ).
IR (neat): 2931, 2872, 1784, 1749, 1708, 1461, 1361 and 1296 cm'1.
HRMS-AP: m/z [2MH + NH4]+: found: 636.4944; C3 6 H66N3 0 6  requires 636.4952.
ferf-Butyl (S,Z)-1-(methoxycarbonyl)-2-oxotetradec-7-en-5-ylcarbamate
(194)
n-Butyl lithium (2.5M solution in hexanes; 0.86 mL, 2.14 mmol) was added to a 
solution of diisopropylamine (0.3 mL, 2.14 mmol) in dry THF (5 mL) at 0 °C, and 
the resulting pale yellow mixture stirred for 30 min under N2. The reaction was 
then cooled to -78 °C, and a solution of dry methyl acetate (0.17 mL, 2.14 mmol) 
in THF (1 mL) added dropwise. The reaction was stirred for a further 30 min, and 
a solution of (5S)-tert-butyl 2-((Z)-non-2-enyl)-5-oxopyrrolidine-1-carboxylate 
(193) (130 mg, 0.43 mmol) in THF (3 mL) added dropwise. The resultant pale 
orange solution was then allowed to warm slowly to rt (gradual darkening in 
colour) over 17 h. The reaction was quenched with sat. aqueous NH4CI solution 
( 2 0  mL), and the layers separated. The aqueous layer was washed with CH2 CI2  
(3 x 30 mL), and the organic washings combined, washed with brine (40 mL) and 
dried over Na2 S0 4. The solvent was removed in vacuo to afford a viscous orange 
oil (150 mg, 93% crude yield).
6 h (500 MHz; CDCI3): 5.44 (1H, apparent dt, J 10.9 & 7.3, one of CH=CH), 5.27 
(1H, apparent dt, J 10.9 & 7.5, one of CH=CH), 4.35 (1H, apparent d, J 8.5, 
NH-Boc), 3.66 (3H, s, C0 2 CH3), 3.54 -  3.47 (1H, m, CH-NHBoc), 3.39 (2H, s,
,0
BocHN
193 194
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CO-CH2 -CO), 2.57 -  2.52 (2H, m, CO-CH2 CH2), 2.23 -  2.15 (1H, m, one of 
CH2 C=C), 2.11 -  2.04 (1H, m, one of CH2 C=C), 1.94 (2H, apparent q, J 7.1, 
CH2 C=C), 1.80 -  1.72 (1H, m, one of CH2 CH2 CO), 1.58 -  1.52 (1H, m, one of 
CH2 CH2 CO), 1.36 (9H, s, ((CH3 )3 COCO), 1.30 -  1.15 (8 H, m, 4 x alkyl CH2 
protons) and 0.80 (3H, t, J 6.9, CH3 CH2 -alkyl).
5c (100 MHz; CDCI3): 201.5 (ketone C=0), 166.6 (ester C=0), 154.8 (carbamate 
C=0), 132.3 (CH=CH), 123.3 (CH=CH), 78.0 ((CH3 )3 C), 51.3 (C0 2 CH3), 49.2 
(CH-NHBoc), 48.1 (CO-CH2 -CO), 38.9 (CH2 CH2 CO), 38.8 (CH2 C=C), 35.0 
(CH2 C=C), 28.7 (CH2 CH-NH), 28.6 (CH2), 28.0 (CH2), 27.4 ((CH3 )3 C), 26.4
(CH2), 21.6 (CH3 CH2 -alkyl) and 13.1 (CH3 CH2 -alkyl).
(2Z)-Methyl 2-((S)-5-(non-2-enyl)pyrrolidin-2-ylidene)acetate (195)
tert-Butyl (S,Z)-1-(methoxycarbonyl)-2-oxotetradec-7-en-5-ylcarbamate (194) 
(160 mg, 0.42 mmol) was dissolved in CH2 CI2  (1 mL), and triflouroacetic acid 
(0.13 mL, 1.7 mmol) added. The resultant dark orange oil was stirred at rt for 3 h. 
The reaction was then quenched with sat. aqueous NaHC03  solution until pH 7 
was reached, and diluted with CH2 CI2  (30 mL). The layers were separated, and 
the aqueous layer extracted with CH2 CI2  (3 x 20 mL). The combined organic 
extracts were dried over Na2 S0 4  and the solvent removed in vacuo. The resulting 
oil was then purified by column chromatography (eluting with EtOAc-Hexane, 
1:9), early fractions (Rf 0.51) giving the title compound (140 mg, 81%) as an 
orange oil (E/Z estimated to be 3:1).
BocHN
o
194 195
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5h (500 MHz; CDCI3): 7.90 (1H, broad s, NH), 5.49 (1H, apparent dt, J 15.2 &
6.7, one of CH=CH), 5.28 (1H, apparent dt, J 15.2 & 7.1, one of CH=CH), 4.41 
(1H, broad s, CH=C-NH), 3.71 (1H, apparent quintet, J 6 .6 , CH-NH), 3.57 (3H, m, 
CO2 CH3 ), 2.60 -  2.42 (2H, m, one of pyrrolidine CH2 C=C & one of CH2 C=C),
2.26 -  2.18 (1H, m, one of CH2 C=C), 2.17 -  2.08 (1H, m, one of pyrrolidine 
CH2 C=C), 1.94 (2H, apparent q, J 7.1, CH2 C=C), 1.58 -  1.48 (2H, m, one of 
pyrrolidine CH2 CH-NH), 1.29 -  1.20 (8 H, m, 4 x alkyl CH2 protons) and 0.81 (3H, 
t, J 6 .8 , CH3 CH2 -alkyl).
6C (125 MHz; CDCI3): 169.8 (ester C=0), 168.2 (C=CH-C02 Me), 134.7 (one of 
CH=CH E-isomer), 124.7 (one of CH=CH E-isomer), 133.7 (one of CH=CH 
Z-isomer), 123.8 (one of CH=CH Z-isomer), 76.0 (C=CH-C02 Me), 59.6 (CH-NH),
50.0 (CO2 CH3 ), 32.6 (CH2 C=C), 31.9 (pyrrolidine CH2 C=C), 31.8 (CH-2 C=C),
29.4 (pyrrolidine CH2 CH-NH), 28.9 (CH2), 27.7 (CH2), 27.5 (CH2), 2 2 . 6  (CH3 CH2- 
alkyl) and 14.1 (CH3 CH2 -alkyl).
[a]D: -18° (c= 1, CH2 CI2 ).
IR (neat): 3420, 2942, 1660 and 1602 cm'1.
MS-ES: m/z (%) = 266 (MH+, 91).
HRMS-ES: m/z [M H f: found: 266.2104; C1 6 H2 8N02  requires 266.2115.
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(3R,7S)-Methyl 1,2,3,5,6,7-hexahydro-7-((E)-non-2-enyl)-3-pentyl-1 - 
thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate -  major diastereoisomer 
(196a) and (3S,7S)-Methyl 1,2,3,5,6,7-hexahydro-7-((E)-non-2-enyl)-3-pentyl- 
1-thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate -  minor diastereoisomer
(196b)
MeOoC
196a
195 CcH
Me02C
196b
Hexanal (100 pL, 0.84 mmol) was added to a solution of trimethylsilyl 
isothiocyanate (120 pL, 0.84 mmol) in dry CH2 CI2  ( 6  mL), and the resulting 
orange solution stirred at rt under N2  for 30 min. A solution of (2Z)-Methyl 2-((S)- 
5-(non-2-enyl)pyrrolidin-2-ylidene)acetate (195) ( 1 1 0  mg, 0.42 mmol) in CH2 CI2  
(4 mL) was added, and the reaction mixture stirred at rt for 45 min. The reaction 
was then quenched with -0.1 M aqueous NaOH solution (30 mL) and the 
aqueous layer extracted with CH2 CI2  (3 x 25 mL). The organic washings were 
combined, dried over Na2 S0 4  and the CH2 CI2  removed in vacuo. The subsequent 
yellow gum (196a:196b=2.01:1) was purified by column chromatography (eluting 
with EtOAc-Hexane, 1:9), yielding the title compounds, in order of elution:
(3R,7S)-Methyl 1,2,3,5,6,7-hexahydro-7-((£)-non-2-enyl)-3-pentyl-1 - 
thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (196a; off-white oil): (231 mg, 58%; 
Rf 0.5):
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5h (400 MHz; CDCI3): 6.57 (1H, broad s, NH), 5.46 (apparent dt, J 15.0 & 6.9, 
one of CH=CH), 5.29 -  5.23 (1H, m, one of CH=CH), 4.52 -  4.47 (1H, m, 
CH-NCS), 4.21 -  4.18 (1H, m, CH-pentyl), 3.65 (3H, s, C02CH3), 3.32 -  3.24 
(1H, m, one of pyrrolidine CH2C=C), 3.02 -  2.98 (1H, m, one of pyrrolidine 
CH2C=C), 2.93 -  2.79 (2H, m, CH2C=C), 2.19 -  2.07 (1H, m, one of CH2C=C),
2.04 -  1.99 (1H, m, one of CH2C=C), 1.94 -  1.84 (2H, m, pyrrolidine CH2CH-N), 
1.63 -  1.44 (2H, m, CH2CHNH), 1.35 -  1.15 (17H, 7 x CH2 alkyl protons & 
CH3CH2OCO) and 0.81 (6H, t, J 6.9, 2 x CH3CH2-alkyl).
5C (125 MHz; CDCI3): 174.4 (C=S), 165.1 (ester C=0), 149.0 (C=C-C02Me),
133.6 (one of CH=CH), 124.0 (one of CH=CH), 98.7 (C=C-C02Me), 62.0 
(CH-NCS), 51.2 (CH-pentyl), 50.2 (C02CH3), 36.8 (pyrrolidine CH2C=C), 31.7 
(CH2C=C), 30.4 (CH2C=C), 29.5 (pyrrolidine CH2CH-N), 28.7 (CH2CH-NH), 28.3 
(CH2), 27.8 (CH2), 26.7 (CH2), 24.6 (CH2), 22.5 (CH2), 21.6 (pentyl CH3CH2),
21.5 (CH3CH2-alkyl), 13.1 (CH3CH2-alkyl) and 13.0 (CH3CH2-alkyl).
[a]D: +10° (c=1, CH2CI2).
IR (neat): 3267, 2941, 2857, 1682, 1654, 1521, 1460, 1380 and 1231 cm'1. 
MS-ES: m/z (%) = 421 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 421.2892; C24H4iN20 2S requires 421.2889.
(3S,7S)-Methyl 1,2,3,5,6,7-hexahydro-7-((E)-non-2-enyl)-3-pentyl-1 - 
thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (196b; yellow gum): (96 mg, 24%; Rf 
0.26):
5h (250 MHz; CDCI3): 7.06 (1H, broad s, NH), 5.53 -  5.41 (1H, m, one of 
CH=CH), 5.34 -  5.18 (1H, m, one of CH=CH), 4.90 -  4.77 (1H, m, CH-NCS),
4.26 -  4.20 (1H, m, CH-pentyl), 3.66 (3H, s, C02CH3), 3.30 -  3.16 (1H, m, one of 
pyrrolidine CH2C=C), 3.02 -  2.87 (1H, apparent dt, J 19.2 & 9.5, one of 
CH2C=C), 2.78 -  2.53 (1H, m, one of pyrrolidine CH2C=C), 2.39 -  2.25 (1H, m, 
one of CH2C=C), 2.07 -  1.89 (3H, m, CH2C=C & one of pyrrolidine CH2CH-N), 
1.83 -  1.73 (1H, m, one of pyrrolidine CH2CH-N), 1.55 -  1.39 (2H, m, 
CH2CH-NH), 1.36 -  1.16 (14H, m, 7 x alkyl CH2 protons) and 0.87 -  0.74 (6H, m, 
2 x CH3CH2-alkyl).
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6c (62.5 MHz; CDCI3): 174.8 (C=S), 165.0 (ester C=0), 149.5 (Me02C-C=C),
133.0 (CH=CH), 122.6 (CH=CH), 99.3 (Me02C-C=C), 62.1 (CH-NCS), 50.7 (CH- 
pentyl), 50.3 (C02CH3), 35.8 (pyrrolidine CH2C=C), 33.4 (CH2C=C), 32.5 
(CH2C=C), 30.8 (pyrrolidine CH2CH-N), 30.5 (CH2CH-NH), 29.4 (CH2), 28.7 
(CH2), 26.6 (CH2), 24.2 (CH2), 22.7 (CH2), 21.7 (CH3CH2-alkyl), 21.6 (CH3CH2- 
alkyl), 13.1 (CH3CH2-alkyl) and 13.0 (CH3CH2-alkyl).
[a]D: -14° (c=1, CH2CI2).
(ZR,7S)- 7-((E)-Non-2-enyl)-4-(methoxycarbonyl)-3-pentyl-2,3,6,7- 
tetrahydropyrrolo[1,2-c]pyrimidine-1(5H)-iminium formate (197)
lodomethane (31 pL, 0.51 mmol) was added to a solution of (3R,7S)-Methyl 
1,2,3,5,6,7-hexahydro-7-((E)-non-2-enyl)-3-pentyl- 1-thioxopyrrolo[ 1,2- 
c]pyrimidine-4-carboxylate (196a) (205 mg, 0.51 mmol) in dry MeOH (2 mL), and 
the reaction mixture heated at reflux under N2 for 1 h. The volatiles were 
removed in vacuo, and the resulting pale gum re-dissolved in dry MeOH (3 mL). 
This solution was then transferred to a mixture of NH4OAc (193 mg, 2.54 mmol) 
in dry MeOH (2 mL), and liquid ammonia bubbled through the reaction for 10 
min. The yellow mixture was heated at in a sealed tube at 80 °C for 48 h. The 
subsequent dark orange mixture was loaded directly onto a silica column (eluting 
with CH2CI2-Me0H-HC00H-H20, 84:14:0.5:0.5), early fractions (Rf 0.99) 
producing a viscous gum, which was further purified by flash column 
chromatography (eluting with CH2CI2 —► EtOAc), late fractions afforded the title 
compound (156 mg, 71%) as an off-brown oil.
196a 197
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6h (500 MHz; CDCI3): 8.23 (2H, broad s, (NH2)+), 5.48 (apparent dt, J 14.9 & 6.6, 
one of CH=CH), 5.38 -  5.35 (1H, m, one of CH=CH), 4.64 -  4.60 (1H, m, CH- 
NC=N), 4.39 -  4.35 (1H, m, CH-NH), 3.66 (3H, s, C02CH3), 3.30 -  3.23 (1H, m, 
one of pyrrolidine CH2C=C), 2.98 -  2.78 (1H, m, one of pyrrolidine CH2C=C),
2.51 -  2.39 (2H, m, CH2C=C), 2.11 -  2.02 (1H, m, one of CH2C=C), 1.96 -  1.91 
(1H, m, one of CH2C=C), 1.87 -  1.82 (2H, m, pyrrolidine CH2CH-N), 1.61 -  1.42 
(2H, m, CH2CHNH), 1.35 -  1.20 (14H, 7 x CH2 alkyl protons) and 0.77 (6H, t, J
6.7, 2 x CH3CH2-alkyl).
6C (125 MHz; CDCI3): 165.2 (ester C=0), 151.2 (guanidine C=N), 150.2 
(C=C-C02Me), 133.9 (one of CH=CH), 124.2 (one of CH=CH), 101.1 
(C=C-C02Me), 59.8 (CH-NC=N), 50.3 (CH-NH), 50.7 (C02CH3), 37.4 (pyrrolidine 
CH2C=C), 32.7 (CH2C=C), 32.9 (CH2C=C), 29.4 (pyrrolidine CH2CH-N), 28.7 
(CH2CH-NH), 28.1 (CH2), 27.6 (CH2), 26.7 (CH2), 24.5 (CH2), 22.1 (CH2), 21.5 
(pentyl CH3CH2), 21.3 (CH3CH2-alkyl), 13.1 (CH3CH2-alkyl) and 13.1 (CH3CH2- 
alkyl).
[a]D: +18° (c=1, CH2CI2).
IR (neat): 3284, 2932, 1665, 1541, 1486, 1384 and 1235 cm'1.
MS-ES: m/z (%) = 404 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 404.3281; C24H42N30 2 requires 404.3277.
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6.5 Experimental Data for Chapter 5
(5S)-Allyl-((S)-1-phenylethyl)pyrrolidin-2-one (206a) and (5/?)-Allyl-((S)-1- 
phenylethyl)pyrrolidin-2-one (206b)71
o^ n^ oh
Ph^ 'Me
186 206a
+
Me' Ph
Boron trifluoride-diethyl etherate (4.67 mL, 38 mmol) was added dropwise to a 
solution of 5-hydroxy-1-((S)-1-phenylethyl)pyrrolidin-2-one (186) (5.2 g, 25.3 
mmol) in dry CH2CI2 (30 mL) at -78 °C under N2. Allyltrimethylsilane (12.05 mL, 
76 mmol) was then added dropwise, and the reaction allowed to warm to room 
temperature over 16 h. The reaction was quenched with sat. aqueous NaHC03 
solution (careful addition; 25 mL), and the layers separated. The aqueous layer 
was then washed with CH2CI2 (3 x 20 mL), and the organic washings combined 
and dried with Na2S04. The solvent was removed in vacuo to afford the title 
compounds (206a:206b = 5.26:1) as a pure viscous orange oil (5.518 g, 95%), 
which crystallised on standing to afford an orange solid.
((2S)-5-Oxo-1 -((S)-1 -phenylethyl)pyrrolidin-2-yl)acetaldehyde (207)
O ^ H
Me'°‘^ Ph 
207
Potassium osmate dihydrate (23 mg, 0.063 mmol), sodium periodate (10.491 g,
49.05 mmol) and 2,6-lutidine (2.86 mL, 24.52 mmol) were added to a solution of 
(5S)-Allyl-((S)-1-phenylethyl)pyrrolidin-2-one (206a) (2.81 Og, 12.26 mmol; d.e. 
ca. 85%) in dioxane-H2Q (3:1, 260 mL) and the resulting white suspension stirred
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at rt under nitrogen for 18 h. The reaction mixture was then quenched with water 
(100 mL) and extracted with CH2 CI2  (3 x 75 mL). The organic extracts were 
combined, washed with brine (100 mL), dried over Na2S04 and the solvent 
removed in vacuo. The resulting dark brown oil was purified by flash column 
chromatography (eluting with EtOAc-Me2 CO, 1:2), affording the title compound 
as a viscous brown oil (2.549 g, 90%).
Note: the d.e. has been enhanced to 87%. From this step onwards, only the data 
for the major diastereoisomer will be reported.
6h (400 MHz; CDCI3): 9.19 (1H, broad s, CHO), 7.26 -  7.12 (5H, m, aromatic 
CH), 5.37 (1H, q, J 7.3, CH-Me), 4.08 (1H, apparent ddt, J 11.8, 7.9 & 3.7, 
pyrrolidine CH-N), 2.42 -  2.35 (2H, m, CH2CHO), 2.26 -  2.19 (1H, m, one of 
pyrrolidine CH2C=0), 2.17 -  2.11 (1H, m, one of pyrrolidine CH2C=0), 2.05 -
2.01 (1H, m, one of pyrrolidine CH2CHN), 1.54 -  1.51 (1H, m, one of pyrrolidine 
CH2CHN) and 1.47 (3H, d, J 7.1, CH3-CHPh).
5c (125 MHz; CDCI3): 199.4 (CHO), 174.8 (lactam C=0), 141.1 (aromatic C),
128.4 (aromatic CH), 127.3 (aromatic CH), 126.9 (aromatic CH), 50.8 (CHMe),
48.7 (pyrrolidine CHN), 47.9 (CH2 CHO), 29.7 (pyrrolidine CH2C=0), 25.3 
(pyrrolidine CH2CHN), 15.5 (CH3-CHPh).
IR (neat): 2974, 1718, 1667, 1528 and 1492 cm'1.
[a]D: -128° (c = 1, CH2CI2).
MS-EI: m/z (%) = 231 (M+, 22); 105 (100).
HRMS-ES: m/z [M+J: found: 231.1265; C1 4 H1 4 NO2  requires 231.1259.
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(5S)-[(Z)-Non-2-enyl)-1 -((S)-1 -phenylethyl]pyrrolidin-2-one (208)
o
Me'' Ph 
207
Me" Ph
208
/7-Butyl lithium (2.5 M solution in hexanes; 8.52 mL, 21.30 mmol) was added 
dropwise to a vigorously stirred solution of heptyltriphenylphosphonium iodide 
(10.394 g, 21.30 mmol) in dry THF (75 mL) at 0 °C under N2. After stirring for 2 h 
at that temperature, the resultant deep red mixture was cooled to -78 °C and a 
solution of ((2S)-5-oxo-1-((S)-1-phenylethyl)pyrrolidin-2-yl)acetaldehyde (207) 
(2.460 g, 10.64 mmo) in THF (8 mL) added dropwise. The resulting brown 
solution was allowed to warm to rt and stirred for 16 h. The reaction was 
quenched with saturated NaHCC> 3  solution (50 mL), and the aqueous layer 
extracted with CH2CI2 (3 x 50 mL). The organic extracts were combined, washed 
with brine (40 mL), dried over MgS04 and the solvent removed in vacuo. The 
resulting brown gum was purified by column chromatography (eluting with 
EtOAc-Hexane, 1:2), early fractions (Rf 0.6) affording the title compound (1.85 g, 
56%; ZJE> 15:1) as a thick orange oil.
5h (400 MHz; CDCI3): 7.31 (2H, d, J 7.2, 2 x aromatic CH), 7.24 (2H, t, J 7.5, 2 x 
aromatic CH), 7.18 (1H, d, J 7.4, 1 x aromatic CH), 5.42 -  5.28 (2H, m, one of 
CH=CH & CHMe), 5.02 -  4.97 (1H, m, one of CH=CH), 3.65 -  3.60 (1H, m, 
CH-N), 2.43 (1H, ddd, J 17.2, 9.3 & 8.1, one of CH2C=0), 2.26 (1H, apparent 
ddd, J 14.7, 9.8 & 4.9, one of CH2C=C), 2.02 -  1.94 (1H, m, one of CH2C=C), 
1.88 -  1.80 (1H, m, one of CH2C=0), 1.75 (2H, apparent q, J 6.6, CH2C=C), 1.65 
-  1.61 (1H, m, one of pyrrolidine CH2CH-N), 1.58 (3H, d, J 7.2, CH3CH), 1.54 -
1.51 (1H, m, one of pyrrolidine CH2CH-N), 1.23 -  1.14 (8H, m, 4 x alkyl CH2 
protons) and 0.81 (3H, t, J 7.1, CH3 CH2-alkyl).
5c (125 MHz; CDCI3): 175.3 (lactam C=0), 142.0 (aromatic C), 133.11 (one of 
CH=CH), 128.3 (aromatic CH), 127.3 (aromatic CH), 127.2 (aromatic CH), 123.9 
(one of CH=CH), 56.1 (CHMe), 49.5 (CHN), 32.1 (CH2C=C), 31.7 (CH2C=0),
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30.3 (CH2 C=C), 29.4 (CH2), 28.9 (CH2), 27.5 (CH2), 24.2 (pyrrolidine CH2 CHN),
22.6 (CH3 CH2 -alkyl), 16.3 (CH3 CHPh) and 14.1 (CH3 CH2 -alkyl).
[a]D: -138° (c= 1, CH2 CI2).
IR (neat): 2930, 2860, 1680, 1493, 1453 and 1406 cm'1.
MS-ES: m/z (%) = 314 (MH+, 100).
HRMS-ES: m/z [MHf: found: 314.2484; C2 i H32NO requires 314.2484.
(5S)-5-[(Z)-Non-2-enyl]pyrrolidin-2-one (192)
208 192
A solution of (5S)-[(Z)-non-2-enyl)-1-((S)-1-phenylethyl]pyrrolidin-2-one (208) 
(760 mg, 2.45 mmol) in liquid NH3 -THF-absolute EtOH (8:1:1; 56 mL) under N2  
was cooled to -78 °C, and sodium chunks (279 mg, 12.14 mmol) added portion- 
wise. After the purple colour had persisted for longer than 3 min, the solution was 
warmed to rt until the reaction turned colourless. Solid NH4CI was then added, 
the ammonia allowed to evaporate and the reaction mixture washed with water 
(15 mL). The aqueous layer was extracted with EtOAc (3 x 30 mL), the combined 
organic washings dried over Na2 S04, and the solvent removed in vacuo. The title 
compound was afforded (e.e. ca. 78%; 512 mg, 100%) as a yellow oil.
6 h (400 MHz; CDCI3): 5.55 (1H, broad s, NH), 5.58 -  5.37 (1H, m, one of 
CH=CH), 5.19 -  5.13 (1H, m, one of CH=CH), 3.51 (1H, apparent quintet, J 6.7, 
CH-NH), 2.24 -  2.10 (4H, m, CH2 C=0 & CH2 C=C), 1.90 -  1.83 (3H, m, CH2 C=C 
& one of pyrrolidine CH2 CHNH), 1.64 -  1.57 (1H, m, one of pyrrolidine 
CH2 CHNH), 1.22 -  1.07 (8 H, m, 4 x alkyl CH2  protons) and 0.73 (3H, t, J 6.9, 
CH3 CH2 -alkyl).
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5C (125 MHz; COCI3 ): 178.5 (lactam C=0), 133.5 (CH=CH), 123.7 (CH=CH),
54.5 (CH-NH), 34.2 (CH2 C=0), 31.7 (CH2 C=C), 30.4 (CH2 C=C), 29.5 (CH2), 28.9 
(CH2), 27.4 (CH2), 26.5 (pyrrolidine CH2 CH-NH), 22.6 (CH3 CH2 -alkyl) and 14.1 
(CH3 CH2 -alkyl).
[a]D: -10° (c= 1, CH2 CI2).
IR (neat): 3237, 2919, 2849, 1690, 1455 and 1290 cm'1.
MS-ES: m/z (%) = 210 (MH+, 90); 419 (2MH+, 90).
HRMS-ES: m/z [MH]+: found: 210.1854; Ci3 H24NO requires 210.1858.
(5S)-5-((Z)-Non-2-enyl)pyrrolidine-2-thione (209)
192 209
Lawesson’s reagent (553 g, 1.37 mmol) was added portion-wise to a solution of 
(5S)-5-[(Z)-non-2-enyl]pyrrolidin-2-one (192) (520 mg, 2.49 mmol) in dry THF (20 
mL), and the resulting suspension stirred at rt under N2  for 2 h. The THF was 
removed in vacuo, and the resultant orange gum purified by column 
chromatography (eluting with CH2 CI2 -EtOAc, 2:1), early fractions (Rf 0.95) 
yielding the title compound (508 mg, 90%) as an orange oil.
5h (400 MHz; CDCI3): 7.51 (1H, broad s, NH), 5.56 -  5.51 (1H, m, one of 
CH=CH), 5.27 -  5.22 (1H, m, one of CH=CH), 3.88 (1H, apparent quintet, J 6.9, 
CH-NH), 2.92 (1H, ddd, J 14.4, 9.4 & 5.1, one of CH2 C=S), 2.87 -  2.78 (1H, m, 
one of CH2 C=S), 2.32 -  2.19 (3H, m, CH2 C=C and one of pyrrolidine 
CH2 CH-NH), 1.97 (2H, apparent q, J 7.1, CH2 C=C), 1.80 (1H, dddd, J 12.9, 9.3,
8.0 & 6.5, one of pyrrolidine CH2 CH-NH), 1.30 -  1.17 (8 H, m, 4 x alkyl CH2  
protons) and 0.82 (3H, t, J 6.9, CH3 CH2 -alkyl).
5C (100 MHz; CDCI3): 206.5 (C=S), 134.5 (one of CH=CH), 123.2 (one of 
CH=CH), 62.4 (CH-NH), 43.1 (CH2 C=S), 33.1 (CH2 C=C), 31.7 (CH2 C=C), 29.5
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(CH2), 29.0 (CH2), 28.9 (CH2), 27.5 (pyrrolidine CH2 CHNH), 22.6 (CH3 CH2 -alkyl),
14.1 (CH3 CH2 -alkyl).
[a]D: -40° (c = 1, CH2 CI2).
IR (neat): 3163, 2918, 2848, 1523, 1459, 1296 and 1261 cm'1.
MS-ES: m/z (%) = 226 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 226.1622; C i3 H24NS requires 226.1624.
(2Z)-Ethyl 2-[(S)-5-(non-2-enyl)pyrrolidin-2-ylidene]acetate (210)
Ethyl bromo-acetate (0.29 mL, 2.59 mmol) was added to a solution of (5S)-5-((Z)- 
non-2-enyl)pyrrolidine-2-thione (209) (490 mg, 2.16 mmol) in dry CH2 CI2  (15 mL), 
and the resulting orange solution stirred at rt under N2  for 3 h. The reaction 
mixture was washed with saturated NaHC03  solution (40 mL), and the organic 
layer separated. The aqueous layer was then washed with CH2 CI2  (3 x 40 mL), 
dried over Na2 S0 4  and the solvent removed in vacuo.
The residue was then redissolved in dry Xylene (12 mL), and triphenylphosphine 
(2.3 g, 8.63 mmol) and dried potassium fe/t-butoxide (24 mg, 0.22 mmol) added. 
The resulting suspension was stirred for 10 min at rt, and then heated at reflux 
for 48 h. The volatiles were then removed in vacuo. The resulting dark orange 
solid was purified by column chromatography (eluting with EtOAc-Hexane, 1:9),
s
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mid-fractions (Rf 0.5) affording the title compound (352 mg, 62%) as a pale 
orange oil.
6 h (400 MHz; CDCI3): 7.92 (1H, broad s, NH), 5.49 -  5.44 (1H, m, one of 
CH=CH), 5.31 -  5.25 (1H, m, one of CH=CH), 4.41 (1H, broad s, CH=C-NH),
4.03 (2H, q, J 7.1, CH2 OCO), 3.72 (1H, apparent quintet, J 6 .6 , CH-NH), 2.59 -
2.46 (2H, m, one of CH2 C=C & one of pyrrolidine CH2 C=C), 2.26 -  2.20 (1H, m, 
one of CH2 C=C), 2.17 -  2.12 (1H, m, one of pyrrolidine CH2 C=C), 2.03 -  1.98 
(1H, m, one of pyrrolidine CH2 CH-NH), 1.93 (2H, apparent q, J 7.1, CH2 C=C), 
1.53 (1H, dddd, J 12.5, 9.0, 8.1 & 6.3, one of pyrrolidine CH2 CH-NH), 1.27 -  1.14 
(11 H, m, 4 x CH2  alkyl protons & CH3 CH2 OCO) and 0.81 (3H, t, J 7.0, CH3 CH2- 
alkyl).
5C (125 MHz; CDCI3): 169.5 (ester C=0), 164.5 (C=CH-C02 Et), 132.4 (CH=CH),
123.5 (CH=CH), 76.7 (C=CH-C02 Et), 58.6 (C0 2 CH2), 57.3 (CH-NH), 32.0 
(CH2 C=C), 30.8 (pyrrolidine CH2 C=C), 28.6 (CH2 C=C), 28.0 (pyrrolidine 
CH2 CHNH), 26.8 (CH2), 26.7 (CH2), 26.5 (CH2), 21.6 (CH3 CH2 -alkyl), 13.7 
(CH3 CH2 OCO) and 13.1 (CH3 CH2 -alkyl).
[a]D: -114° (c= 1, CH2 CI2).
IR (neat): 3370, 2920, 1657 and 1594 cm'1.
MS-ES: m/z (%) = 280 (MH+, 85).
HRMS-ES: m/z [MH]+: found: 280.2268; Ci7 H3 oN02  requires 280.2271.
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(3R,7S)-Ethyl 1,2,3,5,6,7-hexahydro-7-((Z)-non-2-enyl)-3-pentyl-1 - 
thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (major diastereoisomer; 211a) 
and (3S,7S)-Ethyl 1,2,3,5,6,7-hexahydro-7-((Z)-non-2-enyl)-3-pentyl-1- 
thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (minor diastereoisomer; 211b)
Trimethylsilyl isothiocyanate (280 pL, 1.98 mmol) was dissolved in dry CH2 CI2  ( 8  
mL), hexanal (240 pL, 1.98 mmol) added and the resulting pale yellow solution 
stirred at rt under N2  for 30 min. A solution of (2Z)-ethyl 2-[(S)-5-(non-2- 
enyl)pyrrolidin-2-ylidene]acetate (210) (260 mg, 0.99 mmol) in CH2 CI2  (4 mL) was 
added, and the reaction mixture stirred at rt for 45 min. The reaction was then 
quenched with ~0.1 M aqueous NaOH solution (30 mL) and the aqueous layer 
extracted with CH2 CI2  (3 x 25 mL). The organic washings were combined, dried 
over Na2 S0 4  and the solvent removed in vacuo. The subsequent yellow gum 
(2 1 1 a:2 1 1 b=2 .1 :1 ) was purified by column chromatography (eluting with 
EtOAc-Hexane, 1:9), yielding the title compounds.
(3R,7S)-Ethyl 1,2,3,5,6,7-hexahydro-7-((Z)-non-2-enyl)-3-pentyl-1 - 
thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (211a; off-white gum): (231 mg,
58%; Rf 0.5).
6 h (400 MHz; CDCI3): 6.97 (1H, broad s, NH), 5.46 (1H, apparent dt, J 10.8 & 
7.4, one of CH=CH), 5.27 -  5.22 (1H, m, one of CH=CH), 4.51 -  4.47 (1H, m,
211a
+
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CH-NCS), 4.23 -  4.20 (1H, m, CH-pentyl), 4.11 (2H, q, J 7.4, CH2 OCO), 3.30 
(1H, ddd, J 18.1, 5.34 & 3.6, one of pyrrolidine CH2 C=C), 3.04 -  3.00 (1H, m, one 
of CH2 C=C), 2.85 (1H, apparent dt, J 18.1 & 10.4, one of pyrrolidine C/-/2 C=C), 
2.13 (1H, apparent dt, J 13.6 & 9.2, one of CH2 C=C), 2.04 -  1.99 (2H, m, 
CH2 C=C), 1.88 -  1.84 (2H, m, pyrrolidine CH2 CH-N), 1.60 -  1.46 (2H, m, 
CH2 CHNH), 1 .35-1 .15  (17H, 7 x Ctf2  alkyl protons and CH3 CH2 OCO) and 0.82
-  0.79 (6 H, m, 2 x CH3 CH2 -alkyl).
5c (125 MHz; CDCI3): 174.2 (C=S), 164.7 (ester C=0), 148.6 (O C -C 0 2 Et),
132.7 (CH=CH), 123.3 (CH=CH), 99.0 (C=C-C02 Et), 62.1 (CH-NCS), 59.2 
(C0 2 CH2), 51.1 (CH-pentyl), 36.8 (pyrrolidine CH2 C=C), 30.8 (CH2 C=C), 30.4 
(CH2 C=C), 29.5 (pyrrolidine CH2 CH-N), 28.7 (CH2 CH-NH), 28.0 (CH2), 26.7 
(CH2), 27.7 (CH2), 24.0 (CH2), 22.5 (CH2), 21.7 (pentyl CH3 CH2), 21.5 
(CH3 CH2 -alkyl), 13.4 (CH3 CH2 OCO), 13.1 (CH3 CH2 -alkyl) and 13.0 
(CH3 CH2 -alkyl).
[a]D: +100° (c=1, CH2 CI2).
IR (neat): 3288, 3205, 2925, 2852, 1694, 1647, 1527, 1460, 1377 and 1226 
cm'1.
MS-ES: m/z (%) = 421 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 421.2877; C2 4 H4 iN 2 0 2S requires 421.2889.
(3S,7S)-Ethyl 1,2,3,5,6,7-hexahydro-7-((Z)-non-2-enyl)-3-pentyl-1- 
thioxopyrrolo[1,2-c]pyrimidine-4-carboxylate (211b; yellow oil): (129 mg, 28%; Rf 
0.38).
5h (400 MHz; CDCI3): 6.94 (1H, broad s, NH), 5.52-4.48 (1H, m, CH=CH), 5.28
-  5.21 (1H, m, CH=CH), 4.89 -  4.80 (1H, m, CH-NCS), 4.30 -  4.20 (1H, m, 
CH-pentyl), 4.19 -  4.03 (2H, m, C0 2 CH2), 3.26 -  3.20 (1H, m, one of pyrrolidine 
CH2 C=C), 2.99 -  2.90 (1H, m, one of CH2 C=C), 2.69 -  2.55 (1H, m, one of 
pyrrolidine CH2 C=C), 2.38 -  2.26 (1H, m, one of CH2 C=C), 2.08 -  1.86 (3H, m, 
CH2 C=C & one of pyrrolidine CH2 CH-N), 1.80 -  1.72 (1H, m, one of pyrrolidine 
CH2 CH-N), 1.50 -  1.34 (2H, m, CH2 CH-NH), 1.35 -  1.12 (17H, m, 7 x alkyl CH2  
protons & CH3 CH2 OCO) and 0.84 -  0.75 (6 H, m, 2 x CH3 CH2 -alkyl).
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5c (125 MHz; CDCI3): 175.1 (C=S), 165.6 (ester C=0), 150.3 (O C -C 0 2 Et), 
133.9 (CH=CH), 123.7 (CH=CH), 100.6 (C=C-C02 Et), 62.8 (CH-NCS), 60.2 
(CO2 CH2 ), 51.8 (CH-pentyl), 36.8 (pyrrolidine CH2 C=C), 31.8 (CH2 C=C), 31.4 
(CH2 C=C), 31.0 (pyrrolidine CH2 CH-N), 30.4 (CH2 CH-NH), 29.6 (CH2), 29.0 
(CH2), 27.6 (CH2), 24.8 (CH2), 23.7 (CH2), 2 2 . 6  (pentyl CH3 CH2), 2 2 . 6  
(CH3 CH2 -alkyl), 14.4 (CH3 CH2 OCO), 14.2 (CH3 CH2 -alkyl) and 14.0 
(CH3 CH2 -alkyl).
[a]D: -116° (c=1, CH2 CI2 ).
MS-ES: m/z (%) = 421 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 421.2888; C2 4 H4 1 N2 O2 S requires 421.2889.
(3f?,7S)-7-((Z)-Non-2-enyl)-4-(ethoxycarbonyl)-3-pentyl-2,3,6,7- 
tetrahydropyrrolo[1,2-c]pyrimidine-1(5H)-iminium formate
(212)
lodomethane (19 pL, 0.31 mmol) was added to a solution of (3R,7S)-ethyl
1,2,3,5,6,7-hexahydro- 7-((Z)-non-2-enyl)-3-pentyl-1 -thioxopyrrolo-[ 1,2- 
c]pyrimidine-4-carboxylate (211a) (125 mg, 0.31 mmol) in dry MeOH (3 mL), and 
the reaction mixture heated at reflux under N2  for 1  h. The volatiles were 
removed in vacuo and the resulting pale gum re-dissolved in dry MeOH (3 mL). 
This solution was then transferred to a mixture of NH4OAc (100 mg, 1.54 mmol) 
in MeOH (2 mL), and liquid ammonia bubbled through the reaction for 10 min. 
The resultant yellow suspension was heated at in a sealed tube for 48 h at 80 °C 
and loaded directly onto a silica gel column (eluting with CH2 CI2 -MeOH-HCOOH- 
H2 O, 84:14:0.5:0.5), early fractions (Rf 0.99) affording the title compound (91 mg, 
80%) as a dark orange oil.
211a 212
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5h (400 MHz; CDCI3): 8 . 8 6  (1H, broad s, NH), 8.17 (2H, broad s, (C=NH2)+), 5.50 
(1H, apparent dt, J 10.8 & 7.2, one of CH=CH), 5.44 -  5.36 (1H, m, one of 
CH=CH), 4.65 -  4.61 (1H, m, CH-NC=N), 4.40 -  4.37 (1H, m, CH-pentyl), 4.15 
(2 H, q, J 7.2, CO2 CH2 ), 3.28 (1 H, apparent dd, J 18.6 & 7.6, one of pyrrolidine 
CH2 C=C), 2.86 -  2.77 (1H, m, one of CH2 C=C), 2.49 -  2.40 (1H, m, one of 
pyrrolidine CH2 C=C), 2.28 (1H, apparent dt, J 14.3 & 9.2, one of CH2 C=C), 2.04 
-  1.90 (4H, m, CH2 C=C & pyrrolidine CH2 CH-N), 1.62 -  1.49 (2H, m, 
CH2 CH-NH), 1.48 -  1.39 (1H, m, one of CH2 CH2 CH-NH), 1.30 -  1.15 (16H, m, 
13 x alkyl protons & CH3 CH2 OCO) and 0.65 (6 H, t, J 6 .6 , 2 x CH3 CH2 -alkyl).
6 C (125 MHz; CDCI3): 164.9 (ester C=0), 151.0 (guanidine C=N), 149.9 
(Et0 2 C-C=C), 134.2 (CH=CH), 123.2 (CH=CH), 101.4 (Et02 C-C=C), 60.5 
(CH2 OCO), 59.6 (CH-NC=N), 50.2 (CH-pentyl), 37.5 (pyrrolidine CH2 C=C), 31.8 
(CH2 C=C), 31.3 (CH2 C=C), 29.5 (CH2 CH-N=C), 29.3 (pyrrolidine CH2 CH-N),
29.0 (CH2), 28.7 (CH2), 27.6 (CH2), 26.4 (CH2), 23.5 (CH2), 2 2 . 6  (pentyl 
CH3 CH2), 22.6 (CH3 CH2 -alkyl), 14.3 (CH3 CH2 OCO), 14.1 (CH3 CH2 -alkyl) and
14.1 (CH3 CH2 -alkyl).
[a]D: +8 6 ° (c=1, CH2 CI2).
IR (solution in CH2 CI2): 3284, 3154, 2837, 1684, 1537, 1455, 1378 and 1260 
cm'1.
MS-ES: m/z (%) = 404 (MH+, 100).
HRMS-ES: m/z [MH]+: found: 404.3270; C2 4 H4 2 N3 0 2  requires 404.3277.
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(8S,10R,12R)-Ethyl-10-heptyl-6,7,8,9,10,12-hexahydro-12-pentyl-11 aH-
8a,10a,11a-triaza-acenapthylene-4-carboxylate (213a)
Et02C
212
N 11 N
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(3R, 7S)-7-((Z)-non-2-enyl)-4-(ethoxycarbonyl)-3-pentyl-2,3,6,7- 
tetrahydropyrrolo[1,2-c]pyrimidine-1(5H)-iminium formate (212) (90 mg, 0.20 
mmol) was dissolved in acetonitrile (3 mL), and iodine (305 mg, 1.21 mmol) and 
potassium carbonate (81 mg, 0.6 mmol) added. The resulting red-brown mixture 
was stirred at rt under N2 for 3 h, and the solvent removed in vacuo. The 
subsequent red gum was purified by flash column chromatography (eluting with 
CH2CI2 —> EtOAc/Me2CO, 1:1), late washings affording the iodinated tricyclic 
guanidine (213) (115mg, 95%) as a viscous brown oil.
The iodinated tricyclic guanidine (110mg, 0.21 mmol) was immediately 
re-dissolved in EtOAc (6 mL) and triethylamine (0.14 mL, 1.04 mmol), and 10% 
Pd/C (100 mg) added. The black suspension was de-gassed and stirred under 
an atmosphere of H2 for 21/2 h. The reaction mixture was then filtered through 
Celite, and concentrated in vacuo. The subsequent oil was purified by flash 
column chromatography (eluting with CH2CI2 —► EtOAc/Me2CO, 1:1), yielding the 
title compound (67 mg, 80%) as a yellow oil.
6 h (500 MHz; MeOH-c/4): 4.33 (1H, apparent dd, J 7.7 & 4.2, H-12), 4.12 (2H, t, J 
6.9. CO2CH2), 4.07 -  4.00 (1H, m, H-8), 3.58 -  3.53 (1H, m, H-10), 3.34 (1H, 
apparent dd, J 18.8 & 9.3, H-6(3), 2.82 (1H, ddd, J 18.8, 11.2 & 8.3, H-6a), 2 .38-
2.32 (2H, m, H-7{3 & H-9p), 1.68 -  1.54 (2H, m, H-7a & H-9a), 1 .50 - 1.40 (4H, 
m, H-13 & H-18), 1.35 -  1.22 (19H, m, 8 x alkyl CH2 protons & CH3CH2OCO) and 
0.82 -  0.80 (6H, m, 2 x CH3CH2-alkyl).
5C (62.5 MHz; CDCI3): 164.4 (C-3), 148.9 (C-5), 148.1 (C-11), 103.4 (C-4), 60.8 
(C-2), 57.2 (C-8), 51.2 (C-10), 50.7 (C-12), 36.9 (C-13), 34.5 (C-18), 33.8 (C-9),
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31.7 (C-6), 31.2 (C-7), 29.9 (CH2), 29.6 (CH2), 29.2 (CH2), 29.0 (CH2), 25.4 (CH- 
2), 24.2 (CH2), 22.6 (C-16), 22.4 (C-23), 14.3 (0-1) and 14.1 (C-17 & C-24).
[a]D: -150° (c = 0.2, CH2CI2); -30° (c = 0.2, MeOH); lit.1 [a]D: -4.2° (batzelladine C 
methyl ester) (c = 0.93, MeOH), (batzelladine C): [a]o: -3.7° (c 2.4, MeOH).
IR (solution in CH2 CI2): 3274, 3201, 2850, 1715, 1658 and 1451 cm '.
MS-ES: m/z(%) = 404 (MH*, 100).
HRMS-ES: m/z[MH]+: found: 404.3262; C24H42N30 2 requires 404.3277.
(8S,10R,12/?)-11 a-ferf-Butyl-4-ethyl-1O-heptyl-6,7,8,9,10,12- hexahydro-12- 
pentyl-8a,10a,11a-triaza-acenapthylene-4,11a-dicarboxylate (218)
6 7
Et02C
C5 Hh' N N ^C7H15H
Et02C
C5Hu^ 2 U  N 10 C7H15 
13-17 BOC 18-24
53 218
Triethylamine (90 pL, 0.6 mmol) and DMAP (0 -  1 mg, catalytic) were added to a 
solution of (8S, 10R, 12R)-Ethyl-10-heptyl-6,7,8,9,10,12-hexahydro-12-pentyl- 
11 aH-8a,10a,11 a-triaza-acenapthylene-4-carboxylate (213a) (87 mg, 0.2 mmol) 
in dry CH2CI2 (1 mL) under N2. A solution of di-terf-butyldicarbonate (103 mg, 
0.47 mmol) in CH2CI2 (0.2 mL) was then added to the mixture, and the resulting 
pale yellow solution stirred at rt for 18 h. The reaction was quenched with sat. 
aqueous NaHC03 solution (10 mL) and CH2CI2 (20 mL). The layers were 
separated, and the aqueous layer washed with CH2CI2 (3 x 15 mL). The 
combined organic washings were then washed with brine (20 mL), the solvent 
evaporated to ca. 1 mL and the aqueous residue removed by decantation. The 
excess solvent was removed in vacuo, and the resulting oil purified by flash 
column chromatography (eluting with CH2CI2 EtOAc/Me2CO, 1:1), yielding the
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title compound (Rf 0.95; CH2 CI2 -2.5% MeOH) as a viscous brown oil (89 mg, 
82%).
5h (400 MHz; CDCI3): 5 .28 -5 .24  (1H, m, H-12), 4.21 -4 .0 8  (3H, m, C0 2 CH2  & 
H-8 ), 3 .48-3.39 (1H, m, H-10), 3.27 (1H, apparent dd, J 19.1 &9.1, H-6 p), 2.96 
-  2.71 (1H, m, H-6 a), 2.56 -  2.32 (2H, m, H-7P & H-9P), 1.98 -  1.85 (2H, m, 
H-7a & H-9a), 1.82 -  1.72 (1H, m, H-13P), 1.66 -  1.53 (3H, m, H-13a & H-18), 
1.49 (9H, s, ((C/-/3 )3 C), 1.28 -  1.12 (19H, m, 8  x alkyl CH2 protons & 
CH3 CH2 OCO) and 0.82 -  0.79 (6 H, m, 2 x CH3 CH2 -alkyl).
5c (125 MHz; CDCI3): 161.5 (C-3), 156.7 (carbamate C=0), 150.7 (C-11), 150.4 
(C-5), 106.6 (C-4), 87.2 ((C(CH3)3), 60.0 (C-2), 57.6 (C-8 ), 53.0 (C-12), 49.3 
(C-10), 36.2 (C-13), 33.8 (C-18), 32.5 (C-9), 30.7 (C-6 ), 30.2 (C-7), 30.2 (CH2),
28.3 (CH2), 28.0 (CH2), 26.9 ((C(CH3)3), 24.2 (CH2), 24.2 (CH2), 22.7 (CH2), 21.6 
(C-16), 21.6 (C-23), 13.4 (C-1), 13.1 (C-17) and 13.0 (C-24).
IR (solution in CH2 CI2): 2826, 1781, 1704, 1636 and 1447 cm'1.
[a]D: -124° (c = 0.2, CH2 CI2).
(3/?,7S)-Ethyl 3,5,6,7-tetrahydro-1-(methylthio)-7-((Z)-non-2-enyl)-3- 
pentylpyrrolo[1,2-c]pyrimidine-4-carboxylate (224)
2 1 1 a
C6H
224
lodomethane (75 pL, 1.2 mmol) was added to a solution of (3R,7S)-ethyl
1,2,3,5,6,7-hexahydro- 7-((Z)-non-2-enyl)-3-pentyl- 1-thioxopyrrolo[1,2- 
c]pyrimidine-4-carboxylate (211a) (50 mg, 0.12 mmol) in dry CH2 CI2  (4 mL), and 
the resulting orange solution stirred at reflux under N2  for 17 h. The reaction was 
allowed to cool, dry triethylamine (166 pL, 1.2 mmol) added and the mixture
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stirred at rt for 30 min. The solvent was then removed in vacuo and the resultant 
solid washed with hexane. The solid was removed, the filtrate concentrated to 
yield an orange oil and the subsequent thick oil purified by column 
chromatography (eluting with EtOAc-Hexane, 1:12), early fractions (Rf 0.52) 
affording the title compound (39 mg, 76%) as a dark yellow gum.
5h (500 MHz; CDCI3): 5.46 (1H, apparent dt, J 10.7 & 7.4, one of CH=CH), 5.23 
-  5.18 (1H, m, one of CH=CH), 4.53 (1H, apparent dd, J 7.0 & 3.7, CH-pentyl), 
4.19 -  4.02 (2H, m, C0 2 CH2), 3.93 -  3.88 (1H, m, CH-N-C-SMe), 3.13 (1H, 
apparent dd, J 18.4 & 7.2, one of pyrrolidine CH2 C=C), 2.83 -  2.74 (1H, m, one 
of pyrrolidine CH2 C=C), 2.60 (1H, apparent dd, J 14.1 & 6.2, one of CH2 C=C),
2.33 (3H, s, S-CH3), 2.08 (1H, apparent dt, J 14.1 & 9.5, one of CH2 C=C), 2.01 -  
1.92 (2H, m, CH2 C=C), 1.84 -  1.76 (2H, m, pyrrolidine CH2 CH-N), 1.64 -  1.58 
(2H, m, CH2 CH-N=C), 1.40 -  1.05 (17H, m, 7 x alkyl CH2  protons & 
CH3 CH2 OCO) and 0.82 -  0.78 (6 H, m, 2 x CH3 CH2 -alkyl).
5C (62.5 MHz; CDCI3): 167.3 (ester C=0), 152.0 (C=C-C02 Et), C=N-SMe peak 
not observed, 133.7 (CH=CH), 124.1 (CH=CH), 96.5 (C=C-C02 Et), 68.2 
(C0 2 CH2), 60.2 (CH-NC=N), 53.5 (CH-pentyl), 38.9 (pyrrolidine CH2 C=C), 31.9 
(CH2 C=C), 31.8 (CH2 C=C), 30.4 (pyrrolidine CH2 CH-N), 29.6 (CH2 CH-N=C),
29.0 (CH2), 27.4 (CH2), 26.5 (CH2), 24.2 (CH2), 23.0 (CH2), 22.7 (CH3 CH2 -alkyl),
22.7 (CH3 CH2 -alkyl), 14.5 (CH3 CH2 OCO), 14.1 (CH3 CH2 -alkyl) and 13.8 (S-CH3). 
[a]D: +28° (c = 0.5, CH2 CI2).
IR (neat): 2931, 2861, 1690, 1649, 1596, 1455 and 1378 cm'1.
MS-ES: m/z (%) = 435 (MH\ 100).
HRMS-ES: m/z [MH]+: found: 435.3059; C2 5 H4 3 N2 0 2S requires 435.3045.
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(3/?,7S)-3,5,6,7-Tetrahydro-1-(methylthio)-7-((Z)-non-2-enyl)-3-
pentylpyrrolo[1,2-c]pyrimidine-4-carboxylic acid (225)
Et02C
C5H-11' IN O
^  N >
- 1 k ^ C 6 H,3
Me Me
224 225
A solution of sodium hydroxide in MeOH (10% w/v; 0.8 mL) was added to a 
solution of (3R,7S)-Ethyl 3,5,6J-tetrahydro-1-(methylthio)-7-((Z)-non-2-enyl)-3- 
pentylpyrrolo[1,2-c]pyrimidine-4-carboxylate (24 mg, 0.055 mmol) in MeOH (0.4 
mL), and the resulting solution heated in sealed tube at 100 °C for 18 h. The 
reaction was then quenched with sat. aqueous NH4CI solution (12 mL), washed 
with CH2 CI2  (3 x 30 mL) and the organic washings combined and washed with 
brine (20 mL). The excess solvent was then removed in vacuo, the resulting 
organic residue decanted from the aqueous impurities. The title compound 
(crude yield ca. 16 mg, 71%) was afforded as an off-white gum.
5h (500 MHz; CDCI3): 5.44 (1H, apparent dt, J 9.7 & 7.5, CH=CH), 5.27 -  5.18 
(1H, m, one of CH=CH), 4.45 (1H, apparent dd, J 6.4 & 3.7, CH-pentyl), 3.94 -  
3.89 (1H, m, CH-NC=N), 3.62 (3H, s, S-CH3), 3.11 (1H, apparent dd, J 18.1 & 
8.2, one of pyrrolidine CH2 C=C), 2.83 -  2.73 (1H, m, one of pyrrolidine CH2 C=C), 
2 .40 -2 .35  (1H, m, one of CH2 C=C), 2 .27-2.22 (1H, m, one of CH2 C=C), 2.12 
-2 .02  (2H, m, pyrrolidine CH2 CH-N), 1.94 (2H, apparent q, J 6 .8 , CH2 C=C), 1.96 
-  1.74 (2H, m, CH2 CH-N=C), 1.41 -  1.31 (2H, m, alkyl CH2), 1.28 -  1.14 (12 H, 
m, 6  x alkyl CH2  protons) and 0.86 -  0.77 (6 H, m, 3 x CH3 CH2 -alkyl).
6 c (62.5 MHz; CDCI3): 179.0 (carboxylic acid C=0), 153.0 (MeS-C=N), 147.9 
(H02 C-C=C), 132.4 (CH=CH), 127.7 (CH=CH), H0 2 C-C=C peak not observed,
58.5 (CH-NC=N), 52.5 (CH-pentyl), 39.0 (pyrrolidine CH2 C=C), 31.0 (CH2 C=C),
30.8 (CH2 C=C), 28.80 (pyrrolidine CH2 CH-N), 28.78 (CH2 CH-N=C), 28.6 (CH2),
28.4 (CH2), 28.0 (CH2), 26.4 (CH2), 23.0 (CH2), 21.7 (CH3 CH2 -alkyl), 21.6 
(CH3 CH2 -alkyl), 13.1 (CH3 CH2 -alkyl) and CH3S peak not observed.
MS-ES: m/z (%) = 405 (M -  H+, 100).
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tyANBisffe/t-butoxycarbonylJ-Af'-^'-hydroxy butyl)guanidine7 9  (228)
OH NBoc
* » 2 ^N^NHBoc 
H
228
4-amino-butan-1-ol (129 mg, 1.45 mmol) was dissolved in THF/H2 O (14:1; 15 
mL), and a solution of bis-boc thiourea (200 mg, 0.72 mmol) in THF ( 6  mL) 
added dropwise. The resulting pale green solution was stirred at 55 °C for 1  h, 
and then quenched with H20  (20 mL). The layers were separated, and the 
aqueous layer washed with CH2 CI2  (3x10  mL). The combined organic washings 
were dried over Na2 S0 4  and the solvent removed in vacuo. The resultant crude 
oil was purified by flash column chromatography (eluting with CH2 CI2  -> EtOAc), 
late fractions affording the title compound (Rf CH2 CI2: 0.48) as a light yellow oil 
(170 mg, 71%) which crystallised on standing.
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Appendix B
Crystallographic Data
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Table 5. Crystal data and structure refinement for compound 113.
H2
\ P H 3
H25
Empirical formula 
Formula weight 
Temperature 
Wavelength
Crystal system, space group 
Unit cell dimensions
Volume
Z, Calculated density 
Absorption coefficient 
F(000)
Crystal size
Theta range for data collection 
Limiting indices 
Reflections collected / unique 
Completeness to theta = 27.56 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2
C1 7 H2 6 N2 O2 S
322.46 
150(2) K 
0.71073 A 
Triclinic, P-1
a = 8.8940(1) A, a = 106.777(1)°
b = 15.5730(2) A, b = 95.504(1)°
c = 26.7230(4) A, g = 92.328(1)°
3518.35(8) A3
8, 1.218 Mg/m3
0.193 mm
1392
0.25 x 0.10 x 0.10 mm 
2.95 to 27.56 °
-11<=h<=11, -20<=k<=20, -34<=l<=34 
57727/ 16125 [R(int) = 0.1019]
99.1 %
None
0.9810 and 0.9534 
Full-matrix least-squares on F2 
16125/ 108/811 
1.015
204
Final R indices [l>2s(l)]
R indices (all data)
Largest diff. peak and hole
Ri = 0.0959, wR2  = 0.2157 
Ri = 0.1521, wR2 = 0.2451
1.292 and -0.762 e.A'3
Table 6 . Atomic coordinates (x 1 0 ^) and equivalent isotropic displacement 
parameters (A2x 1 0 3) for compound 113. U(eq) is defined as one third of the 
trace of the orthogonalized UU tensor.
X y z U(eq)
0 ( 1 ) -691(4) 3758(2) 6966(1) 44(1)
0 (2 ) -371(3) 2292(2) 6634(1) 39(1)
C(1) 2861(6) 7703(3) 7134(2) 53(1)
0 (2 ) 1456(6) 7304(3) 6773(2) 52(1)
C(3) 1028(5) 6314(3) 6735(2) 40(1)
0(4) 2136(5) 5674(3) 6458(2) 35(1)
0(5) 1813(4) 4691(3) 6433(2) 31(1)
0 (6 ) 324(4) 4234(3) 6119(2) 28(1)
0(7) 142(4) 3270(3) 6125(2) 27(1)
0 (8 ) 555(4) 2614(3) 5723(2) 26(1)
0(9) 752(4) 3617(3) 5177(2) 28(1)
0 (1 0 ) -352(4) 3142(3) 6611(2) 32(1)
0 (1 1 ) -758(6) 2175(4) 7125(2) 52(1)
0 (1 2 ) 708(4) 1627(3) 5640(2) 30(1)
0(13) 1762(4) 1388(3) 5207(2) 32(1)
0(14) 1340(4) 1993(3) 4869(2) 30(1)
0(15) -32(4) 1593(3) 4454(2) 35(1)
0(16) 463(7) 1027(5) 3966(3) 87(2)
0(17) 490(8) 367(6) 3713(3) 105(2)
S(1) 1077(1) 3792(1) 4601(1) 35(1)
N(2) 971(3) 2811(2) 5273(1) 27(1)
N(1) 257(4) 4248(2) 5569(1) 30(1)
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Table 7. Bond lengths [A] and angles [°] for compound 113.
O(1)-C(10) 1.209(5) C(16)-C(17) 1.057(9)
O(2)-C(10) 1.342(5) C(16)-H(23) 0.9500
0(2)-C(11) 1.448(5) C(17)-H(24) 0.9500
C(1)-C(2) 1.496(7) C(17)-H(25) 0.9500
C(1)-H(1) 0.9800 N(1)-H(26) 0.8800
C(1)-H(2) 0.9800
C(1)-H(3) 0.9800 C(110)-O(12)-C(111) 114.8(3)
C(2)-C(3) 1.545(6) C(12)-C(11)-H(1) 109.5
C(2)-H(4) 0.9900 C(12)-C(11)-H(2) 109.5
C(2)-H(5) 0.9900 H(1)-C(11)-H(2) 109.5
C(3)-C(4) 1.518(6) C(12)-C(11)-H(3) 109.5
C(3)-H(6) 0.9900 H(1)-C(11)-H(3) 109.5
C(3)-H(7) 0.9900 H(2)-C(11)-H(3) 109.5
C(4)-C(5) 1.527(6) C(11)-C(12)-C(13) 114.2(4)
C(4)-H(8) 0.9900 C(11)-C(12)-H(4) 108.7
C(4)-H(9) 0.9900 C(13)-C(12)-H(4) 108.7
C(5)-C(6) 1.526(5) C(11)-C(12)-H(5) 108.7
C(5)-H(10) 0.9900 C(13)-C(12)-H(5) 108.7
C(5)-H(11) 0.9900 H(4)-C(12)-H(5) 107.6
C(6)-N(1) 1.472(5) C(14)-C(13)-C(12) 112.8(4)
C(6)-C(7) 1.510(6) C(14)-C(13)-H(6) 109.0
C(6)-H(12) 1 . 0 0 0 0 C(12)-C(13)-H(6) 109.0
C(7)-C(8) 1.344(5) C(14)-C(13)-H(7) 109.0
C(7)-C(10) 1.473(5) C(12)-C(13)-H(7) 109.0
C(8)-N(2) 1.404(5) H(6H7)-C(13)-H(7) 107.8
C(8)-C(12) 1.501(5) C(13)-C(14)-C(15) 115.1(3)
C(9)-N(1) 1.337(5) C(13)-C(14)-H(8) 108.5
C(9)-N(2) 1.369(5) C(15)-C(14)-H(8) 108.5
C(9)-S(1) 1.688(4) C(13)-C(14)-H(9) 108.5
C(11)-H(13) 0.9800 C(15)-C(14)-H(9) 108.5
C(11)-H(14) 0.9800 H(8)-C(14)-H(9H 10) 107.5
C(11)-H(15) 0.9800 C(16)-C(15)-C(14) 115.9(3)
C(12)-C(13) 1.530(5) C(16)-C(15)-H(10) 108.3
C(12)-H(16) 0.9900 C(14)-C(15)-H(10) 108.3
C(12)-H(17) 0.9900 C(16)-C(15)-H(11) 108.3
C(13)-C(14) 1.518(6) C(14)-C(15)-H(11) 108.3
C(13)-H(18) 0.9900 H(10)-C(15)-H(11) 107.4
C(13)-H(19) 0.9900 N(11)-C(16)-C(17) 108.6(3)
C(14)-N(2) 1.484(5) N(11)-C(16)-C(15) 111.1(3)
C(14)-C(15) 1.544(5) C(17)-C(16)-C(15) 110.6(3)
C(14)-H(20) 1 . 0 0 0 0 N(11)-C(16)-H(12) 108.8
C(15)-C(16) 1.467(7) C(17)-C(16)-H(12) 108.8
C(15)-H(21) 0.9900 C(15)-C(16)-H(12) 108.8
C(15)-H(22) 0.9900 C(18)-C(17)-C(110) 125.1(4)
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Table 8 . Hydrogen coordinates (x 104) and isotropic displacement parameters 
(A^x 103) for compound 113.
x y z U(eq)
H(1) 2734 7671 7489 80
H(2) 3046 8332 7144 80
H(3) 3724 7366 7006 80
H(4) 1597 7343 6417 62
H(5) 603 7668 6895 62
H(6 ) 992 6260 7093 48
H(7) 4 6136 6541 48
H(8 ) 3166 5877 6641 41
H(9) 2132 5712 6095 41
H(10) 2652 4346 6278 37
H(11) 1818 4655 6797 37
H(12) -533 4563 6283 33
H(13) -40 2546 7415 77
H(14) -712 1541 7112 77
H(15) -1786 2358 7180 77
H(16) -286 1282 5524 36
H(17) 1161 1511 5965 36
H(18) 2837 1512 5358 39
H(19) 1589 746 5000 39
H(20) 2229 2130 4695 36
H(21) -724 1228 4595 42
H(22) -595 2086 4380 42
H(23) 974 1418 3812 104
H(24) 34 -127 3798 125
H(25) 971 269 3401 125
H(26) -142 4709 5492 36
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Diastereoselective Dimerisation of Alkenylthiazolines: A Combined Synthetic 
and Computational Study
Ariane Beutler,Ial Christopher D. Davies,11)1 Mark C. Elliott,*[aI Natasha M. Galea,faI 
Matthew S. Long,fa| David J. Willock,lal and John L. Wood1**1
Keywords: Heterocycles / Thiazolines /  Dimerisation / Diastereoselectivity /  Semiempirical calculations
The acylative dimerisation of 2-alkenyl-1,3-thiazolines 1 gives been evaluated synthetically, while a computational study
compounds 3 and 8 upon treatment with trichloroacetyl chlo- has elucidated the mechanism of the reaction and the origin
ride and trifluoroacetic anhydride, respectively. This reaction of stereocontrol.
is completely diastereoselective, in particular giving only a (© W iley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim,
single double-bond isomer. The scope of the reaction has Germany, 2005)
Introduction
Over the last few years we have investigated the annu- 
lation reactions for unsaturated azolines with heterocumul- 
enes.1’1 These reactions provide access to a range o f novel 
heterocycles with excellent stereocontrol.t2]
As a continuation o f this study we anticipated that reac­
tion of a simple alkenylthiazoline- such as l a -  with dichlo- 
roketene would be followed by loss o f HC1 to give com­
pound 2a (Scheme 1). In  the event, this reaction turned out 
to be far from straightforward, and the results o f this study 
are described in full herein.[3]
la 2a
Scheme 1.
Results and Discussion
When trichloroacetyl chloride was added to a solution o f 
the alkenylthiazoline la  containing zinc-copper couple, the 
expected product 2a was not obtained. Detailed examina­
tion of the spectroscopic data allowed us to propose struc­
ture 3 for the product, although we were unable at this stage 
to elucidate the double-bond geometry. When the reaction 
was carried out without the zinc-Copper couple present, the
[a] Cardiff School of Chemistry, Cardiff University,
Park Place, Cardiff, CF10 3AT, U K
[b] AstraZeneca,
Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK
acylated dimer was formed once again (Scheme 2). From 
this observation it was clear that the trichloroacetyl chloride 
was reacting with the thiazoline, and furthermore this acyl- 
ation was so rapid that in the presence of zinc-copper cou­
ple, the ketene did not have time to form. The relatively low 
yield is a result o f losses on chromatography, and we were 
able to confirm from N M R  spectra of the crude reaction 
products that only a single stereoisomer had been formed. 
The cis relationship between the phenyl rings was initially 
suggested due to the presence of a 3.5-Hz W-coupling be­
tween the two benzylic protons, and was subsequently con­
firmed by nOe experiments. (Scheme 2).
COCCI
la  3
10% nOe and 
3.5 Hz coupling 
between 
H5 and H7
Scheme 2. a) Cl3CCOCl, DM E, Et20 , 25 °C, 3 h, 29%.
There appears to be no direct precedent for this transfor­
mation, although a related dimerisation of the 2 -(benzyl- 
ideneamino)benzothiazoline 4 to give 5 is known 
(Scheme 3).141
Upon consideration o f the possible mechanisms, the for­
mation o f a single double-bond isomer is particularly sur­
prising. Reaction o f an acylated alkenylthiazoline 6  with 
compound 1 will ultimately give compound 7, either by a 
concerted or stepwise pathway (vide infra). Loss of a proton 
from this compound will then give the observed product 3
Eur. J. Org. Chem. 2005, 3791-3800 D O I: 10.1002/ejoc.200500360 © 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 3791
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n o 2
N0-
5
Scheme 3. a) Xylene, reflux, 60 h, 65%.
(Scheme 4). The stereoselective formation o f tetrasubsti- 
tuted double bonds is particularly challenging, and since 
the environment around the tetrasubstituted double-bond 
in 3 is almost symmetrical it would be optimistic to expect 
much stereocontrol in the deprotonation o f compound 7. 
Indeed, semi-empirical calculations showed that the (E ) and 
(Z ) isomers o f compound 8  have negligible differences in 
energy. We therefore sought to confirm  the double-bond ge­
ometry and probe the mechanism o f this new reaction.
Ph S'
S 'N  
la
Ph"
■N+
COCCl3
Phu S ^ \
coccij
S' N
Y-J
Ph
Ph S - " \
f V W
II 1 COCCI3 
sA N 'S Ph
\_ J
3
Scheme 4. The basic reaction mechanism.
Despite extensive efforts, compound 3 did not produce 
crystals suitable for X-ray diffraction. We therefore decided 
to examine the scope and limitations o f the reaction in the 
hope of producing a crystalline analogue. A  range o f other 
acylating agents was screened for their ability to promote 
the dimerisation o f compound la . T riflic  anhydride, 4-tolu- 
enesulfonyl chloride, acetyl chloride, acetic anhydride and 
methanesulfonyl chloride returned only starting materials 
under a variety o f conditions. The dimerisation was 
smoothly induced by trifluoroacetic anhydride, acylated di­
mer 8a being formed in 41 % yield (Scheme 5). Compared 
to compound 3, the 5-H  in compound 8 a was shifted ap­
proximately 0.5 ppm upfield in the*proton N M R  spectrum. 
We tentatively ascribe this as a difference in the through- 
space effect between the C O C C l3 and C O C F 3 groups; this 
supports the double-bond geometry shown, although it cer­
tainly does not constitute proof.
Ph S ^ \
II I COCF3 
---------------- s N j  Ph
V J
la  8a
Scheme 5. a) TFAA, DM E, Et20 , 25 °C, 3 h, 41 %.
The alkenylthiazolines l a - l f  were prepared by the iod­
ine-catalysed condensation o f 2-methylthiazoline with 4- 
substituted benzaldehydes (Scheme 6). The yields for this 
reaction, although comparable to those reported in the lit­
erature, are modest.l5,6] As an alternative, compounds la  
and the /ert-butyl analogue 10  were prepared by a two-step 
method (Scheme 7).
R
Me
1 a 
sA n  --------------------
v_ / S N\_y
la - f
a, R = Ph, 30%
b, R = 4-BrC6H4, 29%
c, R = 4-N02C6H4, 31%
d, R = 4-MeOC6H4, 33%
e, R -  4-PhC6H4, 21%
f, R -  4-MeC6H4, 35%
Scheme 6. a) RC6H 4CHO, I2, toluene, reflux, 16 h.
Ph Ph
sOH b _
Me
S^N \_I S N
V -f
S N 
\ /
la
/Bu
Me
S^N\__y S 'N
10
Scheme 7. a) «BuLi, THF,-78 °C then PhCHO, 90%; b) TFA, tolu­
ene, 4-A molecular sieves, 1 h, 75%; c) i. nBuLi, THF-78 °C then 
tBuCHO; ii. TFA, toluene, reflux, 3 h, 50% over two steps.
The reaction conditions employed to form the parent 
compound 8a were suitable for the 4-methoxyphenyl ana­
logue 8d, while the 4-bromophenyl, 4-nitrophenyl and 4- 
phenylphenyl analogues 8 b, 8c and 8e called for a change 
in solvent and elevated temperature (75 °C). The 2-(4-meth- 
ylphenyl)ethenyl-l,3-thiazoline ( I f )  did not react under any 
conditions; the tert-butyl substrate 10 was also unreactive 
(Table 1). W ithin this series, it is impossible to see any trend 
in either reactivity or yield. We tentatively attribute the lack 
of reactivity o f compound 10 to steric effects, although the
3792 © 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org Eur. J. Org. Chem. 2005, 3791-3800
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apparent lack of reactivity o f compound I f  is bewildering. 
None of these compounds gave crystals suitable for X -ray  
diffraction. The l3C N M R  spectroscopic data for these 
compounds warrant brief comment. I t  is not surprising, 
given the anticipated low intensity o f quaternary carbons, 
that the expected quartets for the trifluoroacetamide car­
bonyl peaks could not be assigned w ith any degree o f confi­
dence. The C F 3 carbon itself in these compounds was also 
of low intensity, and in the case o f compound 8b was diffi­
cult to observe. M ore surprisingly in all o f compounds 8b, 
8c and 8d only two distinct aromatic C H  peaks were ob­
served in the 13C N M R  spectra, whereas the 'H  N M R  spec­
tra clearly showed the presence o f two different, albeit sim­
ilar, aromatic rings. Compound 3 also shows only three dis­
tinct aromatic C H  peaks, and compound 8a shows four. 
This coincidence o f peaks is unexpected, but all other data 
(including the aromatic quaternary carbon atoms in the 
same 13C N M R  spectra) are fully consistent w ith the pro­
posed structures.
Table 1. Acylative dimerisation of 2-alkenyl-l,3-thiazolines.
TFA A
S N 
V _ J
R S " ^
Ji I c o c f3
S ^N ^R
Y_J
8a - e
Com­
pound
R Conditions Yield %
8a Ph EtaO, D M E , 25 °C, 3 h 41
8b 4-BrC6H 4 CHC13, reflux, 6 h 43
8c 4 -0 2NC 6H 4 CHC13, reflux, 3 h 50
8d 4-MeOC6H 4 Et20 , D M E, 25 °C, 3 h 31
8e 4-PhC6H 4 CHCI3, reflux, 6 h 25W
[a] Compound 8e was obtained with difficulty from a complex mix­
ture and was not obtained analytically pure.
We also briefly investigated whether the reaction could 
be extended to alkenyloxazolines. The 2-styryl-l,3-oxazol- 
ine (12) was prepared in two steps from cinnamoyl chloride 
and ethanolamine via the amide 11 (Scheme 8 ). This com­
pound failed to react with trifluoroacetic anhydride under 
any o f the conditions used for the corresponding thiaz- 
olines.
Having failed to prove the double-bond geometry crys- 
tallographically, we sought indications of the likely geome­
try from the N M R  spectroscopic data. Apart from the dif­
ference in the 5-H  between compounds 3 and 8a mentioned 
above, the only hint was the upheld shift o f two aromatic 
protons away from the body o f the aryl signals, presumably 
due to the proximity o f the trifluoroacetyl group. These 
were shown by nOe studies to be the ortho protons on the 
phenyl ring at the 5-position, tentatively supporting the 
double-bond geometry as drawn throughout. It seemed rea­
sonable that upon replacement o f the trifluoroacetyl group 
with an acetyl group a nOe from the acetyl C H 3 to one of 
the benzylic ring protons might be seen, and the double 
bond geometry therefore unambiguously proven. The tri­
fluoroacetyl group was cleaved reductively using sodium 
borohydride, presenting the dimer as the free enamine 13. 
This reaction was far from clean and the free enamine was 
intolerant to chromatography. Re-acylation o f this com­
pound with trifluoroacetic anhydride returned an impure 
sample of 8a as the same double-bond isomer. Reaction 
with acetic anhydride gave a very impure sample of the de­
sired compound 14 such that no meaningful nOe data could 
be obtained (Scheme 9). However, the relative stability and 
facile acylation o f compound 13 appears to preclude an al­
ternative mechanism for the reaction whereby compound 
la  undergoes dimerisation, this being followed by acylation.
Ph S ^ \
r V N A-AcocFi
Y_J
Ph S%
S N  Ph
V J
13
Ph S'
i f V ^II I COClI3 
s N ^ P h
14
Scheme 9. a) NaBH4, EtOH, 25 °C, 48 h, 80% crude; b) TFAA, 
Et3N, DMAP, CH2C12; c) A c20 ,  DMAP, Et3N, DMAP, 25 °C, 
24 h, see discussion.
Ph
Fh Ph Returning to our original synthetic goal, the formation
C I^ ^ O  a A  b A  o f compounds o f general structure 2 , it was clear that while
- A  I  trichloroacetyl chloride is a sufficiently strong electrophile
OH O NH O to induce dimerisation o f compounds 1, dichloroacetyl
H<X J '  V - t chloride is not. Since dichloroacetyl chloride can be used as
h2N 12 a dichloroketene precursor,[7] we added triethylamine to a
mixture o f compound Id  and dichloroacetyl chloride in 
Scheme 8. a) NaOH, CH2Cb, H 20 , 25 °C, 24 h, 78%; b) MsCl, T HF. This gave the desired compound 2d in 89% yield 
Et3N, CH2C12, 25 °C, 16 h, 90%. (Scheme 10).^
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Scheme 10. a) Cl2CHCOCl, Et3N, THF, 25 °C, 2.5 h, 89%.
This reaction may proceed by attack o f Id  on in situ- 
generated dichloroketene. However, there is a distinct col­
our change on addition o f dichloroacetyl chloride to Id , 
which leads us to favour reaction between these two species 
followed by deprotonation and cyclisation as the more 
likely course o f reaction (Scheme 11). Alkenylthiazoline la  
did not react cleanly under these conditions, possibly re­
flecting the lower nucleophilicity o f this compound.
2d R = 4-MeOC6H4
Scheme 11. Mechanism of formation of compound 2d.
Computational Studies
Since we had been unable to unequivocally determine the 
double-bond geometry by chemical and spectroscopic 
methods, and were unable to rationalise the completely ster­
eoselective formation o f a tetrasubstituted double bond in 
an almost symmetrical local environment, we undertook a 
computational study o f the reaction o f compound la  with 
trifluoroacetic anhydride in order to attempt to answer 
these questions. This study was carried out using the P M 3 191 
Hamiltonian in the M O P A C  program .!101 A ll calculations 
were performed with an SCF tolerance o f 10 6 eV and ge­
ometry optimisations and transition state searches used a 
gradient cut-off o f 4 kFm ol 1 A ‘ . The potential energy sur­
face for the reaction was searched using a series o f con­
strained optimisations to approximately locate transition 
states between minima. In  the following discussion the de­
gree o f freedom constrained will be identified, all other de­
grees o f freedom were optimised at each point o f a search. 
The approximate transition states were optimised using the 
eigenvector follower approach1111 w ithout constraints and 
both minima and transition states were confirmed by a fre­
quency analysis at the same level o f theory, minima being 
recognised by a complete set o f positive normal modes and 
transition states by a single negative (imaginary force con­
stant) mode.
The formation o f intermediate 7 could proceed via a con­
certed aza-D iels-A lder pathway, or a stepwise mechanism 
involving sequential conjugate addition reactions.1121 Proton 
loss from this compound then leads to the formation o f 
compound 8a. We initially had reservations about the abil­
ity o f P M 3 calculations to predict the stereochemical out­
come o f this proton loss. In order to allay these concerns, 
we elected to calculate the reaction pathway leading to com­
pound 7, since i f  we were able to distinguish between con­
certed and stepwise pathways and rationalise the stereo­
chemistry o f this reaction, we could be confident that this 
level o f theory was indeed adequate.
The Concerted Reaction Pathway
This pathway is more straightforward to investigate com­
putationally, as the transition states would be relatively ri­
gid. We investigated both the exo and endo D iels-A lder 
pathways for this reaction, but were unable to locate a tran­
sition state in either case. These transition states were also 
unsuccessfully sought using D F T  calculations (B3LYP 6 - 
3 1 G ** basis set). We were therefore satisfied that the reac­
tion was unlikely to proceed via an initial concerted D ie ls - 
Alder pathway, and so turned our attention to the eventu­
ally more productive stepwise mechanism. This gave en­
tirely reasonable results which explain all o f the stereochem­
ical features o f the pathway, and so we are confident that 
the PM 3 level o f theory is perfectly adequate in this case.
The Stepwise Reaction Pathway
Since the double-bond geometry is defined in the final 
abstraction o f a proton from an intermediate such as 15, 
we examined the barrier to rotation o f the acylated thiaz- 
oline ring in this compound. The rotational profile is essen­
tially sinusoidal with a substantial barrier to rotation 
(33 kPm ol '). Both m inim a 15a and 15b have similar ener­
gies, with the acylated thiazoline ring essentially perpendic­
ular to the bicyclic fragment o f the molecule (Figure 1). 
Therefore, no preference for either clockwise or anticlock­
wise rotation to give a single product isomer is indicated.
It  seemed reasonable that i f  intermediate 15 was formed 
in a given conformation, it would be deprotonated to form  
the final product 8a rapidly. This would preclude rotation 
about the C 6 -C 2 ' bond and so give rise to a single 
double-bond isomer. In order to investigate this possibility, 
we considered all steps in the proposed reaction mechanism 
in order to understand the conformational bias at each 
stage. Since much o f this study did not eventually shed light
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i s " \  H L +>Ph
15
15* 15b
Figure 1. Minimum conformations 15a and 15b of intermediate 15.
on the reason behind the form ation o f a single double-bond 
isomer, it w ill be presented in a condensed form. The s-trans 
conformation 16 o f the free thiazoline is slightly favoured 
(3.5 kJ*mo! !)> while after acylation the s-cis conformation 
17 is more favoured (13kJ*m ol ‘ ) (F igure 2). W hile these 
conformations do in fact give rise to the lowest energy tran­
sition states and intermediates along the reaction coordi­
nate, the entire reaction pathway was investigated beginning 
with the s-cis and s-trans conformers o f  each.
16 17
Figure 2.
Location o f the transition state 18 for nucleophilic attack 
o f 16 onto 17 proved straightforward. In  intermediate 19 
the double-bond geometry for the ring closure is fixed 
(Scheme 12), with the transition state form ing the opposite 
double-bond isomer being 13 kJ*mol 1 higher in energy.
16
+
17
18 19
Scheme 12.
O f the four possible transition states for the actual ring- 
closure step, structures 2 0 a and 2 0 b are shown schemati­
cally in Figure 3. These were located by systematically in­
creasing the corresponding carbon-carbon bond length in
the intermediate 15 (Scheme 13) and its rotamer. The analo­
gous transition states to form the 5,1-anti diastereomeric 
transition states were found to be 19 kJ*mol 1 and 
33 kJ*mol 1 higher in energy than 20a and 20b, respectively. 
Therefore, irrespective o f the double-bond geometry the 
5,1-syn arrangement o f the phenyl groups is overwhelm­
ingly favoured. It  is encouraging that the calculations are 
able to reproduce this aspect o f the experimental observa­
tions.
COCF,
Ph.
J!?X> 
X XS ^ Pb
\U
20a, +0 kJmol"
Ph S ^ \
sXNX ph
\_J
20b, +16 kJmor1
Figure 3.
i S " \y u+>Ph
A X Ph ^
V-J
COCF
20b15
Scheme 13.
Although these calculations had established the likely 
conformation o f the various intermediates and transition 
states along the reaction pathway, conformations 15a and 
15b (o f essentially identical energy) were shown to be fav­
oured from 20a and 20b, respectively. We therefore still had 
no basis upon which to predict which double-bond isomer 
would be formed, or even that any selectivity would be ob­
served. U p  to this point the anion for the cationic interme­
diates had been omitted for simplicity, not least because its 
location is difficult to determine. However, for the final step 
of hydrogen abstraction the inclusion o f a trifluoroacetate 
anion to receive the proton was found to be crucial. A t this 
point the positioning o f the anion is also less ambiguous 
since it must be placed w ith the carboxylate group in close 
proximity to C 6 -H . The bulk o f the phenyl substituents also 
place additional lim itations on its position. W ith  the anion 
in place the calculated energy difference between the two 
intermediate structures 15a*CF3C02 and 15b*CF3C02 is 
now significant as shown in Figure 4.
The introduction o f the anion causes significant confor­
mational change o f the phenyl substituents to allow its in­
teraction with the C 6 proton. This change is more notable 
at the 5-phenyl than the 7-phenyl which is held more rigidly 
in place by the C = C  bond o f the six membered heterocycle. 
However the C 6 -H  and C - N  bonds are still found to be 
near co-planar and so the geometry o f the product double 
bond is still ambiguous at this stage. Transition states for 
the proton removal were located using two methods. Firstly 
a series o f constrained optimisations with the C 6 -H  bond 
length systematically increased was explored and secondly
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1 SrCFiCQf. +0 kJ mol 1 ISfeCFiCOf. +19 kJ mol '
21a*C'FjCO; , +1 kJ mol' 1 UfrCFjCOf, +44 W mol '
Figure 4.
by rotation o f  the acylated thiazoline ring from  each o f the 
intermediates 15a-CF3C 0 2 and 15b*CF3C 0 2 without con­
straining the C 6 -H  distance. Both approaches led to the 
same conclusion that proton loss occurs as the five-mem- 
bered ring rotates to become co -p lanar w ith the six-mem- 
bered heterocycle, so that the form ation o f  the new double 
bond occurs simultaneously w ith proton loss to form the 
neutral acylated dimer. From  15a*CF3C 0 2 we obtained the 
preferred transition state 21a and from  15b*CF3C 0 2 the 
transition state 21b was located. Both structures therefore 
lead to the same (E ) double bond isomer. Rotational se­
arches to find the corresponding (Z )  isomer failed since the 
steric hindrance between the trifluoroacetyl group and the 
7-phenyl prevented the five-membered ring rotating to be­
come co-planar w ith the piperidine ring. I t  appears, then, 
that selectivity is controlled by the ease o f  rotation o f the 
acylated thiazoline ring to form  the new C = C  bond. This 
is impeded by steric interactions between the trifluoroacetyl 
group and the phenyl substituents. In  the case o f the (Z ) 
isomer, the 7-phenyl group has less conform ational mobility 
so that rotation to give the (E )  isomer is the preferred pro­
cess.
Conclusions
A  novel stereoselective acylative dim erisation reaction o f 
alkenylthiazolines has been investigated experimentally and 
computationally. The calculations show the importance of 
including counterions in the structure in order to fully ex­
plain the stereoselectivity in such reactions.
Experimental Section
General Remarks: Melting points were determined with a Gallen- 
kamp melting point apparatus and are uncorrected. Infrared spec­
tra were recorded with a Perkin-Elmer 1600 F T IR  spectrophotom­
eter. Mass spectra were recorded with a Fisons VG Platform II  
spectrometer. High-resolution mass spectra were performed at the 
EPSRC centre for Mass Spectroscopy in Swansea. N M R  spectra 
were recorded at 25 °C with a Bruker DPX 400 spectrometer op­
erating at 400 M H z for 'H  and at 100 M H z for 13C or with a 
Bruker Avance 500 spectrometer operating at 500 M H z for 'H  and 
125 M Hz for ,3C. All chemical shifts are reported in ppm down- 
field from TMS. Coupling constants (J) are reported in Hz. Multi­
plicity in lH  N M R  is reported as singlet (s), doublet (d), double 
doublet (dd), triplet (t), and multiplet (m). Multiplicity in ,3C 
NM R was obtained using the DEPT pulse sequence. Flash 
chromatography was performed using matrex silica 60 35-70 mi­
cron.
4.5-Dihydro-2-|(£)-2-phenylethenyI]-l ,3-thiazole (la): 2-Methylthi- 
azoline (5.06 g, 50 mmol), and benzaldehyde (5.36 g, 50.0 mol) 
were heated under reflux in toluene (50 mL) under Dean-Stark 
conditions. After 1 h iodine (100 mg) was added and reflux allowed 
to continue for 16 h. The reaction mixture was washed with satu­
rated sodium thiosulfate solution (100 mL), dried with MgS04, and 
the solvent removed in vacuo. The resulting thick oil was dissolved 
in diethyl ether and filtered, the filtrate was concentrated in vacuo 
and distilled under reduced pressure (kugelrohr, oven temperature 
180 °C at 0.5 Torr), to give la  (2.8 g, 30%) as a white crystalline 
solid, m.p. 103-105 °C (ref.'6) m.p. 101-102 °C). IR  (CH 2C12): v = 
1583, 1462, 1377 cm-'. 'H  N M R  (400 M Hz, CDC13, 25 °C): S = 
7.43 [dd, 37(H ,H ) = 7.9, V H>H = 1.3, 2 H, aromatic CH], 7.40-7.25 
(m, 3 H, aromatic CH), 7.05 (d, 37 h ,h  = 16.2, I H, one of alkene 
CH), 6.95 (d, 3«/h ,h  = 16.2, 1 H, one of alkene CH), 4.30 (t, V h ,h  
=  8.2, 2 H, C /f2N), 3.25 (t, 37 h ,h  =  8.2, 2 H, C //2S) ppm. ,3C 
N M R  (100 MHz, CDC13, 25 °C): 6 -  168.3 (thiazoline Q , 141.6 
(alkene CH), 135.7 (aromatic C), 129.8 (aromatic CH) 129.3 (aro­
matic CH), 127.9 (aromatic CH), 123.1 (alkene CH), 65.1 (CH2N), 
33.4 (CH2S) ppm. MS (APCI): m/z (%) = 190 (100) [M + H]+.
2-[(£)-2-(4-Bromophenyl)ethenyl]-4,5-dihydro-l,3-thiazole (lb):
2-Methylthiazoline (2.2 g, 20 mmol) and 4-bromobenzaldehyde 
(3.6 g, 20 mmol), were heated under reflux in toluene (100 mL) un­
der Dean-Stark conditions for 1 h. Iodine (100 mg) was added and 
the reflux continued for 16 h. The resulting reaction mixture was 
washed with saturated sodium thiosulfate solution (100 mL), dried 
with MgS04, and the solvent removed in vacuo. The dark oil re­
sulting was dissolved in diethyl ether (40 mL) and filtered. The di­
ethyl ether was removed in vacuo to give a brown solid which was 
purified by column chromatography (eluting with diethyl ether/ 
CH2C12, 1:9), late fractions yielding lb (1.6 g, 30%) as a white so­
lid; m.p. 160-163 °C. IR  (CDC13): *  = 1634, 1574, 1489, 1007 c m 1. 
'H  N M R  (400 M Hz, CDC13, 25 °C): 6 = 7.39 (d, V h.h = 7.4, 2 H, 
aromatic CH), 7.29 (d, Vh,h = 7.4, 2 H, aromatic CH), 6.95 (ap­
parent s, 2 H, 2 x alkene CH), 4.30 (t, Vh.h = 8.0, 2 H, CH2N),
3.25 (t, 37h,h = 8.0, 2 H, C H 2S) ppm. 13C N M R  (100 MHz, CDC13, 
25 °C): <5 = 168.0 (thiazoline Q ,  140.1 (alkene CH), 134.7 (aromatic 
C) 132.5 (aromatic CH), 129.3 (aromatic CH), 123.9 (aromatic Q ,
123.7 (alkene CH), 65.2 (CH 2N), 33.5 (CH2S) ppm. MS (APCI): 
m/z (%) = 270 (100) [M + H ]+, 268 (100) [M + H]+, 71 (58). HRMS  
(Cl) C ,,H n 79BrNS [M + H ]+: 267.9795; found 267.9797.
4.5-Dihydro-2-[(£)-2-(4-nitrophenyl)ethenyl]-l ,3-thiazole ( 1  c):
2-Methylthiazoline (2.20 g, 20 mmol) and 4-nitrobenzaldehyde 
(3.0 g, 22 mmol) were heated under reflux in toluene (100 mL) un­
der Dean-Stark conditions for 1 h. Iodine (100 mg) was added and 
the reflux continued for 16 h. The reaction mixture was washed 
with sodium thiosulfate solution (100 mL), dried with MgS04 and 
the toluene removed in vacuo. Diethyl ether (40 mL) was added to
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the resulting dark oil, and 1c (1.45 g, 31 %) isolated by filtration as 
a light brown solid; m.p. 213-216 °C, (ref.f6l m.p. 214-216 °C) 
which was used without further purification. IR  (C H 2CI2): v= 1629, 
1604, 1508, 1167 cm '. 'H  N M R  (400 M H z, CDC13, 25 °C): 3 =
8.25 (d, V h,h = 8.8, 2 H, aromatic CH), 7.64 (d, V h,h = 8.8, 2 H, 
aromatic CH), 7.17 (d, V h,h = 16.4, 1 H , one of alkene CH), 7.10 
(d> V h,h = 16.4, 1 H, one of alkene CH), 4.40 (t, V h,h = 8.2, 2 H, 
C7/2N), 3.35 (t, V h,h = 8.2, 2 H , C H 2S). 13C N M R  (100 MHz, 
CDCI3, 25 °C): 3 = 167.6 (thiazoline Q ,  148.3 (aromatic Q , 141.9 
(aromatic Q , 139.5 (alkene CH), 128.3 (aromatic CH), 127.1 (al­
kene CH), 124.6 (aromatic CH), 65.4 (C H 2N), 33.7 (CH2S) ppm. 
MS (ammonia Cl): m/z (%) = 235 (26) [M + H ]+, 220 (33), 205 
(100). H R M S  (C l) C , ,H n N 20 2S [M  + H ]+: 235.0541; found 
235.0545.
4,5-Dihydro-2-|(£)-2-(4-methoxyphenyl)etheny 1]-1,3-thiazole (1 d):
2-Methylthiazoline (2.5 g, 25 mmol) and 4-methoxybenzaldehyde 
(2.8 g, 24 mmol) were heated under reflux in toluene (100 mL) un­
der Dean-Stark conditions for 1 h. Iodine (50 mg) was added and 
the reflux continued for 18 h. The resulting brown solution was 
washed with saturated sodium thiosulfate solution (50 mL), dried 
with M gS04 and the solvent removed in vacuo. The brown oil re­
maining was dissolved in diethyl ether (30 mL), filtered and the 
diethyl ether was removed in vacuo, to yield a brown solid which 
was purified by column chromatography (eluting with diethyl ether) 
late fractions yielding Id (1.8 g, 33%,) as colourless plates, m.p. 
100-102 °C (ref.W  m.p. 99-101 °C ). IR  (C H 2C12): 9 = 1463, 
1377 cm’ 1. 'H  N M R  (400 M H z, CDC13, 25 °C): 3 = 7.45 (d, 3/ h,h 
= 8.7, 2 H, aromatic CH), 7.07 (d, Vh,h = 16.1, 1 H , one of alkene 
CH), 6.93 (d, 3/ h,h = 16.1, 1 H , one of alkene CH), 6.89 (d, 37h,h 
= 8.7, 2 H, aromatic CH), 4.35 (t, 37h.h = 8.5, 2 H , C //2N), 3.85 
(s, 3 H, OCHi), 3.30 (t, 37h,h = 8.5, 2 H , C / /2S) ppm. 13C N M R  
(125 MHz. CDCI3, 25 °C): 3 = 168.5 (thiazoline Q ,  160.8 (aromatic 
C), 141.2 (alkene CH), 129.1 (aromatic CH), 128.0 (aromatic C), 
120.2 (alkene C H ), 114.3 (arom atic C H ), 64.3 (C H 2N ) 55.4 
(OCH3), 32.9 (C H 2S) ppm. MS (APCI): m/z (%) = 220 (100) [M + 
H ]+.
2-|(£)-2-(4-Phenylphenyl)ethenyl)-4,5-dihydro-l,3-thiazole (le):
2-Methylthiazoline (1.75 g, 17 mmol) and 4-phenylbenzaldehyde 
(3.15 g, 17 mmol) were heated under reflux in toluene (100 mL) 
under Dean-Stark conditions for 1 h. Iodine (100 mg) was added 
and the reflux continued for 16 h. The reaction mixture was washed 
with saturated sodium thiosulfate solution (100 mL), dried with 
MgS04 and the toluene removed in vacuo. The resulting dark oil 
was dissolved in diethyl ether (40 mL) and filtered. The diethyl 
ether was removed in vacuo to give a brown solid which was puri­
fied by column chromatography (eluting with C H 2C12), late frac­
tions yielding le (960 mg, 21%) as an off-white crystalline solid, 
m.p. 141-144 °C. IR  (C H 2C12): = 1633, 1582, 1488, 1177 cm-'.
'H  N M R  (400 M Hz, CDC13, 25 °C): 3 = 7.74-7.56 (m, 6 H , aro­
matic CH), 7.46 (apparent t, 3/h ,h  = 7.5, 2 H , aromatic CH), 7.36 
(L 3-Aj,h = 7.4, 1 H, aromatic CH), 7.26 (d, Vh,h = 16.2, 1 H, 
alkene CH), 7.08 (d, 3/ h,h = 16.2, 1 H, alkene CH), 4.40 (t, V H)h 
= 8.2, 2 H, CH2N), 3.36 (t, V h,h = 8.2, 2 H , C H 2S) ppm. ,3C 
N M R  (100 MHz. CDCI3, 25 °C): 3 = 168.3 (thiazoline Q ,  142.2 
(aromatic C), 141.1 (alkene CH), 140.7 (aromatic C), 134.7 (aro­
matic C), 129.3, 128.3, 128.1, 127.9 and 127.4 (all aromatic CH),
123.0 (alkene CH), 65.2 (CH 2N), 33.5 (C H 2S) ppm. MS (APCI): 
m/z (%) = 266 (100) [M  + H]+. HR M S (C l) C 17H I6NS [M  + H]+: 
266.1003; found 266.0997.
2-[(£)-2-(4-Methylphenyl)ethenyl]-4,5-dihydro-l,3-thiazole (If):
2-Methylthiazoline (2.5 g, 25 mmol) and 4-tolualdehyde (2.84 g, 
25 mmol) were heated under reflux in toluene (100 m L) under
Dean-Stark conditions for 1 h. Iodine (100 mg) was added and the 
reflux continued for 16 h. The reaction mixture was washed with 
saturated sodium sulfite solution (40 mL). The solvent was re­
moved in vacuo to give a brown solid which was purified by column 
chromatography (eluting with C H 2C12), late fractions affording le 
(1.8 g, 35%) as a white solid, m.p. 148-150 °C (ref.[6) m.p. 148— 
150 °C). IR  (CH2C12): 9 = 1634, 1579, 1318, 1177 cm '. 'H  N M R  
(400 MHz, CDCI3, 25 °C): 3 = 7.31 (d, 3/ h ,h  = 8.0, 2 H, aromatic 
CH), 7.11 (d, 37 h .h  = 8.0, 2 H, aromatic CH), 6.99 (d, V h,h = 
15.8, 1 H, one of alkene CH), 6.93 (d, 37 h ,h  = 15.8, 1 H, one of 
alkene CH), 4.30 (t, 37 h .h  = 8.1, 2 H, C/72N), 3.26 (t, 3- /h ,h  = 8.1,
2 H, CH2S), 2.30 (s, 3 H, C H 3) ppm. l3C N M R  (100 M Hz. CDC13, 
25 °C): 3 = 168.3 (thiazoline C), 141.6 (alkene CH), 140.1 (aromatic 
Q , 133.0 (aromatic Q , 130.0 and 127.8 (aromatic CH), 122.1 (al­
kene CH), 65.1 (C H 2N ), 33.4 (C H 2S), 21.8 (C H 3) ppm. MS  
(APCI): m/z (%) = 204 (100) [M + H ]+.
6-Chloro-2,3-dihydro-7-(4-methoxyphenyl)-5//-|l,3)thiazolo[3,2-al- 
pyridin-S-one (2d): 4,5-Dihydro-2-[(/s)-2-(4-methoxyphenyl)eth- 
enyl]-l,3-thiazole (Id ) (520 mg, 2.4 mmol) was dissolved in dry 
TH F (8 mL). Dichloroacetyl chloride (230 pL, 2.24 mmol) was 
added and the resulting bright red mixture stirred at 25 °C under 
N 2 for 20 min. Triethylamine (340 pL, 2.4 mmol) was added and 
the resulting cloudy brown mixture stirred for a further 2 h. The 
resulting suspension was filtered and the filtrate dried with M gS04, 
and concentrated in vacuo. Purification by column chromatog­
raphy (eluting with diethyl ether/CH2Cl2, 1:5) yielded 2d (625 mg, 
89%) as a light brown solid m.p. 128-130 °C. IR  (CHC13): V = 
1636, 1513 c m 1. 'H  N M R  (400 M Hz, CDC13, 25 °C): 3 = 7.33 (d, 
3/ h ,h  = 8.6, 2 H, aromatic CH), 6.87 (d, 3/ h ,h  = 8.6, 2 H, aromatic 
CH), 6.15 (s, 1 H, 8-H), 4.52 (d, V h,h = 7.4, 2 H, CH 2N), 3.79 (s,
3 H, OCH3), 3.41 (t, V h,h = 7.4, 2 H, C7/2S) ppm. 13C N M R  
(100 MHz. CDCI3, 25 °C)’: 3 = 159.0 (C =0), 157.6 (SCN), 149.6 
(CC1), 144.4 (aromatic C), 128.9 (aromatic CH), 128.3 (aromatic 
O , 116.7 (aromatic C), 112.7 (aromatic CH), 101.4 (8-C), 52.3 
(OCH3), 50.8 (CH2N), 27.9 (CH2S) ppm. MS (APCI): m/z (%) = 
296 (3 5 ) [M  + H ] + , 294 (1 0 0 )  [M  + H ] + . H R M S  ( C l )  
C 12H I3N 0 4S35C1 [M + H]+: 294.0355; found 294.0359.
(5/?S,7/?S,£)-6-(4,5-Dihydro-3-trichloroacetyl-l,3-thiazol-2-ylid- 
ene)-2,3,5,7-tetrahydro-5,7-dipheny 1|1,3]thiazolo[3,2-a]pyridine (3):
4,5-Dihydro-2-[(/s)-2-phenylethenyl]-l,3-thiazole (la ) (250 mg,
1.3 mmol) was dissolved in dry diethyl ether (1 mL) and dry D M E  
(4 mL). Trichloroacetyl chloride (15 pL, 0.8 mmol) was added 
dropwise with stirring under N 2 at 25 °C. The reaction mixture was 
stirred for 3 h, washed with aqueous N aH C 0 3 solution (10 mL) 
then with brine (10 mL), and dried with MgS04. The solvent was 
removed in vacuo to yield a glassy orange solid, which was purified 
by chromatography on neutral alumina (eluting with CH2C12) late 
fractions yielding compound 3 as a colourless solid (98 mg, 29%), 
m.p. 186-188 °C. IR  (CHC13): 9 = 2920, 1691, 1625 cm '. 'H  
N M R  (400 MHz, CDC13, 25 °C): 3 = 7.20-7.10 (m, 8 H, aromatic 
CH), 6.90 (m, 2 H , aromatic CH), 5.05 (d, 47H,h = 3.5, 1 H, 5-/7), 
4.55 (d, 3J h,h = 11-8, 1 H , alkene C H ), 3.95-3.85 (m, 2 H , 
C //2NCO), 3.50-3.35 (m, 3 H , 7-7/ and C/72N), 3.10-2.95 (m, 2 
H, CH 2S), 2.90-2.80 (m, 2 H, C H 2S) ppm. 13C N M R  (100 MHz. 
CDCI3, 25 °C): 3 = 175.6 (C =0), 168.7, 167.2 (both thiazoline Q ,
139.6 and 138.7 (aromatic C), 128.5, 127.8, 127.2 (all aromatic 
CH), 97.5 (CCI3), 96.7 (alkene C), 64.5 (CH2NCO), 60.5 (alkene 
CH), 52.9 (C H 2N ), 50.0 (5-C ), 43.6 (7-C), 33.3 (C H 2S), 27.0 
(CH2S) ppm. MS (APCI): m/z (%) = 525 (9) [M + H]+, 523 (10) [M 
+ H ]+, 190 (100) [M + H ]+ (molecular ion shows expected isotopic 
distribution pattern). HR M S (Cl) C24H 2235C13N 20 2S [M + H l+: 
523.0239; found 523.0240.
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(5/?5,7/?5,E)-6-(4,5-Dihydro-3-trifluoroacetyl-l,3-thiazol-2-ylid- 
ene)-2,3,5,7-tetrahydro-5,7-diphenyl| 1,3]thiazolo|3,2-a]pyridine (8a):
2-[(£)-2-Phenylethenyl]-4,5-dihydro-1,3-thiazole (la )  (150 mg, 
0.8 mmol) was dissolved in dry diethyl ether (1 mL) and dry DM E  
(4 mL). Trifluoroacetic anhydride (70 pL, 0.5 mmol) was added 
dropwise with stirring under N 2 at 25 °C. The reaction mixture was 
stirred for 3 h, washed with aqueous N a H C 0 3 solution (10 mL) 
then with brine (10 mL), and dried with M gS04. The solvent was 
removed in vacuo to yield a glassy orange solid, which was purified 
by chromatography on neutral alumina (eluting with CH2C12), late 
fractions yielding 8a (78 mg, 41%) as a white solid, m.p. 196— 
198 °C. IR  (C H C I3): S = 1691, 1625, 1499 c m 1. •H  N M R  
(400 MHz, CDCI3, 25 °C): 8 = 7.32-7.12 (m, 8 H, aromatic CH), 
6.85 (dd, 3yH>H = 7.5, V h,h = 1.7, 2 H, aromatic CH), 4.56 (d, 
V h,h = 11.1,1 H , alkene CH), 4.51 (d, V H,H = 4.2, 1 H, 5-H),
3.79 (m, 2 H, C //2NCO), 3.41 (dd, V h,h =11.1, V h,h = 4.2, 1 H,
1-H), 3.35-3.30 (m, 2 H, C H 2N), 3.00-2.80 (m, 4 H, 2xS CH2) 
ppm. I3C N M R  (100 M Hz. CDC13, 25 °C): 8 = 166.5 and 164.6 
(both thiazoline Q , 139.5 and 136.9 (both aromatic Q , 127.6,
127.1, 126.9, 126.3 (all aromatic CH), 117.1 (q, 17c,f = 290 Hz, 
CF3), 97.9 (alkene Q , 70.7 (N C O C H 2), 59.1 (alkene CH), 51.8 
(N C H 2), 48.8 (5-C), 40.7 (7-Q , 32.3 (CH2S), 29.2 (CH2S) ppm. 
MS (APCI): m/z (%) = 475 (100) [M + H]+, 102.5 (29). HRMS  
(El) C24H 22F3N 2OS2 [M + H]+: 475.1127; found 475.1125.
(5/?S,7/?5,£)-2,3,5,7-Tetrahydro-5,7-bis(4-bromophenyl)-6-(4,5-di- 
hydro-3-trifluoroacetyl-l ,3-thiazol-2-yIidene)[ 1,3|thiazolo|3,2-a|pyri- 
dine (8b): 2-[(E)-2-(4-Bromophenyl)ethenyl]-4,5-dihydro-1,3-thi­
azole (lb) (200 mg, 0.74 mmol), was dissolved in dry chloroform 
(5 mL). Trifluoroacetic anhydride (75 pL, 0.53 mmol) was added 
dropwise and the reaction mixture heated under reflux for 6 h. The 
resulting orange solution was washed with aqueous N aH C 03 solu­
tion (10 mL) then brine (10 mL), and dried with MgS04. The sol­
vent was removed in vacuo to give a light brown solid which was 
purified by column chromatography on alumina (eluting with 
C H 2C12) early fractions yielding 8b (100 mg, 43%) as a white solid, 
m.p. 200-203 °C. IR  (C H 2C12): 9 = 1692, 1625, 1500, 1464 c m 1. 
'H  N M R  (400 MHz, CDC13, 25 °C): 8 = 7.38 (d, V h,h = 8.4, 2 H, 
aromatic CH), 7.30 (d, Vh.h = 8.4, 2 H, aromatic CH), 7.08 (d, 
3^ h,h = 8.5, 2 H, aromatic CH), 6.73 (d, 3/h ,h  = 8.5, 2 H, aromatic 
CH), 4.50 (d, V h,h = 11.1, 1 H , alkene CH), 4.47 (d, V H>h = 4.2,
1 H, 5-H), 3.80 (apparent t, 3/ h,h = 8.3, 2 H, C i/2NCO), 3.40- 
3.30 (m, 3 H, 1-H  and C //2N), 3.11-3.03 (m, 2 H, CH2S), 2.95- 
2.88 (m, 2 H, CH2S) ppm. 13C N M R  (125 MHz. CDC13, 25 °C): 8 
= 166.5 and 165.8 (both thiazoline C), 138.4 and 136.0 (both aro­
matic C), 130.1, 128.6 (both aromatic CH), 121.7, 120.3 (both C- 
Br), 97.5 (alkene C), 63.2 (C H 2N C O ), 58.5 (alkene CH), 51.8 
(NC H2), 48.4 (5-C), 40.0 (7-Q , 32.4 (SCH2), 26.2 (SCH2) ppm. 
MS (APCI): m/z (%) = 635 (58) [M  + H ]+, 633 (100) [M + H]+, 
631 (48) [M + H]+. HRM S (C l) C24H 1979Br2F3N 2OS2 [M + H]+: 
630.9336; found 630.9335.
(5R5,7/?5,£)-6-(4,5-Dihydro-3-trifluoroacetyl-l,3-thiazol-2-ylid- 
ene)-2,3,5,7-tetrahydro-5,7-bis(4-nitrophenyl)[l,3)thiazolo|3,2-a]pyri- 
dine (8c): 4,5-Dihydro-2-[(£)-2-(4-nitrophenyl)ethenyl]-l ,3-thiazole 
(lc) (200 mg, 0.85 mmol) was dissolved in dry chloroform (5 mL). 
Trifluoroacetic anhydride (83 pL, 0.6 mmol) was added dropwise 
and the solution heated under reflux for 3 h. The resulting orange 
solution was washed with aqueous N a H C 03 solution (10 mL), then 
brine (10 mL), and dried with MgS04. The solvent was removed 
in vacuo to give a yellow solid which was purified by flash 
chromatography on alumina (eluting with C H 2C12), yielding 8c 
(120 mg, 50% ) as a pale yellow solid, m.p. 210-212 °C. IR  
(CH2C12): 9 = 1683, 1625, 1462 cnr1. •H N M R  (400 M Hz, CDC13, 
25 °C): 8 = 8.13 (d, 37h,h = 8.3, 2 H , aromatic CH), 8.09 (d, 3/ h.h
= 8.7, 2 H , aromatic CH), 7.40 (d, Vh,h = 8 .6 , 2 H, aromatic CH),
7.06 (d, V h,h = 8.7, 2 H, aromatic CH), 4.66 (d, 37„,H = 11.1, 1 
H, alkene CH), 4.61 (d, V h,h = 4.1, 1 H, 5-H), 3.71-3.65 (m, 2 H, 
CH2NCO), 3.49 (dd, V h,h = H .l ,  V H.h = 4.1, 1 H, 1-H), 3.45- 
3.40 (m, 1 H, one of C //2N) 3.31 (ddd, 2/ h,h = 10.6, V h,h = 7.7, 
V h.h = 2.9, 1 H, one of C //2N), 3.17-2.98 (m, 4 H, 2 x C / /2S) 
ppm. l3C N M R  (100 M Hz. CDC13, 25 °C): 8 = 168.4, 166.7 (both 
thiazoline C), 148.5, 148.1, 147.7, 145.4 (all aromatic Q , 129.2,
123.8 (both aromatic CH), 118.1 (q, lJc,f  = 290 Hz, CF3), 98.2 
(alkene Q , 64.7 (CH 2NCO), 59.7 (alkene CH), 53.3 (CH2N), 49.6 
(5-C), 41.7 (7-Q , 33.9 (CH2S), 27.7 (CH2S) ppm. MS (APCI): m/z 
(%) = 565 (100) [M + H]+, 65 (57). HRMS (Cl) C ^ H ^ K A F jS ;, 
[M + H]+: 565.0828; found 565.0857.
(5/?5,7/?5,E)-2,3,5,7-Tetrahydro-5,7-bis(4-methoxyphenyl)-6-(4,5-di- 
hydro-3-trifluoroacetyl-l ,3-thiazol-2-ylidene)| 1,3)thiazolo|3,2-a]pyri- 
dine (8d): 2-[(£)-2-(4-Methoxyphenyl)ethenyl]-4,5-dihydro-1,3-thi­
azole (Id) (200 mg, 0.93 mmol) was dissolved in dry diethyl ether 
(1 mL) and dry D M E  (4 mL). Trifluoroacetic anhydride (90 pL, 
0.64 mmol) was added dropwise and the solution stirred under N 2 
at 25 °C for 3 h. The orange solution resulting was washed with 
aqueous N a H C 03 solution (10 mL), then brine (10 mL), and dried 
with MgS04. The solvent was removed in vacuo to give an orange 
solid which was purified by flash chromatography on alumina (elut­
ing with C H 2C12) yielding 8d (77 mg, 31 %) as a pale yellow solid; 
m.p. 183-185 °C. IR  (C H 2C12): 9 = 1683, 1624, 1463 cm '. >H 
N M R  (400 M Hz, CDC13, 25 °C): 8 = 7.10 (d, V h,h = 8.8 , 2 H, 
aromatic CH), 6.80-6.69 (m, 6 H, aromatic CH), 4.52 (d, 3/ h ,h  =
11.1, 1 H, alkene CH), 4.45 (d, V h,h = 3.9, 1 H, 5-H), 3.83 (m, 2 
H, C //2NCO), 3.72 (s, 3 H, O C //3), 3.71 (s, 3 H, O C //3), 3.40 (m, 
3 H, C //2N  and 1-H), 3.05 (m, 2 H , CH2S), 2.93 (m, 2 H, CH2S) 
ppm. 13C N M R  (100 M Hz. CDC13, 25 °C): 8 = 167.9, 167.7 (both 
thiazoline Q , 160.0, 158.9, 133.0, 130.2 (all aromatic Q , 129.5 
(aromatic CH), 118.0 (q, lJc,f  = 290 Hz, CF3), 113.6 (aromatic 
CH), 99.7 (alkene C), 64.6 (C H 2NCO), 60.1 (alkene CH), 55.6 
(OCH3), 55.4 (OCH3), 53.2 (CH 2N), 50.4 (5-C), 41.1 (7-Q , 33.7 
(CH2S), 27.6 (CH2S) ppm. MS (APCI): m/z (%) = 535 (100) [M + 
H] + . H R M S  (E l)  C 24H 20N 4O 5F 3S2 [M ] + : 534.1259; found 
534.1260.
(5/?S,7/?S,jE)-2,3,5,7-Tetrahydro-5,7-bis(4-phenylphenyl)-6-(4,5-di- 
hydro-3-trifluoroacetyl-l,3-thiazol-2-ylidene)[l,3]thiazolo|3,2-a]pyri- 
dine (8e): 2-[(£)-2-(4-Phenylphenyl)ethenyl]-4,5-dihydro-1,3-thi­
azole (le) (150 mg, 0.57 mmol) was dissolved in dry chloroform 
(5 mL). Trifluoroacetic anhydride (70 pL, 0.5 mmol) was added 
dropwise and the solution heated under reflux for 6 h. The resulting 
orange solution was washed with aqueous N a H C 0 3 solution 
(10 mL), then brine (10 mL), and dried with M gS04. The solvent 
was removed in vacuo to give a yellow solid which was purified 
twice by flash chromatography on alumina (eluting with CH2C12), 
yielding 8e (45 mg, 25%) as a pale yellow solid. This compound 
exhibited spectroscopic data in line with compounds 8a-8d, but 
could not be purified to allow full characterisation.
2-(4,5-Dihydro-l,3-thiazol-2-yl)-l-phenyl-l-ethanol (9):(1312-Methyl­
thiazoline (2.0 g, 20 mmol) was dissolved in dry TH F  and cooled 
to-78 °C. w-Butyllithium (8.7 mL of a 2.5 m solution in hexanes, 
22 mmol) was added and the resulting orange solution stirred at- 
78 °C under N 2 for 1 h. Benzaldehyde (2.1 g, 20 mmol) was added 
and the reaction mixture stirred for a further 2 h at-78 °C then 
allowed to warm to 25 °C over 1 h. Saturated ammonium chloride 
solution (20 mL) was added, and the products extracted with di­
ethyl ether (3 x 30 mL), the organic portions were washed with 
brine (20 mL), dried with M gS04, and concentrated in vacuo to 
give compound 9 (3.6 g, 90%) as an orange solid, m.p. 76-79 °C
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(dec.). IR  (C H 2C12): 9 = 3267, 1624, 1434, 1124 cm *. ‘H NM R  
(400 MHz, CDC13, 25 °C): 3 = 7.30 (apparent t, 37h,h = 7.5, 2 H, 
aromatic CH), 7.26 (d, V h,h = 7.6, 2 H , aromatic CH), 7.19 (t, 
Vh,h = 6.9, 1 H, aromatic CH), 5.04 (apparent t, Vh.h = 6.3, 1 
H, C //O H ), 4.70 (broad s, 1 H , O ff), 4.18 (m, 2 H, C H 2N), 3.21 
(apparent t, 37h,h = 8.2, 2 H, C H 2S), 2.72 (m, 2 H , C //2CHOH) 
ppm. ,3C N M R  (100 MHz. CDC13, 25 °C): 3 = 171.0 (thiazoline 
Q , 142.3 (aromatic C), 128.8, 128.0 and 126.2 (aromatic CH), 71.8 
(CHOH), 64.6 (CH2N), 43.1 (C H 2S), 33.8 (C H 2CHOH) ppm. MS 
(APCI): m/z (%) = 208 (40) [M + H ]+, 190 (100).
Alternative Preparation of 2-[(£)-2-Phenylethenyl]-4,5-dihydro-l,3- 
thiazole (la): 2-(4,5-Dihydro-1,3-thiazol-2-yl)-1 -phenyl-1 -ethanol
(9) (1.5 g, 7.2 mmol) was dissolved in toluene (15 mL). Trifluoro­
acetic acid (2 drops) was added followed by 4-A molecular sieves, 
and the mixture heated under reflux for 1 h. After cooling to room 
temperature, the reaction mixture was diluted with dichlorometh- 
ane (50 mL), washed with water (50 mL) and brine (50 mL). The 
resulting solution was dried with M gS04 and the solvent removed 
in vacuo to give an orange solid which was purified by kugelrohr 
distillation (180 °C, 0.5 Torr) to give the title compound (1.03 g, 
75%) as a colourless solid. Data were as previously reported.
4,5-Dihydro-2-[(£)-3,3-dimethyl-l-butenyl|-l,3-thiazole (10): 2-
Methylthiazoline (2.5 g, 25 mmol) was dissolved in TH F (15 mL) 
and cooled to-78 °C. n-Butyllithium (7.8 mL of a 2.5 m solution in 
hexanes, 26 mmol) was added dropwise and the resulting orange 
anion was stirred for 30 min. 2,2-(Dimethyl)propionaldehyde 
( 1.86 g, 21 mmol) was then added dropwise and the clear orange 
solution resulting was stirred for 1 h at-78 °C then warmed to 
25 °C over 2 h. Water (20 mL) was then added, and the organic 
layer separated, the aqueous layers was extracted with diethyl ether 
(3 x 20 mL). The combined organic layers were concentrated in 
vacuo. The resulting red solid was dissolved in toluene (40 mL), 
trifluoroacetic acid (30 mg) was added and the mixture heated un­
der reflux, under Dean-Stark conditions for 1 h. The brown solu­
tion remaining was washed with saturated sodium hydroxide solu­
tion (30 mL), dried with M gS04, and the solvent removed in vacuo 
to yield the essentially pure 10 (2.1 g, 50%) as a yellow oil. IR  
(C H 2C12): 9 = 1647, 1460 cm '. *H N M R  (400 M H z, CDC13, 
25 °C): 3 = 6.26 (d, 3/ h,h = 15.3, 1 H , one of alkene CH), 6.23 (d, 
Vh,h = 15.3, 1 H, one of alkene CH), 4.24 (t, 3/h ,h  = 8.1, 2 H, 
CH2N), 3.20 (t, Vh.h = 8.1, 2 H , C H 2S), 1.03 (s, 9 H 3 x C //3) 
ppm. 13C N M R  (100 M Hz. CDC13, 25 °C): 3 = 171.7 (thiazoline 
Q ,  155.2 (alkene CH ), 120.6 (alkene C H ), 64.5 (C H 2N ), 34.0 
[C(CH3)3], 32.8 (CH2S), 29.0 (3 x CH3) ppm. MS (APCI): m/z (%) 
= 170 (100) [M + H]+. H R M S  (C l) C8H ,6NS [M + H]+: 170.1003; 
found 170.1000.
(£)-/V-(2-Hydroxyethyl)-3-phenyl-2-propenamide (11): (£)-Cinna- 
moyl chloride (1.0 g, 6 mmol) and ethanolamine (336 mg, 6 mmol) 
were dissolved in CH 2C12 (20 mL). A saturated solution of sodium 
carbonate (54 mL) was added and the mixture stirred at 25 °C for 
16 h. Brine was added and the products extracted into C H 2C12 
(3x30m L), dried with M gS04, and concentrated in vacuo to af­
ford a white solid. Recrystallisation from ethyl acetate gave com­
pound 11 (0.91 g, 78%) as a white crystalline solid, m.p. 67-69 °C 
(ref.I14! m.p. 67-68 °C). IR : v (melt) = 3298, 1650, 1597 1556, 
1456 c m 1. ‘H  N M R  (400 M Hz, CDC13, 25 °C): 3 = 7.60 (d, V h.h 
= 15.6, 1 H, alkene CH), 7.55 (m, 2 H, aromatic CH), 7.25 (m,’3 
H, aromatic CH), 6.37 (d, V h,h = 15.6, 1 H, alkene CH), 6.30 
(broad s, 1 H, N H), 3.75 (m, 2 H , CH 20 ),  3.52 (m, 2 H , CH 2N),
3.00 (broad s, 1 H, OH) ppm. 13C N M R  (100 MHz. CDC13, 25 °C): 
3 = 167.6 (amide C=0), 142.0 (alkene CH), 135.0 (aromatic C),
130.3 (aromatic CH), 129.3 (aromatic CH), 128.3 (aromatic CH),
120.6 (alkene CH), 62.7 (C H 20), 43.1 (C H ,N ) ppm. MS (APCI): 
m/z (%) = 192 (100) [M + H ]+.
4,5-Dihydro-2-|(£>2-phenylethenyl]-l,3-oxazole (12): (E )-N -(2- 
Hydroxyethyl)-3-phenyl-2-propenamide (11) (1.1 g 5.75 mmol), was 
dissolved in CH 2C12 (50 mL), triethylamine (580 mg, 5.75 mmol) 
was added and the mixture cooled to 0 °C. Methanesulfonyl chlo­
ride (665 mg, 5.75 mmol) was added and the resulting solution 
stirred at 25 °C for 24 h. The reaction mixture was washed with 
N aH C 03 solution (10 mL), dried with M gS04i and concentrated 
in vacuo to afford a green oil which was purified by column 
chromatography (eluting with ethyl acetate/diethyl ether, 1:10), 
early fractions yielding compound 12 (895 mg, 90%) as a white 
solid, m.p. 51-54 °C (reU15! m.p. 53-55 °C). IR  (CHC13): 9 = 2924, 
1651, 1450 cm '. 'H  N M R  (400 M Hz, CDC13, 25 °C): 3 = 7.28 (d, 
3^ h,h = 7.6, 2 H, aromatic CH), 7.21-7.08 (m, 4 H, aromatic CH  
and one of alkene CH), 6.43 (d, 37 h .h  = 15.1, 1 H, alkene CH), 
4.13 (t, V h,h = 9.3, 2 H , C ff2N), 3.79 (t, 3yH,H = 9.3, 2 H, CH20 )  
ppm. 13C N M R  (100 M Hz. CDC13, 25 °C): 3 = 166.2 (oxazoline 
Q , 140.2 (alkene CH), 135.6 (aromatic Q , 129.8, 129.2 and 127.9 
(all aromatic CH), 115.5 (alkene CH), 67.6 (CH20 ), 55.3 (CH2N) 
ppm. MS (APCI): m/z (%) = 174 (100) [M + H]+.
(5/?S,7 20-5,7-Diphenyl-6-(4,5-dihydro-l,3-thiazol-2-ylidene)-
2,3,6,7-tetrahydro[l,3]thiazolo|3,2-a]pyridine (13): (5RS,lRS,E)-6- 
(4,5-Dihydro-3-trifluoroacetyl-l,3-thiazol-2-ylidene)-2,3,5,7-tetra- 
hydro-5,7-diphenyl[l,3]thiazolo[3,2-o]pyridine (8a) (200 mg,
0.4 mmol) was dissolved in ethanol (10 mL). Sodium borohydride 
(30 mg, 0.8 mmol) was added and the mixture stirred at 25 °C for 
24 h. Water (10 mL) and D C M  (10 mL) were added and the phases 
separated. The organic phase was dried with MgS04, and concen­
trated in vacuo to give compound 13 (127 mg, 80%) as a white 
solid. 'H  N M R  (400 M Hz, CDC13, 25 °C): 3 = 7.31-7.15 (m, 10 
H, aromatic CH), 4.29 (d, 3Jh,h = 11.3, 1 H, alkene CH), 4.11 (d, 
4/ h,h = 5.1, 1 H, 5-H), 3.60 (m, 2 H, C H 2N), 3.49 (dd, 37h ,h  =
11.3, V h,h = 5.1, 1 H , 1-H), 3.21-2.99 (m, 4 H, CH 2N and CH2S),
2.80 (t, 3>h,h = 8.5, 2 H, C H 2S) ppm.
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A B S TR A C T
The chemistry o f alkylidenepyrrolidines is reviewed, 
including the full range o f methods for the synthesis 
and a discussion o f their reactivity and applications in 
heterocyclic chemistry.
K E Y W O R D S : alkylidenepyyolidine, enamine, alkaloid, 
alkylation, acylation
1. IN T R O D U C T IO N
Alkylidenepyrrolidines are versatile intermediates for 
the synthesis o f a range o f heterocycles. As 
heterocyclic enamines, they can be considered to be C, 
jV-dianion equivalents, and so react with a range of 
electrophiles. Diastereoselective reduction reactions 
have also been reported, giving rise to a range of 
(fused) pyrrolidine derivatives. This review will 
describe the range o f methods used for 
alkylidenepyrrolidine formation, and describe a number 
of their applications in heterocyclic chemistry. While 
we have attempted to give examples from the range of 
alkylidenepyrrolidine chemistry, this review is not 
intended to be comprehensive.
Alkylidenepyrrolidines bearing a single electron- 
withdrawing group on the double-bond exist as either 
the (E) isomer 1 or the (Z) isomer 2. It is generally 
observed that where R =  H, the (Z ) isomer is more 
stable as a result o f hydrogen bonding, while where R 
is more bulky the (E ) isomer is usually more stable. 
Various authors have presented evidence for the double­
* Corresponding author: Mark C. Elliott, School of Chemistry, 
Cardiff University, Main Building, Park Place, Cardiff CF10 
3AT, UK
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bond geometry based on infrared stretches o f N -H  
bonds and chemical shifts for the N -H  and 3 -C H 2 
protons. However, it is difficult to make direct 
comparisons o f data, since it is extremely rare that the 
(E) and (Z) isomers o f the same compound have been 
made and unambiguously characterised. We have 
attempted to use Nuclear Overhauser N M R  studies, but 
since the N H  and alkene CH protons are both 
exchangeable with deuterium (and therefore with each 
other) so it is common to see large cross-peaks in 
NOESY N M R  spectra between these hydrogen atoms. 
These should not be used as indicators o f double-bond 
geometry. Based on our own, albeit limited, experience 
we see no apparent differences in reactivity between the 
(E) and (Z) isomers, and are unaware o f literature 
examples which do show such a difference.
Eto2Cv ,C02Et
2. Preparation o f Alkylidenepyrrolidines
2 .1 . Introduction
Most methods for the formation of 
alkylidenepyrrolidines start from the readily available 
pyroglutamic acid derivatives. As the y-lactam carbonyl 
is relatively unreactive, various methods are used to 
enhance the reactivity o f this key functional group. 
Two main methods are common: (i) conversion into the 
thioamide, forming the basis o f the Eschenmoser 
sulfide contraction; (ii) conversion into a more reactive 
iminoether. Additionally, a number o f other methods
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have been used. The methods for the synthesis of 
alkylidenepyrrolidines w ill be discussed within these 
broad classifications, with a particular emphasis on 
scope and limitations o f each method. Their 
applications in synthesis w ill be discussed in the 
following sections.
2.2. Eschenmoser Sulfide Contraction
The sulfide contraction reaction which bears 
Eschenmoser’s name was actually first reported in 1955 
by Knott.1 However, it was during the synthetic studies 
which culminated in the total synthesis o f vitamin B 12 
that this reaction realised its true synthetic potential.2 
As this reaction was reviewed in 1991,3 the present 
discussion w ill be kept brief, and w ill focus on the 
more recent modifications o f reaction conditions. The 
general reaction in shown in Scheme 1 for the reaction 
o f thiolactam 3 with 2-bromoacetone. Alkylation on 
sulfur takes place to provide intermediate 4, which is 
then deprotonated to give thiirane 5. Reaction with a 
thiophile, typically triphenylphosphine, then gives the 
alkylidenepyrrolidine 6 .4 The key features of this 
reaction are a good leaving group on a carbon atom 
which also contains an acidic hydrogen atom, so that 
the reagents (as above) are generally a-halocarbonyl 
compounds. Although the base is not actually 
necessary, lower yields are obtained in its absence.5
s6NH
' t 0 2Et
3
BrCH2 COCH3 f Y
A 0
CH2CI2, 93% \__/
COzEt
4
/V-methylpiperidine 
Ph3 Pf C6H6 
reflux 
69%
C02Et _
Scheme 1
The most complex examples o f the use o f this reaction 
are still the corrins and related systems for which the 
reaction was originally developed.6 A  number of 
modifications o f the Eschenmoser sulfide contraction 
have been developed during the course o f these studies.
One o f these is a Wittig-type reaction in which the 
thiophile has been incorporated into the carbonyl 
component (Scheme 2).7
h3C
toluene
COoBn reflux, 79% Ph3Pc=/ 2
W/CH3
hv C
f-Bu02C
COoBn
f-Bu02C
(CH2)2 C02Me
(CH2 )2C02Me
Scheme 2
These Wittig reactions can also be carried out on the 
lactams i f  a suitable electron-withdrawing group is 
present on nitrogen. For example, in Scheme 3 the 4- 
toluenesulfonyl lactam 7 undergoes smooth reaction to 
give alkylidenepyrrolidine 8 .8
o
( V s
Ph3 P=CHC02Et
xylene, reflux 
26 h, 70%
Et02 C-
NTs
Scheme 3
Halides have been most commonly used as leaving 
groups in Eschenmoser sulfide contractions. However, 
results from the group of Rapoport show that in difficult 
cases, use of triflate can be advantageous. In the example 
shown in Scheme 4, the desired product was obtained in 
73% yield, while a closely related iodide gave only 32% 
of the corresponding alkylidenepyrrolidine.9
O
A
Me3Si
NBn
Me3Si
CO 2t-Bu
i) 9, MeCN, 0 C - 25 °C
ii) Ph3 P,
4 A molecular sieves, - 1 0  °C
iii) 1 -methylpiperidine, - 2 0  °C 
73%
C02Bn
NBn
'C02t-Bu
Scheme 4
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These conditions give only a very small amount of 
racemisation when used with chiral thiolactam esters 
such as that shown above. In contract, use of 
triethylamine as base led to substantial loss of 
stereochemical integrity.10 These conditions were used 
to prepare lactam 10 , the use o f which in a synthesis of 
anatoxin is described in section 3 .11
C02Bn
NBn
10
C02t-Bu
The same reaction conditions have been used by 
Koskinen and Ghiaci in a new synthesis of 
carbapenems, 12 while others have used triethylamine as 
base in conjunction with a triflate leaving group.13 In 
the example shown in Scheme 5, the methoxy group on 
the pyrrolidine ring proved crucial. An acetoxy group 
led to extensive elimination to give the corresponding 
pyrrole.14
N-Unsubstituted thiolactams tend to require more 
forcing conditions for sulfide contraction, so that a 
protection-deprotection strategy has been devised. 
Reaction o f thiolactam 13 with methyl acrylate gave the 
N-alkylated product 14. After sulfide contraction under 
standard conditions, the protecting group was removed 
to give alkylidenepyrrolidine 15 (Scheme 7) .16
A  useful modification o f the Eschenmoser sulfide 
contraction does not require the use o f a halide or 
pseudohalide adjacent to the carbonyl. Methylation of 
thiolactam 16 was followed by treatment with ketoester 
17 to give a Knoevenagel-type reaction in which the 
methanethiolate anion has then added to the enone, 
ultimately forming compound 18 (Scheme 8 ) .17
<^C02Me
NaOH, THF 
70%
S
*
CO2 M6
13 14
BrCH2C02Et 
Et3 N, Ph3P 
MeCN, 2 h 
83%
NMe
Tf0CH2 C02Me
MeO
/ — \  ™  ph3 p< Et3 N. CH2 CI2 ) \~-C02Me 6 6 %66  
Scheme 5
Me02C
MeO C02Me
X 0 2Et EtOzC
|| KHMDS
NH THF. 15 min 
63%
15
Scheme 7
CO2M6
The double-bond geometry in Eschenmoser sulfide 
contractions is controlled by the substituents on the 
nitrogen atom. I f  this position is unsubstituted, the (Z) 
double-bond isomer is generally formed exclusively, 
while almost any substituent on nitrogen favours the 
(E) double-bond isomer. For example, in a recent 
synthesis from G in ’s group in Illinois, reaction of 
substrate 11 gave only alkylidenepyrrolidine isomer 12 
as a single double-bond isomer (Scheme 6 ) .15
Me3Si
MeO-
Me
12
OMe
16
C02 f-Bu
Scheme 6
OMe ch3 I. CH2 CI2
then 17, Et3 N, CH2CI2 
56%
O
17
Scheme 8
The azinomycin (carzinophilin) natural products 
contain an alkylidenepyrrolidine at their core. A  similar 
approach was used to prepare an advanced intermediate 
for use in total synthesis, with the key step (for the 
purpose o f this review) being the coupling of 
compound 20 with azlactone 19 to give 
alkylidenepyrrolidine 21 (Scheme 9) .18
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Although triphenylphosphine is the most commonly 
used thiophile, other phosphorus reagents have been 
used.19 In fact, sulfide contractions are known in which 
no thiophile is used (for example, Scheme 10).20
OBOM
toluene, pyridine
SMe
TESO V-OTBDPS
60 °C, 47% NV|1 °
AcO'-'^SjH
f  N^OTBDPSTESO
20
NMe
-OTBDPS
Scheme 9
BrCH(C02 Et)
CH2 CI2, 25 °C, 1 2  h 
then KHC03, 4 h 
97%
Scheme 10
21
Et02 C> ,C02Et
NMe
-OTBDPS
One further alternative is shown by the use of 
Reformatsky-type reagents. For example, treatment of 
thiolactam 22  with diethyl 2 -bromomalonate and 
activated zinc gave, after a further cyclisation step, 
tricyclic ester 23 (Scheme l l ) . 21
BrCH(C02 Et) Et02C
n^ V Zn, l2l THF 
reflux, 61%
groups in the alkylated intermediate (Scheme 12).22
phJS
i) BrCH(C02 Et)
,NH CH2 CI2, 25 °C, then KHCO3 
ii) 60 'C, 35 min 
84%
Et02 C> -C02Et
24 25
a Ph
Jh 5
0  C02Et
Scheme 12 26
2.3. Formation and Reactions o f Iminoethers
The typical reaction here is alkylation of the amide 
oxygen with, for example, dimethyl sulfate followed by 
reaction with Meldrum’s acid 28. In an early report, 
lactim ether 27 underwent smooth reaction in 
benzene in the presence o f triethylamine to give 
alkylidenepyrrolidine 29. Reaction with sodium 
ethoxide in ethanol then gave the (Z) isomer 15 
exclusively (Scheme 13).23 Alternatively, the final step 
in this sequence can be carried out by reaction with the 
alcohol under Lewis-acidic conditions, for example 
using boron trifluoride etherate in refluxing benzene.24
OMe
27
Et3 N, benzene
reflux, overnight 
94%
X
28
X
( A
29
NaOEt, EtOH 
reflux, overnight 
91%
22 Scheme 11 23
While the Eschenmoser sulfide contraction is very 
effective for the elaboration o f y-thiolactams, reports 
concerning 8 -thiolactams are sparse. A  recent study 
by Michael and co-workers has shown that while 
compound 24 undergoes sulfide contraction to give 
alkylidenepyrrolidine 25, the corresponding 
piperidinethione gives compound 26 in which the 
piperidine nitrogen has attacked one o f the ester carbonyl
15
Scheme 13
More recently, the reaction with Meldrum’s acid has 
been promoted by nickel(II) acetate.25 This now 
appears to be the method o f choice, and has been used
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for a range of other 1,3-dicarbonyl nucleophiles in 
addition to Meldrum’s acid.26 Applications o f the 
products o f these reactions in alkaloid synthesis are 
discussed in the final section o f this review.
Since pyroglutamic acid esters are not particularly 
prone to racemisation, this method is compatible with 
such compounds. For example, reaction o f lactam 30 
with dimethyl sulfate followed by Meldrum’s acid 
provided compound 31 in 83% yield in a one-pot 
procedure (Scheme 14). Solvolysis/decarboxylation 
can be carried out under acidic or basic conditions.27 
Once again, other active methylene compounds have 
been used as nucleophiles in this reaction, in particular 
/-butyl cyanoacetate which allows ready 
decarboxylation under acidic conditions.28
o
6 (Me0)2 S02, Et3NNH 60 °C, 12 h then 
",fc02Me Meldrum's acid, 25 °C, 24 h 
83%
30
Me-^ Me
ox o
Q H
' t 0 2Me
31
BF3 .Et2 0, MeOH 
benzene, reflux 
or NaOMe, MeOH 
60 - 70%
C02Me
CO2M6Scheme 14
Using 1,3-diketones as nucleophiles, it is then 
possible to carry out a mono-deacylation to give 
alkylidenepyrrolidines such as 32 (Scheme 15).29
This approach to alkylidenepyrrolidines may well be 
the method o f choice for compounds containing acid- 
sensitive functionality. For example, iminoether 33 
underwent smooth condensation with ketal 34 to give 
alkylidenepyrrolidine 35 (Scheme 16).30
I f  the ring nitrogen is substituted, formation o f the 
lactim ether is impossible. However, in this case two 
related approaches have been used. In the first, the 
iminium ion 37 can be formed from the lactam 36. This 
then undergoes reaction with ester enolates as before 
(Scheme 17).31 Alternatively, reaction o f lactam 38 
with dimethyl sulfate followed by addition o f sodium 
ethoxide provided intermediate 39 which was directly
allowed to react with 4-chloroacetophenone in the 
absence of solvent to give 40 (Scheme 18).32
O O
Et3N-ref|ux
Me
N
2 d, 45% ^NH
NaOEt, EtOH 
18 h, reflux, 90%
Scheme 15
<£
32
Me
Et O
>N + Et02C ^X xH 3 
MeO OMe
33 34
2 -hydroxypyridine 
90 °C, 10 days 
72%
KJ
Et02C J1^ch3 
35
Scheme 16
36
CH3
Et3Q BF4 
Et2 0, 95%
OEt BF4
&
CHa
37
Me02C^^lv;;^ .Q^
LDA, THF, 91%
M600C
Schem e 17
78 Mark C. Elliott et al.
o
* -Bn
(Me0)2 S0S02 
80 °C, 12 h
then NaOEt, EtOH
EtCL^OEt
38 39
4-CIC6 H4 COCH3 
80 °C, 8  h 
55%
Scheme 18 40
One further example o f this reaction is shown in 
Scheme 19. In this case, the alkylidenepyrrolidine was 
then subjected to a diastereoselective reduction using 
sodium borohydride in acetic acid.33
£ 1
toluene
EtOvJDEt 100 1 h
>^<N'CH3
^Sj-CH3
NaBH4, AcOH 
45%
r si
HO*^T'S
ch 3
V
42
(EtO)2(0)Pv^CN
NaOEt, EtOH
25 °C, 21 h 
95%
41 43
Scheme 20
Initial nucleophilic attack onto nitrile 45 was used as 
the basis for the preparation o f alkylidenepyrrolidine 
46 by Hannick and Kishi. The anion formed by action 
of zinc on methyl 2 -bromoacetate adds to the nitrile. 
This is followed by displacement o f the mesylate by 
the resulting imine nitrogen and tautomerisation 
(Scheme 21). 35
NC
MsO
S'
OMe
45
Zn, BrCH2 C02Me
THF, reflux, 45 min 
79%
Scheme 21
Me02C
HN
s
H ?
OMe
46
Scheme 19
As alkylidenepyrrolidines are enamines, various other 
synthetic possibilities present themselves. Azide 
displacement from the readily accessible co-halo-2 - 
ketoester 47 gave only a modest yield of substitution 
product 48, with intramolecular nucleophilic attack by 
the ketone oxygen being a significant competing 
reaction. Treatment with triphenylphosphine gave an 
essentially quantitative yield of the 
alkylidenepyrrolidine 15 (Scheme 22). The first step in 
this sequence gave much higher yields when applied to 
homologous co-halo-2 -ketoesters, giving six-membered 
ring vinylogous carbamates.36
,C02Et C02Et
2.4. O ther Methods
The two methods described in the preceding sections 
rely on the attack o f a nucleophile onto a modified 
lactam carbonyl. A  related method has been developed 
involving nucleophilic attack onto a nitrone. For 
example, reaction o f nitrone 41 with diethyl 
cyanomethylphosphonate 42 gave a 1:1 mixture of 
double bond isomers 43 and 44 (Scheme 20). This 
method was less efficient for the formation o f the 
corresponding esters, with aziridines being formed as 
by-products or in some cases the major product.34
NaN3, Nal (cat.) Ph3 P, Et20
DMSO, 55 °C 
32%
Scheme 22
C02Et
A  related example introduces the azide in a dianion 
addition. Thus, reaction o f ethyl acetoacetate with 
azidoketone 49 gives azide 50, which then 
undergoes a tandem Staudinger-aza-Wittig reaction to
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give alkylidenepyrrolidine 51 as a 3:1 mixture of 
diastereoisomers (Scheme 23).37
X 0 2Et 2.4 equiv. LDA, THF
C 02Et
MeX 0 °C, 49, 55%
r ^ o
N3
in* •
HO A
50
Ph3P, THF 
45 °C, 24 h 
70%
N3
49
Scheme 23
Alternatively, the azide can be present from the start, 
while the P-ketoester is elaborated using the neutral 
magnesium malonate method as shown in Scheme 24. 
Some epimerisation o f the stereogenic centre bearing 
the nitrogen substituent was observed during this 
sequence. 8
yHCbz CD!, then ¥ HCta
N 3 ^ Y T ° He,o cch coh  " . ' T T Y 00
TBSO O TBSO O O/■PrMgBr, 8 8 %
H2, Pt02  
EtOH, 48%
TBSO, NHCbz
Scheme 24
C02Et
A  related procedure from Michael’s group uses aniline 
nucleophiles to prepare A'-aryl alkylidenepyrrolidines. 
In this case, higher yields are observed, as the aniline 
reacts with the carbonyl group to give the acyclic 
enamine, followed by cyclisation (Scheme 25).39 The 
same method has recently been used by Lhommet’s 
group.40 For these particular A-substituted 
alkylidenepyrrolidines, this method gives higher 
yields than the sulfide contraction method.
,C 02Et PhNH2 
Na2 S04
*0 Na2 HP04 
l2  (cat.), 52%
jC 0 2Et
Jf
f  NHPh 
Cl
Et02C^
( _ }Ph
Scheme 25
Substrates for this alkylidenepyrrolidine formation are 
readily available from lactones by way o f a 
Reformatsky reaction. For example, reaction of 
lactone 52 with the zinc reagent formed in situ from t- 
butyl 2-bromoacetate gave a e-hydroxy-P-ketoester 
which was directly reacted with methanesulfonyl 
chloride. Simply stirring this compound in 
dichloromethane with benzylamine gave the 
alkylidenepyrrolidine 53 (Scheme 26).41
BrCH2 C02 t-Bu
Zn/Cu, THF 
then MsCI 
58%
,C02 f-l
MsO
Bu
PhCH2 NH2
CH2CI2
57%
Bu
N
Bn
Scheme 26
53
Reaction of diester 54 with A-aminophthalimide gave 
bis-alkylidenepyrrolidine 55, which then underwent 
smooth isomerisation to give the pyrrole 56 (Scheme 
27). Subsequent deprotection and a second such 
condensation provided access to A, A ’-bipyrroles.42 
Using ammonium acetate in the condensation provided 
compound 57, which is surprisingly tautomerically 
stable, by an analogous method.43 The same compound 
can be accessed by copper-catalysed decomposition of 
ethyl diazoacetate in the presence o f pyrrole 58.44
One approach to the azinomycins (carzinophilins) has 
already been described. Hydrogenolysis o f the easily 
accessible benzyl carbamate 59 in the presence o f acid 
gave the key fragment 60 in good yield (Scheme 28).45 
Simplified analogues were produced by a related route.46
Alkylidenepyrrolidine lactams 62 are relatively 
straightforward to prepare from the corresponding 
lactones 61 by simple ammonolysis (Scheme 29).47
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¥H2
y = c  Eto2cN^ o ^ c°2Et
Et02C C02Et AcOH, reflux,
15 min, 72%
54 \
NH4OAc
55 *C, 1 h then 85 *C, 40 min 
72%
55
c f 3co2h
CHCI3 , 15 h 
25 *C, 75%
N
Et02C H C02Et 
57
Et°2C s ^ O ^ C02EtN1
| Cu, CH(N2 )C02Et 
I 100 °C, neat, 2 1 %
f lN
H C02Et 
58
Scheme 27
BocHN^C02Et
Ho, PcI/C
O EtOH, HCI, H20  
68%NHBoc
Scheme 28
followed by a cyclisation reaction. These reactions are 
therefore similar in many ways to those described 
above. For example, reaction o f methyl 6-chloro-2- 
hexynoate 65 with aminoester 66 gave 
alkylidenepyrrolidine 67 in good yield (Scheme 31).49
,C02Bn Bn°2c
2,4-(MeO)2 C6 H4 CH2 NH2  I
  toluene, reflux, 30 min
-C02Bn 5 2 0 4
NHCbz
63
CbzHN
Scheme 30
OMe
C02Me
H2 N'
64
C02Me
Cl
65
Me02C
66
Nal, Na2C03 
THF, reflux 
85%
C02Me
67
Scheme 31
NH3, EtOH, 5 h ^ u2cl
then CICH2 CH2CI II
----------------  (^NH
4 A molecular sieves \__1
65 °C, 83%
Scheme 29 62
This alkylidenelactone is essentially a cyclic anhydride 
of a ketoacid derivative such as 63, readily accessible 
from aspartic acid. Treatment o f this compound with 
2,4-dimethoxybenzylamine in refluxing toluene gave 
alkylidenepyrrolidine 64 in moderate yield (Scheme 
30).48
Addition o f an amine nucleophile to a propiolic ester 
w ill give rise to a sim ilar enamine, either 
intramolecularly to give the alkylidenepyrrolidine 
directly, or alternatively intermolecularly which is then
A number of methods which use this general approach 
have been developed and used by Jacobi’s group in the 
synthesis of corrin derivatives. One o f the simpler 
examples from this work is shown in Scheme 32, where 
compound 68  is used as a bis-electrophile. Reaction with 
1-aminopyrrole 69 gave alkylidenepyrrolidine 70. This 
then underwent a photolytic rearrangement to give 
compound 71.50
Further development o f this reaction allows the use of 
unactivated alkynes in a palladium/copper catalysed 
process. For example, cyclisation of substrate 72 in 
methanol under an atmosphere o f carbon monoxide 
gave alkylidenepyrrolidine 73 in moderate yield 
(Scheme 33). TV-Substituted amides such as 74 undergo 
cyclisation with TBAF to give alkylidenepyrrolidines 
such as 75 lacking the usual electron-withdrawing 
group (Scheme 34).51
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CO2M6
II
v^ C02H
68
h2n- n^
Me02C
69
i) EDCI, THF, 24 h
ii) DMF, heat, 2 h
59%
Me02C
C02Me
Et02C,
hv, f-amyl alcohol 
piperylene 
40 - 50%
NH
71
Scheme 32
nh2 PdCI2, CuCI2
MeOH, CO 
61%
Me02C
NH
72
NHBn
74
Scheme 33
TBAF, THF 
84%
Scheme 34
73
NBn
76
The alkylidenepyrrolidine tautomer is generally 
favoured as a result of the electron-withdrawing group 
present, so that deprotonation of 2-methylpyrroline 76 
and quenching with diethyl carbonate gives the 
alkylidenepyrrolidine 15 in good yield (Scheme 35). 
This reaction is not limited to alkylidenepyrrolidine 
synthesis, and works well for other ring sizes and 
acyclic imines.52 Analogous reactions with ester 
electrophiles give alkylidenepyrrolidine ketones.53
Me
76
LDA THF, 0  °C, 30 min
then (EtO)2 CO, THF 
-80 °C, 1 h 
70%
Scheme 35
Iodocyclisation o f an acyclic vinylogous carbamate 
such as 77 gives alkylidenepyrrolidine 78 in good yield 
(Scheme 36).54 This compound was subsequently 
dehydroiodinated to give the corresponding pyrrole.
l2, NaHC03, Ai2 0 3 
'NHPh CH2 CI2, 30 min, 8 6 %
77
Scheme 36
Et02C
1r^NPh
ML,
78
Part of the attraction o f the use o f the Eschenmoser 
sulfide contraction and iminoether methodology is their 
ready applicability to the preparation o f (generally 
glutamate-derived) chiral alkylidenepyrrolidines. In our 
opinion, none o f the methods described so far in this 
section have this key advantage. The following 
methodology appears to be reasonably general and is 
applicable to the formation o f single-enantiomer 
alkylidenepyrrolidines. However, the reader is warned 
that these results are from the reviewer’s own 
laboratories, and so we may be biased!
It is well known that protection of the lactam nitrogen 
as the carbamate renders the lactam carbonyl 
susceptible to attack by a range of nucleophiles. This 
approach was used in 2001 to prepare the sulfonyl 
alkylidenepyrrolidine 79 in the two-step sequence 
shown in Scheme 37. The double-bond geometry of 
this compound was elucidated by nuclear Overhauser 
enhancements in the proton N M R  data.55
Based on this general approach, Elliott and 
Wordingham have devised an efficient method for the 
preparation of a range o f chiral alkylidenepyrrolidines. 
Reaction o f lactams o f general structure 80 with various 
enolate anions gives the ring-opened products 81, 
which then undergo cyclisation without racemisation 
upon treatment with trifluoroacetic acid to give 
alkylidenepyrrolidines 82 (Scheme 38).56
PhS02 CH3, BuLi j " '
S02Ph
^ /N B o c  j h f  25 „c  60% ^  NHBoc
TsOH, MeOH 
reflux, 71%
S02Ph
Scheme 37
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NBoc
80
NHBocTHF, -78 ’C
81
J c f 3co2h
Scheme 38
BnO
CbzHN
H2 , 10% Pd/C
EtOAc, H20  (1:1) 
8  h, 73%
CbzHN
Scheme 40
The same type o f hydrogenation has also been used to 
prepare cw-2,5-disubstituted pyrrolidines. For example, 
the two-step reduction o f alkylidenepyrrolidine 85 into 
86  was accomplished by hydrogenation over Raney 
nickel to reduce the carbon-carbon double-bond 
followed by a routine ester reduction with lithium 
aluminium hydride (Scheme 41).61
3. Use of Alkylidenepyrrolidines
One o f the simpler elaborations of 
alkylidenepyrrolidines is reduction o f the carbon- 
carbon double bond. This is non-trivial, and the carbon- 
carbon double bond o f alkylidenepyrrolidine esters is 
particularly resistant to hydride reduction (significantly 
more so than the corresponding alkylidenepiperidines57). 
However, the reduction can be accomplished using a 
combination o f sodium borohydride and boron 
trifluoride etherate, although no diastereoselectivity 
was observed in the example in Scheme 39.58
A  wide range o f conditions have been used for this 
transformation, along with a significant number of 
substrates. In general, catalytic hydrogenation methods 
generally give good selectivity for the c/s-disubstituted 
pyrrolidine, while hydride reduction is far more
dependant on the substrate, and can give either
diastereoisomers preferentially, but usually with modest 
diastereoselectivity.59 Benzyl ester 83 (or its double­
bond isomer) gave a 10:1 diastereomeric mixture 
favouring 84 simply by stirring under an atmosphere of 
hydrogen in the presence o f 10%  palladium on carbon 
(Scheme 40).60
/ V NaBH4 (3 equiv.) H C02Me
+
H C02Me BF3 .Et20  (2 equiv.) / \
Bu""^n^""|
H C02Me
Scheme 39
C02Me
'n- Bu
85
i) Raney-Ni, H2 (100 bar) 
HCI, MeOH
ii) LiAIH4l Et20  
76%
Scheme 41
^ c h 2oh
6h
'n-Bu 
86
Introduction o f a further electron-withdrawing 
substituent onto the double-bond reduces the ease of 
reduction even more, so that compound 87 could only 
be reduced by hydrogenation over P t0 2 in a mixture of 
trifluoroacetic acid and acetic acid. This also led to 
partial and total reduction o f the ketone group giving 
compounds 88 and 89, both as a mixture of 
diastereoisomers (Scheme 42).62 Hussaini and Moloney 
have investigated a range o f conditions for the 
reduction of similar compounds, and shown that, in 
addition to the conditions shown in Scheme 42, sodium 
cyanoborohydride in ethanol at pH 3 -  5 is effective.63 
Petersen et al. have previously used these conditions to 
reduce alkylidenepyrrolidine esters with only a single 
electron-withdrawing group, and shown them to form 
predominantly the cw-2 ,5-disubstituted pyrrolidine, 
albeit with lower stereoselectivity than hydrogenation 
methods.64
Rapoport uses an elegant variation on this theme in his 
synthesis o f anatoxin and analogues thereof. In the 
hydrogenation of compound 90, both benzyl groups are 
removed, leading to decarboxylation. Under these 
conditions, only the cis isomer o f compound 91 was 
produced (Scheme 43) .11,64,65
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EKTyXHa
A ih
0 0 —v
N N  C02Et
E t 0  CH3 h2. Pt02  88,50%
\  /NH CF3 C02 H, CH3C02 H(1:4)
' t 0 2Et 4 atm., 24 h
87
Scheme 42
EtO Et
%
' t 0 2Et
89, 39%
This type of double-bond reduction can also be carried 
out using a chiral catalyst to effect enantiocontrol. For 
example, with ligand 94, complete conversion to the 
product with 96% ee. was observed (Scheme 45).68
O ^ C0’EtN
Me^O
[Rh(COD)2 ]BF4
CH2 CI2, 94, H2  ( 1  atm.) 
CH2CI2, 12 h 
100% (96% ee.)
0x
MeN NMe
Ph2P PPh2  
94
Scheme 45
O ^ co^N
Me^O
f-BuC^C* O 'O 
Bn C02Bn \__/
90
hco 2 nh4
Pd/C, MeOH 
100 °C, 25 min 
97%
f-Bu02C
Me steps
91
Me
(+)-anatoxin
Scheme 43
One other very synthetically useful transformation is 
shown in Scheme 46. Alkylidenepyrrolidines such as 
95 undergo an efficient decarboxylation upon heating 
with two equivalents o f boric acid.69 As the product 
pyrrolines 96 are ant venom alkaloids, this reaction has 
found significant use in natural product synthesis.70
n~ C 10^21 xs^ C 02Et
H3BO3 n-C1 0H21>
180 *C, 45 min 
90% < y
96
Scheme 46
The diastereoselectivity of these double-bond 
reductions can also be controlled by substituents on the 
nitrogen atom.66 For example, hydrogenation of 
compound 92 (9:1 E .Z  mixture) over palladium on 
carbon gave, surprisingly, the product o f anti hydrogen 
addition 93 as the major stereoisomer (Scheme 44). 
Similar results were obtained with other catalysts, as 
well as with sodium triacetoxyborohydride in acetic 
acid.40’67
EtOjjCv.Me
92
H2, 10% Pd/C
EtOH
92%
Schem e 44
Et02 C ^ .M e  
H j  V
Much of the chemistry o f alkylidenepyrrolidines 
centres on their ambident nucleophilicity. The 
regioselectivity of electrophilic addition to 
alkylidenepyrrolidines is dependant on the nature of the 
electrophile and upon the reaction conditions. It is 
probably affected by the double-bond geometry of the 
alkylidenepyrrolidine, although there is insufficient 
data at present to assess this properly.
Alkylation of alkylidenepyrrolidines bearing a single 
electron-withdrawing group generally occurs on 
carbon. For example, treatment o f compound 15 with 
iodomethane under conditions shown in Scheme 47 
gave compound 97 selectively.71 This reaction type 
has been used as the basis of annulation reactions. 
For example, alkylation o f compound 15 on carbon 
to give adduct 98 was followed by an intramolecular
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C-acylation and subsequent decarboxylation to provide 
new alkylidenepyrrolidine 99 (Scheme 48).72 
Alkylidenepyrrolidine 100, prepared by a similar 
alkylation reaction with an a-bromo Weinreb amide, 
undergoes attack by a range o f organometallic 
nucleophiles followed by facile cyclisation to prepare 
pyrrolizidines such as 101 (Scheme 49).73 A  similar 
approach has been used to prepare saturated 
pyrrolizidine alkaloids.74
X 0 2Et
NaH, toluene
then CH3I 
74%
Scheme 47
X 0 2Et
15
C02Et
NaH, toluene
C02Et
toluene, reflux 
55%
the electrophile o f choice for methylations, while alkyl 
4-toluenesulfonates give good yields and selectivities 
for iV-alkylation with other groups (Scheme 51).76 Such 
alkylations have also been carried out under phase- 
transfer conditions.77
C02Et n-CiHiv ^.C02Et
NaH, toluene, reflux, 1 h n __________________ ^ n-O3 H7 |
NH then 0 X 3 ^ 1, reflux, 12 h 
74%
7 X
< y
15
Ph
r^NH 
Me'l 1
Me
Scheme 50
KOf-Bu, DMF, 25 °C
then R0 S0 2 CeH4CH3 
or (Me0)2 S02 (R = Me) 
41 - 8 8 %
Scheme 51
Ph
/ •
Me-i 1
Me
Although not generally observed for jV-unsubstituted 
alkylidenepyrrolidines, alkylation at the 3-position of 
the pyrrolidine ring has also been observed. This y- 
alkylation, an example o f which is shown in Scheme 
52, is generally observed with P-enaminoesters.78
OMe
NH
Scheme 48 99
Me'
100
BuCCLi, THF Me02C 
C02Me -40 °C, 30 min
then CHCI3 , reflux, 
45 min, 75%
Scheme 49 101
A  second alkylation on carbon is possible, leading to 
the cyclic imine tautomers. Typically this requires 
heating o f the sodium salt o f the alkylidene-pyrrolidine 
with excess alkyl halide (Scheme 50).75
An almost complete change to jV-alkylation can be 
accomplished by choice o f electrophile, although the 
base and solvent also play a role. D im ethyl sulfate is
OMeMeO
LDA, THF, -78 °C 
then
Cl
67%
Cl
Cl
OMe
MeO
Scheme 52
The acylation of alkylidenepyrrolidines is sensitive to 
reaction conditions as well as steric effects. The kinetic
Alkylidenepyrrolidines: synthesis and applications 85
product from compound 15 is compound 102, where 
acylation has taken place on carbon (Scheme 53).79 
However, at higher temperatures, with or without the 
presence o f pyridine as a catalyst, compound 103 is 
favoured.26,80 A  second acylation on carbon is 
straightforward with alkylidenepiperidines, but not with 
alkylidenepyrrolidines.26
C02Et CH3 COCI 
"cold", 1 2  h
Et02C
£
ch3
102
CH3 COCI 
toluene, pyridine
reflux, 3 h, 71%
Et02C
X
15 Scheme 53 103
With the slightly more hindered alkylidenepyrrolidine 
104, only C-acylation was observed in toluene at a 
range o f temperatures (0 °C; 20 °C; 90 °C) (Scheme 
54).81
C02Me Me02 Cv
CH3 COCI, toluene ^ " 3
90 °C, 90 min 
fco2Me 54% COoMe
104 Scheme 54
In contrast, the use o f strong bases (BuLi, NaH, 
/-BuOK) favours 7V-acylation o f alkylidenepyrrolidine 
105 with acetyl chloride, and only in dichloromethane 
in the presence o f triethylamine and D M A P  is any 
appreciable C-acylation observed (Scheme 55).76'82
Acylation o f alkylidenepyrrolidines with a range of 
alkyl and aryl isocyanates have been reported to take 
place exclusively on nitrogen,83 although it has been 
suggested that some o f the products reported may 
actually be the C-acylated alkylidenepyrrolidines.84 In 
earlier work, Micheel and Flitsch reported the reaction 
o f an alkylidenepyrrolidine with phenyl isocyanate, but 
were unable to determine whether the acylation had 
taken place on nitrogen or on carbon.85 It is clear that in
some instances the iV-acylated products are produced, 
as these undergo cyclisation as shown in Scheme 56.86
Me'
X  
£ MeCOCI
O Ph
f^NH
Me"T 1 
Me
106, 39%
X j  Et3 N, DMAP
Me*n CH2 CI2
Me
105
Scheme 55
Et02C.
]) NHMe N»OH. EtOH
Scheme 56
reflux, 2 0  min 
90%
107, 32%
A  number of less common electrophiles have been used 
in this type o f reaction, e.g. the nitrilimine generated in 
situ from iminoyl chloride 108 (Scheme 57)87 and 
diethyl azodicarboxylate 109 (Scheme 58).29
,C02Et Ph
i f  4 N' NHPh Et3 N, EtOH PhHN ^ C 0 2Et
x  + x  -------------   1NH p h ^ c i  20 °C, 15 h, 35%
108
( >
Scheme 57
,C02Et
C02Et
EtOH, reflux Et02CxN,N ^ C 0 2Et 
------------- " H I3 h, 96%
Et02 C-N=N-C02Et
109
Scheme 58
With ambident electrophiles, further possibilities present 
themselves. The reactions o f alkylidenepyrrolidine
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15 with crotonyl chloride and with ethyl crotonate are 
shown in Scheme 59. As above, the use o f toluene and 
pyridine at reflux favours A'-acylation with acid 
chlorides, giving compound 110. This acylation 
attenuates the enamine-type reactivity so cyclisation to 
111 does not occur. With ethyl crotonate, initial attack 
is via the carbon onto the P-position o f the crotonate 
ester - this is followed by ready cyclisation giving 111. 
However, ring-size is important, and with six- and 
seven-membered vinylogous carbamates the annulated 
products are obtained in both cases.88 The reaction is 
clearly sensitive to steric demands, since with acryloyl 
chloride the annulated product (analogous to 111) is 
formed under a range o f conditions.88,89
Eto2C
,C02Et pyridine, toluene 
reflux, 3 h, 72%
110
15
QH3
H,C^^OEt I X
NaH, Et20  \  ,N 0
12 h, 63% v —'
111
Scheme 59
Additional functionality can be readily incorporated 
into the unsaturated carbonyl compound to suit target 
synthesis. For example, in the preparation of 
angiotensin-converting enzyme inhibitor A58365A  
(115), benzyl ester 112 underwent annulation with 
anhydride 113 to give compound 114 as a 2:1 mixture 
of diastereoisomers (Scheme 60).24,90 Related 
annulation reactions have been carried out with 
succinic anhydride.91
In the previous case, oxidation to the aromatic pyridone 
was accomplished using D D Q , but it is also possible to 
incorporate a leaving group on the P-position o f the 
unsaturated ester double bond, so that elimination 
follows annulation giving this oxidation state directly 
(Scheme 61).92
As a further alternative, propiolic acid and its 
derivatives can be used in annulation reactions. 
Although propiolic acid itself undergoes annulation in 
low yield by way o f a D C C coupling, 5 higher yields
be achieved with propiolate esters. For example, 
reaction of alkylidenepyrrolidine 15 with ethyl 
propiolate again proceeds via Michael addition to give
116. This can then be followed by treatment with 
sodium ethoxide to give the annulated product 117 in 
good yield (Scheme 62).93
C0 2Me
Bn02C
benzene, reflux 
95%
112
'C02Me
114
co2h
steps
'"co2h
co2h
Scheme 60
115
X 0 2MeC^02Me ^C02Me f
ff 2 f  Et3 N, EtOH Me02C ^ L
X nH C I^ S  65 h, 92% ' X  X
\  / C02Me O
Scheme 61
,C02Et
ethyl propiolate
EtOH, reflux 
18 h, 74%
15 116
NaOEt (cat.) 
EtOH, reflux 
2 h, 63%
Et02C
Scheme 62 117
In reactions with doubly-substituted alkyne esters, 
the double-bond geometry formed depends upon the 
reaction conditions. For example, in the reaction of
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alkylidenepyrrolidine 15 with diester 118 at room 
temperature in benzene, the (Z ,Z) isomer 119 is formed 
preferentially (92%  isolated yield after 24 h), while at 
reflux the (E,E) isomer 120 is the major product (72%  
after 2 h) (Scheme 63).91
c o 2Et
118
MeC^C—=  COjMg 
see text
CO2 M6
Me02Css^ s s ^C02Et Et02C
C02Me
119 120
Scheme 63
With dehydro-aminoacid derivative 121 this approach 
forms the basis o f a useful annulation reaction to give 
dipeptide mimetics as well as a range o f neurokinin 
A  and substance P receptor antagonists. For instance, 
reaction o f alkylidenepyrrolidine 104 gave a 2.4:1 
mixture o f diastereoisomers 122 and 123 (Scheme 
64).94
C02Me
121
NHCbz
V
co2h
M eO zC v^^ ,\NHCbz 
'C02Me
122
C02Me
104
EtN=C=N(CH2 )3 NMe2 
HOBt, CH2 CI2, 25 °C, 48 h 
57%
Me02C v ^ \^ N H C b z
<fc0 2Me
123
A  number o f related annulation reactions have 
been reported. For example, reaction of
alkylidenepyrrolidine 124 with unsaturated ketone 125 
gives cycloadduct 126 in 77%  yield (Scheme 65).95
Eto2C
124
EtOH, 80 °C
^  xo?E t "  eto2c
2  10 h, 77%
Scheme 65
I f  one desires conjugate addition reactions initiated by 
attack of nitrogen rather than carbon, this can be 
achieved by a simple but effective modification o f the 
order o f steps. For example, reaction of thiolactam 13 
with unsaturated ester 127 gave adduct 128. This was 
then followed by Eschenmoser sulfide contraction to 
give the alkylidenepyrrolidine 129. Subsequent steps 
converted this compound into the indolizidine 130 
(Scheme 66).96
Et02C
13
+
\
n-CsHi!
127
EtO,C
NaOH,THF 
25 °C, 20 h, 74% <  N n-CsH^
128
BrCH2 C02Et 
MeCN, 25 “C 
then Ph3 P, Et3N 
85%
Et02C
j I steps
Et02C Et02C
n-CsHi!
130
Scheme 66
129
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Alkylidenepyrrolidines have been used in Nenitzescu- 
type annulation reactions97 with 1,4-quinones. In this 
case, the regiochemical outcome can be controlled by 
use of either the quinone or the quinone ketal. For 
example, reaction o f 15 with quinone 131 gave 
regioisomer 132, while the use of ketal 133 gave 
compound 134 instead (Scheme 67).98
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Others have used the same method, followed by 
oxidation to the indolequinone, for the preparation and 
biological evaluation o f a range o f mitosene 
analogues." The quinone oxidation state is directly 
accessible by way o f quinone 135. In this way, 
indolequinone 137 was prepared by annulation of 
alkylidenepyrrolidine 136 (Scheme 68).38
133131
HN.
15 MeO'MeO' MeOH
AcOH
reflux
56%
NaHX 
THF \  
then HCI 
82%
MeMe
C02Et
HO.HO.
Me'MeO'
OMeMe
132 Scheme 67 134
indole 143 in good overall yield (Scheme 70).101 It is 
worth noting that in most o f the examples in this early 
report, palladium acetate was used in stoichiometric 
amounts.
+
(OC)3Fe bf4
138
;02Me
139
LDA, THF
-78 °C to 25 °C 
95%
(OC)3Fet:
02Me 
^ H "V-N.
140
Cp2 FePF6  
Na2 C03 
CICH2 CH2CI 
84 “C, 3 h, 65%
l_l C02Me
O CkFef
Scheme 69
Me^X^Br
T T
M e C r ' | f ' B r
O
135
C02Et
NHCbz
HN I
OTBS
136
142
C02Et p<j(OAc) 2  (0.2 equiv.)
Ph3P, Et3 N, CH3CN 
reflux, 25.5 h, 98%
Scheme 70 143
Me
K2 C03, CuBr2
MeCN, 50 °C
94%
0 C02Et
Y T ' V . N H C b z
)" i i '
N J]
o //OTBS
137
Scheme 68
The tricarbonyl[q 5-cyclohexadienyHum] iron salt 138 
provides a viable alternative to quinones in such indole 
synthesis. For example, with alkylidenepyrrolidine 139 
the C-alkylated product 140 was formed first. This 
underwent oxidative cyclisation to give the indole-iron 
complex 141 in good yield (Scheme 69 ).100
Similar compounds have also been formed by 
intramolecular Heck reactions. For example, 
alkylidenepyrrolidine 142 underwent cyclisation to give
A  combination o f the Nenitzescu methodology with a 
Heck cyclisation has been used to great effect by Luly 
and Rapoport in their synthesis o f mitosene analogues. 
Starting this time with the saturated pyrrolidine 144, 
reaction with quinone 135 was followed by a 
photochemical disproportionation reaction to give 
alkylidenepyrrolidine 145. This was then followed by a 
palladium-catalysed oxidation to regenerate the 
quinone followed by an intramolecular Heck reaction to 
furnish indolequinone 146 (Scheme 71).102 Other 
annulation reactions have been reported where the final 
ring-closure is by C-N  bond formation onto an aromatic 
ring. Compound 147 (contaminated with some of the 
methyl ester), prepared by condensation of a P- 
ketoester with an iminoether, underwent such a 
cyclisation to give quinolone 148 (Scheme 72).103
Reactions with bis-acid chlorides can be complex, and 
the outcome o f the reaction depends on a number of 
factors. Ring size, in particular, is important so that
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reactions of alkylidenepyrrolidines do not translate well 
to the piperidine and azepane analogues. Reaction of 
alkylidenepyrrolidine 15 with malonyl chloride gives 
the simple double addition product 149 (Scheme 73).104 
With phthaloyl chloride the reaction is more complex, 
as the initial adduct undergoes reaction with a second 
equivalent of 15 to give compound 150, albeit in 
modest yield (Scheme 73).105
MeO.
i) AcOH, K2 C03 9 h
C6 H6  M e O ^ J v ^ B r QQ2Et
,C02Et
144
ii) hv, CgHg 
71% - w
145
i) Pd/C, EtOAc 
air, 75 min 
ii) Pd(OAc)2, Et3N 
MeCN, 2 h 
97%
MeO.
C02Et
o
Scheme 71
146
and phosphinoaryloxazolines falls outside the scope of 
this-review.
C02Et
malonyl chloride Et02C
CH2CI2) -10 °C 
57 - 70 %
15
15
phthaloyl dichloride
DABCO, CH2CI2 
reflux, 22 h, 14%
Scheme 73
CN
/-Buo2c r^ j—v
149
150
c f3c o 2h
CN
H N -VHN" /  23 °C, 8 min ,
C02Me C02Me
151 OEt
v a
Me02C
CF3C02H
c ic h 2c h2ci
65 °C, 6 h 
70%
152
C02Et NaH, THF Et02C
147
70 °C, 2.5 h 
64%
Scheme 72
148 Scheme 74
-N HN- 
Me02C C02Me
153
One particularly important application of 
alkylidenepyrrolidine chemistry is in the preparation of 
semi-corrin ligands, pioneered by the group o f Pfaltz. 
For example, alkylidenepyrrolidine 151, prepared by 
the iminoether method, underwent smooth 
decarboxylation upon treatment with trifluoroacetic 
acid at room temperature. Further treatment with the 
same reagent in the presence o f iminoether 152 gave 
semi-corrin 153 (Scheme 74 ).106 The use o f these 
compounds as chiral ligands, and their ultimate 
development towards the now ubiquitous bis-oxazolines
Kishi’s group turned their attention to the synthesis 
o f saxitoxin in the late 1970s. Following an initial 
report o f a three-component coupling of an 
alkylidenepyrrolidine with isocyanic acid and 
acetaldehyde,107 the first synthesis of the racemic 
natural product was reported in 1977.108 This work was 
subsequently extended using the diastereoselective 
three-component coupling reaction shown in Scheme 
75 to provide an enantioselective synthesis of the 
natural product.109
Elliott and Long have used an analogous annulation of 
alkylidenepyrrolidine 154 to prepare compound 155 as
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a model for the left-hand side o f batzelladine A, a 
marine natural product with anti-H IV  properties 
(Scheme 76).84’110
MeQjC
Hf<
© VO y ^ °
H
Si(NCS)4, benzene 
80% (80% de.)
Scheme 75
C02Me
OTBS .OTBS
Si(NCS)4, MeCHO
C05Et benzene, 3 h
54%
Et02C
NH
'CH3
Mel, MeOH 
reflux, 1 h 
then NH3, NH4 OAc 
80 °C, 48 h 
73%
OH +
/  NH 
EtOjC
155
2.hco 2
NH
'CH3
Scheme 76
A  relatively unusual diazo-transfer reaction occurs 
between alkylidenepyrrolidine 124 and diazoindolone 
156, giving the triazole 157 (Scheme 77). This reaction 
is in fact relatively general, and works with many 
vinylogous carbamates and amides.111
Eto2c
Et02C
toluene, reflux V— n
------------   A m78% \ N
157
124
There are a number o f ring-transposition reactions 
during which the alkylidenepyrrolidine ring is either 
formed or lost. In the first example o f these, heating 
compound 158 causes equilibration to form 
alkylidenepyrrolidine 159. Upon treatment with 
aqueous acid, this compound undergoes decarboxylation 
to give the endocyclic enamine 160 (Scheme 78).112
MeN NMe
95% EtOH
heat, 1 0 0 %
Me Me
158 159
HCI, HzO 
: heat
NMe
Scheme 78 160
Dannhardt and co-workers have used 
alkylidenepyrrolidine ketones to prepare a range of 
pyrazole and isoxazole derivatives with antibacterial 
activity. For example, treatment o f substrate 161 with 
hydrazine sulfate gave pyrazole 163 via hydrazone 162 
(Scheme 79).113 Similar reactions with hydroxylamine 
hydrochloride give the analogous isoxazoles,114 
including W-alkyl and V-acyl derivatives.115
nh2 nh2 .h2 so4
NaOAc, MeOH, H20  
8  h, reflux, 78%
H,N
Scheme 77 Scheme 79
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One further ring-transposition reaction is shown in 
Scheme 80. Reaction o f alkylidenepyrrolidine 15 with 
trithiazyl trichloride 164 gives thiadiazole 166 by way 
o f the isolable intermediate 165.116
?'
N'S*N
C02Et C r S'N *SxCI 
164
CCI4, reflux, 18 h 
50%
Et02 C,
165
Et02C
&
Cl
Scheme 80 166
Alkylidenepyrrolidines such as 167 can undergo ring- 
expansion reactions. In this case the Wagner-Meerwein 
type rearrangement is initiated by bromohydrin 
formation (Scheme 81 ).117
Et02(X  -Me
Br2, Et20 , -60 °C Eg >2Cw Me 
----------------------► Y  NMe
then H20 , EtaN 
70%
Scheme 81
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Abstract— The reactions of alkylidenepyrrolidine esters with isocyanates generally favour C-acylation, except in the case of benzyl iso­
cyanate. Reactions with alkyl isocyanates are slow, and require forcing conditions. Reactions with isothiocyanates give exclusively the 
C-acylated products.
©  2006 Elsevier Ltd. All rights reserved.
1. Introduction
Alkylidenepyrrolidines 1 are versatile heterocyclic ambident 
nucleophiles, which have been extensively used in organic 
synthesis.1 During the course o f our studies towards the 
synthesis o f the batzelladine alkaloids,2 we had occasion 
to undertake a three-component coupling reaction of an 
alkylidenepyrrolidine with an aldehyde and a silyl isothio- 
cyanate.3 Since the stereoselectivity in this reaction was 
modest, we sought an understanding o f the mechanism in 
order to optimise this. For this study, we required a range 
of compounds o f general structure 2 in order to study the 
stereoselectivity o f their reactions with aldehydes. The 
N-acylation o f alkylidenepyrrolidines has been reported 
with a range o f alkyl and aryl isocyanates.4 However, 
when we attempted to repeat some o f the reactions in this 
report, we observed somewhat different results. In order to 
verify the trends observed during this work, a number of 
additional heterocumulenes were also investigated. We 
now report our results herein.
r 1o 2 c>
" a ;
co2r
NH
products favouring N-acylation. W ith alkyl isocyanates, re­
actions were carried out in pyridine at room temperature 
for 2 h, while reactions with aryl isocyanates were under­
taken in benzene at reflux (12 h). The examples reported 
are shown in Scheme 1.
&
C02Et Et02C\
R-NCO 7) ,i,HR
R -  Me, n-Bu, n-CgH^, c-CgH^, Bn, Ph, 3-CICgH4, 
4-CIC6H4, 4-CH3CgH4
Scheme 1.
In our hands, reaction of phenyl isocyanate with (Z)-alkylidene- 
pyrrolidine 3 in chloroform under reflux gave a 3.4:1 crude 
mixture of C - and N-acylated products 4 and 5. The isolated 
yields approximately reflect this regioselectivity (Scheme 2). 
At room temperature in the same solvent, a 2.1:1 mixture of 
the same compounds was obtained. When benzene (reflux) 
was used as solvent, a 5.2:1 mixture was obtained, while 
T H F  (also at reflux) gave the highest selectivity at 7:1. In 
all cases, the C-acylated product 4 predominated.
2. Results and discussion
The publication by Tronche4 states that in general, all 
isocyanates used gave an approximately 70:30 mixture of
C02Et EtOzCv^CONHPh EtOzC^
PhNCO, CHCI3 |J |j NHPh
reflux, 2 h A  NH A  N A dNH
Scheme 2.
NH
4, 71% 5, 17%
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A ll compounds in our study have been fully characterised 
(*H  N M R , 13C NM R +D E PT, IR , M S, HR M S). The ‘H  N M R
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and melting point data which we have obtained for com­
pound 5 are entirely in line with those reported by Tronche.4 
In an attempt to favour N-acylation, compound 3 was depro- 
tonated with sodium hydride prior to reaction with phenyl 
isocyanate. However, this gave only a mixture o f compound 
4 and the novel heterocycle 6 (Scheme 3). Clearly the 
formation of compound 6 requires N-acylation, but this 
could occur after the C-acylation. In  no case have we been 
able to obtain a mixture favouring the N-acylated product 5.
C 0 2Et
NH
NaH,THF 
then PhNCO
Et02 C^CONHPh
NH
PhN NPh
4, 31%
Y
6, 13%
Scheme 3.
In contrast, reaction o f alkylidenepyrrolidine 3 with benzyl 
isocyanate proceeds to give a 2:1 mixture o f N-acylated com­
pound 8 and C-acylated compound 7, exactly as reported 4 
We chose to carry out this reaction in chloroform rather 
than pyridine, and obtained poor conversion (Scheme 4). 
Upon heating, the overall yields were dramatically improved 
at the expense o f regioselectivity (1:1). Deprotonation of the 
alkylidenepyrrolidine with sodium hydride gave good 
selectivity for C-acylation (5.3:1). In  this case, the bicyclic 
compound 9 was also formed (9%  yield), while the low con­
version meant that compound 8 was not actually isolated.
A t this point we felt that we were beginning to establish 
a trend, and that alkyl isocyanates would give predominantly 
N-acyl products while aryl isocyanates would give predomi­
nantly C-acyl products. In  order to verify this, reactions were 
carried out with cyclohexyl and butyl isocyanates. In both
C 0 2Et E t0 2C v ^ C O N H B n  E t O ,C ^
j BnNCO, C H C I3 || |j NHBn
NH 25 °C, 18 h ‘ A n h  + A n \
C02Et 
| NaH, THF
7, 13% 
E t0 2C v ^ C O N H B n
8 , 25% 
0 O
NH then BnNCO 
25 °C,18h
i v ^ C  II II
|[ + B n N 'Y , NBn
O "  H
7, 35% 9, 9%
Scheme 4.
cases, no reaction was observed in either chloroform or 
pyridine at room temperature. W ith butyl isocyanate, upon 
heating for 65 h at 100 °C , C-acylation was again found to 
predominate (Scheme 5).
C02Et n-BuNCO, Et02 Cv ,^CONHn-Bu Et02C^
pyridine Y  jl NH”-Bu
NH sealed tube, NH (  N O
100 °C, 65 h \__/ \__/
10, 65% 11, 19%
Scheme 5.
Following on from these results, a number of other isocya­
nates and some isothiocyanates were investigated in this re­
action. The results are summarised in Table 1. O f these other 
compounds, only 4-methylphenyl isocyanate was found to 
produce any of the N-acylated product, this being the minor 
compound produced. As we have previously discussed,2 we 
believe that the data reported by Tronche for the N-acylated
Table 1. Reactions of alkylidenepyrrolidine 3 with a range of heterocumulenes
Entry Heterocumulene Conditions Ratio C:N acylation Products (% isolated yield)
1 PhNCO CHCI3 , 25 °C, 18 h 2 .1 :1 4 (53%); 5 (20%)
2 PhNCO CHCI3 , reflux, 2 h 3.4:1 4 (71%); 5 (17%)
3 PhNCO Benzene, reflux, 2 h 5.2:1 Not purified
4 PhNCO THF, reflux, 2 h 7:1 Not purified
5 PhNCO NaH, THF, 18 h 1 : 0 4 (31%); 6  (13%)
6 BnNCO CHCI3 , 25 °C, 18 h 1 : 2 7 (13%); 8  (25%)
7 BnNCO CHCI3 , reflux, 20 h 1 : 1 7 (39%); 8  (50%)
8 BnNCO NaH, THF, 18 h 5.3:1 7 (35%); 9 (9%)
9 n-BuNCO Pyridine, 100 °C, 65 h 2.3:1 10 (65%); 11 (19%)
1 0 4-MeC6 H4NCO CHCI3 , reflux, 2 h 2.3:1 12 (56%); 13 (23%)
11 TsNCO CHCI3 , 25 °C, 2 h 1 : 0 14 (94%)
1 2 CI3CCONCO CHCI3 , 25 °C, 18 h 1 : 0 15 (51%)
13 PhNCS CHCI3 , reflux, 18 h 1 : 0 16 (58%)
14 BnNCS CHCI3 , reflux, 18 h 1 : 0 17 (6 6 %)
15 n-BuNCS Pyridine, 100 °C, 46 h 1 : 0 18 (89%)
16 BnNCS NaH, THF, 18 h 1 : 0 17 (38%); 19 (25%)
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product 13 are actually more consistent with the C-acylated 
product 12, so that our results are actually in agreement. In 
particular, the melting point reported for compound 13 is 
close to that which we have measured for compound 12. 
In all other cases, the C-acylated product was formed exclu­
sively, and in each case as a single double-bond isomer 
according to the spectroscopic data. The double-bond 
geometry is presumed to be that shown as a result o f more 
favourable hydrogen bonding.5
Et02C
CNH
CH,
Et02C
HN
N^O
CH,
12 13
W ith the benefit o f hindsight, it is straightforward to distin­
guish the C- and N-acyl compounds by mass spectrometry 
(electrospray or A PC I). The former all give a strong peak 
at m/z 182 corresponding to fragment 20, while the latter 
all give a peak at m/z 156, which presumably corresponds 
to 21.
Et02C ^ ^ Et02C
C NH
while an unspecified mixture o f (E ) and (Z) isomers leads 
to the 70:30 mixture favouring N-acylation. In their 1988 
paper,4 Tronche and co-workers do state that a mixture of 
double-bond isomers was used. However, they prepared 
alkylidenepyrrolidine 3 by an Eschenmoser sulfide contrac­
tion, which is known to strongly favour the (Z)-alkylidene- 
pyrrolidine,1 and indeed the authors state in their 
experimental section that the (Z ) isomer 3 was isolated in 
46% yield, while the (£ ) isomer was unstable and was 
not isolated under these conditions 4 Assuming that the (Z) 
isomer 3 and (E ) isomer give C - and N-acylation products 
respectively, it is difficult to see how a mixture favouring 
the (Z) isomer could possibly give a 70:30 mixture favouring 
N-acylation. We are only aware o f a single unequivocal 
example of the synthesis o f the (E) isomer of a simple 
N H  alkylidenepyrrolidine.9 W hile many authors do draw 
the (E) isomer, it seems likely that this is for convenience, 
and generally no comment is made about the double-bond 
geometry. In the cases where the (E ) isomer has been drawn 
and spectroscopic data are presented, all of these compounds 
appear to be the (Z) isomer.
Based on these observations, we can offer no conclusive ex­
planation for the discrepancies between our own results and 
those of Tronche. Nevertheless, our results have proven to be 
reproducible and consistent over a range of heterocumu­
lenes, and with batches of alkylidenepyrrolidine 3 prepared 
on a number o f different occasions. We therefore feel that the 
results reported herein represent the norm for the acylation 
of alkylidenepyrroldines with heterocumulenes.
20 21
Tronche’s group subsequently reported the formation of pyr- 
rolo[l,2-c]pyrim idines 22 as shown in Scheme 6.6 A ll of 
these compounds presented plausible N M R  and analytical 
data, and it is difficult to see how any of these compounds 
could have been formed from the C-acyl isomers. We there­
fore have no doubt that the N-acyl compounds were indeed 
formed, although particularly in the case o f R =n -B u  and 
c-C6H 13, we are unable to reproduce their formation. The 
alkylidenepyrrolidine literature shows numerous examples 
of subtle reactivity,7 so it seems possible that impurities pres­
ent in either Tronche’s or our own starting materials could 
affect the regioselectivity.
NaOH
22
R = Me, n-C4 H9, n-C6H13, c-CgH ,^ Bn, Ph
Scheme 6 .
The other factor which could affect the regiochemical out­
come is the double-bond geometry in the alkylidenepyrrol­
idine. Earlier reports8 from the group of Tronche state 
that the (Z)-alkylidenepyrrolidine 3 gives exclusively the 
C-acylation product with methyl and phenyl isocyanates,
3. E xperim ental
3.1. General
A ll reactions were carried out under an atmosphere o f dry 
nitrogen. M elting points were determined on a Gallenkamp 
melting point apparatus and are uncorrected. Infrared spec­
tra were recorded on a Perkin-Elm er 1600 F T IR  spectro­
photometer. Mass spectra were recorded on a Fisons V G  
Platform I I  spectrometer and on a Micromass Q -TO F M icro  
spectrometer. N M R  spectra were recorded on a Bruker D P X  
400 spectrometer operating at 400 M H z  for ‘H  and at 
100 M H z  for 13C at 25 °C. A ll chemical shifts are reported 
in parts per million downfield from T M S . Coupling con­
stants (J) are reported in hertz. M ultip licity in 13C N M R  
was obtained using the D E P T pulse sequence. Flash chroma­
tography was performed using Matrex silica 60 35 -70  pm. 
Compound 3 was prepared according to a literature 
method.10
3.1 .1 . iV -P h e n y l-2 -p y rro lid in -(2 E )-y lid e n e -m a lo n a m ic  
acid ethyl ester (4) and (l-ph en ylcarb am oyl-p yrro lid in - 
(2E)-ylidene)-acetic acid ethyl ester (5). To a solution of 
(Z)-pyrrolidin-2-ylidene-acetic acid ethyl ester 3 (106 mg, 
0.7 mmol) in CHC13 (6 m L) was added phenyl isocyanate 
(89 pL, 0.8 mmol), and the mixture stirred at 25 °C for 
18 h. The solvent was then removed in vacuo. The resulting 
orange oil was purified by column chromatography (eluting 
with ethyl acetate/hexane 4.5:7) to give compound 4 
(R /=  0.8) (99 mg, 53% ) and compound 5 (^ = 0 .3 7 )  
(38 mg, 20%).
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Data fo r  compound 4: yellow solid, mp 7 6 -7 8  °C; vmax 
(C H 2C l2)/cm -1 3236, 1650, 1614; <5H (400 M H z; CDC13)
11.44 (1H , br s, C H 2N tf), 11.29 (1H , br s, PhNH ), 7.50 
(2H , d, J  7.6, aromatic C H ), 7.21 (2H , apparent t, J  7.9, 
aromatic CH), 6.95 (1H , t, J  7.4, aromatic C H ), 4.14 (2H, 
q, J  7.1, C 0 2C tf2C H 3), 3.52 (2H , t, J  7.7, C / /2N H ), 3.11 
(2H , t, 7 7.9, C H 2C = C ) ,  1.91 (2H , m, C /72C H 2N H ), 1.25 
(3H , t, 7 7.1, C 0 2C H 2CH f) \ 6C (100 M H z; CDC13) 174.9 
(C H 2CN H), 169.9 ( C = 0 ) ,  168.9 ( C = 0 ) ,  139.2 (aromatic 
C), 128.7 (aromatic C H ), 123.0 (aromatic C H ), 120.6 (aro­
matic CH), 87.0 (C O C C 0 2Et), 59.9 (C 0 2C H 2C H 3), 47.7 
(C H 2N H ), 36.5 (C H 2C = C ) ,  21.3 (C H 2C H 2N H ), 14.6 
(C 0 2C H 2C H 3); m/z (ES+) 297.2 (M N a +, 7% ), 275.3 (M H +, 
2), 183.1 (28), 182.1 (100), 154.0 (99), 138.0 (98); HRM S  
(ES+) calcd for C 15H 19N 20 3 (M H +) 275.1396, found 
275.1373.
Data fo r compound 5: colourless solid, mp 127-129 °C (lit.4 
mp 128 °C); vmax (C H z C l^ /c m -1 3377,1689,1660,1594; 6H 
(400 M H z; CDC13) 7.31 (2H , d, 7  7.7, aromatic CH), 7.22 
(2H , apparent t, 7 7.9, aromatic C H ), 7.01 (1H, t, 7  7.4, aro­
matic C H ), 6.95 (1H , br s, N/TPh), 6.34 (1H , apparent d, 
7 1.6, C H =  C), 4.03 (2H , q, 7  7.1, C 0 2C //2C H 3), 3.64 (2H, 
t, 7  7.1, C / /2N C O ), 3.12 (2H , apparent dt, 7  1.6, 7.8, 
C H 2C = C ) ,  1.87 (2H , apparent quintet, 77 .4, C/72C H 2NC O ),
1.16 (3H , t, 77 .1, C 0 2C H 2C //3). <5c (100 M H z; CDC13) 168.9 
(ester C = 0 ) ,  158.2 (alkene C), 152.1 (urea C = 0 ) ,  137.5 
(aromatic C), 129.0 (aromatic C H ), 124.3 (aromatic CH),
120.7 (aromatic CH), 95.6 (alkene C H ), 59.4 (C 0 2CH2),
49.4 (C H 2N C O ), 31.9 (C H 2C = C ) ,  21.1 (C H 2C H 2NCO),
14.5 (C H 3C H 2OCO); m/z (ES+) 275 (M H +, 55%), 156 
(100); H R M S  (ES+) calcd for C 15H 19N 20 3 (M H +) 
275.1396, found 275.1397.
3.1.2. l,3-Dioxo-2-phenyl-l,2,3,5,6,7-hexahydro-pyr- 
rolo[l,2-c]pyrimidine-4-carboxylic acid phenylamide
(6). To a stirred suspension o f sodium hydride (60% disper­
sion in oil, 35 mg, 1.5 m m ol) in dry T H F  (15 mL), was 
added dropwise a solution o f (Z)-pyrrolidin-2-ylidene- 
acetic acid ethyl ester 3 (207 mg, 1.3 mmol) in TH F  
(5 mL) at 0 °C. The mixture was then stirred for 2 h at 
25 °C. Phenyl isocyanate (159 mg, 1.3 mm ol) was added, 
and the mixture stirred for 18 h at rt. The reaction mixture 
was quenched with saturated N H 4C1 solution (30 mL), the 
organic layer extracted, and the aqueous layer washed with 
D C M  (3 x 3 0  mL). The combined organic washings were 
washed with brine (2 x 5 0  m L), dried over M g S 0 4, and 
the solvent removed in vacuo. The residue was recrystal­
lised from ethanol to give the title compound (60 mg, 
13%) as a pale yellow solid, mp 25 3-255  °C; vmax 
(C H s C y /c m -1 3239, 1705, 1682, 1591, 1437; <5H 
(400 M H z; CDC13) 11.12 (1H , br s, P h N //C O ), 7 .60-7 .35  
(5H , m, aromatic C H ), 7 .30-7 .15 (4H , m, aromatic C H ),
7.00 (1H, t, 7  7.3, aromatic C H ), 4 .00 (2H , t, 7  7.5, 
C/72NC O ), 3.77 (2H , t, 7  7.9, C H 2C = C ) ,  2.17 (2H , appar­
ent quintet, 7  7.7, C / /2C H 2N C O ); <5C (100 M H z; CDC13)
164.9 ( C = 0 ) ,  163.5 ( C = 0 ) ,  160.6 ( C = 0 ) ,  147.8 
(C H 2CNCO), 137.2 (aromatic C), 133.4 (aromatic C),
128.7 (aromatic C H ), 128.3 (aromatic C H ), 127.9 (aro­
matic C H ), 127.1 (aromatic C H ), 123.0 (aromatic C H ), 
119.3 (aromatic C H ), 100.3 (N H C O -C -C O ), 48.2  
(C H 2NC O ), 33.4 (C H 2C = C ) ,  19.4 (C H 2C H 2N C O ); m/z 
(ES+) 370.3 (M N a+, 92% ), 348.3 (M H +, 100), 273.2 (44),
255.2 (95); H R M S  (ES+) calcd for C 20H i 8N 3O 3 (M H +) 
348.1348, found 348.1343. Purification o f the filtrate by 
flash column chromatography gave compound 4 (113 mg, 
31% ) (data as above).
3.1.3. jV-Benzyl-2-pyrrolidin-(2£)-ylidene-malonamic 
acid ethyl ester (7) and (1-benzylcarbamoyl-pyrrolidin- 
(2U)-ylidene)-acetic acid ethyl ester (8). To a solution of 
(Z)-pyrrolidin-2-ylidene-acetic acid ethyl ester 3 (103 mg, 
0.7 mmol) in CHC13 (6 m L) was added benzyl isocyanate 
(80 pL, 0.7 mmol), and the mixture stirred at 25 °C for 
18 h. The solvent was then removed in vacuo and the result­
ing orange oil purified by column chromatography (eluting 
with ethyl acetate/hexane 3:7) giving, in order of elution, 
compound 7 (R /= 0 .4 1 ) (25 mg, 13%) and compound 8 
(/? /=0.18) (48 mg, 25% ).
Data fo r  compound 7: yellow solid, mp 95 -98  °C; vmax 
(N u jo iyc n T 1 3408, 1639, 1594; <5H (400 M H z; CDC13)
11.40 (1H , s, C H 2N 70, 9.51 (1H , m, PhCH2N //) ,  1.21-1  AS 
(5H, m, aromatic C H ), 4.43 (2H , d, 7 5.7, PhC/72N H ), 4.09 
(2H , q, 7  7.1, C 0 2C / /2C H 3), 3.50 (2H , t, 7 7.4, C / /2N H ),
3.09 (2H , t, 7  7.9, C H 2C = C ) ,  1.92 (2H , apparent quintet, 
7 7.7, CJ72C H 2N H ), 1.22 (3H , t, 7  7.1, C 0 2C H 2C tf3); 6C 
(100 M H z; CDC13) 174.4 (C H 2C N H ), 170.5 ( C = 0 ) ,  169.7 
( C = 0 ) ,  139.6 (aromatic C), 128.5 (aromatic CH ), 127.3 
(aromatic C H ), 126.8 (aromatic C H ), 86.6 (C O C C 0 2Et),
59.5 (C 0 2C H 2C H 3), 47.5 (PhCH2N H ), 43.0 (C H 2N H ),
36.2 (C H 2C = C ) ,  21.4 (C H 2C H 2N H ), 14.6 (C 0 2C H 2C H 3); 
m/z (ES+) 311 (M N a + H 20 +, 26% ), 289 (M H +, 10), 243 (5), 
182 (100); H R M S  (ES+) calcd for C 16H 22N 20 3 (M H +) 
289.1552, found 289.1548.
Data fo r  compound 8: colourless solid, mp 88 -92  °C, l i t 4 
mp 86 °C; vmax (N u jo l)/cm _1 3357, 1669, 1604; <5H 
(400 M H z; CDC13) 7 .28 -7 .14  (5H , m, aromatic C H ), 6.41 
(1H , apparent t, 7  1.7, C H =  C ), 5.32 (1H , br s, N /7C H 2Ph), 
4.38 (2H, d, 7  5.6, N H C 7/2Ph), 4.02 (2H , q, 7  7.1, 
C 0 2C H 2C H 3), 3.54 (2H , t, 7  7.1, C H 2N C O ), 3.11 (2H , ap­
parent dt, 7 1.7, 7.8, C / /2C = C H ) ,  1.87 (2H , apparent quin­
tet, 7 7 .5 , C tf2C H 2N C O ), 1.16 (3H , t, 7  7.1, C 0 2C H 2C / /3); 
6C (100 M H z; CDC13) 169.1 (ester C = 0 ) ,  158.3
(C H 2CNCO ), 154.5 (urea C = 0 ) ,  158.5 (aromatic C),
128.7 (aromatic C H ), 127.7 (aromatic C H ), 127.5 (aromatic 
CH), 95.0 (C H = C ),  59.2 (C 0 2C H 2C H 3), 49.1 (N H C H 2Ph),
44.5 (C H 2N C O ), 31.8 (C H 2C = C ) ,  21.1 (C H 2C H 2NC O ),
14.5 (C 0 2C H 2C H 3); m/z (ES+) 329 (M + N a+ H 20 ,  65%), 
261 (38), 156 (100), 128 (97); H R M S (ES+) calcd for 
C j6H 22N 20 3 (M H +) 289.1552, found 289.1548.
3.1.4. l,3-Dioxo-2-benzyl-l,2,3,5,6,7-hexahydro-pyr- 
roIo[l,2-c]pyrimidine-4-carboxylic acid benzylamide
(9). To a stirred suspension of sodium hydride (60% disper­
sion in oil, 45 mg, 1.1 mmol) in dry T H F  (15 m L), was 
added dropwise a solution o f (Z)-pyrrolidin-2-ylidene-acetic 
acid ethyl ester 3 (159 mg, 1.0 mmol) in T H F  (5 mL) at 0 °C. 
The mixture was then stirred for 2 h at 25 °C. Benzyl iso­
cyanate (0.13 mL, 1.0 mmol) was added, and the mixture 
stirred for 18 h at 25 °C. The reaction mixture was quenched 
with saturated N H 4C1 solution (30 mL), the organic layer 
was separated and the aqueous layer washed with C H 2C12 
(3 x  30 mL). The combined organic layers were washed 
with brine (2 x 5 0  m L), dried over M g S 0 4, and the solvent
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removed in vacuo. The resulting orange solid was purified 
by column chromatography (eluting w ith 3:7 ethyl acetate/ 
hexane) giving, in order o f elution, compound 9 (R f=0.51) 
(36 mg, 9% ) and compound 7 (R /= 0 .4 1 ) (103 mg, 35%) 
(data as above).
Data fo r  compound 9: yellow solid, mp 117-120 °C; j/max 
(C H 2C l2)/cm -1 3248, 1705, 1646, 1623, 1545, 1442; <5H 
(400 M H z; CDC13) 11.10 (1H , br s, C H 2N tfC O ), 7.31 (4H, 
apparent t, 7 7 .6 , aromatic C H ), 7 .2 6 -7 .12  (6H , m, aromatic 
CH), 5.04 (4H , apparent s, 2 x P h C //2N ), 3.64 (2H, t, 7 7.6, 
C //2N C O ), 3.39 (2H , t, 7  8.0, C H 2 C = C ) ,  2.06 (2H, apparent 
quintet, 7 7.8, C H 2C H 2N C O ); <5C (100 M H z; CDC13) 177.2 
(C13C C = 0 ) ,  165.2 ( C = 0 ) ,  162.4 ( C = 0 ) ,  151.6 
(C H 2CN CO ), 137.6 (aromatic C ), 137.6 (aromatic C),
128.5 (aromatic C H ), 128.4 (aromatic CH), 128.2 
(aromatic C H ), 127.4 (aromatic C H ), 127.3 (aromatic CH),
88.5 (N H C O -C -C O ), 48.2 (C H 2N C O ), 44.19, 44.16 
(2 x P h C H 2N ), 35.3 (C H 2C = C ) ,  20.8 (C H 2C H 2NCO); m/z 
(ES+) 376 (M H +, 100% ), 310 (32), 238 (23), 123 (66); 
H R M S  (ES+) calcd for C 22H 22N 30 3 (M H +) 376.1661, found 
376.1657.
3.1.5. /V-ButyI-2-pyrrolidin-(2E)-ylidene-malonainic acid 
ethyl ester (10) and (l-/i-butylcarbamoyl-pyrrolidin- 
(2Zs)-yli dene)-ace tic acid ethyl ester (11). To a solution 
of (Z)-pyrrolidin-2-ylidene-acetic acid ethyl ester 3 
(147 mg, 0.9 mm ol) in pyridine (0.5 m L) was added butyl 
isocyanate (128 pL, 1.1 m m ol). The solution was stirred at 
100 °C in a sealed tube for 65 h, after which time the solvent 
was removed under reduced pressure. The resulting dark 
brown oil was purified by column chromatography (eluting 
with ethyl acetate/hexane 4:7), to give compound 10 
(/? /=0.33) (156 mg, 65% ) and compound 11 (Rf = 0.11) 
(45 mg, 19%) both as pale yellow  oils.
Data fo r  compound 10: pale yellow  oil; pmax (C H 2C l2)/cm _1 
3314, 1654, 1598; <5H (400 M H z ; CDC13) 11.45 (1H, br s, 
C H 2N # ) ,  9.10 (1H , br s, C H 2N /7C O ), 4.10 (2H , q, 7  7.1, 
CO 2C H 2), 3.51 (2H , t, 7  7.4, C t f2N H ), 3.21 (2H , apparent 
q, 7  6.5, C / /2N H C O ), 3.08 (2H , t, 7  7.9, C H 2C = C ), 1.93 
(2H, apparent quintet, 7  7.7, C / / 2C H 2N H ), 1.46 (2H , appar­
ent quintet, 7  7.3, C H 3C H 2C /72), 1.31 (2H , apparent sextet, 
7 7.4, C H 3C / /2C H 2), 1.23 (3H , t, 7  7.1, C 0 2C H 2C H 3), 
0.85 (3H, t, 7  7.3, C H 3C H 2C H 2); 6C (100 M H z; CDC13)
174.1 (C H 2C N H ), 170.3 ( C = 0 ) ,  169.6 ( C = 0 ) ,  86.5 
(C O C C 0 2Et), 59.3 (C 0 2C H 2), 47.3 (C H 2N H ), 38.6 
(C H 2N H C O ), 36.0 (C H 2C = C ) ,  31.8 (C H 3C H 2C H 2), 21.3 
(C H 2C H 2N H ), 20.3 (C H 3C H 2C H 2), 14.4 ( C 0 2C H 2C H 3),
13.8 (C H 3C H 2C H 2); m/z (A P C I) 255 (M H +, 24% ), 182 
(100); HR M S (ES+) calcd for C n H 23N 20 3 (M H +) 
255.1709, found 255.1704.
Data fo r  compound 11: pale yellow  oil; vmAX (C H 2C l2)/cm _1 
3348, 1646, 1565; <5H (400 M H z; CDC13) 6.28 (1H , br s, 
alkene C H ), 4.97 (1H , br s, N //C O N ), 4 .04 (2H , q, 7  7.1, 
CO 2C H 2), 3.56 (2H , t, 7  7.1, C /72N C O ), 3.21 (2H , apparent 
q, 7  6.6, C / /2N H C O ), 3.13 (2H , t, 7  7.7, C H 2C = C ) ,  1.89 
(2H , apparent quintet, 77 .4 , C / /2C H 2N C O ), 1.47 (2H , appar­
ent quintet, 7 7.4, C H 3C H 2CT/2), 1.29 (2H , apparent sextet, 
7 7.4, C H 3C/72C H 2), 1.18 (3H , t, 7  7.1, C 0 2C H 2C H 3), 
0.87 (3H, t, 7  7.3, C H 3C H 2C H 2); <5C (100 M H z; CDC13)
169.0 (ester C = 0 ) ,  158.4 (C H 2CN CO ), 154.4 (urea C = 0 ) ,
94.3 (C H C C 0 2Et), 59.2 (C 0 2C H 2), 49.2 (C H 2N C O ), 40.4  
(C H 2N H C O ), 32.0 (C H 2C = C ) ,  31.9 (C H 3C H 2C H 2), 21.1 
(C H 2C H 2N H ), 20.9 (C H 3C H 2C H 2), 14.5 (C 0 2C H 2C H 3),
13.8 (C H 3C H 2C H 2); m/z (A P C I) 273 (M + H 30 +, 42% ), 255 
(M H +, 19%), 227 (16), 156 (100); H R M S  (ES+) calcd for 
C ,3H 23N 20 3 (M H +) 255.1709, found 255.1704.
3.1.6. 2-Pyrrolidin-(2Z?)-ylidene-/V-p-tolyI-inalonainic 
acid ethyl ester (12) and (l-p-tolylcarbamoyl-pyrrolidin- 
(2£’)-ylidene)-acetic acid ethyl ester (13). To a solution o f 
(Z)-pyrrolidin-2-ylidene-acetic acid ethyl ester 3 (161 mg, 
1 mmol) in CHC13 (6 m L) was added p-tolyl isocyanate 
(130 pL, 1 mmol), and the solution stirred under reflux 
for 2 h. The solvent was removed in vacuo to produce a 
yellow oil, which solidified on standing. The yellow solid 
was purified by column chromatography (eluting with 
EtOAc/hexane 4.5:7) giving, in order of elution, compound 
12 (R f= 0 .1 6 ) (168 mg, 56% ) and compound 13 (/? /=0.29) 
(69 mg, 23%).
Data fo r  compound 12: pale yellow solid, mp 150-153 °C; 
I'max (solution)/cm_1 3216, 1649, 1619; <5H (400 M H z; 
CDC13) 11.40 (1H , br s, C H 2N H ), 11.25 (1H , br s, A rN /7), 
7.37 (2H , apparent d, 77 .4 , aromatic C H ), 7.01 (2H , apparent 
d, 77 .4, aromatic C H ), 4.12 (2H , q, 77 .1 , C O 2C H 2), 3.49 (2H , 
t, 77 .4 , C H 2N H ), 3.08 (2H , t, 7 7 .9 , CH 2C = C ) ,  2.20 (3H , s, 
C H 3Ar), 1.88 (2H , apparent quintet, 77 .7, C / /2C H 2N H ), 1.23 
(3H, t, 7  7.1, C 0 2C H 2C773); <5c (100 M H z; CDC13) 174.8 
(C H 2C N H ), 169.9 ( C = 0 ) ,  168.8 ( C = 0 ) ,  136.5 (aromatic 
C), 132.5 (aromatic C), 129.3 (aromatic CH ), 120.4 (aro­
matic C H ), 87.0 (C O C C 0 2Et), 59.8 (C 0 2C H 2), 47.6 
(C H 2N H ), 36.5 (C H 2C = C ) ,  21.3 (C H 2C H 2N H ), 20.9 
(C H 3Ar), 14.6 (C 0 2C H 2C H 3); m/z (ES+) 311 (M N a +, 
30%), 289 (M H +, 30), 182 (100); H R M S (ES+) calcd for 
C 16H 22N 20 3 (M H +) 289.1552, found 289.1537.
Data fo r  compound 13: colourless solid, mp 132-135 °C, lit.4 
mp 155 °C; vmax ( C H ^ l^ /c m - 1 3448, 1694, 1609; <5H 
(400 M H z; CDC13) 7.25 (2H , apparent d, 7 8.3, aromatic 
CH), 7.04 (2H, apparent d, 7  8.3, aromatic CH), 6.77 (1H , 
s, N //A r), 6.31 (1H , apparent t, 7  1.6, C H = C ) ,  4.04 (2H , q, 
7 7.1, C 0 2CH 2), 3.66 (2H , t, 7  7.1, C H 2NC O ), 3.15 (2H , 
apparent dt, 7  1.7, 7.8, C H 2C = C ) ,  2.24 (3H, s, C H 3Ar), 
1.90 (2H , apparent quintet, 7 7.4, C / /2C H 2N C O ), 1.17 
(3H, t, 7  7.1, C 0 2C H 2C H 3); 6c (100 M H z; CDC13) 168.8 
(ester C = 0 ) ,  158.1 (C H 2C N C O ), 152.1 (urea C = 0 ) ,
134.8 (aromatic C), 134.0 (aromatic C H ), 129.5 (aromatic 
C H), 120.7 (aromatic C H ), 95.4 (C H = C ),  59.3 (C 0 2C H 2),
49.4 (C H 2N C O ), 32.0 (C H 2C = C ) ,  21.1 (C H 2C H 2NCO ),
20.8 (C H 3Ar), 14.5 (C 0 2C H 2C H 3); m/z (ES+) 311 
(M N a+, 22% ), 289 (M H +, 8), 156 (100), 110 (34); HR M S  
(ES+) calcd for C i6H 20N 2O 3Na (M N a+) 311.1372, found 
311.1356.
3.1.7. 3-Oxo-2-pyrrolidin-(21?)-ylidene-3-(toIuene-4-sul- 
fonylamino)-propionic acid ethyl ester (14). To a solution 
of (Z)-pyrrolidin-2-ylidene-acetic acid ethyl ester 3 
(102 mg, 0.7 mmol) in CHC13 (6 m L) was added /?-tosyl iso­
cyanate (100 pL, 0.7 mmol) and the mixture stirred at reflux 
for 2 h. The solvent was removed in vacuo to yield the title 
compound (220 mg, 94% ) as a white crystalline solid, with­
out need for further purification, mp 154-158 °C; vmax 
(Nujol)/cm_1 3447, 1644, 1594; <5H (400 M H z; CDC13) 12.20
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(1H , s, C / /2N H ), 11.30 (1H , s, S 0 2N //C 0 ) ,  7.83 (2H , appar­
ent d, 7  8.3, aromatic C H ), 7.18 (2H , apparent d, 7  8.3, aro­
matic C H ), 4.09 (2H, q, 7  7.1, C 0 2C / /2C H 3), 3.46 (2H, t, 
7 7.5, C / /2N H ), 3.05 (2H , t, 7  7.9, C H 2C = C ) ,  2.29 (3H, s, 
C H 3A i ), 1.89 (2H, apparent quintet, 7  7.7, C / /2C H 2NH), 
1.20 (3H , t, 7 7.1, C 0 2C H 2C / /3); <5c (100 M H z; CDC13)
175.9 (C H 2CNH), 169.5 ( C = 0 ) ,  167.7 ( C = 0 ) ,  143.9 (aro­
matic C), 137.4 (aromatic C), 129.3 (aromatic C H ), 128.1 
(aromatic CH), 86.5 (C O C C 0 2Et), 60.5 (C 0 2CH2C H 3),
48.1 (C H 2N H ), 36.6 (C H 2C = C ) ,  21.6 (C H 3Ar), 20.8 
(C H 2C H 2N H ), 14.4 (C 0 2C H 2C H 3); m/z (ES+) 353 (M H +, 
34%), 182 (100); H R M S  (ES+) calcd for C 16H 21N 20 5S 
(M H +) 353.1171, found 353.1166.
3.1.8. 3-O xo-2-pyrro lid in-(2E )-ylidene-3-(2 ,2,2-tri- 
chloro-acetylamino)-propionic acid ethyl ester (15). To
a stirred solution o f (Z)-pyrrolidin-2-ylidene-acetic acid 
ethyl ester 3 (63 mg, 0.4 m m ol) was added trichloroacetyl 
isocyanate (48 pL, 0.4 mmol) and the mixture stirred for 
18 h at 25 °C. The solvent was then removed in vacuo. 
The resulting yellow oil was purified by column chromato­
graphy (eluting with ethyl acetate/hexane 4:7) to give the 
title compound (R f= 0.25) (72 mg, 51% ) as an off-white 
solid, mp 110-112 °C; vmax (solution)/cm_1 3197, 1750, 
1664, 1614; <5H (400 M H z; CDC13) 13.38 (1H, br s, 
C l3C C O -N //-C O ), 11.31 (1H , br s, C H 2N tf) , 4.20 (2H, q, 
J  7.1, CO 2C H 2), 3.66 (2H , t, J  7.5, C /72N H ), 3.20 (2H, t, 
J  7.9, C / /2C = C ) ,  2.04 (2H , apparent quintet, J  7.8, 
C //2C H 2N H ), 1.28 (3H , t, J  7.1, C 0 2C H 2C H 3); 6C 
(100 M H z; CDC13) 176.6 (C l3C C O N H ), 174.9 (C H 2CNH),
169.8 (ester C = 0 ) ,  167.8 (N H C O C = C ), 93.2 (C13C),
87.8 (C O C C 0 2Et), 60.8 (C 0 2C H 2), 48.4 (C H 2N H ), 36.9 
(C H 2C = C ) ,  20.9 (C H 2C H 2N H ), 14.4 (C 0 2C H 2CH3); m/z 
(ES+) 343 (M H +, 18%) (-i-consistent isotopomer peaks), 
182 (100); H R M S (ES+) calcd for C n H 14N 20 435C l3 
(M H +) 343.0019, found 343.0015.
3.1.9. PhenyIthiocarbamoyl-(2Z)-pyrrolidin-2-ylidene- 
acetic acid ethyl ester (16). To a stirred solution of (Z)-pyr- 
rolidin-2-ylidene-acetic acid ethyl ester 3 (60 mg, 0.4 mmol) 
in CHC13 (6 m L) was added phenyl isothiocyanate (46 pL,
0.4 mmol), and the mixture stirred for 20 h under reflux. 
The solvent was removed in vacuo and the resulting brown 
solid recrystallised from aqueous ethanol to yield the title 
compound (65 mg, 58% ) as colourless needles, mp 118— 
120 °C; vmax (solution)/cm_1 3176, 1649, 1248; <5H 
(400 M H z; CDC13) 13.28 (1H , br s, C H 2N /7), 12.47 (1H, 
br s, PhNH ), 7.38 (2H , d, J  7.6, aromatic C H ), 7.31 (2H, 
apparent t, J  7.9, aromatic C H ), 7 .16 (1H , t, J  7.4, aromatic 
CH ), 4.18 (2H , q, J  7.2, C O 2C H 2), 3.64 (2H , t, J 1A , 
C H 2N H ), 3.15 (2H, t, 7  7.8, C / /2C = C ) ,  1.98 (2H , apparent 
quintet, 77 .6, C/72C H 2N H ), 1.28 (3H , t ,7 7 .2 , C 0 2C H 2C/73); 
<5C (100 M H z; CDC13) 190.2 (thioamide C = S ) ,  174.1 
(C H 2C N H ), 170.2 (ester C = 0 ) ,  139.7 (aromatic C), 128.6 
(aromatic C H ), 126.3 (aromatic C H ), 126.2 (aromatic C H ),
95.0 (CSCCO), 60.4 (C 0 2C H 2), 48.0 (C H 2N H ), 37.8 
(C H 2C = C ) ,  21.9 (C H 2C H 2N H ), 14.4 (C 0 2C H 2C H 3); m/z 
(ES+) 291 (M H +, 29% ), 198 (100); H R M S  (ES+) calcd for 
C 15H i9N 20 2S (M H +) 291.1167, found 291.1172.
3.1.10. BenzyIthiocarbamoyl-(2Z)-pyrrolidin-2-ylidene- 
acetic acid ethyl ester (17). To a solution o f (Z)-pyrroli- 
din-2-ylidene-acetic acid ethyl ester 3 (155 mg, 1 mmol)
in CHC13 (6 m L) was added benzyl isothiocyanate 
(160 pL, 1.2 mmol), and the solution was stirred under 
reflux for 23 h. The mixture was allowed to cool, and the sol­
vent was removed in vacuo. The resulting dark orange oil 
was purified by column chromatography (eluting with ethyl 
acetate/hexane 1:4) to give the title compound (/fy=0.41) 
(204 mg, 66% ) as buff waxy solid, mp 83 -87  °C; vmax (solu­
t i o n ) / ^ " 1 3197, 1639, 1268; <5H (400 M H z; CDC13) 13.05 
(1H, br s, C H 2N H ), 12.22 (1H , br s, PhCH2N H ), 7.18-7.11  
(5H, m, aromatic C H ), 4.79 (2H , apparent d, 7 4.9, 
P hC //2N H ), 4.08 (2H , q, 7  7.2, C 0 2CH 2) 3.59 (2H , t, 
7 7.3, C / /2N H ), 3.09 (2H , t, 7  7.8, C H 2C = C ) ,  1.93 (2H , 
apparent quintet, 7  7.6, C7/2C H 2N H ), 1.20 (3H, t, 7  7.2, 
C 0 2C H 2C H 3); 6c (100 M H z; CDC13) 190.0 (thioamide 
C = S ),  173.4 (C H 2C N H ), 169.9 (ester C = 0 ) ,  137.7 (aro­
matic C), 128.7 (aromatic C H ), 127.9 (aromatic C H ),
127.3 (aromatic C H ), 94.3 (C S C C 0 2Et), 60.1 (C 0 2C H 2),
49.1 (PhCH2N H ), 47.8 (C H 2N H ), 37.5 (C H 2C = C ) ,  21.9 
(C H 2C H 2N H ), 14.4 (C 0 2C H 2C H 3); m/z (ES+) 305 (M H +, 
100%), 259 (24), 198 (78); H R M S  (ES+) calcd for 
C i6H 21N 20 2S (M H +) 305.1324, found 305.1300.
3.1.11. /i-Butylthiocarbamoyl-(2Z)-pyrrolidin-2-ylidene- 
acetic acid ethyl ester (18). To a solution of (Z)-pyrroli- 
din-2-ylidene-acetic acid ethyl ester 3 (160 mg, 1.0 mmol) 
in pyridine (0.5 m L) was added butyl isothiocyanate 
(149 pL, 1.2 mmol). The solution was stirred at 100 °C in 
a sealed tube for 46 h, after which time the solvent was re­
moved under reduced pressure. The resulting dark orange 
solid was recrystallised from aqueous ethanol to give the title 
compound (240 mg, 89% ) as an orange solid, mp 53 -56  °C; 
vm«x (C H 2C l2)/cm “ 1 3176, 1633, 1257; 8H (400 M H z;  
CDC13) 13.05 (1H , br s, C H 2N tf), 10.92 (1H , br s, 
C H 2N //C S ), 4.13 (2H , q, 7  7.2, C 0 2C H 2), 3.59 (2H , appar­
ent q, 7  7.3, C /72N H C S ), 3.58 (2H , t, 7  7.3, C/72N H ), 3.08 
(2H, t, 7  7.8, C H 2C = C ), 1.94 (2H , apparent quintet, 
7 7.6, C H 2C H 2N H ), 1.58 (2H , apparent quintet, 7 7.3, 
C H 3C H 2C H 2), 1.36 (2H , apparent sextet, 7 7.4,
C H 3C/72C H 2), 1.24 (3H , t, 7 7.2, C 0 2C H 2C H 3), 0.88 (3H , 
t, 7  7.3, C H 3C H 2C H 2); 6c (100 M H z; CDC13) 189.5 (thio- 
carbamoyl C = S ) ,  173.1 (C H 2C N H ), 169.9 (ester C = O),
94.0 (C S C C 02Et), 60.0 (C 0 2C H 2), 47.6 (C H 2N H ), 44.7 
(C H 2NHCS), 37.4 (C H 2C = C ) ,  30.3 (C H 3C H 2C H 2), 21.8 
(C H 2C H 2N H ), 20.4 (C H 3C H 2C H 2), 14.3 (C 0 2C H 2C H 3),
13.8 (C H 3C H 2C H 2); m/z (A P C I) 271 (M H +, 74% ), 225 
(26), 198 (100), 156 (19); H R M S  (ES+) calcd for 
C 13H 23N 20 2S (M H +) 271.1480, found 271.1476.
3.1.12. 2-Benzyl-3-oxo-l-thioxo-l,2,3,5,6,7-hexahydro- 
pyrrolo[l,2-c]pyrim idine-4-carbothioic acid benzyl- 
amide (19). To a stirred suspension of sodium hydride 
(60% dispersion in oil, 18 mg, 0.44 mmol) in dry T H F  
(10 m L), was added dropwise a solution of (Z)-pyrrolidin- 
2-ylidene-acetic acid ethyl ester 3 (62 mg, 0.4 mmol) in 
T H F  (5 m L) at 0 °C. The mixture was then stirred for 2 h 
at 25 °C. Benzyl isothiocyanate (53 pL, 1.0 mmol) was 
added, and the mixture stirred for 18 h at 25 °C. The reaction 
mixture was quenched with saturated N H 4C1 solution 
(30 m L), the organic layer separated, and the aqueous layer 
extracted with C H 2C12 (3 x 3 0  mL). The combined organic 
layers were washed with brine (2 x 5 0  mL), dried over 
M g S 0 4, and the solvent removed in vacuo. The resulting 
dark orange solid was purified by column chromatography
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(eluting with ethyl acetate/hexane 3:7) to give, in order of 
elution, compound 17 (/? /=0.68) (46 mg, 38% ) (data as 
above) and the title compound (/? /= 0 .45 ) (42 mg, 25%) as 
a pale solid, mp 130-132 °C; r max (C H 2C l2)/cm _1 3337, 
1664, 1288; <5H (400 M H z; CDC13) 14.0 (1H, br s, 
PhCH2NtfC S), 7 .45-7.05 (10H , m, aromatic CH), 6.45 
(2H , s, one of PhCH2N ), 5.73 (2H , s, one of PhCH2N), 
3.74 (2H , t, J 1.4, C H 2N C S ), 3.55 (2H , t, J  7.9, 
C H 2C — C ), 2.17 (2H , apparent quintet, J  7.7, 
C //2C H 2NCO); 6c (100 M H z ; CDC13) 191.0 (C = S ),
183.4 (C = S ) ,  176.6 ( C = 0 ) ,  157.8 (alkene C), 135.6 
(aromatic C), 135.5 (aromatic C), 127.3 (aromatic 
CH), 127.2 (aromatic C H ), 126.5 (aromatic CH), 126.1 (ar­
omatic C H ), 125.6 (aromatic C H ), 125.6 (aromatic CH),
102.8 (alkene C), 56.0 (C H 2N ), 50.5 (C H 2N), 47.9 
(C H 2N ), 37.1 (C H 2), 20.1 (C H 2); m/z (ES+) 408 (M H +, 
100%), 383 (28), 303 (22), 238 (29), 182 (58); HRMS  
(ES+) calcd for C 22H 22N 3OS2 (M H +) 408.1204, found 
408.1208.
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Abstract: A highly diastereoselective three-component coupling 
reaction has been used in a concise approach to the left-hand side of 
batzelladine A. The stereoselectivity of this reaction, along with re­
lated observations described herein, provides insight into the mech­
anism of this reaction.
Key words: multicomponent reactions, alkaloids, imines, stereose­
lectivity, isothiocyanates
The batzelladine alkaloids form  part o f a structurally and 
biologically fascinating group o f natural products ob­
tained from  marine sources.1 Fifteen members o f this 
group have now been isolated,2 w ith representative struc­
tures shown in Figure 1. Batzelladines A  (1 ) and B (2) in­
hibit the binding o f H IV  glycoprotein g p l2 0  to the C D 4  
receptor, and so are o f  therapeutic interest for the treat­
ment o f H IV .  Batzelladines C -E , o f which batzelladine D  
(3) is structurally representative, are cytotoxic. Various 
analogues o f the batzelladine alkaloids have also been 
shown to disrupt the g p l2 0 -C D 4  interaction.3
These compounds have been the subject o f a number of 
synthetic studies, leading to the development o f a wealth 
o f new methodology. In  particular, batzelladines A ,4 D ,5 
E ,6 F ,7 and dehydrobatzelladine C 8 have been synthe­
sized.9
O ur own work in this area10 has focused on the use o f the 
Kishi three-component coupling11 o f an alkylidenepyrro­
lidine with a silyl isothiocyanate and an aldehyde to give 
the key p yrro lo [l,2 -c ]pyrim id in e  core. How ever, w ith a 
stereochemical directing-group at the 5-position o f the 
pyrrolidine, as shown in Scheme 1, the stereoselectivity is 
typically 2:1, which falls far short o f the total stereocon- 
trol which we observed during the form ation o f sim ilar 
compounds by annulation o f  alkenylazolines w ith isocy­
anates.12
In order to improve the stereoselectivity o f  this reaction, 
we sought an understanding o f the reaction mechanism. 
The mechanism originally proposed required in itia l N -  
acylation o f the alkylidenepyrrolidine by the isothiocyan­
ate, followed by condensation w ith  the aldehyde and cy-
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clisation. How ever, isothiocyanates only react with  
alkylidenepyrrolidines under relatively forcing condi­
tions,13 giving only the product o f acylation o f the enam- 
ine carbon. On this basis, we would tentatively exclude 
this mechanism.
NH
NH
Me''"
batzelladine A (1)
NH
NH
Me'
H2NY n> ^ 0'
NH
batzelladine B (2 )
H
N,Y
NH Me'' 'C6H
batzelladine D (3)
Me*
Me"
batzelladine F (4)
Figure 1
The reaction o f trim ethylsilyl isothiocyanate with alde­
hydes under Lew is acidic conditions is known to give 
compounds o f general structure 8 .14 This provides prece­
dent for the nucleophilic addition o f trimethylsilyl isothio­
cyanate onto aldehydes, so that generation o f an 
intermediate o f structure 9 or 10 is not unreasonable. Such 
species would presumably be capable o f reacting with the 
enamine carbon o f alkylidenepyrrolidine 11 to give a 
compound 12, which would undergo rapid tautomerism to 
compound (Z )-13 . Double-bond isomerisation could then 
provide the E-isomer, which would cyclise to give the f i ­
nal product 14 (Scheme 2).
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W e felt that intermediates such as 13 could be stabilised 
by additional hydrogen bonding, and therefore investigat­
ed the reaction o f alkylidenepyrrolid ine 11 w ith known  
im ine 15, and the corresponding ethyl ester 17 w ith  the N -  
cyanoimine formed in situ from  hexanal and cyanamide. 
These gave compounds 1 6 15 and 1 8 ,16 respectively 
(Scheme 3), thus lending support to our mechanistic hy­
pothesis. W h ile  compound 16 was stable, compound 18 
reverted to the alkylidenepyrrolidine 17 over approxi­
mately three days.
/ ‘"'■NH
V ^ ^ C 0 2Me
H
Ph'
N
A
C02Me
H
15
CH2 CI2, 18 h 
25 °C, 67%
11
Ph-
16
>^ "NH
V-^s^C02Et
H
17
Scheme 3
n-CsHnCHO, H2NCN
CH2 CI2, 25 °C, 3 h
87% (crude) -^CsH,, 'n 'I
CN
18
-Et
I f  this stereogenic centre in the Kishi three-component 
coupling reaction is form ed by attack o f an electrophile at 
the alkene carbon adjacent to the ester, the closest site for 
a stereochemical directing group would be the 3-position 
o f the pyrrolidine ring. A  protected hydroxy directing 
group was chosen, w ith  the eventual goal o f removal by 
deoxygenation. Therefore, com m ercially available amino 
acid 19 was readily converted into lactam 20 (Scheme 4). 
The primary alcohol in this compound was silylated e ffi­
ciently under the conditions shown, whereas use o f 
TBSC1 in C H 2C12 w ith E t3N  and D M A P  gave mixtures o f 
the desired product and the silyl iminoether. Thionation o f 
lactam 21 was fo llow ed by Eschenmoser sulfide contrac­
tion to give the alkylidenepyrrolidine 23. This compound 
was smoothly deprotected to give compound 24. To our 
surprise, alkylidenepyrrolidine 23 is unreactive under the 
conditions o f the three-component coupling. However, 
compound 24 underwent a completely diastereoselective 
three-component coupling reaction w ith aldehyde 26 to 
give pyrro lo [l,2 -c ]pyrim id ine 25 corresponding to the 
left-hand side o f batzelladine A .17
This short and efficient sequence (6 steps, 9%  overall 
yield) compares extremely favourably with the three pre­
viously reported routes to this part o f the natural prod­
uct.4,18 Compound 25 exhibited no diagnostic N O E  
enhancements which would perm it direct assignment o f 
the stereochemistry. How ever, the required stereoisomer 
for the natural product could be formed by appropriate 
choice o f starting-material enantiomer followed by deox­
ygenation and guanidine formation from compound 2 5 .19
W hile  we had expected the bulky silyl ether in compound 
23 to block one face o f the alkylidenepyrrolidine, it actu­
ally prevents reaction completely. This is particularly per­
plexing, since Kishi has reported successful and high 
yielding three-component coupling reactions with a diox- 
ane 27 or a dithiane 28  at this position (Figure 2 ) .11 A l­
though improved diastereoselectivity was anticipated in 
the reaction o f compound 24 compared to that o f com­
pound 5, we were particularly delighted to see the forma­
tion o f only one isomer o f product 25. W hile the details 
are presently unclear, we would attribute this high level o f
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/ ^ nh2
y-co2H
HO
19
TMS2NH, cat. TMSCI
xylene, reflux, 16 h then aq HCI 
91% HO
20
TBSCI
imidazole, DMAP 
THF, 18 h, 70%
TBSO
Lawesson's reagent
THF, 25 °C, 90 min 
74% TBSO
22 21
methyl 2-bromoacetate, CH2CI2, 3 h 
then f-BuOK, Ph3P, xylene, reflux, 48 h 
78%
/  NH
C02Me
TBSO
23
S
JJ
/  N NH 
TBSO C02Me
TBAF, THF 
40 min, 85%
/^ NH
\^-k^C 02Me
HO
24
26, TMSNCS 
CH2CI2, 90 min 
29%
NH
"OTBDPSHO C02Me
25, single diastereomer
i) TBDPSCI, Et3N 
DMAP, CH2CI2
ii) K2 0s04, Nal04 
dioxane
83%
TBDPSO^M^^CHO
26
Scheme 4
stereocontrol to a direct interaction between the reacting 
electrophile and the hydroxy group.
<5vJD02Me-sx,C02Me
27 28
Figure 2
In conclusion, we have completed a short synthesis o f the 
bicyclic guanidine core present in batzelladine A , and in 
doing so gained insight into the mechanism o f the Kishi 
three-component coupling reaction. Further studies are 
under way to delineate the mechanism o f this fascinating 
reaction.
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